<?xml version="1.0" encoding="utf-8"?><feed xmlns="http://www.w3.org/2005/Atom"><title type="text">Ackura PressRoom: Latest Press Releases</title><subtitle type="text">The Latest Press Releases from all Ackura PressRooms</subtitle><id>Ackura PressRoom Releases</id><updated>2012-02-22T18:01:36Z</updated><link rel="alternate" href="http://www.ackura.com/" /><entry><id>3d2c95d3-05cf-4fce-a3dd-80d8903cf842</id><title type="text">Charity encourages public to ‘Go Purple!’ for World Kidney Day</title><updated>2012-02-22T11:45:15Z</updated><link rel="alternate" href="http://pressroom.ackura.com/kidneyresearchuk/1044-Charity-encourages-public-to--Go-Purple---for-World-Kidney-Day.aspx" /><content type="html">&lt;p&gt;A national charity is encouraging people across the UK to &amp;lsquo;Go Purple!&amp;rsquo; for a day and support a special event intended to highlight the dangers of kidney disease.&lt;/p&gt;</content></entry><entry><id>c134704a-75f8-4c8e-9ea0-03783078e094</id><title type="text">Help Finley take the final step towards his dream</title><updated>2012-02-21T11:05:01Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/1043-Help-Finley-take-the-final-step-towards-his-dream.aspx" /><content type="html">&lt;p&gt;&amp;nbsp;A Chichester family have just two months to raise the &amp;pound;10,000 they desperately need to make their sons&amp;rsquo; dream of walking unaided for the first time come true.&amp;nbsp; Lydia and Dean Fairs have been tirelessly fundraising for six year old Finley to have his life changing operation, and have now received the news that they have been waiting for. The operation will take place at Frenchay Hospital, Bristol on 24&lt;sup&gt;th&lt;/sup&gt; April, but this means the pressure is on to raise the rest of the money, fast.&lt;/p&gt;</content></entry><entry><id>ce666649-53e7-4cc8-824e-dbf53b3620ff</id><title type="text">Disabled children celebrate success of ground-breaking online campaign to help shape future</title><updated>2012-02-16T16:36:03Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/883-Disabled-children-celebrate-success-of-ground-breaking-online-campaign-to-help-shape-future.aspx" /><content type="html">&lt;p&gt;Disabled children inspired hundreds of Twitter users to tweet positive messages through the launch of a ground-breaking digital campaign yesterday called &amp;ldquo;I&amp;rsquo;m Lucky Because.&amp;rdquo;&lt;/p&gt;
&lt;p&gt;The children and their siblings launched the campaign from the world-famous home of Manchester United Football Club, Old Trafford, and enlisted the support of CBeebies star, Alex Winters, and renowned author, Mel Sherratt.&lt;/p&gt;
&lt;p&gt;Hundreds of Twitter users are now following the children as they share tweets about their thoughts on living with disability and their hopes and dreams for the future.&lt;/p&gt;</content></entry><entry><id>e34a524b-1752-4b1d-b2b3-682525b7d891</id><title type="text">TREE AID Sahel Appeal</title><updated>2012-02-15T15:41:45Z</updated><link rel="alternate" href="http://pressroom.ackura.com/treeaid/882-TREE-AID-Appeal.aspx" /><content type="html">&lt;p&gt;International development charity, TREE AID, has today announced an appeal for funds to help end the ongoing cycle of drought and famine for families living in the Sahel region of sub-Saharan Africa.&lt;/p&gt;</content></entry><entry><id>003b1611-3ffe-41e4-9f9b-79a40f4a9181</id><title type="text">Kidney charity and dialysis provider join forces to save lives</title><updated>2012-02-15T13:37:41Z</updated><link rel="alternate" href="http://pressroom.ackura.com/kidneyresearchuk/881-Kidney-charity-and-NHS-dialysis-provider-join-forces-to-save-lives.aspx" /><content type="html">&lt;p&gt;A national kidney charity has joined forces with a leading global dialysis company, combining cutting-edge research with life-saving treatment to help improve the lives of the thousands of people affected by kidney disease.&lt;/p&gt;</content></entry><entry><id>4fa82ff1-fad4-4963-b712-b92ea09a5440</id><title type="text">Saab Pledge To Keep Saab Owners Motoring</title><updated>2012-02-15T09:14:50Z</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/561-Saab-Pledge-To-Keep-Saab-Owners-Motoring.aspx" /><content type="html">&lt;p&gt;Saab Automobile Parts UK Ltd (trading as Saab Parts UK), a wholly-owned subsidiary of Saab Automobile Parts A.B., has commenced trading in the UK. This newly formed company has been set up to provide on-going supply of genuine Saab Parts and service packages to Saab drivers.&lt;/p&gt;</content></entry><entry><id>32accc5a-58ce-4982-9766-849324264a7d</id><title type="text">Disabled tweeters ask ‘why are you lucky?’</title><updated>2012-02-14T17:58:47Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/880-Disabled-tweeters-ask--why-are-you-lucky--.aspx" /><content type="html">&lt;p&gt;CBeebies presenter, Alex Winters, and successful author Mel Sherratt, will join the launch of an innovative digital campaign by disabled children.&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&amp;ldquo;I&amp;rsquo;m Lucky Because&amp;hellip;&amp;rdquo; will be viewed by thousands of Twitter users on Wednesday, 15&lt;sup&gt;th&lt;/sup&gt; February, as children with various disabilities, and their siblings, make inspirational tweets about how lucky they are.&lt;/p&gt;</content></entry><entry><id>2d51d5c4-8d8e-4475-935e-948aa1aca4db</id><title type="text">Big donation for Daniella</title><updated>2012-02-14T17:49:04Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/877-Big-donation-for-Daniella.aspx" /><content type="html">&lt;p&gt;A disabled youngster from Hampshire is enjoying a wheely great time thanks to a national children&amp;rsquo;s charity.&lt;/p&gt;</content></entry><entry><id>0120843e-a976-47d8-b6b1-f086aab390d0</id><title type="text">Valentine's Messages of Love</title><updated>2012-02-10T14:13:37Z</updated><link rel="alternate" href="http://pressroom.ackura.com/treeaid/879-Valentine-s-Messages-of-Love.aspx" /><content type="html">&lt;p&gt;This Valentines Day support TREE AID&amp;rsquo;s work in Africa and purchase  &amp;lsquo;Chalk and Trees&amp;rsquo; as a special gift for your loved one. This collection  of tree art and tree inspired poems, such as Red Rose, is sure to win  hearts&amp;hellip;&lt;/p&gt;</content></entry><entry><id>5079592f-198e-425d-92da-2a5b5db2043d</id><title type="text">River Trees project launched</title><updated>2012-02-10T14:00:14Z</updated><link rel="alternate" href="http://pressroom.ackura.com/treeaid/878-River-Trees-project-launched.aspx" /><content type="html">&lt;p&gt;TREE AID&amp;rsquo;s River Trees project to improve watershed management in the  Bongo District of Nothern Ghana through forest restoration along river  banks has been officially launched in the Capital.&lt;/p&gt;</content></entry><entry><id>f89ddcf3-760b-436a-9b00-385ff7d5a7b7</id><title type="text">Reece comes a step closer to his dream</title><updated>2012-02-07T11:25:55Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/876-Reece-comes-a-step-closer-to-his-dream.aspx" /><content type="html">&lt;p&gt;Little Reece Walker, 3, from Stanford-le-Hope is one step closer to having his dream of walking unaided for the first time come true.&amp;nbsp; His parents Scott and Laura recently received the phone call they had been waiting for telling them that Reece can undergo the life changing surgery that they have worked relentlessly to raise funds for in just a matter of weeks.&lt;/p&gt;</content></entry><entry><id>0b6e8e04-351b-4c67-8058-d2caaebc6bbc</id><title type="text">Action packed prizes up for grabs for those who go the extra mile</title><updated>2012-02-07T11:13:58Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/875-Action-packed-prizes-up-for-grabs-for-those-who-go-the-extra-mile.aspx" /><content type="html">&lt;p&gt;Stoke-based charity, Caudwell Children, have put adrenaline filled prizes up for grabs ahead of this year&amp;rsquo;s Potters Arf Marathon to help encourage runners to raise funds.&lt;/p&gt;</content></entry><entry><id>3455f98d-bd58-4c3f-a6c8-f4f9129cbf80</id><title type="text">Could you be an extreme superhero for the day?</title><updated>2012-02-07T10:58:57Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/874-Could-you-be-an-extreme-superhero-for-the-day-.aspx" /><content type="html">&lt;p&gt;One of the UK&amp;rsquo;s most thrilling fundraising events is set to land at an Oxfordshire airfield and local residents are being urged to get involved.&lt;/p&gt;</content></entry><entry><id>e8e864a6-50dc-4c25-a4db-e2ad1bedb3c2</id><title type="text">Help Susanna’s wish come true</title><updated>2012-02-07T10:43:31Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/873-Help-Susanna-s-wish-come-true.aspx" /><content type="html">&lt;p&gt;A family are calling on the Polish community to show a little love this February and help them raise the &amp;pound;60,000 needed to enable their four year old daughter Susanna, 4, achieve her dream of walking for the first time.&lt;/p&gt;</content></entry><entry><id>d7a2ac9d-79f3-45ed-95aa-9e7f4745fbd9</id><title type="text">Help Reece to take his first steps</title><updated>2012-02-07T10:28:50Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/872-Help-Reece-to-take-his-first-steps.aspx" /><content type="html">&lt;p&gt;The past three years have been tough for Laura and Scott Walker from Basildon.&amp;nbsp; Their joy at giving birth to premature twin boys Marcus and Reece soon turned to sadness when after a desperate fight for life Marcus died.&lt;/p&gt;</content></entry><entry><id>15485de9-2c56-4e47-b6b7-6c020bc08df0</id><title type="text">Slum dwellers in Zimbabwe claim land rights </title><updated>2012-02-03T11:48:10Z</updated><link rel="alternate" href="http://pressroom.ackura.com/homelessinternational/871-Slum-dwellers-in-Zimbabwe-claim-land-rights-.aspx" /><content type="html">&lt;p&gt;More than 35,000 people living in a slum in Zimbabwe are about to obtain secure land rights to their settlement, according to UK charity Homeless International. As a result, the families will be able to undertake large-scale improvements to housing and local services. Above all, they will finally be recognised as legitimate citizens in their communities.&lt;/p&gt;</content></entry><entry><id>f177c675-dbfc-4a0f-bebb-c60568b477ba</id><title type="text">IAPB Raises Blindness Prevention Profile at WOC 2012</title><updated>2012-01-31T15:43:28Z</updated><link rel="alternate" href="http://pressroom.ackura.com/vision2020/868-IAPB-Raises-Blindness-Prevention-Profile-at-WOC-2012.aspx" /><content type="html">&lt;p&gt;As well as promoting VISION 2020: The Right to Sight at the World Ophthalmology Congress in Abu Dhabi, IAPB will be raising awareness of its forthcoming 9th General Assembly (9GA), and new services to international eye health, including the new Standard List online procurement tool.&lt;/p&gt;</content></entry><entry><id>9b2f8cdf-fb5d-48e7-94dd-c831056c492a</id><title type="text">Trees play a "critical role" in preventing famine in West Africa </title><updated>2012-01-31T15:19:16Z</updated><link rel="alternate" href="http://pressroom.ackura.com/treeaid/869-Trees-play-a--critical-role--in-preventing-famine-in-West-Africa-.aspx" /><content type="html">&lt;p&gt;As leading aid agencies demand that governments, donors, the United Nations and NGOs &amp;lsquo;don&amp;rsquo;t delay&amp;rsquo; if severe food shortages are to be avoided in West Africa&amp;nbsp;this spring, TREE AID warns of continued cycles of deforestation, drought and famine in the region if the role of trees continues to be ignored.&lt;/p&gt;</content></entry><entry><id>b5763c53-d8b6-4853-bf0a-ebf9c1e3d10b</id><title type="text">Salford housing trust shows fundraising can profit businesses, as well as charities</title><updated>2012-01-31T14:09:09Z</updated><link rel="alternate" href="http://pressroom.ackura.com/kidneyresearchuk/870-Salford-housing-trust-shows-fundraising-can-profit-businesses--as-well-as-charities.aspx" /><content type="html">&lt;p&gt;A West Salford housing trust has combined corporate social responsibility with team building to raise thousands of pounds for Kidney Research UK, in a partnership which demonstrates that fundraising can be as beneficial for businesses as it is for charities.&lt;/p&gt;</content></entry><entry><id>6a652d32-0770-4b97-8fbf-fb2876cf538c</id><title type="text">Introducing The New Citroen C1: Sharper &amp; ‘Greener’ Than Ever</title><updated>2012-01-31T12:59:25Z</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/559-Introducing-The-New-Citroen-C1--Sharper----Greener--Than-Ever.aspx" /><content type="html">&lt;p&gt;Citroen&amp;rsquo;s popular C1 has a sparkling new look and even greater buyer appeal for 2012. After making its world debut at the Brussels Motor Show on 10 January, the New C1 will be available in the UK from April 2012.&amp;nbsp; The entry-level city car has already attracted over 620,000 customers worldwide, with more than 80,000 sold in the UK since its launch in 2005. Now, with new styling, enhanced levels of equipment and a more frugal engine, the New C1 sets an even higher benchmark in the segment.&lt;/p&gt;</content></entry><entry><id>78742849-52ce-4528-93fa-4bcb690e483b</id><title type="text">Gorvins sponsor Stockport Business Awards </title><updated>2012-01-30T17:50:34Z</updated><link rel="alternate" href="http://pressroom.ackura.com/gorvins/531-Gorvins-sponsor-Stockport-Business-Awards-.aspx" /><content type="html">&lt;p&gt;Stockport Business Awards organisers have promised to bring a 'world class' event to the town.&lt;br /&gt;&lt;br /&gt;The 2012 awards - which will culminate in a black tie awards dinner in October - were officially launched last Thursday (26th January 2012) at adidas HQ in Stockport.&lt;/p&gt;</content></entry><entry><id>9c0958c5-1f25-48f8-8346-93e4d878f119</id><title type="text">Help needed to get Kent girl wheely going again</title><updated>2012-01-30T09:44:32Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/866-Help-needed-to-get-Kent-girl-wheely-going-again.aspx" /><content type="html">&lt;p&gt;A national children&amp;rsquo;s charity is appealing for support to help get a Kent youngster back on track with a piece of vital equipment.&lt;/p&gt;</content></entry><entry><id>0fde9d8d-9836-4be4-97fc-90462c992319</id><title type="text">New life-line for parents in Glasgow </title><updated>2012-01-30T09:44:20Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/865-New-life-line-for-parents-in-Glasgow-.aspx" /><content type="html">&lt;p&gt;A new life-line is set to become available for parents of children diagnosed with life-threatening conditions and disabilities in Glasgow.&lt;/p&gt;
&lt;p&gt;National charity, Caudwell Children, is behind the scheme which will train volunteers to provide vital information and support in hospital.&lt;/p&gt;</content></entry><entry><id>59bccded-101d-469e-9b33-64ad6325a9a1</id><title type="text">Charity calls for City runners</title><updated>2012-01-30T09:44:10Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/867-Charity-calls-for-City-runners.aspx" /><content type="html">&lt;p&gt;A national charity is scouring the UK to find the country&amp;rsquo;s leading fundraisers to take on a gruelling challenge, and think top executives in the City may be the answer.&lt;/p&gt;</content></entry><entry><id>d48ff949-29d2-4bdb-8ab4-2c1f0bf6bdc0</id><title type="text">Success of local appeal helps Ashleigh get new wheels</title><updated>2012-01-30T09:44:01Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/864-Success-of-local-appeal-helps-Ashleigh-get-new-wheels.aspx" /><content type="html">&lt;p&gt;A disabled youngster from Evesham is enjoying a racing start to 2012, thanks to the generosity of local people.&lt;/p&gt;
&lt;p&gt;Eight -year-old Ashleigh Simpson, who has Congenital Muscular Dystrophy, has received a Trici Trainer Tricycle worth &amp;pound;2,178 from Caudwell Children following an appeal in the local community.&lt;/p&gt;</content></entry><entry><id>70c7a2fa-9b29-4d8a-946e-eeb57efbf0ea</id><title type="text">Water and sanitation project leads to increased opportunities for women in Africa</title><updated>2012-01-26T11:00:26Z</updated><link rel="alternate" href="http://pressroom.ackura.com/homelessinternational/863-Water-and-sanitation-project-leads-to-increased-opportunities-for-women-in-Africa.aspx" /><content type="html">&lt;p&gt;Slum charity Homeless International's year-long project to improve water and sanitation for poor communities in Malawi, Tanzania and Zimbabwe has helped over 10,000 people to access better water and toilet facilities. Many more are set to benefit over the coming year, with women in particular seeing a real boost to their livelihoods and way of life.&lt;/p&gt;</content></entry><entry><id>e142e0d2-2cd1-404a-afe7-d85fb223bd3e</id><title type="text">‘Words can’t describe how grateful I am to the little boy who saved my life.’</title><updated>2012-01-24T09:56:14Z</updated><link rel="alternate" href="http://pressroom.ackura.com/kidneyresearchuk/862--Words-can-t-describe-how-grateful-I-am-to-the-little-boy-who-saved-my-life--.aspx" /><content type="html">&lt;p&gt;A chorister from South Wales is hoping to strike a chord with transplant patients across the UK by dedicating a piece of music to the family of the young donor who saved his life.&lt;/p&gt;</content></entry><entry><id>f824a274-3dba-48f8-ba60-518471c8566b</id><title type="text">Pentagon Open New Nissan Dealership In Barnsley</title><updated>2012-01-20T11:31:42Z</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/560-Pentagon-Open-New-Nissan-Dealership-In-Barnsley.aspx" /><content type="html">&lt;p&gt;Pentagon Group opened their new Nissan dealership in Barnsley this week, giving local people a chance to experience Nissan&amp;rsquo;s latest cars and commercial vehicles.&lt;/p&gt;
&lt;p&gt;The new dealership is located at their existing site on Claycliffe Road, Barugh Green to the north of the town.&lt;/p&gt;</content></entry><entry><id>b7267ea3-5c2b-4105-8a09-921eab191101</id><title type="text">From the Floriade 2012 World Horticultural Expo to Yorkshire in the 1940s and the Perugia Eurochocolate Festival</title><updated>2012-01-13T16:45:02Z</updated><link rel="alternate" href="http://pressroom.ackura.com/greatrail/861-From-the-Floriade-2012-World-Horticultural-Expo-to-Yorkshire-in-the-1940s-and-the-Perugia-Eurochocolate-Festival.aspx" /><content type="html">&lt;p&gt;If you are a garden enthusiast, fascinated by the 1940&amp;rsquo;s or love experiencing popular UK events such as the Edinburgh Tattoo and York Mystery Plays or international events such as the 100 Year Anniversary of the Jungfrau Express, the Floriade World Horticultural Expo and the Gardens of Holland, the carnivals in Venice and Viareggio; confectionary celebrations; as well as the Mardis Gras of America&amp;rsquo;s Deep South then look no further. Escorted rail holiday specialist, Great Rail Journeys, has launched its new &amp;lsquo;Special Interest &amp;amp; Events 2012&amp;rsquo; brochure featuring special event holidays including carnivals, flower shows, steam events and musical occasions.&lt;/p&gt;</content></entry><entry><id>eb2188f4-b4a6-4d83-82e2-8ebf46b279df</id><title type="text">Great Rail Journeys' Winter Season Collection</title><updated>2012-01-13T12:35:46Z</updated><link rel="alternate" href="http://pressroom.ackura.com/greatrail/859-Great-Rail-Journeys--Winter-Season-Collection.aspx" /><content type="html">&lt;p&gt;Whether its the snow-capped mountains of Europe or a sun-drenched adventure further afield, if you are thinking of holidaying by rail this winter, then look no further than escorted rail specialist, Great Rail Journeys, which has launched its winter season collection featuring tours ranging from the palaces of India to the Christmas markets of the UK and Europe.&lt;/p&gt;</content></entry><entry><id>008a06ea-99f6-4cab-8cca-47abad152e98</id><title type="text">CHARITY CALLS FOR UNWANTED CHRISTMAS GIFTS  TO SUPPORT ITS HEALTHCARE SERVICES </title><updated>2012-01-13T12:28:51Z</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/858-CHARITY-CALLS-FOR-UNWANTED-CHRISTMAS-GIFTS--TO-SUPPORT-ITS-HEALTHCARE-SERVICES-.aspx" /><content type="html">&lt;p&gt;National health and social care charity Sue Ryder is encouraging people to donate any unwanted clothes, books, jewellery, bric-a-brac or furniture including Christmas gifts to its 370 charity shops across the country.&amp;nbsp;&lt;/p&gt;</content></entry><entry><id>2b9dfc0f-0f34-4022-b6af-5169293732c2</id><title type="text">Homeless International extends Namibia Community Challenge Registration</title><updated>2012-01-12T12:15:49Z</updated><link rel="alternate" href="http://pressroom.ackura.com/homelessinternational/853-Homeless-International-extends-Namibia-Community-Challenge-Registration.aspx" /><content type="html">&lt;p&gt;The slum charity Homeless International has just extended the registration deadline for its Namibia Community Challenge, giving applicants until the end of January to sign up. Register today to join Homeless International in July for this epic journey through one of Africa's most beautiful countries.&lt;/p&gt;</content></entry><entry><id>c91e1db8-d725-4f00-8cc8-8dea35a47e41</id><title type="text">Grow a tree of hope this Mother’s Day</title><updated>2012-01-11T18:30:46Z</updated><link rel="alternate" href="http://pressroom.ackura.com/treeaid/856-Grow-a-tree-of-hope-this-Mother-s-Day.aspx" /><content type="html">&lt;p&gt;This Mother&amp;rsquo;s Day help TREE AID celebrate 25 years of supporting mums in Africa by planting a tree for your own mum. &amp;nbsp;For just &amp;pound;10 you could grow a mango, shea or baobab tree in her name and help African women and their families grow themselves a better future.&lt;/p&gt;</content></entry><entry><id>dabc8154-20b6-4330-95b2-d67c3d0d3d96</id><title type="text">Pentagon Sheffield Take Two Orders In One Day For The Revolutionary New Vauxhall Ampera</title><updated>2012-01-11T17:47:24Z</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/558-Pentagon-Sheffield-Take-Two-Orders-In-One-Day-For-The-Revolutionary-New-Vauxhall-Ampera.aspx" /><content type="html">&lt;p&gt;Vauxhall has today opened its order books for the revolutionary Ampera E-REV, and Pentagon Vauxhall in Sheffield have already taken their first orders.&lt;/p&gt;
&lt;p&gt;As one of only 23 Vauxhall dealers chosen to supply the new Ampera, Pentagon welcomed Ralph Goodson from Matlock to their showroom on Savile Street in Sheffield and were delighted that he was their first customer to place an order.&lt;/p&gt;</content></entry><entry><id>eee6f2fa-10ff-4023-9952-4f2e347727b4</id><title type="text">London Luton Airport announces Sue Ryder as New Charity Partner for 2012 and 2013</title><updated>2012-01-11T17:21:07Z</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/857-London-Luton-Airport-announces-Sue-Ryder-as-New-Charity-Partner-for-2012-and-2013.aspx" /><content type="html">&lt;p&gt;The public have voted Sue Ryder as the new London Luton Airport Charity Partner for 2012 and 2013. The Airport has pledged an initial donation of &amp;pound;5,000 to the charity, and employees will work closely with the team at Sue Ryder to involve staff and passengers in fundraising activities throughout the year.&amp;nbsp;&amp;nbsp;&lt;/p&gt;</content></entry><entry><id>a11d4b65-bcfc-46f7-a221-b32c8dcea454</id><title type="text">Star-studded cookbook launched to help kidney charity</title><updated>2012-01-11T12:07:59Z</updated><link rel="alternate" href="http://pressroom.ackura.com/kidneyresearchuk/855-Star-studded-cookbook-launched-to-help-kidney-charity.aspx" /><content type="html">&lt;div id="_mcePaste" class="mcePaste" style="position: absolute; width: 1px; height: 1px; overflow: hidden; top: 0px; left: -10000px;"&gt;?&lt;/div&gt;
&lt;p&gt;&lt;span style="line-height: 150%; font-family: &amp;quot;Lucida Sans&amp;quot;,&amp;quot;sans-serif&amp;quot;; color: windowtext; font-size: 10pt; mso-bidi-font-family: 'Lucida Sans Unicode';" lang="EN-GB"&gt;
&lt;p class="MsoNormal" style="line-height: 150%; margin: 0cm 0cm 0pt;"&gt;&lt;span style="line-height: 150%; font-family: &amp;quot;Verdana&amp;quot;,&amp;quot;sans-serif&amp;quot;; color: windowtext; font-size: 8pt; mso-bidi-font-family: 'Lucida Sans Unicode';" lang="EN-GB"&gt;Kidney Research UK has published a special cookbook, containing recipes from some of the nation&amp;rsquo;s favourite celebrities, to help fund research into kidney disease.&lt;/span&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;/span&gt;&lt;/p&gt;</content></entry><entry><id>e3ba1442-744a-4837-8f00-1de0edf61a82</id><title type="text">Stairlift finds new home with Lucy</title><updated>2012-01-11T11:55:39Z</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/854-Stairlift-finds-new-home-with-Lucy.aspx" /><content type="html">&lt;p&gt;&lt;span style="font-size: small;"&gt;Lucy, of&amp;nbsp;Regent Crescent&amp;nbsp;in Skipton, was diagnosed for the second time with cervical cancer in July this year and faces weeks of chemotherapy and the knowledge that her condition is terminal.&lt;/span&gt;&lt;/p&gt;</content></entry><entry><id>da54b157-c1ff-4fa1-a971-20e691e8d3df</id><title type="text">Vauxhall Enters Fresh Territory With All-New Small SUV</title><updated>2012-01-10T17:28:04Z</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/557-Vauxhall-Enters-Fresh-Territory-With-All-New-Small-SUV.aspx" /><content type="html">&lt;p&gt;These are the first official pictures of Vauxhall&amp;rsquo;s new small SUV, which will take the company into new market territory when it&amp;rsquo;s unveiled at this year&amp;rsquo;s Geneva Motor Show in March.&lt;br /&gt;&lt;br /&gt;Called the Mokka, the new model will enter the growing sub-compact SUV B-segment. The Mokka is 4.28metres long, yet despite its neat dimensions can accommodate five adults in comfort.&lt;/p&gt;</content></entry><entry><id>d50042e8-eecb-43e2-af6d-ae21f007a3fb</id><title type="text">Pentagon Peugeot Recognised As One Of The Best By Achieving Gold Lion Status</title><updated>2012-01-10T16:37:21Z</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/556-Pentagon-Peugeot-Recognised-As-One-Of-The-Best-By-Achieving-Gold-Lion-Status.aspx" /><content type="html">&lt;p&gt;Peugeot has presented Pentagon Peugeot in Burton-on-Trent with its prestigious Guild of Gold Lion Award, in recognition of its performance in 2011.&lt;/p&gt;</content></entry><entry><id>08a90ff3-e8d8-48e7-85d8-05716d2f5702</id><title type="text">Gorvins Solicitors launches new employment product to keep businesses on track</title><updated>2012-01-09T15:55:23Z</updated><link rel="alternate" href="http://pressroom.ackura.com/gorvins/530-Gorvins-Solicitors-launches-new-employment-product-to-keep-businesses-on-track.aspx" /><content type="html">&lt;p&gt;Leading Stockport law firm, Gorvins, has launched a new product to help guide businesses through the maze of employment law issues.&lt;/p&gt;
&lt;p&gt;The product called &amp;lsquo;Pathfinder&amp;rsquo;, has been developed by Gorvins&amp;rsquo; employment team and provides employers with a cost-effective, bespoke package of employment support and services.&lt;/p&gt;</content></entry><entry><id>cfc4556e-e045-4d53-b81b-246c4c9c191a</id><title type="text">The Water Run, 1000 Miles, 20 Litres Of Water, 60 Days!</title><updated>2012-01-02T11:04:25Z</updated><link rel="alternate" href="http://pressroom.ackura.com/thewaterrun/852-The-Water-Run--1000-Miles--20-Litres-Of-Water--60-Days-.aspx" /><content type="html">&lt;p&gt;&lt;em&gt;&lt;strong id="internal-source-marker_0.482167343609035"&gt;In the month of July 2012, Ollie Mason a young fundraiser aged 22, will set out on a journey from John O&amp;rsquo;Groats to Lands&amp;rsquo; End, carrying a 20 Litre jerry can full of water with no aid or apparatus! &amp;nbsp;With a big vision in mind, Ollie&amp;rsquo;s aim is to raise awareness and money for thousands of communities in developing countries, who have to carry water this way every day of their lives.&lt;/strong&gt;&lt;/em&gt;&lt;/p&gt;</content></entry><entry><id>65417215-e664-42c5-9070-a3ff6290d5f1</id><title type="text">The Pentagon Sale Starts Today With Huge Reductions</title><updated>2011-12-27T14:50:05Z</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/555-The-Pentagon-Sale-Starts-Today-With-Huge-Reductions.aspx" /><content type="html">&lt;p&gt;The Pentagon Sale starts this week with even bigger discounts on over 1300 new, ex-management and used clearance cars than ever before.&lt;/p&gt;</content></entry><entry><id>b332b06f-1fdb-4311-8ff5-da19d399bfb2</id><title type="text"> UB40 STAR TO OPEN NEW SUE RYDER CHARITY SHOP IN KINGS HEATH </title><updated>2011-12-21T16:29:29Z</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/851--UB40-STAR-TO-OPEN-NEW-SUE-RYDER-CHARITY-SHOP-IN-KINGS-HEATH-.aspx" /><content type="html">&lt;p&gt;Bargain hunters will be in their element next month when Sue Ryder opens a new charity shop in the retail heart of Kings Heath, Birmingham.&amp;nbsp;&amp;nbsp;&lt;/p&gt;
&lt;p&gt;Officially opening the brand new store on Wednesday January 4 will be UB40 star Brian Travers. Doors open at 10.30am and, as well as some serious shopping opportunities, the store opening event will give early bird shoppers the chance to win a fabulous prize in a grand prize draw&lt;/p&gt;</content></entry><entry><id>a10c116e-1fc2-42c8-b58e-87ab86763e14</id><title type="text">Soap star uses panto performance to help charity</title><updated>2011-12-21T15:36:12Z</updated><link rel="alternate" href="http://pressroom.ackura.com/kidneyresearchuk/850-Soap-star-uses-panto-performance-to-help-charity.aspx" /><content type="html">&lt;p&gt;&lt;strong&gt;Former &lt;em&gt;EastEnders&lt;/em&gt; favourite Stefan Booth is using his appearance in panto at Redditch Palace Theatre to raise vital funds for a worthy cause, in the run up to Christmas.&lt;/strong&gt;&lt;/p&gt;</content></entry><entry><id>189fc799-bf78-4f19-9822-6c9484e02841</id><title type="text">Public asked to help charity stocks snowball this Christmas</title><updated>2011-12-20T16:35:40Z</updated><link rel="alternate" href="http://pressroom.ackura.com/kidneyresearchuk/849-Public-asked-to-help-charity-stocks-snowball-this-Christmas.aspx" /><content type="html">&lt;p&gt;&lt;strong&gt;A leading UK charity is asking people across the UK to spare a thought for others in the run up to Christmas and donate any unwanted items they may have around the house to a worthy cause.&lt;/strong&gt;&lt;/p&gt;</content></entry><entry><id>14b1cbfe-076c-463e-81c9-944f9242e292</id><title type="text">Pentagon Wins Autotrader Dealer Website Of The Year</title><updated>2011-12-16T11:23:05Z</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/554-Pentagon-Wins-Autotrader-Dealer-Website-Of-The-Year.aspx" /><content type="html">&lt;p&gt;A strong homepage performance was the key to Pentagon winning 'Dealer Group Website of the Year' at the 2011 Autotrader Click Awards. Pentagon Marketing Director James Reeve received his award from Will Greenwood and Sharon Randall (Auto Trader UK Sales Director).&lt;/p&gt;</content></entry><entry><id>eb791e17-8484-49d6-8112-e6e12abf3027</id><title type="text">Gorvins bucks the trend with upsurge in residential conveyancing transactions</title><updated>2011-12-14T16:40:22Z</updated><link rel="alternate" href="http://pressroom.ackura.com/gorvins/529-Gorvins-bucks-the-trend-with-upsurge-in-residential-conveyancing-transactions.aspx" /><content type="html">&lt;p&gt;The residential conveyancing team at Stockport&amp;nbsp;solicitors, Gorvins, has seen a 35% increase in turnover and completions over the past six months, compared to the same period last year.&lt;/p&gt;
&lt;p&gt;The current figures equate to the number of transactions being completed by the team pre-recession, and the rate of growth shows no sign of slowing down.&lt;/p&gt;</content></entry><entry><id>7b280c91-ae31-4b59-855a-9d5282328977</id><title type="text">Peruvian Cabinet Reshuffle Sparks Authoritarian Fears</title><updated>2011-12-13T10:56:24Z</updated><link rel="alternate" href="http://pressroom.ackura.com/perusupportgroup/848-Peruvian-Cabinet-Reshuffle-Sparks-Authoritarian-Fears.aspx" /><content type="html">&lt;p&gt;President Ollanta Humala announced a major cabinet reshuffle on December 11, following the departure of Salomon Lerner Ghitis as president of the Council of Ministers. Lerner has been replaced by Oscar Vald&amp;eacute;s Dancuart, a retired colonel, previously interior minister.&amp;nbsp;The reshuffle, which saw several left-of-centre figures dropped from the cabinet, has been widely seen as ushering in a period of more authoritarian government.&lt;/p&gt;</content></entry><entry><id>f22dab20-2c87-4fb9-9bf3-596077e98261</id><title type="text">Kidney charity supports NICE guidelines to boost number of organ donors</title><updated>2011-12-12T15:59:14Z</updated><link rel="alternate" href="http://pressroom.ackura.com/kidneyresearchuk/846-Kidney-charity-supports-NICE-guidelines-to-boost-organ-donors.aspx" /><content type="html">&lt;p&gt;National kidney disease charity, Kidney Research UK, welcomes new guidelines released today &lt;a href="http://bit.ly/vkPlUO"&gt;http://bit.ly/vkPlUO&lt;/a&gt; from the National Institute for Health and Clinical Excellence (NICE), to boost the organs available for transplant.&lt;/p&gt;</content></entry><entry><id>8c3e3cb6-5ed8-47fc-abcb-2b8a49db32bf</id><title type="text">Gorvins wins 'Working with Young People' award</title><updated>2011-12-09T17:06:12Z</updated><link rel="alternate" href="http://pressroom.ackura.com/gorvins/528-Gorvins-wins--Working-with-Young-People--award.aspx" /><content type="html">&lt;p&gt;Gorvins has been awarded a Working with Young People Award at the Stockport Young Stars Awards.&lt;/p&gt;</content></entry><entry><id>f6aee6e4-67c4-4141-ad7d-32861059ef79</id><title type="text">Kidney charity welcomes PM’s plan for drug innovation </title><updated>2011-12-09T12:19:52Z</updated><link rel="alternate" href="http://pressroom.ackura.com/kidneyresearchuk/845-Kidney-charity-welcomes-PM-s-plan-for-drug-innovation-.aspx" /><content type="html">&lt;p&gt;National charity Kidney Research UK has welcomed news of a Government scheme that would allow seriously ill patients to receive promising new drugs before they have cleared full clinical trials.&lt;/p&gt;</content></entry><entry><id>559285f3-d59a-439f-9e2a-c72f21d508c1</id><title type="text">New Government cardiovascular strategy must address kidney disease</title><updated>2011-12-09T12:13:57Z</updated><link rel="alternate" href="http://pressroom.ackura.com/kidneyresearchuk/844-New-Government-cardiovascular-strategy-must-address-kidney-disease.aspx" /><content type="html">&lt;p&gt;&lt;span class="messageBody"&gt;Government plans for a new strategy to tackle cardiovascular disease sound promising but must address issues around kidney disease if they are to be successful.&lt;/span&gt;&lt;/p&gt;</content></entry><entry><id>f364d66c-5348-4ba7-970a-fcfd9242dd92</id><title type="text">Colchester woman returns from 500km cycle in India to help  LEPRA Health in Action fight diseases of poverty </title><updated>2011-12-08T16:26:16Z</updated><link rel="alternate" href="http://pressroom.ackura.com/leprahealthinaction/843-Colchester-woman-returns-from-500km-cycle-in-India-to-help--LEPRA-Health-in-Action-fight-diseases-of-poverty-.aspx" /><content type="html">&lt;p&gt;Celia Richardson (56) has returned from a 500km bike ride in India, her second this year, fundraising and&amp;nbsp; supporting the work that local charity&amp;nbsp;&lt;a href="http://www.leprahealthinaction.org/category/our-work/diseases/lymphatic-filariasis/"&gt;LEPRA Health in Action&lt;/a&gt;&amp;nbsp;carries out fighting&amp;nbsp;&lt;a href="http://www.leprahealthinaction.org/category/our-work/diseases/lymphatic-filariasis/"&gt;diseases of poverty&lt;/a&gt;&amp;nbsp;in remote and poor communities.&lt;/p&gt;</content></entry><entry><id>eb7e788c-4cb9-4239-8764-f47d3691300c</id><title type="text">Abolition of discriminatory act in Bangladesh: hopes for improved access to vital services for leprosy affected people.</title><updated>2011-12-08T15:09:19Z</updated><link rel="alternate" href="http://pressroom.ackura.com/leprahealthinaction/833-Abolition-of-discriminatory-act-in-Bangladesh--hopes-for-improved-access-to-vital-services-for-leprosy-affected-people-.aspx" /><content type="html">&lt;p&gt;LEPRA Health in Action welcomes the abolition of a discriminatory act in Bangladesh contravening the human rights of leprosy affected people.&amp;nbsp;It is clear, however, that much remains to be done.&lt;/p&gt;
&lt;p&gt;LEPRA&amp;rsquo;s self-care clinics provide essential care for people disabled by leprosy. Sadly this is not the story elsewhere where people with leprosy are banned from entering hospitals, something that the abolition of this act will help address.&lt;/p&gt;
&lt;p&gt;Reconstructive surgery can also have a dramatic impact on someone&amp;rsquo;s life, but there are just two reconstructive surgeons in the whole of Bangladesh (one of whom works for LEPRA), so this severely limits the number of people who can benefit from surgery.&lt;/p&gt;</content></entry><entry><id>e636e84c-5625-4043-8ffb-ac68cbe4bab1</id><title type="text">Christmas with a difference by train</title><updated>2011-12-08T14:42:55Z</updated><link rel="alternate" href="http://pressroom.ackura.com/greatrail/842-Christmas-with-a-difference-by-train.aspx" /><content type="html">&lt;p&gt;If you are looking for a Christmas break with a difference this year, then how about a tour by rail with Great Rail Journeys and sister company Treyn?&amp;nbsp; Whether its a UK Christmas in Scotland or Yorkshire, a European one with guaranteed snow in somewhere like the Alps, then there is still availability for a last minute Christmas.&lt;/p&gt;</content></entry><entry><id>21c92785-37bb-4f28-b8c5-2a363b9a9f7e</id><title type="text">Pentagon Gets Ready For New Combo</title><updated>2011-12-05T14:50:10Z</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/553-Pentagon-Gets-Ready-For-New-Combo.aspx" /><content type="html">&lt;p&gt;Pentagon Vauxhall Business Centre Teams are getting ready for the arrival of Vauxhall&amp;rsquo;s all-new Combo panel van which is set to become a firm favourite of owner-drivers and large fleets alike with its combination of state-of-the-art technology and class-leading features.&lt;/p&gt;</content></entry><entry><id>408f8df3-0d55-4b5c-9a7c-99189ec2ec62</id><title type="text">Peru's New Political Direction</title><updated>2011-12-01T15:48:50Z</updated><link rel="alternate" href="http://pressroom.ackura.com/perusupportgroup/841-Peru-s-New-Political-Direction.aspx" /><content type="html">&lt;p&gt;Javier Diez Canseco, a congressman with Peru's ruling Gana Per&amp;uacute; party, describes changes in Peruvian politics since July and outlines plans for tackling corruption, social conflict and exclusion in the country.&lt;/p&gt;</content></entry><entry><id>feb19f61-75c6-497f-80ad-f7781fa2343c</id><title type="text">Latest draft guidance from NICE on oral multiple sclerosis drug Fingolimod </title><updated>2011-12-01T11:17:28Z</updated><link rel="alternate" href="http://pressroom.ackura.com/mstrust/840-Latest-draft-guidance-from-NICE-on-oral-multiple-sclerosis-drug-Fingolimod-.aspx" /><content type="html">&lt;p&gt;The MS Trust continues to be disappointed that the latest draft guidance that NICE issued today proposes that fingolimod should not be made automatically available to people with multiple sclerosis on the NHS. Fingolimod is licensed under the Novartis owned trade name of Gilenya.&lt;/p&gt;</content></entry><entry><id>a2aee1d6-f073-4705-b0d1-6c341cdeb269</id><title type="text">Peruvian Economic Policy under Ollanta Humala</title><updated>2011-11-30T16:08:22Z</updated><link rel="alternate" href="http://pressroom.ackura.com/perusupportgroup/838-Peruvian-Economic-Policy-under-Ollanta-Humala.aspx" /><content type="html">&lt;p&gt;Diego Moya-Ocampos, Peru analyst at&amp;nbsp;&lt;strong&gt;&lt;a href="http://www.ihs.com/products/global-insight/index.aspx"&gt;IHS Global Insight&lt;/a&gt;&lt;/strong&gt;, reflects on changes and continuity in Peruvian economic policy since Humala's inauguration. He also identifies a number of challenges for the administration going forward, including the renegotiation of the Camisea gas contracts and the country's ongoing social conflicts.&lt;/p&gt;</content></entry><entry><id>85ab4962-c002-4622-b341-a021f6c1c423</id><title type="text">Stigma Under The Lens</title><updated>2011-11-28T15:45:10Z</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/835-Stigma-Under-The-Lens.aspx" /><content type="html">&lt;p&gt;Christian Aid has partnered with Magnum Photos to launch &amp;lsquo;Stigma Under The Lens&amp;rsquo;, a series of thought-provoking audio-photographic slideshows for World AIDS day featuring brave people around the world living with HIV under the shadow of stigma.&lt;/p&gt;</content></entry><entry><id>c43c233b-23b4-42d3-847b-4370f68ba467</id><title type="text">Appeal launched to help provide life changing equipment</title><updated>2011-11-28T13:14:58Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/801-Appeal-launched-to-help-provide-life-changing-equipment.aspx" /><content type="html">&lt;p&gt;An urgent appeal has been launched to help get a disabled youngster from Frinton-on-Sea a vital piece of life-changing equipment.&lt;/p&gt;</content></entry><entry><id>2e7e9153-7f56-4e2f-bdfd-4909d482bcd2</id><title type="text">Sweet treat for children’s charity</title><updated>2011-11-28T13:14:51Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/807-Sweet-treat-for-children-s-charity.aspx" /><content type="html"></content></entry><entry><id>310f0cb5-802c-485c-a803-622b4ca37ab4</id><title type="text">Finley, 6, approved for £24,000 operation that could change his life.  </title><updated>2011-11-28T13:14:44Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/822-Finley--6--approved-for--24-000-operation-that-could-change-his-life---.aspx" /><content type="html">&lt;p&gt;The parents of a six-year-old from Chichester have received confirmation that their son has been chosen for a ground-breaking Cerebral Palsy operation, but now face a desperate race against time to raise &amp;pound;24,000 to pay for the private treatment&lt;/p&gt;</content></entry><entry><id>93c7ecab-287c-4b97-8abf-7fa0f0f2e16a</id><title type="text">Lincolnshire tot is sitting pretty thanks to special donation </title><updated>2011-11-28T13:14:21Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/804-Lincolnshire-tot-is-sitting-pretty-thanks-to-special-donation-.aspx" /><content type="html">&lt;p&gt;A Lincolnshire toddler has received vital equipment to help get him to important medical appointments and enjoy family days out again.&lt;/p&gt;
&lt;p&gt;Born with a condition which affects 1 in 25,000 people, 2 year old Jamie Boorman has received a specially adapted car seat worth over &amp;pound;980.&lt;/p&gt;</content></entry><entry><id>834639e6-ea78-4a68-bb92-813707c17ab3</id><title type="text">Mum’s the word for brave duo</title><updated>2011-11-28T13:14:06Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/805-Mum-s-the-word-for-brave-duo.aspx" /><content type="html">&lt;p&gt;One of the UK&amp;rsquo;s most terrifying zip wires awaits two South Yorkshire mums with seriously ill children, who are taking on the challenge to raise vital funds for charity.&lt;/p&gt;
&lt;p&gt;&amp;nbsp;Louise Harper (29), from Barnsley and Vikky Skidmore (33) from Rotherham, who both have children with life-threatening conditions; are set to zip wire over 220 metres across the River Tyne in Newcastle-Upon-Tyne later this month.&lt;/p&gt;</content></entry><entry><id>66e3ceba-0bfa-4498-b655-9e1fb0db5b57</id><title type="text">Appeal launched to help provide life changing equipment</title><updated>2011-11-28T13:13:50Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/802-Appeal-launched-to-help-provide-life-changing-equipment.aspx" /><content type="html">&lt;p&gt;An urgent appeal has been launched to help get a disabled youngster from Buckinghamshire a vital piece of life-changing equipment.&lt;br /&gt;&lt;br /&gt;Three and a half year old Maya Czerminska from Olney has Spinal Muscular Atrophy, a degenerative muscle weakening condition, which means she will never be able to walk.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;/p&gt;</content></entry><entry><id>532529a5-c013-4f1e-98e3-9e3349f6d338</id><title type="text">Store’s season of goodwill starts with charity spectacular</title><updated>2011-11-28T13:13:37Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/815-Store-s-season-of-goodwill-starts-with-charity-spectacular.aspx" /><content type="html">&lt;p&gt;Debenhams department store in The Potteries shopping centre has announced a glamorous &amp;lsquo;Ladies Night&amp;rsquo; event in aid of a local charity to launch their festive season and Spectacular Sale.&lt;/p&gt;</content></entry><entry><id>c00af96c-8f8e-4890-b05f-aad4d025f6e1</id><title type="text">Sporting stars set for Birmingham karting clash </title><updated>2011-11-28T13:13:24Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/806-Sporting-stars-set-for-Birmingham-karting-clash-.aspx" /><content type="html">&lt;p&gt;Two stars of the motor circuit are coming to Birmingham to get in a spin as part of an action-packed charity race day.&lt;/p&gt;
&lt;p&gt;&amp;nbsp;Formula 3 driver Oliver Webb and Bernie Ecclestone&amp;rsquo;s Formula Kart Star, Bobby Thompson, will be joined by two celebrity teams as they battle it out against members of the public at the first Caudwell Children Karting Cup.&lt;/p&gt;</content></entry><entry><id>32a99326-ba6b-416e-abdc-19b9c46b21ad</id><title type="text">Getting to America is only the start of James’s incredible journey</title><updated>2011-11-28T13:13:13Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/798-Getting-to-America-is-only-the-start-of-James-s-incredible-journey.aspx" /><content type="html">&lt;p&gt;The parents of a five-year-old from Worthing are making a final desperate plea for help to get their disabled son the life-changing treatment that could help him walk for the first time.&lt;/p&gt;</content></entry><entry><id>729cbdd6-1094-4bf9-bc45-00162d8ad9fe</id><title type="text">Fluffy friends set to help raise funds for children’s charity</title><updated>2011-11-28T13:12:41Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/803-Fluffy-friends-set-to-help-raise-funds-for-children-s-charity.aspx" /><content type="html">&lt;p&gt;A Staffordshire hotel has enlisted the help of some cuddly friends to help make a difference to the lives of disabled children.&lt;/p&gt;
&lt;p&gt;&amp;nbsp;Best Western Manor House Hotel are set to launch &amp;ldquo;Ted in the Bed&amp;rdquo; to help raise money for local charity, Caudwell Children, who&amp;nbsp; provide treatment, therapy equipment and family support services for disabled children throughout the UK.&lt;/p&gt;</content></entry><entry><id>5c06ff64-4591-4503-8ddb-c05a95b31960</id><title type="text">Chance to double your money for disabled children</title><updated>2011-11-28T13:12:29Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/834-Chance-to-double-your-money-for-disabled-children.aspx" /><content type="html">&lt;p&gt;A children&amp;rsquo;s charity has announced that any donations made during the first week of December are set to be doubled, thanks to a national incentive scheme.&lt;/p&gt;</content></entry><entry><id>3b25559b-81ef-4f8c-9606-d76225ef8178</id><title type="text">Ponds Forge support employee’s desperate appeal</title><updated>2011-11-28T13:12:11Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/823-Ponds-Forge-support-employee-s-desperate-appeal.aspx" /><content type="html">&lt;p&gt;Managers and staff at one of Sheffield&amp;rsquo;s top sporting venues are backing an appeal by one of their employees to raise &amp;pound;55,000 for life-changing Cerebral Palsy treatment.&lt;/p&gt;</content></entry><entry><id>fc516829-5e72-4bfa-ae5e-ed048ebb0434</id><title type="text">Charity stages spook-tastic fun for families</title><updated>2011-11-28T13:12:03Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/800-Charity-stages-spook-tastic-fun-for-families.aspx" /><content type="html">&lt;p&gt;A Halloween themed torchlight trail for families in Staffordshire has been organised to help raise funds for disabled children.&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;</content></entry><entry><id>0c2396fe-f52a-409f-b869-f23b36f51c58</id><title type="text">Susanna, 4, approved for £60,000 operation that could change her life.  </title><updated>2011-11-28T13:11:48Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/799-Susanna--4--approved-for--60-000-operation-that-could-change-her-life---.aspx" /><content type="html">&lt;p&gt;The parents of a four-year-old from St Helens have received confirmation that their daughter had been chosen for a ground-breaking Cerebral Palsy operation in the United States, but now face a desperate race against time to raise &amp;pound;60,000 to pay for the treatment and aftercare.&lt;/p&gt;</content></entry><entry><id>6a6d1d3e-6682-4a7a-8a60-09ece7711a9e</id><title type="text">Gorvins acts for Together Trust on £7.5m college development</title><updated>2011-11-28T11:17:06Z</updated><link rel="alternate" href="http://pressroom.ackura.com/gorvins/527-Gorvins-acts-for-Together-Trust-on--7-5m-college-development.aspx" /><content type="html">&lt;p&gt;Gorvins' Managing Partner, Lorraine Lockie has acted for the Together Trust in the acquisition of a former Rolls-Royce factory in Openshaw, Manchester.&lt;/p&gt;</content></entry><entry><id>9a34360f-a536-4071-b1b9-52f212ec3dfb</id><title type="text">Pentagon Vauxhall In Rochdale Is Moving </title><updated>2011-11-23T09:32:41Z</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/552-Pentagon-Vauxhall-In-Rochdale-Is-Moving-.aspx" /><content type="html">&lt;p&gt;Rochdale Council has agreed terms with local car dealership Pentagon for the acquisition of their property on John Street in Rochdale Town Centre.&lt;/p&gt;</content></entry><entry><id>4d8e5d7a-f682-4d77-b038-f6ff9988629f</id><title type="text">M&amp;S Vouchers Worth £400 Up For Grabs At Pentagon SEAT</title><updated>2011-11-17T13:59:31Z</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/551-M-S-Vouchers-Worth--400-Up-For-Grabs-At-Pentagon-SEAT.aspx" /><content type="html">&lt;p&gt;Local car buyers could get their Christmas shopping all wrapped up by paying a visit to local SEAT retailer Pentagon in Nottingham and Scunthorpe this weekend.&lt;/p&gt;
&lt;p&gt;Not only could they drive away from the dealers showroom in a shiny new SEAT&amp;hellip; they could also pocket &amp;pound;400 of Marks and Spencer vouchers to put towards the family&amp;rsquo;s festive celebrations.&lt;br /&gt;&lt;br /&gt;&lt;/p&gt;</content></entry><entry><id>29156a69-055a-4986-a6d7-5c64a28861c5</id><title type="text">Sue Ryder in negotiations to move into new state of the art hospice in Henley</title><updated>2011-11-16T16:24:51Z</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/826-Sue-Ryder-in-negotiations-to-move-into-new-state-of-the-art-hospice-in-Henley.aspx" /><content type="html">&lt;p&gt;Sue Ryder, the health and social care charity, is looking to move from its existing location in Nettlebed to a new purpose-built hospice in Henley and is in talks with NHS Oxfordshire (PCT) to use new facilities to be built in the grounds of Townlands Community Hospital.&lt;/p&gt;</content></entry><entry><id>52ac7857-c3b0-4b16-9f6a-b942e027d5c7</id><title type="text">New charity shop attracts hundreds of customers on its first day</title><updated>2011-11-15T15:38:24Z</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/825-New-charity-shop-attracts-hundreds-of-customers-on-its-first-day.aspx" /><content type="html">&lt;p&gt;Sue Ryder opened its first charity shop in Meanwood on Thursday (Thu 10 November) and welcomed hundreds of customers throughout the day raising over &amp;pound;4,000 for the charity.&lt;/p&gt;</content></entry><entry><id>3e2c4804-181d-421d-896d-f4d8caf406ba</id><title type="text">National charity wins first amendment to healthcare bill </title><updated>2011-11-15T15:35:49Z</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/824-National-charity-wins-first-amendment-to-healthcare-bill-.aspx" /><content type="html">&lt;p&gt;National charity, Sue Ryder, has enjoyed a victory in its campaign to change Government policy on VAT relief for charities providing hospice care.&lt;/p&gt;</content></entry><entry><id>a4ec0857-f371-44b4-afd9-b2775d6de477</id><title type="text">Save Up To £8000 Off RRP In The Chevrolet Sale At Pentagon</title><updated>2011-11-10T11:33:02Z</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/550-Save-Up-To--8000-Off-RRP-In-The-Chevrolet-Sale-At-Pentagon.aspx" /><content type="html">&lt;p&gt;Most big sales take place after Christmas, but then Chevrolet has never been a manufacturer to do things conventionally.&lt;br /&gt;&lt;br /&gt;That&amp;rsquo;s why at Pentagon Chevrolet there are incredible reductions on several of the most popular Chevrolet models in the run-up to the festive period.&lt;/p&gt;</content></entry><entry><id>72348ae9-90e8-4e6e-8f5d-1570a7462e98</id><title type="text">What’s Hot and What’s New For 2012? - Plus, Great Rail Journeys and Treyn Unveil Key Trends In Rail Experience Holidays On Back of Customer Research</title><updated>2011-11-08T15:40:30Z</updated><link rel="alternate" href="http://pressroom.ackura.com/greatrail/814-What-s-Hot-and-What-s-New-For-2012----Plus--Great-Rail-Journeys-and-Treyn-Unveil-Key-Trends-In-Rail-Experience-Holidays-On-Back-of-Customer-Research.aspx" /><content type="html">&lt;p&gt;India, Scotland, Floriade - the World Horticultural Expo, the Jungfrau Express&amp;rsquo; 100 Year Anniversary, Italy and Food &amp;amp; Wine tours &amp;ndash; these are just some of the hot rail holiday ideas for 2012 as identified by Great Rail Journeys, the UK&amp;rsquo;s leading specialist in holidays by rail, and its sister company Treyn. And, with over 60 new tours across both brands for 2012, including destinations from Yorkshire to the USA, Great Rail Journeys has put together what it sees as its key trends for 2012.&lt;/p&gt;
&lt;p&gt;As well as commenting on what it sees as key trends for 2012, the company has also undertaken research amongst 1,300 of its customers to find out what they think about rail experience holidays and their destination choices for next year.&lt;/p&gt;</content></entry><entry><id>8c79fa27-aad8-47be-8354-2a11f2e142cb</id><title type="text">Get a new wardrobe and help to make a difference to people's life</title><updated>2011-11-07T17:29:52Z</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/813-Get-a-new-wardrobe-and-help-to-make-a-difference-to-people-s-life.aspx" /><content type="html">&lt;p&gt;A group of charitable ladies in Northamptonshire, calling themselves Champagne Thursday, are hosting a series of monthly Swishing events to raise vital funds for Sue Ryder.&lt;/p&gt;</content></entry><entry><id>aca799b1-4a37-4acc-85ea-9297afaa2747</id><title type="text">Sue Ryder shorlisted for prestigious National award for its work with prisoner volunteers</title><updated>2011-11-07T17:01:43Z</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/812-Sue-Ryder-shorlisted-for-prestigious-National-award-for-its-work-with-prisoner-volunteers.aspx" /><content type="html">&lt;p&gt;Sue Ryder&amp;rsquo;s pioneering work with prison volunteers across the UK has been recognised in the prestigious Personnel Today Awards 2011.&lt;/p&gt;</content></entry><entry><id>73b46625-f771-4a29-b9c7-a3718c5e43d4</id><title type="text">New Seat Mii Details Released</title><updated>2011-11-07T16:36:28Z</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/549-New-Seat-Mii-Details-Released.aspx" /><content type="html">&lt;p&gt;This is the Mii, SEAT&amp;rsquo;s new city car and its latest venture into the ever-expanding A00 segment. Its practicality, drivability, efficiency and innovative technologies make it the ideal companion for urban living.&lt;/p&gt;
&lt;p&gt;The Mii combines sporty Mediterranean design with quality craftsmanship   and enormous scope for personalisation. It is outstanding value for   money and, with low maintenance costs, is an easily attainable option   for customers who want a small but perfectly formed city car.&lt;br /&gt; &amp;nbsp;&lt;br /&gt; A three-door version of the Mii will go on sale in Spain by the end of   the year. It&amp;rsquo;ll be followed by a five-door version and launch in the   rest of Europe in spring 2012. &lt;br /&gt; &amp;nbsp;&lt;br /&gt; The Mii launches with two new 1.0-litre petrol engines that produce 60   PS and 75 PS. Because the car weighs just 854kg, it&amp;rsquo;s extremely agile   and efficient. In fact, the Ecomotive version will produce just 97g/km   of CO2.&lt;/p&gt;</content></entry><entry><id>71d1f485-ee5a-4fbb-b021-5c1bb1cb9ef3</id><title type="text">Join charity to celebrate the gift of life at Peterborough Cathedral service</title><updated>2011-11-07T11:55:58Z</updated><link rel="alternate" href="http://pressroom.ackura.com/kidneyresearchuk/811-Join-charity-to-celebrate-the-gift-of-life-at-Peterborough-Cathedral-service.aspx" /><content type="html">&lt;p&gt;A Peterborough charity is encouraging members of the public to take time out from their busy year to consider the three million people in the UK whose lives are at risk from chronic kidney disease (CKD).&lt;/p&gt;</content></entry><entry><id>7a7547f7-f5f8-4cf7-9c97-bf4bd2939338</id><title type="text">Celebrate your special memories of loved ones with Sue Ryder's Lights of Love</title><updated>2011-11-04T16:23:33Z</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/810-Celebrate-your-special-memories-of-loved-ones-with-Sue-Ryder-s-Lights-of-Love.aspx" /><content type="html">&lt;p&gt;This Christmas, Sue Ryder is inviting people to celebrate their special memories of loved ones and share them with others by taking part in its annual Lights of Love campaign.&lt;/p&gt;</content></entry><entry><id>e4da2cdf-4f46-4f18-a20b-dbeb7c10ffaa</id><title type="text">Peugeot Regenerates With The New 208 </title><updated>2011-11-04T14:19:39Z</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/548-Peugeot-Regenerates-With-The-New-208-.aspx" /><content type="html">&lt;p&gt;With a desire to reinvent the principles on which the success of icons like the 205, 206 and 207 were built and to "regenerate" them, Peugeot has created the new 208.&lt;/p&gt;</content></entry><entry><id>768a9a16-1a2f-4127-9ef5-662c6f513cd4</id><title type="text">Thorpe Hall given full planning permission to build new hospice</title><updated>2011-11-03T12:53:06Z</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/809-Thorpe-Hall-given-full-planning-permission-to-build-new-hospice.aspx" /><content type="html">&lt;p&gt;Plans submitted by Sue Ryder - Thorpe Hall Hospice in Longthorpe to build a new state-of-the art hospice have been approved by Peterborough City Council and English Heritage.&lt;/p&gt;</content></entry><entry><id>4bce6a4e-1c08-47b3-a8ba-6d34dbacbd7a</id><title type="text">Get Ready For A Harsh Winter With Snow Socks, Free With A Special £129 Winter Service At Pentagon Vauxhall</title><updated>2011-10-28T16:19:19+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/547-Get-Ready-For-A-Harsh-Winter-With-Snow-Socks--Free-With-A-Special--129-Winter-Service-At-Pentagon-Vauxhall.aspx" /><content type="html">&lt;p&gt;Pentagon Vauxhall are again offering a comprehensive range of great accessories in preparation for the winter months, including the popular and highly effective AutoSock Snow Socks.&amp;nbsp;&lt;/p&gt;</content></entry><entry><id>9d2f5451-8a71-4e0a-b1cf-e8ce006b1b7f</id><title type="text">Pentagon Gets Behind 'Wear it Pink'</title><updated>2011-10-28T09:58:17+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/546-Pentagon-Gets-Behind--Wear-it-Pink-.aspx" /><content type="html">&lt;p&gt;On Friday 28th October 2011 Pentagon Staff at all locations are taking part in Breast Cancer Campaigns Wear it Pink Day and aim to raise a substantial amount of money for charity in just one day.&lt;/p&gt;</content></entry><entry><id>5b0de5ed-3e17-4382-bb56-d69e33eca358</id><title type="text">Sartorius Concludes Agreement to Acquire the Liquid Handling Business of the Finnish Laboratory Supplier Biohit </title><updated>2011-10-27T15:40:15+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/808-Sartorius-Concludes-Agreement-to-Acquire-the-Liquid-Handling-Business-of-the-Finnish-Laboratory-Supplier-Biohit-.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.sartorius.com/" target="_blank"&gt;&lt;span&gt;Sartorius&lt;/span&gt; &lt;/a&gt;&lt;span&gt;, a leading international process and laboratory technology provider, today signed an agreement to acquire the liquid handling business of the Finnish laboratory supplier&lt;/span&gt; &lt;a href="http://www.biohit.com/" target="_blank"&gt;&lt;span&gt;Biohit Oyj&lt;/span&gt; &lt;/a&gt;&lt;span&gt;. With its liquid handling segment, Biohit is one of the global market leaders for mechanical and electronic pipettes, as well as for the associated consumables. The segment, which employs some 400 people, generated net sales of approximately 38 million euros and an EBITDA margin of approx. 13% in fiscal 2010. Its major customers are research, quality assurance and academic laboratories as well as hospitals. This deal will enable Sartorius to expand its product portfolio with an important component in the area of laboratory instruments, which currently includes lab balances, lab water purification systems, moisture analyzers and sample preparation consumables.&lt;/span&gt;&lt;/p&gt;</content></entry><entry><id>d64f8464-424e-4928-a2ad-6113110834bf</id><title type="text">Get a new job and make a real difference</title><updated>2011-10-25T14:24:27+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/796-Get-a-new-job-and-make-a-real-difference.aspx" /><content type="html">&lt;p&gt;Writemycv.info teams up with Sue Ryder to raise funds for the Big Wigs Business Challenge in Northamptonshire&lt;/p&gt;</content></entry><entry><id>31f8a7ae-53d1-4bb7-92b9-03d786db1168</id><title type="text">Raise your business profile and funds for Sue Ryder</title><updated>2011-10-25T14:16:11+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/795-Raise-your-business-profile-and-funds-for-Sue-Ryder.aspx" /><content type="html">&lt;p&gt;BNI Wellingborough is organising a Corporate Charity Networking Lunch to raise funds as part of their Northants Sue Ryder Big Wigs Business Challenge&lt;/p&gt;</content></entry><entry><id>62b01f95-2d06-4eb0-9fd8-7ea337425266</id><title type="text">Sue Ryder develops new palliative care education programme</title><updated>2011-10-25T14:00:47+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/794-Sue-Ryder-develops-new-palliative-care-education-programme.aspx" /><content type="html">&lt;div class="description"&gt;Sue Ryder has launched a new education programme aimed at enhancing practitioners&amp;rsquo; skills and knowledge in palliative and end-of-life care&lt;/div&gt;</content></entry><entry><id>8434b3db-7007-4337-8ce1-3cfb5e9c3017</id><title type="text">10 Day Big Sale At Pentagon</title><updated>2011-10-21T07:14:50+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/545-10-Day-Big-Sale-At-Pentagon.aspx" /><content type="html">&lt;p&gt;For 10 days only car dealer group Pentagon are offering local drivers the opportunity to purchase a new 61 plate car or one of around 610 massively discounted used cars with savings of up to &amp;pound;8,340 off the previous price.&lt;/p&gt;</content></entry><entry><id>b01454e4-d6d1-4b8e-9d75-641135e5e6b2</id><title type="text">EYE launches their new Digital Arrivals Network</title><updated>2011-10-19T17:32:58+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/eye/766-EYE-launches-their-new-Digital-Arrivals-Network.aspx" /><content type="html">&lt;p&gt;LONDON &amp;ndash; EYE&amp;rsquo;s rollout of its new digital media assets continues with its new Digital Arrivals Network, a digital screen network being introduced at Gatwick, Stansted and Manchester airports this summer. EYE has secured a number of brands to launch the newly built sites, with remaining space now limited.&lt;/p&gt;</content></entry><entry><id>1f6a7333-f307-432c-892f-f7e7b8cb119f</id><title type="text">Sony Vaio, ITV and IBM target airport business passengers with Business First from EYE</title><updated>2011-10-19T17:32:58+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/eye/776-Sony-Vaio--ITV-and-IBM-target-airport-business-passengers-with-Business-First-from-EYE.aspx" /><content type="html">&lt;p&gt;EYE launches a unique opportunity to reach high value premium Flyers through our new Business First network. This network of 12 x 70 inch portrait digital screens is located in direct proximity to the business lounges at EYE airports around the UK. The network gives advertisers a brand new opportunity to communicate with a valuable business audience.&lt;/p&gt;</content></entry><entry><id>b7cf46b5-b739-4392-954b-a540387218b6</id><title type="text"> EYE launches new Digital Landmark</title><updated>2011-10-19T10:47:54+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/eye/712--EYE-launches-new-Digital-Landmark.aspx" /><content type="html">&lt;p&gt;LONDON &amp;ndash; EYE, the airport media owner, is pleased to announce the launch of its new Digital Landmark sites, the first wave of the company&amp;rsquo;s extensive asset development programme across its national portfolio of eight airports.&lt;/p&gt;</content></entry><entry><id>0da8e550-f629-40b7-abba-ce21c3272dfc</id><title type="text">Sue Ryder and Demos Call for Democratic Revolution in Care Homes</title><updated>2011-10-19T09:20:51+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/793-Sue-Ryder-and-Demos-Call-for-Democratic-Revolution-in-Care-Homes.aspx" /><content type="html">&lt;p&gt;&lt;em&gt;Leading health charity and national think-tank say homes should be run by residents, for residents&lt;/em&gt;&lt;/p&gt;</content></entry><entry><id>3df36ee6-b3b5-419a-896c-87718fd3cf27</id><title type="text">39 new tours added to Great Rail Journeys and Treyn's escorted holidays by rail programmes for summer 2012</title><updated>2011-10-18T16:06:22+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/greatrail/792-39-new-tours-added-to-Great-Rail-Journeys-and-Treyn-s-escorted-holidays-by-rail-programmes-for-summer-2012.aspx" /><content type="html">&lt;p&gt;Escorted rail holiday specialist, Great Rail Journeys, has launched its new &amp;lsquo;Europe &amp;ndash; Holidays by Rail 2012&amp;rsquo; brochure and sister brand, Treyn has also launched its new &amp;lsquo;European &amp;amp; Worldwide Rail Holidays 2012&amp;rsquo; brochure. Between them, the brochures feature a total of 39 new tours, and marks the largest ever programme for both brands, as well as Treyn&amp;rsquo;s first ever long-haul programme.&lt;/p&gt;</content></entry><entry><id>12aec229-6977-46d5-a553-15ea22eaccca</id><title type="text">Follow in the footsteps of Wills and Kate to Canada - Great Rail Journeys sees rise in Canadian tours</title><updated>2011-10-18T15:53:43+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/greatrail/791-Follow-in-the-footsteps-of-Wills-and-Kate-to-Canada---Great-Rail-Journeys-sees-rise-in-Canadian-tours.aspx" /><content type="html">&lt;p&gt;Just back from their successful tour of Canada, The Duke and Duchess of Cambridge had the windows of the world on them as they visited Ottawa, Montreal, Quebec City, Charlottetown, Prince Edward Islands, Yellowknife and Calgary. And, according to rail specialist Great Rail Journeys, it seems as if the Royal couple have inspired many UK residents to holiday in Canada, as the company has seen a rise in demand for its Canada tours since Wills and Kate visited.&lt;/p&gt;</content></entry><entry><id>81cb3082-ca91-458d-9279-0f79c3740d3e</id><title type="text">Travel Trade: Great Rail Journeys sees rise in Canadian tours due to 'Wills and Kate effect'</title><updated>2011-10-18T15:22:06+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/greatrail/790-Travel-Trade--Great-Rail-Journeys-sees-rise-in-Canadian-tours-due-to--Wills-and-Kate-effect-.aspx" /><content type="html">&lt;p&gt;Just back from their successful tour of Canada, The Duke and Duchess of Cambridge had the windows of the world on them as they visited Ottawa, Montreal, Quebec City, Charlottetown, Prince Edward Islands, Yellowknife and Calgary. And, according to rail specialist Great Rail Journeys, it seems as if the Royal couple have inspired many UK residents to holiday in Canada, as the company has seen a rise in demand for its Canada tours since Wills and Kate visited.&lt;/p&gt;</content></entry><entry><id>e0dbf0b0-23bb-4cf9-9d29-8ab0bb76ca11</id><title type="text">Travel Trade: Great Rail Journeys launches new 2012 Cruising by Rail brochure with five new tours</title><updated>2011-10-18T14:55:52+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/greatrail/789-Travel-Trade--Great-Rail-Journeys-launches-new-2012-Cruising-by-Rail-brochure-with-five-new-tours.aspx" /><content type="html">&lt;p&gt;Escorted rail holiday specialist, Great Rail Journeys, has launched its new &amp;lsquo;Cruising By Rail 2011 - 2012&amp;rsquo; brochure featuring five new river and ocean cruising holidays by rail from a total of 26 tours. The holidays, which all combine rail travel with the cruising experience, have various departure dates between December 2011 and October 2012 and the overall lead-in price is &amp;pound;620 per person for a five day Rhineland Markets Cruise.&lt;/p&gt;</content></entry><entry><id>e7da2bf3-3021-40e5-b504-ce57cc119dbf</id><title type="text">Gorvins launches 100 Days for Stockport</title><updated>2011-10-13T09:24:46+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/gorvins/526-Gorvins-launches-100-Days-for-Stockport.aspx" /><content type="html">&lt;p&gt;Stockport charities, community groups and residents are to be given a boost over the next year, thanks to a new volunteering initiative from local law firm, Gorvins.&amp;nbsp;&amp;nbsp;&lt;/p&gt;</content></entry><entry><id>dbe38b30-5065-4233-91fc-aa335e047cc5</id><title type="text">New Chevrolet  Aveo Set To Arrive At Pentagon January 2012</title><updated>2011-10-12T12:13:11+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/544-New-Chevrolet--Aveo-Set-To-Arrive-At-Pentagon-January-2012.aspx" /><content type="html">&lt;p&gt;The all-new Chevrolet Aveo is set to arrive at Pentagon showrooms next January, with great value pricing to match its striking looks.&amp;nbsp;&lt;/p&gt;
&lt;p&gt;At only &amp;pound;9,995 for the 1.2 LS model, the Aveo looks set to build on Chevrolet&amp;rsquo;s reputation for delivering great value for money &amp;ndash; but it&amp;rsquo;s more than the keen pricing that will make it appeal to customers.&lt;/p&gt;</content></entry><entry><id>f2841255-bb39-4aa9-8d28-17518b0374c4</id><title type="text">World’s first online procurement platform specifically developed for eye care NGOs launched on World Sight Day</title><updated>2011-10-11T14:14:31+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/vision2020/788-World-s-first-online-procurement-platform-specifically-developed-for-eye-care-NGOs-launched-on-World-Sight-Day.aspx" /><content type="html">&lt;p&gt;An elite group of eye health NGOs has collaborated&amp;nbsp;to launch the new &lt;strong&gt;IAPB Standard List&lt;/strong&gt;, enabling eye care programmes to access essential equipment and supplies at preferential prices.&lt;/p&gt;</content></entry><entry><id>26e1d472-e6b6-43a0-ab64-165d47ac9bdc</id><title type="text">NHS services for people with multiple sclerosis remain poor</title><updated>2011-10-10T16:32:54+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/mstrust/787-NHS-services-for-people-with-multiple-sclerosis-remain-poor.aspx" /><content type="html">&lt;p&gt;Services that people with multiple sclerosis depend upon from the NHS have shown little or no improvement in the last five years, and guidelines issued by NICE for the management of patients with MS are no closer to being met today than when they were first launched in 2003.&lt;/p&gt;</content></entry><entry><id>5b0fa0d7-6871-4d25-8ca5-90655f70d7f1</id><title type="text">Christian Mancier is new President of Stockport Chamber</title><updated>2011-10-07T11:09:08+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/gorvins/525-Christian-Mancier-is-new-President-of-Stockport-Chamber.aspx" /><content type="html">&lt;p&gt;Christian Mancier, a Partner at Gorvins Solicitors, has been elected&lt;em&gt; &lt;/em&gt;Stockport President of Greater Manchester Chamber of Commerce having been involved in the organisation for the last seven years.&lt;em&gt;&lt;/em&gt;&lt;/p&gt;</content></entry><entry><id>fe88b6ee-79b3-4d44-b698-54d75206f1da</id><title type="text">Sue Ryder encourages people to support its vital work</title><updated>2011-10-06T16:48:34+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/785-Sue-Ryder-encourages-people-to-support-its-vital-work.aspx" /><content type="html">&lt;p&gt;To coincide with this year&amp;rsquo;s World Hospice and Palliative Care Day (8 Oct) national health and social care charity Sue Ryder is highlighting the importance of supporting hospices in their vital role of caring for people living with complex care needs.&lt;/p&gt;
&lt;p&gt;&lt;br /&gt;Sue Ryder is using this event to encourage people to support the charity by taking on a fundraising challenge including for instance the spectacular Hadrian&amp;rsquo;s Wall trek, the Jurassic coast trek or the Great Wall of China trek and by supporting its 350 shops across the country to help raise the &amp;pound;20m it needs to continue to support the thousands of people it cares for every year.&lt;/p&gt;</content></entry><entry><id>52639511-21be-486d-ad2c-544593467f9b</id><title type="text">Gorvins maintains strong position in Legal 500</title><updated>2011-10-05T14:45:39+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/gorvins/524-Gorvins-maintains-strong-position-in-Legal-500.aspx" /><content type="html">&lt;p&gt;Gorvins has maintained its ranking&amp;nbsp;across&amp;nbsp;ten disciplines in this year's UK Legal 500 guide - confirming its position as Stockport's leading law firm&lt;/p&gt;</content></entry><entry><id>f070c79f-73e8-4376-a5cc-5996989c11ba</id><title type="text">Children’s Oncology and Apeiron to Jointly Conduct Phase II Study in Neuroblastoma </title><updated>2011-10-03T11:49:15+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/784-CHILDREN-S-ONCOLOGY-GROUP-AND-APEIRON-TO-JOINTLY-CONDUCT-PHASE-II-STUDY-IN-NEUROBLASTOMA-WITH-hu14-18-IL2--APN301--.aspx" /><content type="html">&lt;p&gt;Philadelphia, Vienna, Madison: 29 September 2011 - Children&amp;acute;s Oncology Group (COG) and APEIRON Biologics AG (Apeiron) announced today that they will jointly investigate Apeiron&amp;acute;s APN301 in a clinical phase II study in pediatric neuroblastoma patients.&lt;/p&gt;</content></entry><entry><id>17fb578c-3fa1-477a-b426-0a1cbb935a9d</id><title type="text">We’ve launched a new site for bcToolkit</title><updated>2011-09-30T10:33:57+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/kmp/783-We-ve-launched-a-new-site-for-bcToolkit.aspx" /><content type="html">&lt;p&gt;&lt;a title="Exonero" href="http://exonero.com/" target="_blank"&gt;Exonero&lt;/a&gt; approached us with two clear objectives. The first was to streamline  the sign up process and therefore increase the number of sign-ups they  achieve. The second was to improve the layout of the information on the  website.&lt;/p&gt;</content></entry><entry><id>ec14e3cc-ea8a-4a65-9173-1f9d45848821</id><title type="text">Great Rail Journeys launches new 2012 Cruising by Rail brochure with five new tours</title><updated>2011-09-19T11:30:40+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/greatrail/780-Great-Rail-Journeys-launches-new-2012-Cruising-by-Rail-brochure-with-five-new-tours.aspx" /><content type="html">&lt;p&gt;From Scotland&amp;rsquo;s Caledonian Canal to the Seine, the Yonne, the Rhine and the Mediterranean, now you can experience each of these iconic stretches of water on a tour from the UK&amp;rsquo;s leading operator of escorted holidays by rail, Great Rail Journeys, which has launched its new &amp;lsquo;Cruising Holidays By Rail 2011 - 2012&amp;rsquo; brochure featuring five new river and ocean cruising holidays from a total of 26 tours.&amp;nbsp;&lt;/p&gt;</content></entry><entry><id>a0af6b12-e118-45eb-8e2c-b06cc8be1358</id><title type="text">Travel Trade: Great Rail Journeys and Treyn launch winter brochure collection</title><updated>2011-09-19T11:09:24+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/greatrail/779-Travel-Trade--Great-Rail-Journeys-and-Treyn-launch-winter-brochure-collection.aspx" /><content type="html">&lt;p&gt;Great Rail Journeys and Treyn have launched their winter collection of brochures including for the first time, a worldwide winter stand-alone brochure from Great Rail Journeys. 14 new tours are offered in total across the brands, including the first long haul departure for Treyn to India and more UK tours due to their phenomenal success in summer this year.&lt;/p&gt;</content></entry><entry><id>a62c7f92-f131-4569-a9f3-216994f07474</id><title type="text">Merseyside pharmaceutical firm secures Series A investment package</title><updated>2011-09-19T10:22:52+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/778-Merseyside-pharmaceutical-firm-secures-Series-A-investment-package.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.evgen.com/"&gt;Evgen Limited&lt;/a&gt; has secured its first significant venture capital investment from a syndicate led by The &lt;a href="http://www.thenorthwestfund.co.uk/the-funds/biomedical"&gt;North West Fund for Biomedical&lt;/a&gt; and EV Group&amp;rsquo;s Rising Stars Growth Fund.&lt;/p&gt;</content></entry><entry><id>9c0164ee-6794-4c61-b0c3-dbf6107e29d2</id><title type="text">Boyd Group Income Fund Announces September 2011 Cash Distribution </title><updated>2011-09-19T09:29:02+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/777-Boyd-Group-Income-Fund-Announces-September-2011-Cash-Distribution-.aspx" /><content type="html">&lt;p&gt;WINNIPEG, MB, Sept. 16, 2011 - Boyd Group Income Fund (TSX: BYD.UN) today announced a cash distribution for the month of August 2011 of $0.035 per trust unit.&amp;nbsp; The distribution will be payable on October 27, 2011 to unitholders of record at the close of business on September 30, 2011.&amp;nbsp;&lt;/p&gt;</content></entry><entry><id>636fc8ad-8531-413e-a751-705ab1b73e0e</id><title type="text">Increased Efficiency for Organic Acid Leach for Resource Mining Corporation (ASX:RMI) at Wowo Gap</title><updated>2011-09-19T07:25:51+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/rmc/520-Increased-Efficiency-for-Organic-Acid-Leach-for-Resource-Mining-Corporation--ASX-RMI--at-Wowo-Gap.aspx" /><content type="html">&lt;p&gt;Leaching efficiency for a new green-tech nickel recovery process has been increased by more than 65 per cent compared to traditional atmospheric acid leaching in trials conducted by innovative Perth-based minerals explorer Resource Mining Corporation (ASX:RMI) .&lt;/p&gt;</content></entry><entry><id>2ff156c4-7719-47c6-a7bf-a06701b0a48a</id><title type="text">Win A Subaru And Provide Essential Aid To Japan</title><updated>2011-09-15T17:25:07+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/543-Win-A-Subaru-And-Provide-Essential-Aid-To-Japan.aspx" /><content type="html">&lt;p&gt;Assisting a national crisis tens of thousands miles away from your own doorstep is not normally within our remit but Pentagon Subaru in Ashbourne has joined a national competition to help the victims of the earthquake in Japan, with the top prize being a brand-new 2.5-litre Subaru Legacy Outback.&lt;/p&gt;</content></entry><entry><id>78436b0d-c76f-4930-bf4f-97a170bc1901</id><title type="text">Charity prepare for all-star purple carpet</title><updated>2011-09-12T16:48:09+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/775-Charity-prepare-for-all-star-purple-carpet.aspx" /><content type="html">&lt;p&gt;National charity, Caudwell Children, is preparing for a star-studded purple carpet on Thursday as celebrities turn out to attend the 2011 Butterfly Ball in London&amp;rsquo;s Battersea Park.&lt;/p&gt;
&lt;p&gt;Famous names including Peter Andre, Amy Childs, Alex Reid and Lotus Formula 1 driver, Brunno Senna are among the high-profile guests expected at the annual fundraiser.&lt;/p&gt;</content></entry><entry><id>cbd8b78d-c8f0-43ec-bb62-006b79c0bf1c</id><title type="text">Pentagon Group choose Ackura Pressroom to drive their news exposure</title><updated>2011-09-12T16:13:12+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/ackura/657-Pentagon-Group-choose-Ackura-Pressroom-to-drive-their-news-exposure.aspx" /><content type="html">&lt;p&gt;The UK's leading car dealership group, Pentagon, have chosen Pressroom to promote their news online to the newswires and social web.&lt;/p&gt;
&lt;p&gt;The agreement coincides with the development of new functionality in Pressroom that allows Pentagon to create categorised press releases, each with their own unique feed, which will allow Pentagon to create vehicle franchise focused press releases that are published on their related websites, while managing the administration from one central account.&lt;/p&gt;</content></entry><entry><id>ac3b5870-a1b3-457c-ae4c-992bee8d89c9</id><title type="text">Vauxhall Ampera Takes Top Green Prize</title><updated>2011-09-09T12:07:16+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/542-Vauxhall-Ampera-Takes-Top-Green-Prize.aspx" /><content type="html">&lt;p&gt;What Car?, the UK&amp;rsquo;s leading consumer focused motoring magazine, has named the Vauxhall Ampera as its Green Car of the Year 2011. The Ampera was also its top alternative-fuel car.&lt;/p&gt;</content></entry><entry><id>9592314b-fe93-451a-ae07-174604ba7df4</id><title type="text">Saab Air Con and Health Check At Pentagon Saab Now Under £30</title><updated>2011-09-07T14:58:50+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/541-Saab-Air-Con-and-Health-Check-At-Pentagon-Saab-Now-Under--30.aspx" /><content type="html">&lt;p&gt;Motorists understand the importance of feeling comfortable when driving, particularly in hot weather. Over the summer months, many of us will have relied upon air conditioning to keep cool whilst travelling in the car, and so until 30th September, Pentagon Saab is offering local Saab drivers an air-conditioning service for just &amp;pound;29.99.&lt;/p&gt;
&lt;p&gt;&lt;br /&gt;All Saab owners who book their vehicle in for an air-conditioning service at Pentagon in Oldham or Sheffield will also receive a free-of-charge summer health and fluid check, comprising of a 25 point visual inspection.&lt;/p&gt;</content></entry><entry><id>5cef2042-c58e-41cd-8386-043e2f177792</id><title type="text"> HOW YOU CAN HELP TO MAKE A REAL DIFFERENCE TO PEOPLE’S LIFE </title><updated>2011-09-07T12:50:28+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/774--HOW-YOU-CAN-HELP-TO-MAKE-A-REAL-DIFFERENCE-TO-PEOPLE-S-LIFE-.aspx" /><content type="html">&lt;p&gt;Stapleford Park is hosting a special White Tie and Tiara Ball on September 24th to raise vital funds for Sue Ryder, a national health and social care charity.  Staff at Stapleford Park are encouraging people to come along to th</content></entry><entry><id>51c377ae-383d-45a8-828c-f47aaec02c9c</id><title type="text">Gorvins strengthens personal injury team</title><updated>2011-09-07T11:47:08+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/gorvins/523-Gorvins-strengthens-personal-injury-team.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.gorvins.com/"&gt;Gorvins &lt;/a&gt;has strengthened its Personal Injury team with the appointment of a new Senior Associate.&lt;/p&gt;</content></entry><entry><id>b37d2e81-78e6-4cbf-9adc-7f79c9af654f</id><title type="text">Wowo Gap Drilling Costs Slashed by Nearly 70 Per Cent for Resource Mining Corporation (ASX:RMI)</title><updated>2011-09-05T06:58:57+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/rmc/519-Wowo-Gap-Drilling-Costs-Slashed-by-Nearly-70-Per-Cent-for-Resource-Mining-Corporation--ASX-RMI-.aspx" /><content type="html">&lt;p&gt;Innovative Perth-based minerals explorer Resource Mining Corporation (ASX:RMI) has reduced drilling costs by nearly 70 per cent as it completes a 300 hole drill program at its Wowo Gap Nickel deposit, located 200 kilometres east of Port Moresby in Papua New Guinea in an area known to host significant Nickel-Cobalt mineralisation .&lt;/p&gt;</content></entry><entry><id>248fcac7-54f8-458a-a7b3-fc7e8758650a</id><title type="text">More stars added to Butterfly Ball event, this time in the kitchen.</title><updated>2011-09-01T16:00:42+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/773-More-stars-added-to-Butterfly-Ball-event--this-time-in-the-kitchen-.aspx" /><content type="html">&lt;p&gt;Organisers of the glamorous Caudwell Children &amp;lsquo;Butterfly Ball&amp;rsquo; have today announced yet another star to be added to their celebrity-filled line-up, this time in the kitchen.&lt;/p&gt;
&lt;p&gt;Michelin-starred celebrity chef, Angela Hartnett, has been confirmed as the Head Chef at the annual fundraising event set to take place in Battersea Park, London on September 15&lt;sup&gt;th&lt;/sup&gt;.&lt;/p&gt;</content></entry><entry><id>da6690da-0ad0-478f-8840-d2b5fd63b865</id><title type="text">Vauxhall Set To Unveil Two New Cars At Frankfurt</title><updated>2011-08-26T17:24:52+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/539-Vauxhall-Set-To-Unveil-Two-New-Cars-At-Frankfurt.aspx" /><content type="html">&lt;p&gt;Vauxhall is set to unveil two new cars at this year&amp;rsquo;s Frankfurt Show (September 15-25) in addition to the surprise debut of an experimental car that will emphasise the company&amp;rsquo;s passion for driver-focused vehicles.&lt;/p&gt;</content></entry><entry><id>e2dfa385-39f1-41a1-83c1-7f8fc5ff7fdd</id><title type="text">Chrysler Delta: Why Should Compact Mean Compromise?</title><updated>2011-08-25T12:27:55+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/540-Chrysler-Delta--Why-Should-Compact-Mean-Compromise-.aspx" /><content type="html">&lt;p&gt;The new Delta from Chrysler is a new compact car that offers luxury beyond all expectations. In Pentagon showrooms now, the Delta is a car that challenges perceptions to offer a combination of beauty, space, quality and innovation.&lt;/p&gt;</content></entry><entry><id>9f7be0cf-0396-4d5c-af89-0aa290b434ef</id><title type="text">Celebrate a Century with Pentagon Chevrolet</title><updated>2011-08-25T11:54:50+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/538-Celebrate-a-Century-with-Pentagon-Chevrolet.aspx" /><content type="html">&lt;p&gt;Chevrolet is celebrating its 100th birthday this September and Pentagon want you to come to the party! For 10 days in September, Pentagon will be holding a very special birthday celebration!&lt;/p&gt;</content></entry><entry><id>bacb6636-d1da-4216-ba80-5bfd3a33b228</id><title type="text">Open your eyes on World Sight Day! Avoidable blindness "shames us all", says sector leader</title><updated>2011-08-24T09:28:41+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/vision2020/764-Open-your-eyes-on-World-Sight-Day--Avoidable-blindness--shames-us-all---says-sector-leader.aspx" /><content type="html">&lt;p&gt;Health planners must stop ignoring avoidable blindness and visual  impairment. A modest investment could help over 200 million people to  see clearly, vastly improving the economic outlook of low income  communities.&lt;/p&gt;</content></entry><entry><id>184a0df8-fe3e-484b-abf9-41c1de2940ce</id><title type="text">Appeal to take big step to help others</title><updated>2011-08-23T14:46:24+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/771-Appeal-to-take-big-step-to-help-others.aspx" /><content type="html">&lt;p&gt;Daredevils in the South West are being invited to join a 200ft abseil in a bid to help change the lives of disabled children.&lt;/p&gt;
&lt;p&gt;Taking place at the Avon Gorge, Bristol, participants will take one of the biggest steps of their lives in this dramatic landscape whilst helping raise funds for Caudwell Children who provide treatment, therapy equipment and family support services for disabled children,&lt;/p&gt;
&lt;p&gt;Open to everyone, the Mega Avon Abseil will take place on Sunday, September 25&lt;sup&gt;th&lt;/sup&gt; and the charity hope it will attract more than 20 participants.&lt;/p&gt;</content></entry><entry><id>15d62614-e652-4657-9a7c-ff1427095b3e</id><title type="text">Hotel help towards getting seriously ill youngsters closer to dream </title><updated>2011-08-23T14:46:11+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/770-Hotel-help-towards-getting-seriously-ill-youngsters-closer-to-dream-.aspx" /><content type="html">&lt;p&gt;A Birmingham hotel is leading the way in a local campaign to get children battling life-threatening conditions on the trip of a lifetime.&lt;/p&gt;
&lt;p&gt;The Malmaison Hotel, Birmingham is the first company to register and get the &amp;ldquo;West Midlands Business Challenge&amp;ldquo; off the ground.&lt;/p&gt;
&lt;p&gt;National charity, Caudwell Children, launched the appeal last month to help get a group of youngsters with life-threatening illness on the charity&amp;rsquo;s Destination Dreams holiday later this year.&lt;/p&gt;</content></entry><entry><id>af033b63-2a63-492d-8919-d5694cc9c85d</id><title type="text">Bee Gee named in line up for this year’s Butterfly Ball</title><updated>2011-08-23T14:45:43+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/772-Bee-Gee-named-in-line-up-for-this-year-s-Butterfly-Ball.aspx" /><content type="html">&lt;p&gt;Legendary international recording artist and songwriter Robin Gibb CBE is the latest artist to be confirmed as one of the performers at this year&amp;rsquo;s prestigious Caudwell Children Butterfly Ball on Thursday, 15&lt;sup&gt;th&lt;/sup&gt; September.&lt;/p&gt;</content></entry><entry><id>a8944d09-64f2-485b-8c74-0d70156c6bd4</id><title type="text">Appeal for cyclists to join challenge of a lifetime</title><updated>2011-08-23T14:45:06+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/769-Appeal-for-cyclists-to-join-challenge-of-a-lifetime.aspx" /><content type="html">&lt;p&gt;Cycling enthusiasts are being urged to join an overseas challenge of a lifetime to help change lives.&lt;/p&gt;
&lt;p&gt;National charity, Caudwell Children, will stage The Rajasthan Tiger Challenge in India later this year, which will take participants 480kms across Rajasthan, also known as the Land of Kings.&lt;/p&gt;
&lt;p&gt;They will bike through deserts, exquisite forts and bustling cities. By the end they will be one of few mountain bikers in the World to explore this idyllic region, punctuated with villages reminiscent of time gone by.&lt;/p&gt;
&lt;p&gt;During the week-long trip participants will also get to see tigers in their natural habitat and visit the iconic Taj Mahal Palace.&lt;/p&gt;</content></entry><entry><id>ecb638ea-26ee-46be-b1bc-20090df35588</id><title type="text">Software specialists set sky-high target for children’s charity</title><updated>2011-08-23T14:16:40+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/768-Software-specialists-set-sky-high-target-for-children-s-charity.aspx" /><content type="html">&lt;p&gt;A team of adventurous software specialists based in Maidenhead have announced a charity challenge which will see them scale the highest peak in North Africa next month.&lt;/p&gt;
&lt;p&gt;In total, 18 employees from global software company, &lt;a href="http://www.alfresco.com/"&gt;Alfresco Software Ltd&lt;/a&gt;, will attempt to scale Mount Toubkal in Morocco during a seven day challenge from 6&lt;sup&gt;th&lt;/sup&gt; September 2011.&lt;/p&gt;</content></entry><entry><id>74633449-bf21-4bdb-97b8-c070b5d94b98</id><title type="text">Tony Christie’s Big Band Jam is coming to Birmingham</title><updated>2011-08-18T12:12:16+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/767-Tony-Christie-s-Big-Band-Jam-is-coming-to-Birmingham.aspx" /><content type="html">&lt;p&gt;Singing legend Tony Christie is teaming up with the Midland Youth Jazz Orchestra (MYJO) for a one-night-only showcase of his greatest hits and the very best Big Band music.&lt;/p&gt;</content></entry><entry><id>f01bc48d-aea0-4baa-a5cb-8f25bc67b609</id><title type="text">THE ENGLISH HERITAGE BY CHRISTY BEDLINEN COLLECTION</title><updated>2011-08-17T14:32:26+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/christy/525-THE-ENGLISH-HERITAGE-BY-CHRISTY-BEDLINEN-COLLECTION.aspx" /><content type="html">&lt;p&gt;Two established, iconic British brands, Christy and English Heritage, have collaborated to launch a new bedlinen collection this summer.&lt;/p&gt;
&lt;p&gt;Initially unveiling two ranges, the partnership is set to be the beginning of a long relationship to produce high quality and historically inspired linens for the bedroom.&lt;/p&gt;</content></entry><entry><id>193ff3dc-3817-454d-ad2e-d7de8fd98fff</id><title type="text">INTERNATIONAL WOMEN’S GROUP PUTS THE FUNDRAISING WHEELS IN MOTION FOR SUE RYDER</title><updated>2011-08-11T16:24:27+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/765-INTERNATIONAL-WOMEN-S-GROUP-PUTS-THE-FUNDRAISING-WHEELS-IN-MOTION-FOR-SUE-RYDER.aspx" /><content type="html">&lt;p&gt;National health and social care charity Sue Ryder has been chosen as charity of the year 2011-12 by the Association of Inner Wheel Clubs, Great  Britain and Ireland.&amp;nbsp;&amp;nbsp;&lt;/p&gt;</content></entry><entry><id>2f6ed25b-0893-4205-9c60-47d2db9c1f2f</id><title type="text">More Motability Options With No Advance Payment At Pentagon Chevrolet This Summer</title><updated>2011-08-11T10:39:16+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/537-More-Motability-Options-With-No-Advance-Payment-At-Pentagon-Chevrolet-This-Summer.aspx" /><content type="html">&lt;p&gt;Pentagon Chevrolet are pleased to announce fantastic new offers available through Motability this summer. &lt;br /&gt;&lt;br /&gt;As established Motability partners, Pentagon Chevrolet have a number of excellent offers available at their showrooms in Derby, Mansfield, Nottingham, Sheffield, Barnsley and Rochdale.&lt;/p&gt;</content></entry><entry><id>3a20158e-6233-44ba-bec6-4bf3558e69c5</id><title type="text">Free football predictor game Soccer Saturday Super 6 back for the Premier League launch</title><updated>2011-08-10T15:20:56+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/braben/762-Free-football-predictor-game-Soccer-Saturday-Super-6-back-for-the-Premier-League-launch.aspx" /><content type="html">&lt;p&gt;The wait is nearly over! For the millions of footy fans who&amp;rsquo;ve missed their weekly Barclays Premier League football fix, there&amp;rsquo;s no better way to get their football juices flowing again than to play the free football predictor game &lt;a title="Sky Sports Super6" href="http://www.skysports.com/super6" target="_blank"&gt;Sky Sports&amp;rsquo; Soccer Saturday Super 6&lt;/a&gt; for the 2011/12 season.&lt;/p&gt;
&lt;p&gt;The ultimate test of Barclays Premier League football knowledge, the &lt;strong&gt;free-to-enter&lt;/strong&gt; football predictor game is back with a bang this season.&lt;/p&gt;</content></entry><entry><id>ec4816fb-a766-497b-ae80-4c2f5887e103</id><title type="text">Tea Dance Is Step In The Right Direction For Charity</title><updated>2011-08-10T11:48:13+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/763-Tea-Dance-Is-Step-In-The-Right-Direction-For-Charity.aspx" /><content type="html">&lt;p&gt;The first in a new series of afternoon tea dances have been launched in Droitwich to help raise funds for disabled children in the area.&lt;/p&gt;
&lt;p&gt;More than &amp;pound;100 was raised by dance enthusiasts at the first event staged by the Eagle and Sun, Hanbury Road, to help raise money for Caudwell Children.&lt;/p&gt;</content></entry><entry><id>00ea2b08-a2cb-4625-9685-4ec0a06a061a</id><title type="text">Charity Thanks Festival Fans</title><updated>2011-08-10T10:36:16+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/757-Charity-Thanks-Festival-Fans.aspx" /><content type="html">&lt;p&gt;A local charity is praising festival goers who helped raise over &amp;pound;1,100.&lt;/p&gt;
&lt;p&gt;Hundreds of music lovers who enjoyed The Penkhull Jazz &amp;amp; Blues Festival (Saturday, July 23&lt;sup&gt;rd&lt;/sup&gt;) helped raise vital funds for Stoke-based charity, Caudwell Children, who provide treatment, therapy, equipment and family support services for sick and disabled children throughout the UK.&lt;/p&gt;</content></entry><entry><id>a30d9351-7f0a-4e10-ae46-8a6747c86cfe</id><title type="text">Business Challenge Begins</title><updated>2011-08-10T10:36:05+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/756-Business-Challenge-Begins.aspx" /><content type="html">&lt;p&gt;Local businesses are being challenged to help get terminally ill children from the West Midlands on the holiday of a lifetime.&lt;/p&gt;</content></entry><entry><id>938b168f-3b0c-449b-82cb-64e1f287494e</id><title type="text">TrekAmerica Live celebrates its 1st birthday with an award and ROI</title><updated>2011-08-08T11:58:07+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/kmp/761-TrekAmerica-Live-celebrates-its-1st-birthday-with-an-award-and-ROI.aspx" /><content type="html">&lt;p&gt;In its first year &lt;a title="TrekAmerica Live" href="http://www.trekamericalive.com/"&gt;TrekAmerica Live&lt;/a&gt;, created by KMP Digitata, reached its break-even point, went on to generate a return on TrekAmerica&amp;rsquo;s investment and won the &amp;ldquo;&lt;a title="TrekAmerica Live - Best use of Social Media" href="http://kmp.co.uk/2011/07/trek-america-live-takes-the-gold-at-this-years-travelmole-awards/"&gt;Best use of Social Media&lt;/a&gt;&amp;rdquo; category at the TravelMole awards 2011.&lt;/p&gt;</content></entry><entry><id>1d7b8830-0346-45ab-a27e-a200221a357e</id><title type="text">Draft NICE guidance would deny up to 5,500 people with MS a valuable extra treatment fingolimod</title><updated>2011-08-05T08:13:46+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/mstrust/759-Draft-NICE-guidance-would-deny-up-to-5-500-people-with-MS-a-valuable-extra-treatment-fingolimod.aspx" /><content type="html">&lt;p&gt;MS Trust is disappointed that draft guidance from NICE recommends that fingolimod (licensed under the Novartis owned trade name of Gilenya) should not be made automatically available to people with multiple sclerosis on the NHS. &lt;br /&gt;&lt;br /&gt;Fingolimod has already been granted a European license for people with rapidly evolving MS and we believe and it should be automatically available on that basis in the UK through the NHS - and not just available to those who can afford it on private prescription.&lt;br /&gt;&lt;br /&gt;People with relapsing remitting multiple sclerosis (RRMS) currently have limited treatment options and without treatment face the very real prospect of potentially severe disability at an early age.&lt;/p&gt;</content></entry><entry><id>3f44d06d-c2ef-4b5b-a62e-01d566dd78bd</id><title type="text">Multiple Sclerosis Services shows early signs of NHS strain</title><updated>2011-08-03T14:44:12+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/mstrust/758-Multiple-Sclerosis-Services-shows-early-signs-of-NHS-strain.aspx" /><content type="html">&lt;p&gt;The MS Trust is becoming increasingly concerned at the impact NHS reorganisation and cost pressures are having on services for people with MS, in particular MS nursing services.&lt;br /&gt;&lt;br /&gt;We now know of a number of existing posts where nurses have left and recruitment is on hold. This is resulting in areas being left with no MS nurse support at all, or one MS nurse covering two to three times as many patients as they should. And it's adding to the existing shortfall of at least 100 nurses needed to help the UK's 100,000 people living with MS.&lt;/p&gt;</content></entry><entry><id>e84b4816-a7fa-4267-ac39-8eb10a2b567c</id><title type="text">Local solicitors issues warning about Wills</title><updated>2011-08-03T10:38:05+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/gorvins/522-Local-solicitors-issues-warning-about-Wills.aspx" /><content type="html">&lt;p&gt;Gorvins Solicitors is encouraging people to get their affairs in order by registering their Will on a national online registry &amp;ndash; &lt;a href="http://www.certainty.co.uk"&gt;www.certainty.co.uk&lt;/a&gt;.&lt;/p&gt;
&lt;p&gt;The Stockport based law firm is encouraging new and existing clients to register their Wills on the database, which will ensure that their Will can be easily found by family members and that their final requests are honoured.&lt;/p&gt;</content></entry><entry><id>5d4a8ddb-1554-4b17-a1cf-430c4cc3f979</id><title type="text">SPARK Impact announces second set of investments</title><updated>2011-08-03T09:58:48+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/755-SPARK-Impact-announces-second-set-of-investments.aspx" /><content type="html">&lt;p&gt;North West biomedical companies Alchemy Healthcare Ltd and Future Medical Technologies Ltd have each received &amp;pound;50K Pathfinder investments from the &amp;pound;25m &lt;a href="http://www.thenorthwestfund.co.uk/the-funds/biomedical"&gt;North West Fund for Biomedical&lt;/a&gt;.&lt;/p&gt;</content></entry><entry><id>84e46e9d-d716-42e5-8bfe-7caf78b7fcdc</id><title type="text">Gorvins advises on new business acquisition by homes4u</title><updated>2011-08-02T17:07:02+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/gorvins/521-Gorvins-advises-on-new-business-acquisition-by-homes4u.aspx" /><content type="html">&lt;p&gt;Gorvins solicitors recently advised Manchester&amp;rsquo;s leading residential sales and letting company, homes4u, on the acquisition of its most recent branch, in Altrincham.&lt;/p&gt;</content></entry><entry><id>7c3c2cbf-1726-4249-a090-dd70dd3f93b7</id><title type="text">SuppreMol Employs Protagen Biomarkers in SLE Study</title><updated>2011-08-02T15:08:17+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/754-SuppreMol-Employs-Protagen-Biomarkers-in-SLE-Study.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.suppremol.com/" target="_blank"&gt;SuppreMol GmbH&lt;/a&gt;, a privately held biopharmaceutical company developing innovative therapeutics for the treatment of autoimmune diseases and allergies, and &lt;a href="http://www.protagen.de/" target="_blank"&gt;Protagen AG&lt;/a&gt;, a specialist in &lt;em&gt;in-vitro&lt;/em&gt; diagnostics and GMP-compliant protein analysis, today announced a collaboration to identify therapy-related biomarkers in patients with Systemic Lupus Erythematosus (SLE).&lt;/p&gt;</content></entry><entry><id>aef8d459-ea02-499e-a203-ba12b274b09e</id><title type="text">Completed GMP Manufacture of Midkine Test </title><updated>2011-08-02T14:44:47+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/753-Completed-GMP-Manufacture-of-Midkine-Test-.aspx" /><content type="html">&lt;p&gt;&lt;strong&gt;&lt;a href="http://www.cellmid.com.au/" target="_blank"&gt;Cellmid Limited&lt;/a&gt; (ASX: CDY) &lt;/strong&gt;has completed technology transfer in relation to its &lt;a href="http://www.cellmid.com.au/content_common/pg-midkine-elisa-kit.seo" target="_blank"&gt;midkine blood test&lt;/a&gt; (MK ELISA) and the test kits have been successfully produced in a GMP compliant environment in AsureQuality&amp;rsquo;s fully accredited facility in Melbourne.&lt;/p&gt;</content></entry><entry><id>d3b9ec3a-3657-4a3f-8547-b3fcea7d4dad</id><title type="text">SuppreMol nutzt Biomarker von Protagen für SLE-Studie</title><updated>2011-08-02T14:23:56+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/752-SuppreMol-nutzt-Biomarker-von-Protagen-f%C3%BCr-SLE-Studie.aspx" /><content type="html">&lt;p&gt;Die &lt;a href="http://www.suppremol.com/"&gt;SuppreMol GmbH&lt;/a&gt;, ein privat finanziertes biopharmazeutisches Unternehmen, das neue Arzneimittel zur Behandlung von Autoimmunerkrankungen und Allergien entwickelt, und die &lt;a href="http://www.protagen.de/"&gt;Protagen AG&lt;/a&gt;, ein Spezialist f&amp;uuml;r in-vitro Diagnostik und GMP-konforme Proteinanalytik, gaben heute bekannt, dass beide Unternehmen bei der Identifizierung von therapierelevanten Biomarkern im Serum von Patienten mit systemischem Lupus erythematodes (SLE) zusammenarbeiten werden.&lt;/p&gt;</content></entry><entry><id>ea983da3-d07a-4a6b-b968-f0d9fd90bba0</id><title type="text">Pentagon Is The New Name For Seat and Peugeot in Scunthorpe</title><updated>2011-08-02T13:32:08+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/536-Pentagon-Is-The-New-Name-For-Seat-and-Peugeot-in-Scunthorpe.aspx" /><content type="html">&lt;p&gt;Pentagon Group have today announced that they have bought Rusty's Seat and Peugeot in Scunthorpe, North Lincolnshire. Pentagon already have one Seat dealership in Nottingham that they took on in May this year and they have represented Peugeot for the past 6 years in Burton on Trent, Staffordshire.&lt;/p&gt;</content></entry><entry><id>924c6fd4-10de-4232-8c5c-de23643ba1bd</id><title type="text">Fiat 500 By Gucci At Pentagon This Month</title><updated>2011-08-02T12:23:18+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/535-Fiat-500-By-Gucci-At-Pentagon-This-Month.aspx" /><content type="html">&lt;p&gt;Two Italian powerhouses, Fiat and Gucci, have united to create the 500byGucci which hits our showroom in Barnsley this month.&lt;/p&gt;</content></entry><entry><id>980a3521-9118-4734-ac39-6c166836fd13</id><title type="text">IAPB General Assembly links VISION 2020, eye health, poverty and development</title><updated>2011-07-29T17:16:34+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/vision2020/748-IAPB-General-Assembly-links-VISION-2020--eye-health--poverty-and-development.aspx" /><content type="html">&lt;p&gt;The IAPB General Assembly is the premier global event for discussion of blindness and visual impairment as public health issues, highlighting progress in VISION 2020: The Right to Sight, IAPB&amp;rsquo;s global joint initiative with the World Health Organization for the elimination of avoidable blindness.&lt;/p&gt;
&lt;p&gt;Registrations and Abstract Submissions for the International Agency for the Prevention of Blindness (IAPB) 9th General Assembly (9GA) go live on 1st September at www.9ga.iapb.org.&lt;/p&gt;</content></entry><entry><id>c1dd30b2-9a81-4619-877f-e2e7c9259b92</id><title type="text">Gorvins warns of rogue Will Writers on back of Legal Services Consumer Panel Investigation</title><updated>2011-07-29T12:54:18+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/gorvins/520-Gorvins-warns-of-rogue-Will-Writers-on-back-of-Legal-Services-Consumer-Panel-Investigation.aspx" /><content type="html">&lt;p&gt;&lt;em&gt;Gorvins Solicitors in Stockport &lt;/em&gt;welcomes the recent recommendation by the Legal Service Consumer Panel that Will-writing services should be regulated.&lt;/p&gt;</content></entry><entry><id>e1efd7d1-dc7b-4cf4-b863-40b84b811a16</id><title type="text">Gorvins nominates Royal Manchester Children's Hospital to receive donation</title><updated>2011-07-28T14:57:55+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/gorvins/519-Gorvins-nominates-Royal-Manchester-Children-s-Hospital-to-receive-donation.aspx" /><content type="html">&lt;p&gt;Health cash plan provider, UK Healthcare has donated &amp;pound;2,000 to Royal Manchester Children's Hospital, after the charity was nominated by Gorvins.&lt;/p&gt;</content></entry><entry><id>ee4c51a1-2f53-46db-bc1a-c82ad9d69dd6</id><title type="text">PBS Biotech Selects Green Cross Medical Sciences as Exclusive Bioreactor Distributor in Korea </title><updated>2011-07-26T10:02:29+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/747-PBS-Biotech-Selects-Green-Cross-Medical-Sciences-as-Exclusive-Bioreactor-Distributor-in-Korea-.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.pbsbiotech.com/" target="_blank"&gt;PBS Biotech, Inc.&lt;/a&gt;, a developer of state of the art single-use bioreactors for the fast growing biotechnology market, announced today it has signed an exclusive distribution agreement in Korea with Green Cross Medical Sciences Corp. (GCMS), a division of Green Cross Corporation one of Korea&amp;rsquo;s largest pharmaceutical firms. Under terms of the agreement GCMS will market, sell and support the complete line of &lt;a href="http://pbsbiotech.com/products-technology/" target="_blank"&gt;PBS Biotech single-use bioreactors&lt;/a&gt; for R&amp;amp;D and production to the more than 200 biopharma firms of the burgeoning Korean drug, vaccine and biosimilar industry.&lt;/p&gt;</content></entry><entry><id>c7fe2c33-2a68-4217-9c04-adbb6edd1ce9</id><title type="text">CEVEC Raises €6M to Grow CAP® Technology Based Protein and Vaccine Business</title><updated>2011-07-25T10:15:51+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/745-CEVEC-Raises--6M-to-Grow-CAP--Technology-Based-Protein-and-Vaccine-Business.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.cevec.com/" target="_blank"&gt;CEVEC Pharmaceuticals&lt;/a&gt;, licensing its human CAP&lt;sup&gt;&amp;reg;&lt;/sup&gt; Technology based expression system for proteins and vaccines, today announced the closing of a &amp;euro;6M financing round. NRW.BANK and Creathor Venture Fonds led this round which included the participation from current investors, a group of private and institutional investors and ERP Startfonds of KfW bank. The funding enables CEVEC to strengthen the growth of its protein and vaccine commercialization business of the proprietary CAP&lt;strong&gt;&lt;sup&gt;&amp;reg;&lt;/sup&gt;&lt;/strong&gt; Technology platform. CEVEC also intends to develop certain vaccines together with partners based on a further financing round, to be closed by the end of 2011.&lt;/p&gt;</content></entry><entry><id>d569bd5c-037c-4afd-949c-8596df7a7ccd</id><title type="text">GATC Biotech and ETH Zurich to Establish Method for Food Quality Assurance</title><updated>2011-07-21T11:26:52+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/740-GATC-Biotech-and-ETH-Zurich-to-Establish-Method-for-Food-Quality-Assurance.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.gatc-biotech.com/" target="_blank"&gt;GATC Biotech&lt;/a&gt;, in collaboration with the Institute of Food, Nutrition and Health at the&amp;nbsp;Swiss Federal Institute of Technology Zurich (ETH Zurich), is developing a cost efficient method for taxonomic characterization of microbial communities present in food.&lt;/p&gt;</content></entry><entry><id>fc1d5485-a9c6-4eb4-b364-d6c63e7fbae1</id><title type="text">Vauxhall Flexible 0% APR Finance For 5 Years With No Deposit  At Pentagon</title><updated>2011-07-19T13:57:05+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/534-Vauxhall-Flexible-0--APR-Finance-For-5-Years-With-No-Deposit--At-Pentagon.aspx" /><content type="html">&lt;p&gt;Pentagon Vauxhall are cutting costs for motorists everywhere by launching an  innovative new and simple way for drivers to get behind the wheel of a  brand new car with 5 years' interest free finance with no deposit to pay.&lt;/p&gt;</content></entry><entry><id>074bc4a0-711b-4ad2-9f54-14188c145b0f</id><title type="text">Renold increase transmission by going Mobile</title><updated>2011-07-19T10:24:29+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/kmp/734-Renold-increase-transmission-by-going-Mobile.aspx" /><content type="html">&lt;p&gt;&lt;strong&gt;We are very happy to announce that we have just launched the new mobile website for &lt;a title="Renold Mobile Homepage" href="http://m.renold.com/" target="_blank"&gt;Renold Plc.&lt;/a&gt; as part of their B2B digital strategy.&lt;/strong&gt;&lt;/p&gt;</content></entry><entry><id>ab4c4b6f-aca6-4d15-bc0f-cc7626d87599</id><title type="text">Vauxhall Service With Free AA Cover Now Only £99 At Pentagon</title><updated>2011-07-18T16:07:43+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/533-Vauxhall-Service-With-Free-AA-Cover-Now-Only--99-At-Pentagon.aspx" /><content type="html">&lt;p&gt;Pentagon Vauxhall is offering an interim service with 12 months free Vauxhall / AA Roadside Assistance for just &amp;pound;99.&amp;nbsp; Vauxhall Roadside Assistance provides help at both the Roadside and Home and, if the vehicle cannot be repaired, recovery to a Vauxhall Retailer or any single destination in the UK.&lt;/p&gt;</content></entry><entry><id>d72a2ac0-923f-4018-9050-54d0c1b18760</id><title type="text">AiCuris’ Novel HSV Compound AIC316 Shows Efficacy in Phase II</title><updated>2011-07-18T11:20:07+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/731-AiCuris--Novel-HSV-Compound-AIC316-Shows-Efficacy-in-Phase-II.aspx" /><content type="html">&lt;p&gt;Phase II results for &lt;a href="http://www.aicuris.com/" target="_blank"&gt;AiCuris'&lt;/a&gt; novel non-nucleosidic herpes simplex virus (HSV) inhibitor AIC316 reveal safety and efficacy in persons with genital herpes. The data were presented at the 19&lt;sup&gt;th&lt;/sup&gt; ISSTDR Meeting (International Society for Sexually Transmitted Diseases Research) in Quebec, Canada, by the coordinating investigator of the trial, Professor Anna Wald from the University of Washington and Fred Hutchinson Cancer Research Center in Seattle, USA.&lt;/p&gt;</content></entry><entry><id>343121ae-3ea0-4c15-a34c-345d9d65a853</id><title type="text">Lophius Biosciences Closes Additional Financing Round with Current Investors Totaling 1.4 Million EUR </title><updated>2011-07-18T09:56:20+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/730-Lophius-Biosciences-Closes-Additional-Financing-Round-with-Current-Investors-Totaling-1-4-Million-EUR-.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.lophius.de/en/home.html" target="_blank"&gt;Lophius Biosciences&lt;/a&gt;, a leading developer of novel, innovative T-cell-based diagnostic test systems, announced today closing of an additional financing round totaling 1.4 million EUR. All current financial investors, such as S-Refit, High-Tech Gr&amp;uuml;nderfonds (HTGF) as well as Bayernkapital participated in this financing round. The funds will be used for the market introduction of the T-Track&lt;sup&gt;&amp;copy;&lt;/sup&gt; CMV/EBV tests in the field of transplantation, for further development of a diagnostic test for the differential diagnosis of tuberculosis, as well as for the new development of a novel, blood-based multiple sclerosis test.&lt;/p&gt;</content></entry><entry><id>791d5198-8696-45ba-b22c-ad10e6f9e422</id><title type="text">Vetter Wins Frost &amp; Sullivan Award</title><updated>2011-07-14T17:06:51+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/728-Vetter-Wins-Frost---Sullivan-Award.aspx" /><content type="html">&lt;p&gt;Leading contract development and manufacturing organization (CDMO) &lt;a href="http://www.vetter-pharma.com/" target="_blank"&gt;Vetter&lt;/a&gt; has received the Frost &amp;amp; Sullivan 2011 European Prefilled Injection Systems Customer Service Leadership Award. The international consulting company recognized Vetter for best practices in its collaboration with global customers, in particular, the added value due to the outstanding quality of service the company creates for its partners. Vetter plays a significant role in the success of its clients by providing crucial support from early development of drugs through regulatory approval and market supply worldwide. The award ceremony is to be held on September 29 in London ( Great   Britain).&lt;/p&gt;</content></entry><entry><id>23679b27-312a-4370-87ba-65ce8ec9c02a</id><title type="text">Pluripotent Stem Cell Evaluation Agreement Between Roslin Cells and Pfizer for Regenerative Medicine Development</title><updated>2011-07-13T15:55:46+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/727-Pluripotent-Stem-Cell-Evaluation-Agreement-Between-Roslin-Cells-and-Pfizer-for-Regenerative-Medicine-Development.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.roslincells.com/" target="_blank"&gt;Roslin Cells&lt;/a&gt; and Pfizer Limited have signed an agreement for Pfizer to evaluate Roslin&amp;rsquo;s GMP quality Pluripotent Stem Cells (PSC).&lt;/p&gt;</content></entry><entry><id>4c221ef2-e9b9-4de5-8096-012417007769</id><title type="text">New twist on community music event set to be bigger than ever before</title><updated>2011-07-13T11:35:26+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/726-New-twist-on-community-music-event-set-to-be-bigger-than-ever-before.aspx" /><content type="html">&lt;p&gt;The annual Penkhull Jazz and Blues Festival is set to hit the high note yet again but this year organisers have introduced a twist which they hope will make it bigger and better than ever before.&lt;/p&gt;
&lt;p&gt;The 2011 &amp;ldquo;Penkhull Jazz and Blues Festival &amp;ndash; with a bit of rock&amp;rdquo; will take place on Saturday, July 23&lt;sup&gt;rd&lt;/sup&gt; and is going ahead thanks to generous contributions made by local individuals, businesses from Penkhull and North Staffordshire, as well as local venues.&lt;/p&gt;</content></entry><entry><id>9b6af053-46f5-40ef-a6cb-aef5d968e249</id><title type="text">Appeal to make garden dream for disabled youngster a reality</title><updated>2011-07-13T11:25:25+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/718-Appeal-to-make-garden-dream-for-disabled-youngster-a-reality.aspx" /><content type="html">&lt;p class="MsoPlainText" style="margin: 0cm 0cm 0pt; line-height: 150%;"&gt;&lt;span style="font-size: 11pt; line-height: 150%; font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;"&gt;An appeal has been launched in Sheffield to help make a disabled youngster&amp;rsquo;s dream a reality.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span style="font-size: 11pt; line-height: 150%; font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;"&gt;National charity, Caudwell Children, are urgently seeking help to carry out a garden makeover for 11-year-old, Husnain Munir, so he can play outside with twin brother, Hashim, and friends.&lt;/span&gt;&lt;/p&gt;</content></entry><entry><id>31922f50-0aa3-4eee-b90b-f4d42b8fa80a</id><title type="text">Biotage Introduces New Microwave Peptide Synthesizer Delivering Higher Reliability, Purity and Yield </title><updated>2011-07-12T16:09:19+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/725-Biotage-Introduces-New-Microwave-Peptide-Synthesizer-Delivering-Higher-Reliability--Purity-and-Yield-.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.biotage.com/" target="_blank"&gt;Biotage&lt;sup&gt;&amp;reg;&lt;/sup&gt;&lt;/a&gt; (STO: BIOT), a leading supplier of tools and technology for analytical, medicinal, and peptide chemistry, introduced an innovative, new instrument for peptide professionals at the 2011 American Peptide Symposium in San Diego, California USA.&lt;/p&gt;</content></entry><entry><id>4ddf4a6c-6de8-4863-b8ae-3cef19d5032d</id><title type="text">Roche NimbleGen and Caliper Collaborate to Offer Automated Target Enrichment Pipeline Solution for Next-Generation Sequencing</title><updated>2011-07-12T15:11:31+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/724-Roche-NimbleGen-and-Caliper-Collaborate-to-Offer-Automated-Target-Enrichment-Pipeline-Solution-for-Next-Generation-Sequencing.aspx" /><content type="html">&lt;p&gt;Roche and Caliper Life Sciences , Inc. (NASDAQ: CALP) today announced a co-marketing agreement for the development and optimization of automated protocols for the NimbleGen SeqCap EZ Library solution-based capture method for Caliper&amp;rsquo;s Sciclone NGS Workstation. The collaboration aims to simplify high throughput targeted resequencing workflows by developing automated methods for sequencing library preparation and enrichment of target regions, quantification, and quality control. The automated methods will enable biomedical researchers worldwide to analyze large cohorts to discover and confirm genetic variants that contribute to human disease.&lt;/p&gt;</content></entry><entry><id>b8d81e46-5464-47da-83ef-2e55ee0b755e</id><title type="text">Lophius Biosciences Expands its Management Team and Prepares for Market Entry at the Beginning of 2012 </title><updated>2011-07-11T09:58:49+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/723-Lophius-Biosciences-Expands-its-Management-Team-and-Prepares-for-Market-Entry-at-the-Beginning-of-2012-.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.lophius.de/en/home.html" target="_blank"&gt;Lophius Biosciences&lt;/a&gt;, a leading developer of novel, innovative T-cell-based diagnostic test systems, announced the expansion of its existing management team today. In addition to its CEO, Dr. Michael Lutz, the CSO and cofounder Dr. Ludwig Deml, and the cofounder and Head of the Business Development, Dr. Nadja Prang, Lophius Biosciences will supplement its experienced management team with the following people:&lt;/p&gt;</content></entry><entry><id>cdc01e03-687d-4a2c-8606-bd3cf1b258cc</id><title type="text"> SUE RYDER’S ST JOHN’S HOSPICE GETS THE VIP TREATMENT – AGAIN! </title><updated>2011-07-08T16:51:55+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/722--SUE-RYDER-S-ST-JOHN-S-HOSPICE-GETS-THE-VIP-TREATMENT---AGAIN--.aspx" /><content type="html">&lt;p&gt;Thanks to its recent &amp;pound;568,000 renovation, Sue Ryder&amp;rsquo;s St John&amp;rsquo;s Hospice is already going from strength to strength in providing even better services and facilities for local people needing high quality end of life care.&lt;/p&gt;</content></entry><entry><id>42f26be1-3a00-4a78-abb9-341236e0fccb</id><title type="text">SUE RYDER SYNERGY CAFÉ – A LIFELINE FOR LOCAL PEOPLE WITH DEMENTIA AND THEIR CARERS</title><updated>2011-07-08T15:36:29+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/721-SUE-RYDER-SYNERGY-CAF%C3%89---A-LIFELINE-FOR-LOCAL-PEOPLE-WITH-DEMENTIA-AND-THEIR-CARERS.aspx" /><content type="html">&lt;p&gt;Having dementia and caring for someone with this devastating condition can be tough and isolating, which is why Sue Ryder&amp;rsquo;s Synergy Caf&amp;eacute; on Chantry Park is seen as a lifeline by many local people, including Ipswich couples Donna and Steve Fenton and Jenny and Mick Webster.&lt;/p&gt;</content></entry><entry><id>cc47e9e6-5efa-4af1-b73d-213838a623c3</id><title type="text">Biotage Raises the Bar in Microwave Synthesis </title><updated>2011-07-08T15:34:30+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/720-Biotage-Raises-the-Bar-in-Microwave-Synthesis-.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.biotage.com/" target="_blank"&gt;Biotage&lt;sup&gt;&amp;reg;&lt;/sup&gt;&lt;/a&gt;, a leading supplier of tools and technology for analytical, medicinal, and peptide chemistry, announced a new microwave synthesizer with state of the art user interface and industry leading operating range.&lt;/p&gt;</content></entry><entry><id>3e1f792e-e001-4d3c-9d47-d60a5787e352</id><title type="text">The New Chevrolet Camaro Is Set To Arrive Here Next Year</title><updated>2011-07-08T14:57:16+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/532-The-New-Chevrolet-Camaro-Is-Set-To-Arrive-Here-Next-Year.aspx" /><content type="html">&lt;p&gt;Arriving in Pentagon showrooms in early 2012, the beefy American muscle car will be available from only &amp;pound;34,995 on-the-road. For that, customers will get a 6.2-litre V8 engined performance icon, with 432PS and suspension fine-tuned for European roads.&amp;nbsp;&lt;/p&gt;</content></entry><entry><id>dfd5bb8c-7912-4764-b529-b628687f3159</id><title type="text">Help's On Hand For Alfie</title><updated>2011-07-08T11:18:17+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/698-Help-s-On-Hand-For-Alfie.aspx" /><content type="html">&lt;p&gt;A disabled youngster in South Wales is set to receive specialist equipment that will help him spend time with his family outdoors.&lt;/p&gt;
&lt;p&gt;Four-year-old, Alfie Hooper who has Dystonic Tremor Syndrome and Developmental Delay, will soon have a specialist buggy to help him leave his Aberdare home.&lt;/p&gt;</content></entry><entry><id>48b7c42a-b94e-4fa7-aab5-631352156203</id><title type="text">Urgent Appeal To Get Yorkshire Youngster Wheely Going</title><updated>2011-07-08T11:15:08+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/717-Urgent-Appeal-To-Get-Yorkshire-Youngster-Wheely-Going.aspx" /><content type="html">&lt;p class="MsoNormal" style="margin: 0cm 0cm 0pt; line-height: 150%;"&gt;&lt;span style="font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;"&gt;&lt;span style="font-size: small;"&gt;An urgent appeal has been launched to help keep a disabled youngster from South Yorkshire on the right track.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin: 0cm 0cm 0pt; line-height: 150%;"&gt;&lt;span style="font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;;"&gt;&lt;span style="font-size: small;"&gt;&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span style="font-size: 11pt; font-family: &amp;quot;Arial&amp;quot;,&amp;quot;sans-serif&amp;quot;; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; mso-ansi-language: EN-GB; mso-fareast-language: EN-GB; mso-bidi-language: AR-SA;"&gt;Four-year-old Oliver Fahey, has a rare condition known as Angelman Syndrome, which causes seizures, effects development and means he requires round the clock care. Often misdiagnosed in youngsters as Cerebral Palsy, the rare neuro-genetic condition also affects mobility and means Oliver requires regular physiotherapy&lt;/span&gt;&lt;/p&gt;</content></entry><entry><id>f3724f80-6450-4dcd-96e3-90a91fd562ff</id><title type="text">Metanomics Health Launches its Energy Metabolite Platform – a Unique Target Platform Based on Metabolite Profiling </title><updated>2011-07-07T09:30:55+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/716-Metanomics-Health-Launches-its-Energy-Metabolite-Platform---a-Unique-Target-Platform-Based-on-Metabolite-Profiling-.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.metanomics-health.de/" target="_blank"&gt;Metanomics Health GmbH&lt;/a&gt; today announced the official launch of its new &lt;a href="http://www.metanomics-health.de/metabolite-profiling-1056.html#A1090" target="_blank"&gt;Energy Metabolite Platform&lt;/a&gt;. This targeted platform maps key metabolites affecting the energy status of a biological system. Metanomics Health GmbH, a Berlin  based BASF Group company, is market leader in offering non-targeted and targeted metabolite profiling to healthcare customers.&lt;/p&gt;</content></entry><entry><id>69ea0218-9af6-4d6a-944a-b94eb2e69563</id><title type="text">Oncolytics Biotech Announces Appointment of Dr. George M. Gill as Chief Medical Officer</title><updated>2011-07-06T09:42:16+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/715-Oncolytics-Biotech-Announces-Appointment-of-Dr--George-M--Gill-as-Chief-Medical-Officer.aspx" /><content type="html">&lt;p&gt;Oncolytics Biotech Inc. today announced the appointment of George M. Gill, MD as Chief Medical Officer. He has been Senior Vice President of Clinical Safety and Regulatory Affairs and an officer of Oncolytics since 2002.&lt;/p&gt;</content></entry><entry><id>6006c6ca-82e6-4646-8106-a077010aeec8</id><title type="text">Nuvo Research announces marketing authorization application for Pliaglis® validated by European Regulatory Agencies</title><updated>2011-07-06T09:28:26+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/714-Nuvo-Research-announces-marketing-authorization-application-for-Pliaglis--validated-by-European-Regulatory-Agencies.aspx" /><content type="html">&lt;p&gt;Nuvo Research Inc. a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain, today announced that its Marketing Authorization Application (MAA) for Pliaglis has been validated in the European Union (EU). The MAA was submitted using the decentralized procedure to request marketing approval for Pliaglis for the indication of producing local dermal anaesthesia on intact skin in adults prior to superficial dermatological procedures.&amp;nbsp; Worldwide marketing rights for Pliaglis have been licensed to Galderma Pharma S. A., a global specialty pharmaceutical company focused on dermatology.&lt;/p&gt;</content></entry><entry><id>92bf30c1-ce5a-4807-babd-cd04e5f2c736</id><title type="text">Sue Ryder comments on the Palliative Care Funding Review</title><updated>2011-07-01T09:53:21+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/711-Sue-Ryder-comments-on-the-Palliative-Care-Funding-Review.aspx" /><content type="html">&lt;p&gt;Paul Woodward, Chief Executive of Sue Ryder, comments&amp;nbsp;on the Palliative Care Funding Review published today.&lt;/p&gt;</content></entry><entry><id>5bf6fe3d-ffc0-4982-9952-b6655fecd5b6</id><title type="text">Great Rail Journeys and Treyn launch winter brochure collection</title><updated>2011-06-30T09:39:41+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/greatrail/710-Great-Rail-Journeys-and-Treyn-launch-winter-brochure-collection.aspx" /><content type="html">&lt;p&gt;Great Rail Journeys and Treyn have launched their winter collection of brochures including for the first time, a worldwide winter stand-alone brochure from Great Rail Journeys. 14 new tours are offered in total across the brands, including the first long haul departure for Treyn to India and more UK tours due to their phenomenal success in summer this year.&lt;/p&gt;</content></entry><entry><id>fb1417b7-7c64-494a-a7f8-40e2604fecc9</id><title type="text">Charity Adds To Colour Of Oldham Mela</title><updated>2011-06-29T15:11:30+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/707-Charity-Adds-To-Colour-Of-Oldham-Mela.aspx" /><content type="html">&lt;p&gt;A national charity has announced a partnership with Oldham&amp;rsquo;s largest cultural festival in their bid to reach out and help disabled children in Asian communities across the UK.&lt;/p&gt;
&lt;p&gt;Caudwell Children, who provide life-changing support for children with disabilities, will be attending the Preston Mela in Alexandra Park, and providing activities and information for visitors&lt;/p&gt;</content></entry><entry><id>7fb72027-901a-42a9-8c07-7891cf59a108</id><title type="text">Plea To Join Life-Changing Team</title><updated>2011-06-29T15:10:18+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/697-Plea-To-Join-Life-Changing-Team.aspx" /><content type="html">&lt;p&gt;A national children&amp;rsquo;s charity is urging volunteers to come forward and help make their work in Northern Ireland more life-changing than ever before.&lt;/p&gt;
&lt;p&gt;Caudwell Children is seeking support from across the country to join their charity team, who are committed to changing the lives of children by providing specialist equipment, treatment and therapy; as well as its annual Destination Dreams holiday and family support services.&lt;/p&gt;</content></entry><entry><id>dedcb453-842e-4c62-a567-bfdd3789e037</id><title type="text">Charity Adds To Colour of Leeds Asian Festival</title><updated>2011-06-29T15:09:49+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/708-Charity-Adds-To-Colour-of-Leeds-Asian-Festival.aspx" /><content type="html">&lt;p&gt;A national charity has announced a partnership with one of Leeds&amp;rsquo; largest cultural festival in their bid to reach out and help disabled children in Asian communities across the UK.&lt;/p&gt;
&lt;p&gt;Caudwell Children, who provide life-changing support for children with disabilities, will be attending the Leeds Asian Festival in Roundhay Park, and providing activities and information for visitors.&lt;/p&gt;</content></entry><entry><id>21addb49-686e-4c13-ba1f-5cd36064fe3e</id><title type="text">Teenager In Danger Of Losing Only Chance To Walk</title><updated>2011-06-29T15:07:55+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/700-Teenager-In-Danger-Of-Losing-Only-Chance-To-Walk.aspx" /><content type="html">&lt;p&gt;A Mother from Southsea is making a final desperate plea for help to send her brave disabled son to America for a life-changing operation.&lt;/p&gt;
&lt;p&gt;For the past three months the generous friends and family of&amp;nbsp;Sara Findlay have come together to support 13-year-old Daniel&amp;rsquo;s campaign to receive ground-breaking Cerebral Palsy treatment in the USA and have so far raised &amp;pound;32,000&lt;/p&gt;</content></entry><entry><id>a50b464f-9561-43f4-968a-8576eb212861</id><title type="text">Charity Adds To Colour Of Preston Mela</title><updated>2011-06-29T15:07:33+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/701-Charity-Adds-To-Colour-Of-Preston-Mela.aspx" /><content type="html">&lt;p&gt;A national charity has announced a partnership with Preston&amp;rsquo;s largest cultural festival in their bid to reach out and help disabled children in Asian communities across the UK.&lt;/p&gt;
&lt;p&gt;Caudwell Children, who provide life-changing support for children with disabilities, will be attending the Preston Mela in Avenham Park, and providing activities and information for visitors.&lt;/p&gt;</content></entry><entry><id>b70f5cf3-7eff-4842-8493-619e77965268</id><title type="text">Charity Appeal To Help Light Up Disabled Boys World</title><updated>2011-06-29T15:07:15+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/699-Charity-Appeal-To-Help-Light-Up-Disabled-Boys-World.aspx" /><content type="html">&lt;div id="_mcePaste" class="mcePaste" style="position: absolute; width: 1px; height: 1px; overflow: hidden; top: 0px; left: -10000px;"&gt;?&lt;/div&gt;
&lt;p&gt;An urgent appeal has been launched to help a disabled toddler from Greater Manchester get vital equipment.&lt;br /&gt;&lt;br /&gt;Two-year-old Haris Mahmood, who has Epilepsy, developmental delay, megablastic anaemia and visual impairment, requires sensory equipment at home to help with his frequent seizures and developmental delay.&lt;/p&gt;</content></entry><entry><id>2076316b-9fe6-4671-b975-3094cf6ab6eb</id><title type="text">Storage Company Triples Space For Local Charity</title><updated>2011-06-29T15:07:00+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/706-Storage-Company-Triples-Space-For-Local-Charity.aspx" /><content type="html">&lt;p&gt;A national storage company has donated extra space to meet the needs of a Staffordshire based children&amp;rsquo;s charity.&lt;/p&gt;
&lt;p&gt;Armadillo Self Storage, on Victoria Road, Fenton, have tripled Caudwell Children&amp;rsquo;s storage space, helping the charity expand its resources further.&lt;/p&gt;</content></entry><entry><id>4bf838d6-29fb-45bc-b267-33150b978ff0</id><title type="text">RUN FOR CHARITY AND MAKE THE GREAT NORTH RUN  AN UNFORGETTABLE EXPERIENCE </title><updated>2011-06-29T12:40:29+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/705-RUN-FOR-CHARITY-AND-MAKE-THE-GREAT-NORTH-RUN--AN-UNFORGETTABLE-EXPERIENCE-.aspx" /><content type="html">&lt;p&gt;Failed to get a ballot place in the Great North Run? Health and social care charity Sue Ryder is delighted to offer runners 60 guaranteed places into the world&amp;rsquo;s most iconic half marathon - but be quick, as places are going fast. This event welcomes runners at all levels to come and join the charity in what proves to be a magnificent event.&lt;/p&gt;</content></entry><entry><id>404488b3-01aa-4a8f-b445-e08700c55e0e</id><title type="text">Treyn add new German Christmas Market tours</title><updated>2011-06-29T10:38:59+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/treyn/704-Treyn-add-new-German-Christmas-Market-tours.aspx" /><content type="html">&lt;p&gt;Treyn have introduced a selection of new tours to various Christmas Markets in Germany within their newly launched winter programme. Alongside a range of existing tours, customers can visit the Christmas Markets of the Black Forest, plus Munich and Bavarian Christmas Markets. A selection of dates are available but early booking is advised.&lt;/p&gt;</content></entry><entry><id>d9bc9069-9077-42d7-8218-dd08e139e3b8</id><title type="text">Significant Assay Results for Wowo Gap Nickel Deposit</title><updated>2011-06-28T10:00:39+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/rmc/517-Significant-Assay-Results-for-Wowo-Gap-Nickel-Deposit.aspx" /><content type="html">&lt;p&gt;Wowo Gap Nickel Deposit Bigger&lt;br /&gt;&amp;nbsp;&lt;br /&gt;Innovative Perth-based minerals explorer Resource Mining Corporation (ASX:RMI) has recorded significant nickel and cobalt assay results from its latest drill program at its Wowo Gap Nickel deposit, located 200 kilometres east of Port Moresby in Papua New Guinea in an area known to host significant Nickel-Cobalt mineralisation.&lt;/p&gt;</content></entry><entry><id>edf26e99-deba-40ef-8fbe-d405982c145a</id><title type="text">Randox Announce Worldwide Launch of Automated Biochemistry Assay for Heart-type Fatty Acid Binding Protein (H-FABP)</title><updated>2011-06-23T12:13:02+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/703-Randox-Announce-Worldwide-Launch-of-Automated-Biochemistry-Assay-for-Heart-type-Fatty-Acid-Binding-Protein--H-FABP-.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.randox.com/" target="_blank"&gt;Randox Laboratories Ltd&lt;/a&gt;, the international clinical diagnostics company, has today announced the official worldwide launch of an automated laboratory assay for Heart-type Fatty Acid Binding Protein (H-FABP), to be used in the diagnosis and management of patients with suspected acute coronary syndrome (ACS).&lt;/p&gt;</content></entry><entry><id>1085f6c9-aa41-42b5-9509-f9fb55c03700</id><title type="text">Sue Ryder picks up honours in the  Business in the Community  East of England 2011 Awards for Excellence </title><updated>2011-06-22T16:13:03+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/702-Sue-Ryder-picks-up-honours-in-the--Business-in-the-Community--East-of-England-2011-Awards-for-Excellence-.aspx" /><content type="html">&lt;p&gt;Sue Ryder scooped the Right Step Award in the Business in the Community East of England 2011 Awards for Excellence at a ceremony held at Hengrave Hall, Bury St Edmunds.&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;p&gt;This Award was open to companies who have adopted the most innovative approach to working with the criminal justice system to help reduce re-offending in the East of England region.&amp;nbsp;&lt;/p&gt;</content></entry><entry><id>48714199-4443-4bad-aefc-484c854b70e1</id><title type="text">TIPPING POINT FILM FUND – Press Preview Screening of Just Do It – A Tale of Modern-Day Outlaws - followed by Q&amp;A with Director Emily James</title><updated>2011-06-22T12:39:57+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/tippingpoint/680-TIPPING-POINT-FILM-FUND---Press-Preview-Screening-of-Just-Do-It---A-Tale-of-Modern-Day-Outlaws---followed-by-Q-A-with-Director-Emily-James.aspx" /><content type="html">&lt;p&gt;Ahead of its release on 15th July, TPFF Film Club is screening &lt;strong&gt;&amp;lsquo;Just Do It&amp;rsquo;&lt;/strong&gt; &amp;ndash; a tale of modern-day outlaws - a feature documentary by Emily James about environmental direct action. Emily James will be taking part in a Q&amp;amp;A following the screening.&lt;/p&gt;</content></entry><entry><id>524e0443-4a14-4d70-94b6-c59004c30533</id><title type="text">The New Chevrolet Captiva SUV Arrives At Pentagon Chevrolet</title><updated>2011-06-22T09:25:42+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/531-The-New-Chevrolet-Captiva-SUV-Arrives-At-Pentagon-Chevrolet.aspx" /><content type="html">&lt;p&gt;The new-look Chevrolet Captiva SUV is now on sale at Pentagon Chevrolet in Derby, Nottingham, Mansfield, Sheffield, Barnsley and Rochdale.&lt;/p&gt;</content></entry><entry><id>d6b915c3-5776-4055-beb8-0532ab808074</id><title type="text">Roche Diagnostics Supports European Union’s DETECTIVE Project to Reduce Animal Testing</title><updated>2011-06-21T16:55:02+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/696-Roche-Diagnostics-Supports-European-Union-s-DETECTIVE-Project-to-Reduce-Animal-Testing.aspx" /><content type="html">&lt;p&gt;The xCELLigence RTCA System of Roche is being used in the European Union&amp;rsquo;s DETECTIVE ("Detection of endpoints and biomarkers for repeated dose toxicity using &lt;em&gt;in vitro&lt;/em&gt; systems&amp;rdquo;) Project, a joint study funded by the European Cosmetics Association (&lt;a title="Colipa" href="http://www.colipa.eu/" target="_blank"&gt;Colipa&lt;/a&gt;) and the European Commission, where Roche is a member of the consortium . The DETECTIVE Project encompasses fifteen scientific and commercial partners from different EU states under the leadership of Professor Dr. J&amp;uuml;rgen Hescheler from the University  of Cologne, a pioneer in producing cardiomyocytes from stem cells. The goal is to establish a screening pipeline of high content and high throughput, using classical functional genomics, proteomics, and &amp;ldquo;cellomics&amp;rdquo; technologies. Ultimately, human biomarkers will be identified and characterized for use in cellular models using repeated dose &lt;em&gt;in vitro&lt;/em&gt; testing, in particular for use in the field of cosmetics.&lt;/p&gt;</content></entry><entry><id>5c03b39c-e231-4a77-9f9f-021680c11f7d</id><title type="text">Treyn adds extra capacity to French rail holidays</title><updated>2011-06-21T11:50:55+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/treyn/695-Treyn-adds-extra-capacity-to-French-rail-holidays.aspx" /><content type="html">&lt;p&gt;Treyn &amp;ndash; the rail holidays specialist &amp;ndash; has boosted capacity on escorted rail holidays to France this summer, after many of its Spring departures sold out.&lt;/p&gt;</content></entry><entry><id>b88f4a9c-becd-461f-b869-70da6d670048</id><title type="text">Peugeot 207 Is The Most Reliable Car Built In Europe </title><updated>2011-06-21T08:34:17+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/530-Peugeot-207-Is-The-Most-Reliable-Car-Built-In-Europe-.aspx" /><content type="html">&lt;p&gt;Warranty Direct has revealed that the most reliable car made by a European car company is the Peugeot 207, available at Pentagon Peugeot in Burton on Trent.&lt;/p&gt;</content></entry><entry><id>4d2aafce-1886-465d-a7ff-714990b0119e</id><title type="text">PLIGHT OF REFUGEES:  KEY TO RESOLVING PALESTINIAN-ISRAELI CONFLICT, CHRISTIAN AID</title><updated>2011-06-20T10:07:37+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/694-PLIGHT-OF-REFUGEES---KEY-TO-RESOLVING-PALESTINIAN-ISRAELI-CONFLICT--CHRISTIAN-AID.aspx" /><content type="html">&lt;p&gt;The plight of Palestinian refugees must be urgently addressed if peace between Israel and the Palestinians is ever to become a reality, warns Christian Aid in a new report.&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;p&gt;&lt;em&gt;&amp;nbsp;&lt;/em&gt;&lt;/p&gt;</content></entry><entry><id>932da315-c8f7-412b-ae48-6de938353629</id><title type="text">Boehringer Ingelheim extends "one stop shop" service with new fill and finish capabilities</title><updated>2011-06-20T09:34:46+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/693-Boehringer-Ingelheim-extends--one-stop-shop--service-with-new-fill-and-finish-capabilities.aspx" /><content type="html">&lt;p&gt;To round off its full-service capabilities for clients, Boehringer Ingelheim is expanding its capacities and capabilities in fill &amp;amp; finish for biopharmaceuticals at their state-of-the-art facility in Biberach, Germany, with a new filling line. The new line is available as of today for contract filling of liquid and lyo vials from 0,5 ml- 100 ml. The expansion to a combination line for single and double chamber catridges will be up and running in Q4 2012. To meet the customers&amp;rsquo; demand for clinical and commercial scale filling the batch sizes range from 6.000 &amp;ndash; 110.000 ml for vials and 50.000 &amp;ndash; 100.000 ml for carpoules.&lt;/p&gt;</content></entry><entry><id>d466dbe4-3d9a-4215-9b71-26e2fe43f5a7</id><title type="text">EMBROIDERED DESIGNS FROM CHRISTY - FRESH FOR THE SUMMER</title><updated>2011-06-19T16:07:21+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/christy/524-EMBROIDERED-DESIGNS-FROM-CHRISTY---FRESH-FOR-THE-SUMMER.aspx" /><content type="html">&lt;p&gt;Christy introduces delicate embroidered designs with textural detailing to its bed linen collections.&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;</content></entry><entry><id>bbbd8007-6d11-458a-b565-d9f5641cb10f</id><title type="text">National Charity Highlights Importance of Supporting UK's 6 Million Carers</title><updated>2011-06-17T16:56:16+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/676-National-Charity-Highlights-Importance-of-Supporting-UK-s-6-Million-Carers.aspx" /><content type="html">&lt;p&gt;To coincide with this year&amp;rsquo;s Carers Week (13 &amp;ndash; 19 June) national health and social care charity Sue Ryder is highlighting the importance of supporting carers in their vital role of looking after a loved one.&amp;nbsp;&lt;/p&gt;
&lt;p&gt;According to new estimates from a recent survey conducted by Carers UK and the University of Leeds, the care provided by carers, who provide unpaid support for an ill, fragile or disabled loved one, is worth a staggering &amp;pound;119billion to the economy*.&lt;/p&gt;</content></entry><entry><id>e529194b-a496-46ca-8001-86f7f7050659</id><title type="text">Vauxhall Starts Summer With 20 Per Cent Off New Cars</title><updated>2011-06-17T09:21:31+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/528-Vauxhall-Starts-Summer-With-20-Per-Cent-Off-New-Cars.aspx" /><content type="html">&lt;p&gt;Summer savings at Pentagon Vauxhall just got hotter as they can now offer customers 20 per cent off a brand new Vauxhall. Buyers can expect savings of nearly &amp;pound;5,000 on the British-built Astra Sports Tourer or drive away a new Corsa S from only &amp;pound;6795.&lt;/p&gt;</content></entry><entry><id>19874d13-49b2-4275-9d90-8265392c5631</id><title type="text">Lamellar Biomedical Secures its First Orphan Drug Licence</title><updated>2011-06-16T13:29:12+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/692-Lamellar-Biomedical-Secures-its-First-Orphan-Drug-Licence.aspx" /><content type="html">&lt;p&gt;Glasgow biopharmaceutical firm, &lt;a href="http://www.lamellar.com/" target="_blank"&gt;Lamellar Biomedical Ltd&lt;/a&gt;, launched four years ago to develop a new class of therapies for the prevention, treatment and control of severe respiratory disease, today announced that their lead clinical candidate &lt;a href="http://www.lamellar.com/pipeline.html" target="_blank"&gt;LMS-611&lt;/a&gt; for the treatment of patients with cystic fibrosis has received Orphan Drug Designation from the European Commission. The designation follows a positive opinion from the Committee for Orphan Medicinal Products (COMP) within the European Medicines Agency (EMA) earlier this month.&lt;/p&gt;</content></entry><entry><id>5ae09b0a-d16f-4b79-8558-a87e7b30be43</id><title type="text">Seat Copa S Now Reduced To £9995 At Pentagon Seat Nottingham</title><updated>2011-06-16T11:45:57+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/529-Seat-Copa-S-Now-Reduced-To--9995-At-Pentagon-Seat-Nottingham.aspx" /><content type="html">&lt;p&gt;At Pentagon SEAT in Nottingham we pride ourselves on offering unparalleled cars for unmatched value. The new Copa range is the definition of this principle. Available in both the SEAT Ibiza and SEAT Leon car families, Copa combines everything you expect from a SEAT - sleek style, cutting edge technology and thrilling performance - with a range of upgrades, as standard.&lt;/p&gt;</content></entry><entry><id>d6dbe73c-1770-4a4b-9cc3-3cac88b85608</id><title type="text">CEVEC and Catalent Pharma Solutions Offer Joint Cell Line Development Service</title><updated>2011-06-16T11:18:29+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/690-CEVEC-and-Catalent-Pharma-Solutions-Offer-Joint-Cell-Line-Development-Service.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.cevec.com/" target="_blank"&gt;CEVEC Pharmaceuticals&lt;/a&gt;, the German developer of a novel, market leading human protein expression system derived from amniocytes, and &lt;a href="http://www.catalent.com/" target="_blank"&gt;Catalent Pharma Solutions&lt;/a&gt;, a leading global drug development and delivery solutions provider, announced today a joint commercial cell line development service for pharma and biotech customers worldwide. The offering combines the benefits of CEVEC&amp;rsquo;s human cell line, &lt;a href="http://www.cevec.com/technology" target="_blank"&gt;CAP-Technology&lt;/a&gt;, with Catalent&amp;rsquo;s unique &lt;a href="http://www.catalent.com/index.php#development/biologics/gpex" target="_blank"&gt;GPEx&amp;reg;&lt;/a&gt; (Gene Product Expression) Technology to generate high expressing stable human cell lines in a much shorter timeframe than traditional methods.&lt;/p&gt;</content></entry><entry><id>d510c416-7c9c-4f09-ba7f-1588258c7e09</id><title type="text">BIA Separations Awarded by KAPPA-Health as a Model SME in EU Co-funded Projects</title><updated>2011-06-16T11:00:55+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/689-BIA-Separations-Awarded-by-KAPPA-Health-as-a-Model-SME-in-EU-Co-funded-Projects.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.biaseparations.com/" target="_blank"&gt;BIA Separations&lt;/a&gt;, Austrian-Slovenian developer and manufacturer of &lt;a href="http://www.biaseparations.com/sp/209/cim-technology" target="_blank"&gt;CIM&amp;reg;&lt;/a&gt; short monolithic chromatographic columns optimized for the separation and purification of large bio-molecules on laboratory and industrial scale, announces that it has received the &lt;a href="http://www.kappa-health.org/News/259.aspx" target="_blank"&gt;KAPPA-HEALTH AWARD 2011&lt;/a&gt; for being one of the most successful research-intensive and high-tech SMEs in European Union. It received the award because it demonstrated during its participation in Framework 6 &amp;amp; 7 Projects that it is &amp;ldquo;a model of the wide range of successful research-intensive SMEs participating in an EU co-funded project&amp;rdquo;.&lt;/p&gt;</content></entry><entry><id>98916f1b-f42f-4c0a-8deb-78d129e272d5</id><title type="text">UK government must fully support domestic workers’ rights</title><updated>2011-06-15T16:39:36+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/688-UK-government-must-fully-support-domestic-workers--rights.aspx" /><content type="html">&lt;p&gt;The UK government must honour its commitment to a new international convention protecting domestic workers from exploitation and stop trying to attempt to dilute proposed safeguards, a coalition of non-governmental organisations &amp;ndash; which includes the TUC, Christian Aid and Anti-Slavery International &amp;ndash; says today.&lt;/p&gt;</content></entry><entry><id>f025a448-a9bb-4c7e-9163-39a75a729724</id><title type="text">Vetter Invests in Additional Lyophilization Capacity</title><updated>2011-06-15T16:28:53+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/687-Vetter-Invests-in-Additional-Lyophilization-Capacity.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.vetter-pharma.com/start-en/startseite-en?set_language=en" target="_blank"&gt;Vetter&lt;/a&gt;, a leading specialist in aseptic filling, has installed three additional state-of-the-art lyophilizers at the company&amp;rsquo;s Ravensburg Vetter South facility, nearly doubling its number of freeze-dryers. Altogether, the site will be able to produce up to 24 million lyophilized units annually. The new equipment increases the number of lyophilizers across all Vetter facilities by 30 percent. The company made the investment to meet anticipated future demand for aseptically filled biologics and other sensitive compounds, which often require lyophilization to prolong shelf life and potency. In the last three years, more than 30 percent of all novel drugs approved in the United States were lyophilized, according to the U.S. Food and Drug Administration. Experts predict continued growth.&lt;/p&gt;</content></entry><entry><id>0ee97134-21af-4bd3-b90f-2b85a7e92744</id><title type="text">MPs’ India report is a valuable contribution to the aid debate</title><updated>2011-06-15T16:16:55+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/686-MPs--India-report-is-a-valuable-contribution-to-the-aid-debate.aspx" /><content type="html">&lt;p&gt;A new House of Commons report on British aid to India is a welcome endorsement of efforts to tackle the devastating discrimination which excludes many millions of people from mainstream Indian society, Christian Aid says today (Tuesday).&lt;/p&gt;</content></entry><entry><id>986dd5c9-58e1-4350-b3e7-16450c4ad078</id><title type="text">Treyn offers first all-inclusive tour - new for 2011</title><updated>2011-06-15T14:58:23+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/treyn/685-Treyn-offers-first-all-inclusive-tour---new-for-2011.aspx" /><content type="html">&lt;p&gt;&lt;strong&gt;NEW FOR 2011 - Treyn &lt;/strong&gt;has launched its first all inclusive tour, which offers an exploration of Austria&amp;rsquo;s Alpine resorts and mountains and all-inclusive meals whilst in the region. The &amp;lsquo;Tyrolean All Inclusive&amp;rsquo; is an eight day tour which departs between May and October 2011 and is priced from &amp;pound;795 per person based on two sharing. It includes return rail travel from London&amp;rsquo;s St Pancras International, seven nights&amp;rsquo; hotel accommodation with breakfast, seven dinners, four lunches and all inclusive drinks whilst in the Hopfgarten, a journey on the Zillertalbahn Railway to Mayrhofen, excursion to Kitzbuhel, visit to Kufstein, cruise on the River Inn and the services of a Tour Manager.&lt;/p&gt;</content></entry><entry><id>b73cf823-4141-434e-aa5d-e9c4dee17d19</id><title type="text">Response to NHS reforms</title><updated>2011-06-14T16:36:14+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/679-Response-to-NHS-reforms.aspx" /><content type="html">&lt;p&gt;We welcome many of the changes suggested by the Future Forum and accepted by the government. We support the idea of competition based on quality of care and not cost. We believe that this will drive standards up in the area and allow charities such as Sue Ryder an excellent chance of entering the marketplace.&lt;/p&gt;</content></entry><entry><id>f5c8d25b-690d-4efd-b317-2a2f10d832fe</id><title type="text">Run For Congo Women on July 3rd with Pamela Stephenson</title><updated>2011-06-13T16:54:06+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/women4women/678-Run-For-Congo-Women-on-July-3rd-with-Pamela-Stephenson.aspx" /><content type="html">&lt;p&gt;Run for Congo Women 3 July...and help women traumatised by the human conflict rebuild their lives&lt;br /&gt;&lt;br /&gt;Take part in our 10K Run for Congo, in Regents Park, London,&amp;nbsp; on 3 July and join hundreds of other runners including TV personality Pamela Stephenson&amp;nbsp; who are raising funds to help women devastated by the human conflict in the Democratic Republic of Congo (where 5.5 million have died) to rebuild their lives.&lt;/p&gt;</content></entry><entry><id>8cf8f911-d4ab-47d5-baeb-1aec0d264218</id><title type="text">Xceleron Announces Key Board and Executive Appointments</title><updated>2011-06-13T10:32:30+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/677-Xceleron-Announces-Key-Board-and-Executive-Appointments.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.xceleron.com/" target="_blank"&gt;XCELERON&lt;/a&gt;, a leader in accelerating drug development using ultra-sensitive bioanalytical analyses, today announced that Dr. David Roblin has been appointed to its Board of Directors in a non-Executive capacity and Dr. Stuart Best has joined the company as Senior Director Operations.&lt;/p&gt;</content></entry><entry><id>ab259e23-3913-42c1-95ff-690533c7cc36</id><title type="text">Crucial questions for IMF candidates</title><updated>2011-06-10T14:58:25+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/675-Crucial-questions-for-IMF-candidates.aspx" /><content type="html">&lt;p&gt;With nominations for the next International Monetary Fund (IMF) leader now in, campaigners including Christian Aid, ActionAid and the Bretton Woods Project are demanding that the candidates debate each other publicly.&lt;/p&gt;</content></entry><entry><id>c63e9d31-6d12-4acf-a3a4-5f8bf833b77e</id><title type="text">Brave Youngster Cheated Death And Now Fights To Walk</title><updated>2011-06-10T11:14:46+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/670-Brave-Youngster-Cheated-Death-And-Now-Fights-To-Walk.aspx" /><content type="html">&lt;p&gt;The parents of a courageous youngster who cheated death are calling for support in their bid to help him walk for the first time as they raise money for a life-changing operation.&lt;/p&gt;
&lt;p&gt;At just 8 weeks old James O&amp;rsquo;Hagan suffered a near-fatal heart attack at his Worthing home. His Mum, Grace, carried out CPR as paramedics rushed to their aid.&lt;/p&gt;</content></entry><entry><id>d2975cf4-9734-4abe-89b4-94d498a0df7a</id><title type="text">Boyzone Star Set To Host Celebrity Golf Classic</title><updated>2011-06-10T11:14:32+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/667-Boyzone-Star-Set-To-Host-Celebrity-Golf-Classic.aspx" /><content type="html">&lt;p&gt;The famous Irish singer-songwriter, Mikey Graham, has been unveiled as the host of a glamorous celebrity golf tournament set to take place in Scotland later this year.&lt;/p&gt;
&lt;p&gt;The Caudwell Children Celebrity Golf Classic will take place at the World-famous Carrick Golf Course on the banks of Loch Lomond between September 29&lt;sup&gt;th&lt;/sup&gt; and October 1&lt;sup&gt;st&lt;/sup&gt; and will raise funds for national charity, Caudwell Children.&lt;/p&gt;</content></entry><entry><id>ab52068a-c80b-4034-8485-afeb83ae9778</id><title type="text">Kind-Hearted Students Raise £9,000 For Fellow Pupil</title><updated>2011-06-10T11:14:18+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/669-Kind-Hearted-Students-Raise--9-000-For-Fellow-Pupil.aspx" /><content type="html">&lt;p&gt;Pupils at St Patrick&amp;rsquo;s High School in Eccles have raised nearly &amp;pound;9,000 for a fellow pupil who needs a life-changing Cerebral Palsy operation in the United States.&lt;/p&gt;
&lt;p&gt;The kind hearted kids have held collections and sponsored walks to raise the funds for 12-year-old Lewis Brierley, who hopes to travel to America for the treatment next month.&lt;/p&gt;</content></entry><entry><id>ebaa3c22-40dc-4e33-87e8-b404afd6d830</id><title type="text">Harry, 2, approved For £60,000 Operation That Could Change His Life</title><updated>2011-06-10T11:14:02+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/666-Harry--2--approved-For--60-000-Operation-That-Could-Change-His-Life.aspx" /><content type="html">&lt;p&gt;The parents of a two-year-old from Plumstead received confirmation this week that their son had been chosen for a ground-breaking Cerebral Palsy operation in the United States, but now face a desperate race against time to raise &amp;pound;60,000 to pay for the treatment.&lt;/p&gt;</content></entry><entry><id>72acb973-3e76-4242-a3cf-e1e362133440</id><title type="text">Private Dinner Raises £1,550,000 For Charity</title><updated>2011-06-10T11:13:49+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/665-Private-Dinner-Raises--1-550-000-For-Charity.aspx" /><content type="html">&lt;p&gt;A private dinner for friends and associates of philanthropist, John Caudwell, has raised over &amp;pound;1.5million for the charity he founded.&lt;/p&gt;
&lt;p&gt;The Caudwell Children &amp;lsquo;Butterfly Benefit&amp;rsquo; took place last night (Thursday 12&lt;sup&gt;th&lt;/sup&gt; May) at The Banqueting House in Whitehall for just 200 guests.&lt;/p&gt;
&lt;p&gt;The audience enjoyed a six-course gourmet taster menu and entertainment from Robbie Williams and Robin Gibb.&lt;/p&gt;</content></entry><entry><id>399441b1-da70-46f8-96a0-5ef222917cf1</id><title type="text">Gorvins takes a fresh look at its brand</title><updated>2011-06-09T17:04:06+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/gorvins/512-Gorvins-takes-a-fresh-look-at-its-brand.aspx" /><content type="html">&lt;p&gt;Stockport based solicitors, Gorvins, has unveiled a refreshed brand identity to help the firm achieve ambitious growth plans in a changing, more competitive legal landscape.&lt;br /&gt;&lt;br /&gt;The revamp reflects Gorvins&amp;rsquo; position of being South Manchester&amp;rsquo;s leading law firm and underlines the firm&amp;rsquo;s personal and practical approach.&lt;/p&gt;</content></entry><entry><id>b70fa00a-0f0f-4c7e-97ae-67b33772b9fb</id><title type="text">ADD FLORAL FOLKLORE TO YOUR BEDROOM WITH CHRISTY’S POPPY RANGE</title><updated>2011-06-09T16:07:14+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/christy/521-ADD-FLORAL-FOLKLORE-TO-YOUR-BEDROOM-WITH-CHRISTY-S-POPPY-RANGE.aspx" /><content type="html">&lt;p&gt;A beautiful and vibrant addition to this season&amp;rsquo;s collection is Poppy.&lt;/p&gt;</content></entry><entry><id>f5934db5-8f4d-4141-a183-0b26c5426cc9</id><title type="text">KMP Digitata complete Gorvins’ re-brand with a brand new website</title><updated>2011-06-09T13:48:05+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/kmp/672-KMP-Digitata-complete-Gorvins--re-brand-with-a-brand-new-website.aspx" /><content type="html">&lt;p&gt;&lt;strong&gt;As part of their re-branding, &lt;a title="Gorvins" href="http://www.gorvins.com/" target="_blank"&gt;Gorvins&lt;/a&gt; required a fresh new website that would focus on the needs of their clients and emphasize Gorvins&amp;rsquo; personal approach.&lt;/strong&gt;&lt;/p&gt;</content></entry><entry><id>f49226e7-f587-4263-b068-5b361733e4ec</id><title type="text">Hello Huddersfield! Pentagon Opens New Nissan Dealership </title><updated>2011-06-09T10:46:55+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/527-Hello-Huddersfield--Pentagon-Opens-New-Nissan-Dealership-.aspx" /><content type="html">&lt;p&gt;Pentagon opened their new Nissan dealership in Huddersfield on Monday 6th June, giving local people a chance to experience Nissan&amp;rsquo;s latest cars and commercial vehicles.&lt;/p&gt;</content></entry><entry><id>849e6aab-c038-4085-9525-18df97d84eeb</id><title type="text">Chevrolet Cruze 5 Door Hatch Arrives At Pentagon Next Month</title><updated>2011-06-09T09:42:35+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/526-Chevrolet-Cruze-5-Door-Hatch-Arrives-At-Pentagon-Next-Month.aspx" /><content type="html">&lt;p&gt;The striking new Cruze hatchback arrives at Pentagon Chevrloet next month, offering premium specification and great styling all at a surprisingly affordable price.&lt;br /&gt;&lt;br /&gt;With the range kicking off at only &amp;pound;13,995, the Cruze 5-door brings extra levels of sleekness and practicality to the motorsport-proven line-up, the Cruze saloon won both the 2010 BTCC Drivers championship and both drivers&amp;rsquo; and manufacturers&amp;rsquo; titles in the WTCC.&lt;/p&gt;</content></entry><entry><id>968e2145-053c-41b4-ab13-f36de64e9e75</id><title type="text">TIPPING POINT FILM FUND – Free Screening of Naomi Klein’s ‘The Take’</title><updated>2011-06-08T15:38:27+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/tippingpoint/668-TIPPING-POINT-FILM-FUND---Free-Screening-of-Naomi-Klein-s--The-Take-.aspx" /><content type="html">&lt;p&gt;To mark the Co-operatives Fortnight initiative (25th June &amp;ndash; 9th July), TPFF is screening &amp;lsquo;&lt;strong&gt;The&amp;nbsp;Take&lt;/strong&gt;&amp;rsquo; &amp;ndash; a powerful and moving film made by Naomi Klein about auto-workers in Buenos Aires&amp;nbsp;who take control over their destiny when the collapse of their banks and economy leaves the&amp;nbsp;nation in shock.&lt;/p&gt;</content></entry><entry><id>280e5cb6-e79f-4667-b14b-d17a64a9f185</id><title type="text">SPARK Impact expands investment team </title><updated>2011-06-08T11:03:27+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/664-SPARK-Impact-expands-investment-team-.aspx" /><content type="html">&lt;p&gt;Early stage venture capital company SPARK Impact, which manages the &amp;pound;25m &lt;a href="http://www.thenorthwestfund.co.uk/the-funds/biomedical"&gt;North West Fund for Biomedical&lt;/a&gt; for The North West Fund, has welcomed two new members of staff to its investment team.&lt;/p&gt;</content></entry><entry><id>63880ec6-e8a6-4073-8d9a-e8b281e89d90</id><title type="text">Vauxhall Astra GTC On Sale Now</title><updated>2011-06-08T10:33:19+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/525-Vauxhall-Astra-GTC-On-Sale-Now.aspx" /><content type="html">&lt;p&gt;These are the first official shots of the new Astra GTC, which will lay down the gauntlet to VW&amp;rsquo;s Scirocco and Renault&amp;rsquo;s Megane Coupe with a heady mix of dynamic excellence, dramatic design features and competitive pricing as order books open at Pentagon Vauxhall dealerships today. &lt;br /&gt;&lt;br /&gt;&lt;/p&gt;</content></entry><entry><id>83b12e95-c0d0-44a6-a7a3-6283fbcbb20d</id><title type="text">Ventria Bioscience Invited to Present ExpressTec™ at the 4th International Plant-Based Vaccines &amp; Antibodies Conference </title><updated>2011-06-06T16:55:01+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/663-Ventria-Bioscience-Invited-to-Present-ExpressTec--at-the-4th-International-Plant-Based-Vaccines---Antibodies-Conference-.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.ventria.com/"&gt;Ventria Bioscience&lt;/a&gt; will showcase its &lt;a href="http://ventriabiotech.com/technology/" target="_blank"&gt;ExpressTec&amp;trade;&lt;/a&gt; biomanufacturing technology at the 4&lt;sup&gt;th&lt;/sup&gt; International Plant-Based Vaccines &amp;amp; Antibodies (PBVA) Conference.  Scott Deeter, President and CEO, will present &amp;ldquo;High Yielding and  Scalable Plant-based Recombinant Protein Production in Monocots,&amp;rdquo; as  part of the Facilities and Production plenary session on Friday, June 10&lt;sup&gt;th&lt;/sup&gt; , 2011. The PBVA conference provides an international forum for the  medical, veterinary, and plant biotechnology research communities to  discuss the current state-of-the art in plant-based biologics technology  and research and development related to new product development.&lt;/p&gt;</content></entry><entry><id>0861b4a6-4b73-48b4-8445-bb9a06ee5c17</id><title type="text">Raptor Pharmaceutical Provides Update on Phase 3 Clinical Trial of DR Cysteamine for the Potential Treatment of Nephropathic Cystinosis</title><updated>2011-06-06T13:19:13+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/662-Raptor-Pharmaceutical-Provides-Update-on-Phase-3-Clinical-Trial-of-DR-Cysteamine-for-the-Potential-Treatment-of-Nephropathic-Cystinosis.aspx" /><content type="html">&lt;p&gt;Raptor Pharmaceutical Corp.&amp;nbsp; today announced that on June 3 the last clinical trial patient visits were completed and final data analysis will commence this week on the Phase 3 clinical trial of its delayed-release oral formulation of cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis. The Company announced that 41 patients have completed the nine-week study protocol and the Company expects to report the data from this trial by the end of July 2011. The extension phase of the clinical trial, in which all patients completing the Phase 3 study may elect to continue on DR Cysteamine therapy, is ongoing.&lt;/p&gt;</content></entry><entry><id>a73a02be-6228-49ae-8815-2e64874f0b17</id><title type="text">Trifunctional Antibody Catumaxomab Triggers Vaccination Effect Against Cancer</title><updated>2011-06-06T11:35:17+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/661-Trifunctional-Antibody-Catumaxomab-Triggers-Vaccination-Effect-Against-Cancer.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.trionpharma.de/"&gt;TRION Pharma&lt;/a&gt; announces today that the results from two different studies demonstrate &lt;a href="http://www.trionpharma.de/removabar/"&gt;catumaxomab&lt;/a&gt;&amp;rsquo;s capacity to activate the immune system in a way that can otherwise only be achieved through vaccination. The data were obtained by two independent research teams using catumaxomab in malignant ascites and gastric cancer, respectively. The results were recently presented at the annual meeting of the American Society of Clinical Oncology (ASCO).&lt;/p&gt;</content></entry><entry><id>40b4297e-1272-495a-aed6-331fe5766a3f</id><title type="text">CRUNCH TIME AS UK PREPARES FOR HISTORIC VOTE ON A NEW INTERNATIONAL LAW TO PROTECT DOMESTIC WORKERS </title><updated>2011-06-01T18:28:51+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/660-CRUNCH-TIME-AS-UK-PREPARES-FOR-HISTORIC-VOTE-ON-A-NEW-INTERNATIONAL-LAW-TO-PROTECT-DOMESTIC-WORKERS-.aspx" /><content type="html">&lt;p&gt;The British government must stop dragging its feet and fully support a new international convention to protect domestic workers from abuse and slavery, says a coalition of charities and Trade Unions including Anti-Slavery International and Christian Aid. &amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/p&gt;</content></entry><entry><id>dbd5a272-9ab3-4d2c-ba78-ff085856208f</id><title type="text">LIMITED EDITION 125TH ANNIVERSARY WIMBLEDON TOWEL COLLECTION - THE PERFECT WIMBLEDON SOUVENIR FROM CHRISTY </title><updated>2011-06-01T16:07:06+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/christy/523-LIMITED-EDITION-125TH-ANNIVERSARY-WIMBLEDON-TOWEL-COLLECTION---THE-PERFECT-WIMBLEDON-SOUVENIR-FROM-CHRISTY-.aspx" /><content type="html">&lt;p&gt;Christy and Wimbledon have joined forces for over two decades to bring tennis enthusiasts the official towel collection to The Championships, which also includes a special limited edition 125th Anniversary towel to commemorate the landmark occasion.&lt;/p&gt;</content></entry><entry><id>ced36cd5-79bd-4cff-ab04-33a16587ccff</id><title type="text">Vauxhall's New Greener Insignia Goes Below 120g/km </title><updated>2011-06-01T09:13:11+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/524-Vauxhall-s-New-Greener-Insignia-Goes-Below-120g-km-.aspx" /><content type="html">&lt;p&gt;Vauxhall&amp;rsquo;s European Car of the Year-winning Insignia range is now an even more compelling choice for private and business users with the addition of an ultra-low emissions ecoFLEX diesel model and a new-to-range 1.4 Turbo petrol engine.&lt;/p&gt;</content></entry><entry><id>3b82f0e2-db36-4e72-9a7b-b1ac23484a1e</id><title type="text">VOLUNTEER SUPPORT SAVES SUE RYDER £19.5 MILLION</title><updated>2011-06-01T08:07:52+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/659-VOLUNTEER-SUPPORT-SAVES-SUE-RYDER--19-5-MILLION.aspx" /><content type="html">&lt;p&gt;To coincide with this year&amp;rsquo;s Volunteers Week (1-7June) celebrations, national health and social care charity, Sue Ryder has unveiled findings of its first ever Volunteer Investment and Value Report.*&amp;nbsp;&lt;/p&gt;
&lt;p&gt;The report highlights the annual monetary value of its 8000 volunteers at &amp;pound;19.5million.&lt;/p&gt;</content></entry><entry><id>c933c5f6-bd9c-45d2-9e75-c20ede2be763</id><title type="text">The New Zafira Tourer Is Coming To Pentagon Soon</title><updated>2011-05-27T12:11:22+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/523-The-New-Zafira-Tourer-Is-Coming-To-Pentagon-Soon.aspx" /><content type="html">&lt;p&gt;Vauxhall has confirmed that the Zafira Tourer concept, previewed at this year&amp;rsquo;s Geneva Motor Show, will become a production reality, with first cars in Pentagon showrooms early in 2012.&lt;/p&gt;
&lt;p&gt;Called the Zafira Tourer, the new model will sit above the current Zafira model in Vauxhall&amp;rsquo;s line-up and is set to raise the bar for design, luxury, flexibility and innovation in the MPV sector.&lt;/p&gt;</content></entry><entry><id>e2588c33-d47c-4d50-9c3a-21a88b93a25c</id><title type="text">Free MOT For Saab Owners At Pentagon</title><updated>2011-05-25T15:01:59+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/522-Free-MOT-For-Saab-Owners-At-Pentagon.aspx" /><content type="html">&lt;p&gt;Pentagon Saab is proud to offer its customers free membership to the Saab Service Club, a loyalty scheme that provides a host of exclusive benefits including free visual health checks and discounts on parts, servicing and Saab accessories.&lt;/p&gt;</content></entry><entry><id>409c098e-f63a-4249-a9d3-9e87155cd126</id><title type="text">Pennies the electronic charity box included in Giving White Paper </title><updated>2011-05-25T11:19:52+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pennies/658-Pennies-the-electronic-charity-box-included-in-Giving-White-Paper-.aspx" /><content type="html">&lt;p&gt;The Pennies Foundation is pleased that Pennies, the electronic charity box, is mentioned in the Government&amp;rsquo;s White Paper as an example of a successful existing micro-donation channel.&lt;/p&gt;</content></entry><entry><id>e4c3c3ea-2b44-4794-b2c6-fba9e58e37a6</id><title type="text">The Perfectly Proportioned Nissan Qashqai</title><updated>2011-05-25T09:05:04+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/520-The-Perfectly-Proportioned-Nissan-Qashqai.aspx" /><content type="html">&lt;p&gt;April proved an exceptional month as the Nissan Qashqai received a well deserved ego boost. Having benefitted from a make-over, the refined 2011 model secured fifth place in the industry accredited Top 100 Driver Power survey (up an impressive 35 places from the previous year!)&lt;/p&gt;</content></entry><entry><id>5a6f34aa-4c91-4fec-b975-7a5813d53f17</id><title type="text">Upgrade Your Car At Pentagon</title><updated>2011-05-24T17:42:43+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/521-Upgrade-Your-Car-At-Pentagon.aspx" /><content type="html">&lt;p&gt;Local car dealer Pentagon have just announced an innovative 'Upgrade' deal which is being offered during a special event aimed at both new and existing customers who currently have a car on finance.&lt;br /&gt;&lt;br /&gt;&lt;/p&gt;</content></entry><entry><id>d4c0c1ee-630f-4a03-a04c-044a63106ee8</id><title type="text">DS3 Wins Diesel Car Of TheYear</title><updated>2011-05-24T16:57:48+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/519-DS3-Wins-Diesel-Car-Of-TheYear.aspx" /><content type="html">&lt;p&gt;Diesel Car magazine has acclaimed the Citro&amp;euml;n DS3 with two highly prestigious honours in its annual awards: Best Small Car and overall Car of the Year 2011.&lt;/p&gt;</content></entry><entry><id>3f724f5a-c9ac-400c-b816-652ce6c9cbe5</id><title type="text">Subaru Customers Enjoy Day In The Country</title><updated>2011-05-24T16:56:42+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/512-Subaru-Customers-Enjoy-Day-In-The-Country.aspx" /><content type="html">&lt;p&gt;Pentagon Subaru customers enjoyed a fun-packed day out at Upper Anho Grounds in Oxfordshire in March.&lt;/p&gt;
&lt;p&gt;The beautiful venue is set in a 250 acre estate and the all guests enjoyed a fantastic day of activities including Clay Pigeon shooting, Falconry and Off Road driving in both the Subaru Forester and Outback.&lt;/p&gt;</content></entry><entry><id>595817b7-90a2-405a-8394-9233e6f4aa8c</id><title type="text">Awesome New Corsa VXR Ready To Go</title><updated>2011-05-24T16:55:57+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/514-Awesome-New-Corsa-VXR-Ready-To-Go.aspx" /><content type="html">&lt;p&gt;These are the first official pictures of Vauxhall&amp;rsquo;s most powerful Corsa  ever, the new VXR N&amp;uuml;rburgring Edition, which goes on sale at Pentagon in late May  and aims to raise the bar in the hot-hatch class for performance and  dynamics.&lt;/p&gt;</content></entry><entry><id>82777b58-0deb-4a26-b323-cc3905de2471</id><title type="text">Vauxhall Van Deal with Easilift</title><updated>2011-05-24T16:52:05+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/500-Vauxhall-Van-Deal-with-Easilift.aspx" /><content type="html">&lt;p&gt;The Pentagon Vauxhall Business Centre in Sheffield has struck another commercial vehicle deal with Easilift Loading Systems to supply 18 new commercial vehicles.&lt;/p&gt;</content></entry><entry><id>63a73b1d-a687-41ff-923e-d008f460996d</id><title type="text">Special Spring Offers from Pentagon Saab</title><updated>2011-05-24T16:51:56+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/515-Special-Spring-Offers-from-Pentagon-Saab.aspx" /><content type="html">&lt;p&gt;Pentagon Saab is celebrating the arrival of Spring by offering the most comprehensive and competitive range of customer finance packages it has ever devised.&lt;/p&gt;</content></entry><entry><id>a7d7a75e-2c14-41a3-8344-c2a369863a57</id><title type="text">KMP Digitata chosen to take care of Sue Ryder’s digital strategy</title><updated>2011-05-24T10:30:34+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/kmp/656-KMP-Digitata-chosen-to-take-care-of-Sue-Ryder-s-digital-strategy.aspx" /><content type="html">&lt;p&gt;&lt;strong&gt;KMP Digitata is extremely pleased to announce a hugely significant new account win in national UK charity Sue Ryder. Sue Ryder provides health and social care services in local communities for people living with end of life and long-term conditions.&lt;/strong&gt;&lt;/p&gt;</content></entry><entry><id>d1d9bd80-1789-45d5-b0e8-8843b322592e</id><title type="text">Charity chief says grant win will change lives</title><updated>2011-05-16T13:25:23+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/654-Charity-chief-says-grant-win-will-change-lives.aspx" /><content type="html">&lt;p&gt;A national children&amp;rsquo;s charity is celebrating after winning a grant that they say will help them dramatically change the lives of sick and disabled children in Northern Ireland.&lt;/p&gt;
&lt;p&gt;Caudwell Children, who currently provide treatment, equipment and therapy to sick and disabled children across the country, have won a grant from The Big Lottery Fund Northern Ireland, which will now be used&amp;nbsp; to reach and support families in need.&lt;/p&gt;</content></entry><entry><id>e9c2b716-0685-4517-8ebb-711ad76dcb13</id><title type="text">Death Remains A Taboo Subject Amongst Brits</title><updated>2011-05-16T12:08:05+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/653-Death-Remains-A-Taboo-Subject-Amongst-Brits.aspx" /><content type="html">&lt;p&gt;Death remains a taboo subject in Britain, according to new research commissioned by the Dying Matters Coalition, of which Sue Ryder is a member of.&amp;nbsp; Although the majority of people think that talking about death is less of a taboo than it was 20 years ago, two-thirds of all people agree that people in Britain are uncomfortable discussing dying and death.&lt;/p&gt;</content></entry><entry><id>d6e33f75-b110-4558-935e-c27976d4d6f2</id><title type="text">Fans help score support for local families</title><updated>2011-05-16T11:54:41+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/652-Fans-help-score-support-for-local-families.aspx" /><content type="html">&lt;p&gt;A lifeline for families in Stoke-on-Trent has been given a sporting boost thanks to footie fans at Britannia Stadium.&lt;/p&gt;
&lt;p&gt;More than &amp;pound;1,490 has been donated to help support Caudwell Children&amp;rsquo;s Family Support Service thanks to supporters who watched Stoke City take on Wolverhampton Wanderers&amp;nbsp; on Tuesday, April 26&lt;sup&gt;th&lt;/sup&gt;.&lt;/p&gt;</content></entry><entry><id>42afa0dc-b955-482b-b5ca-3fa713ab1cae</id><title type="text">IMPROVING END OF LIFE CARE FOR THE LOCAL COMMUNITY</title><updated>2011-05-12T17:32:45+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/651-IMPROVING-END-OF-LIFE-CARE-FOR-THE-LOCAL-COMMUNITY.aspx" /><content type="html">&lt;p&gt;In 2010 the Department of Health released a &amp;pound;40million grant to improve end of life care for people living with life-limiting conditions. Sue Ryder Wheatfields Hospice in Leeds was one of the 123 hospices to benefit from these funds.&lt;/p&gt;</content></entry><entry><id>10c523bb-0a44-4aad-b521-385ea75ec2cc</id><title type="text">GATC Biotech and LifeCodexx Develop a Diagnostic Test for Early Detection of Preeclampsia</title><updated>2011-05-12T13:14:36+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/649-GATC-Biotech-and-LifeCodexx-Develop-a-Diagnostic-Test-for-Early-Detection-of-Preeclampsia.aspx" /><content type="html">&lt;p&gt;Preeclampsia &amp;nbsp;is a hypertensive disorder of the mother during pregnancy. It is among the leading causes of death of mother and unborn child and occurs in approximately two to five percent of all pregnancies in Germany. Early detection is critical and improves the prognosis for the further course of the pregnancy.&lt;/p&gt;</content></entry><entry><id>07096347-fd67-41e9-9de7-e5e057d25314</id><title type="text">CLC Genomics Workbench goes hand in hand with Ion Torrent data</title><updated>2011-05-12T13:04:21+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/648-CLC-Genomics-Workbench-goes-hand-in-hand-with-Ion-Torrent-data.aspx" /><content type="html">&lt;p&gt;This week, in an independent&amp;nbsp;experiment, Dr. Nick Loman from the University of Birmingham, looked at&amp;nbsp;&lt;em&gt;de novo&lt;/em&gt;&amp;nbsp;assembly of&amp;nbsp;&lt;em&gt;E.coli&amp;nbsp;&lt;/em&gt;data from a single run&amp;nbsp;with&amp;nbsp;approximately 10x coverage from Ion Torrent's Personal Genome Machine (PGM&amp;trade;). The experiment compares several commercial and open&amp;nbsp;source &lt;em&gt;de novo&lt;/em&gt; assemblers, and in this experiment CLC Genomics Workbench&amp;nbsp;is not&amp;nbsp;only the fastest assembler, but also has the highest N50 value.&lt;/p&gt;</content></entry><entry><id>fc123877-e0fc-4a36-a3c3-da53cde2c489</id><title type="text">Oncolytics Biotech® Inc. Enters into Commercial Supply Agreement with SAFC®</title><updated>2011-05-11T14:43:26+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/647-Oncolytics-Biotech--Inc--Enters-into-Commercial-Supply-Agreement-with-SAFC-.aspx" /><content type="html">&lt;p&gt;Oncolytics Biotech Inc. today announced that it has entered into a commercial supply agreement with SAFC, a Division of Sigma-Aldrich Corporation, for the commercial manufacture of REOLYSIN&lt;sup&gt;&amp;reg;&lt;/sup&gt;, Oncolytics proprietary reovirus. Under the terms of the agreement, SAFC will perform process validation of the product, will continue to supply clinical requirements and will supply commercial material upon approval of the product.&lt;/p&gt;</content></entry><entry><id>885c54ef-a3d1-49d6-a87f-f056c4ae7911</id><title type="text">Sistemic and Roslin Cells Ink Stem Cell Standardisation Deal </title><updated>2011-05-10T10:54:59+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/646-Sistemic-and-Roslin-Cells-Ink-Stem-Cell-Standardisation-Deal-.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.sistemic.co.uk/" target="_blank"&gt;Sistemic Ltd&lt;/a&gt; and &lt;a href="http://www.roslincells.com" target="_blank"&gt;Roslin Cells Ltd&lt;/a&gt; today signed a Memorandum of Understanding to promote the development of new technologies for the standardisation of the manufacture of stem cells for their use in cell therapy and drug development screening. Both parties believe that only through the development of stem cell standardisation can the full potential of this major opportunity be unlocked.&lt;/p&gt;</content></entry><entry><id>edce8df4-6a3f-47fd-a1b4-b7b027bad48e</id><title type="text">ICP achieves positive results from Counter-Current Leaching - Potassium Recovery Rates Improve to 97% from 91%</title><updated>2011-05-09T17:12:41+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/645-ICP-achieves-positive-results-from-Counter-Current-Leaching---Potassium-Recovery-Rates-Improve-to-97--from-91-.aspx" /><content type="html">&lt;p&gt;IC Potash Corp. announced today very positive results of metallurgical testing focused on increasing the recovery of potassium sulphate from the polyhalite resource of the Company's flagship Ochoa project in New Mexico.&lt;/p&gt;</content></entry><entry><id>f275ec70-c916-4d63-add2-86884266574c</id><title type="text">Sartorius Stedim Biotech Launches UniVessel® SU Single-Use Bioreactor for Small-Scale Cell Culture Applications</title><updated>2011-05-09T17:08:01+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/643-Sartorius-Stedim-Biotech-Launches-UniVessel--SU-Single-Use-Bioreactor-for-Small-Scale-Cell-Culture-Applications.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.sartorius-stedim.com/" target="_blank"&gt;Sartorius Stedim Biotech&lt;/a&gt;, a leading supplier of the biopharmaceutical industry, launches &lt;a href="http://www.sartorius-stedim.com/univessel-su" target="_blank"&gt;UniVessel&amp;reg; SU&lt;/a&gt; , a single-use bioreactor with 2 L working volume. UniVessel&amp;reg; SU is suitable for mammalian, insect and plant cell culture. Typical applications range from small-scale protein expression to media or process optimization studies. UniVessel&amp;reg; SU is irradiated prior to delivery and ready-to-use out of the box. It is designed to the same safety standards which are required for classical multi-use bioreactors. The complete culture vessel is disposed after use thus reducing cleaning time and eliminating autoclaving and re-installation hassle as well as the risk of cross-contamination.&lt;/p&gt;</content></entry><entry><id>ea5822a1-ca0e-4587-9c4d-030e32932236</id><title type="text">SPECTRAL ACHIEVES IMPORTANT MILESTONE IN ITS PIVOTAL U.S. CLINICAL TRIAL FOR SEPSIS </title><updated>2011-05-05T17:40:36+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/642-SPECTRAL-ACHIEVES-IMPORTANT-MILESTONE-IN-ITS-PIVOTAL-U-S--CLINICAL-TRIAL-FOR-SEPSIS-.aspx" /><content type="html">&lt;p&gt;Spectral Diagnostics Inc. a Phase III company developing the first theranostic treatment for&amp;nbsp; septic shock, today announced that the 15 carefully chosen clinical sites for its EUPHRATES trial are all screening and able to enrol patients.&lt;/p&gt;</content></entry><entry><id>d74cb8e9-a18d-4a54-9601-488beb6515cc</id><title type="text">Selvita Completes $ 5.5 Million Private Placement. Shares to be listed in June 2011</title><updated>2011-05-05T10:45:08+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/638-Selvita-Completes---5-5-Million-Private-Placement--Shares-to-be-listed-in-June-2011.aspx" /><content type="html">&lt;p&gt;The largest Polish drug discovery company &lt;a href="http://www.selvita.com" target="_blank"&gt;Selvita&lt;/a&gt; announced today it has entered into definitive agreements with investors in Poland to sell in a private placement 2,7 million shares of its stock at a price of PLN 5.5 per share, resulting in gross proceeds to the company of PLN 14,85 million ($ 5.5 million). The capitalization of the company after the issue will be around $ 21 million. Selvita expects its stock to be listed on the Warsaw Stock Exchange NewConnect market in June 2011, subject to regulatory approvals.&lt;/p&gt;</content></entry><entry><id>8adc8424-2f68-4163-a30b-60a49c08f2c0</id><title type="text">Pentagon Buys Willoughby Seat And Subaru In Nottingham</title><updated>2011-05-04T21:44:24+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/517-Pentagon-Buys-Willoughby-Seat-And-Subaru-In-Nottingham.aspx" /><content type="html">&lt;p&gt;Pentagon Group has today completed the acquisition of Willoughby Seat and Subaru in Nottingham. Pentagon already has one Subaru site in Ashbourne, Derbyshire but this will be their first Seat dealership.&lt;/p&gt;</content></entry><entry><id>985fa596-5274-4b67-99ad-1a50db578730</id><title type="text">Kids learn footie skills from the FA</title><updated>2011-04-26T15:04:38+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/637-Kids-learn-footie-skills-from-the-FA.aspx" /><content type="html">&lt;p&gt;Children from across Stoke on Trent took to the pitch this week thanks to specialist training sessions from The Football Association.&lt;/p&gt;
&lt;p&gt;More than 20 youngsters who have benefitted from Stoke-based charity, Caudwell Children, got to learn top tips from the Staffordshire FA&amp;rsquo;s Disability Coach as part of a special football experience included in The FA&amp;rsquo;s &amp;lsquo;Ability Counts awareness programme.&amp;rsquo;&lt;/p&gt;</content></entry><entry><id>1dafa662-dca6-45bc-b250-f87baf3bfcdc</id><title type="text">AiCuris Receives Orphan Drug Designation for its Innovative Phase II Drug AIC246 for the Prevention of HCMV Disease</title><updated>2011-04-21T11:08:18+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/636-AiCuris-Receives-Orphan-Drug-Designation-for-its-Innovative-Phase-II-Drug-AIC246-for-the-Prevention-of-HCMV-Disease.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.aicuris.com/" target="_blank"&gt;AiCuris&lt;/a&gt; announced today that AIC246, the Company&amp;rsquo;s inhibitor against the human cytomegalovirus HCMV, currently undergoing phase IIb testing, has been granted Orphan Drug designation for the prevention of HCMV disease. This decision was made by the European Commission following the positive opinion released by the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA).&lt;/p&gt;</content></entry><entry><id>cf148ce4-2ccc-410b-ac8e-f97110f87c1a</id><title type="text">Oncolytics Biotech® announces positive data from translational clinical trial investigating REOLYSIN® in Patients with Metastatic Colorectal Cancer </title><updated>2011-04-21T11:00:21+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/635-Oncolytics-Biotech--announces-positive-data-from-translational-clinical-trial-investigating-REOLYSIN--in-Patients-with-Metastatic-Colorectal-Cancer-.aspx" /><content type="html">&lt;p&gt;Oncolytics Biotech Inc. today announced interim data from a U.K. translational clinical trial (REO 013) investigating intravenous administration of REOLYSIN in patients with metastatic colorectal cancer prior to surgical resection of liver metastases. The principal investigator of the study was Professor Alan Melcher of Leeds Institute of Molecular Medicine, University of Leeds, UK.&lt;/p&gt;</content></entry><entry><id>6763244b-2b01-49bb-8172-e9d024c5b363</id><title type="text">If You Want A Car You Can Trust, Choose A Chevrolet From Pentagon</title><updated>2011-04-20T16:39:33+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/513-If-You-Want-A-Car-You-Can-Trust--Choose-A-Chevrolet-From-Pentagon.aspx" /><content type="html">&lt;p&gt;When it comes to endurance, the Chevrolet brand has long had a reputation for dependable, long-life service &amp;ndash; after all, the company wouldn&amp;rsquo;t be celebrating its centenary this year were it not for cars that were engineered to deliver reliability and satisfaction to their owners. But now, the brand has gone one better &amp;ndash; knocking Japanese Brand Honda off the top spot in Warranty Direct&amp;rsquo;s Reliability Index (&lt;a href="http://www.reliabilityindex.co.uk" target="_blank"&gt;www.reliabilityindex.co.uk&lt;/a&gt;)&lt;/p&gt;</content></entry><entry><id>faab26b1-9e3e-48de-a3d0-fc802e14ccac</id><title type="text">Biofortuna Announces an Exclusive Distribution Agreement with Abbott for its Freeze-Dried HLA-Typing Kits in the Transplantation Market</title><updated>2011-04-19T16:46:36+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/633-Biofortuna-Announces-an-Exclusive-Distribution-Agreement-with-Abbott-for-its-Freeze-Dried-HLA-Typing-Kits-in-the-Transplantation-Market.aspx" /><content type="html">&lt;p&gt;Biofortuna Ltd, a UK-based molecular diagnostics company, today announced that they have signed an exclusive distribution agreement with Abbott&amp;rsquo;s molecular diagnostics business, whereby Biofortuna will design, develop and manufacture a range of freeze-dried HLA-typing kits called SSPGo.&amp;nbsp; Financial terms have not been disclosed.&lt;/p&gt;</content></entry><entry><id>3c33790c-83f2-47c5-9537-f887f18b5e1e</id><title type="text">Biotage® Introduces EVOLUTE® WAX, Providing a Total Solution for Acidic Compounds</title><updated>2011-04-19T16:25:00+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/632-Biotage--Introduces-EVOLUTE--WAX--Providing-a-Total-Solution-for-Acidic-Compounds.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.biotage.com/" target="_blank"&gt;Biotage&lt;/a&gt;, a leading supplier of tools and technology for medicinal and analytical chemistry, today announced the further expansion of its successful family of sample preparation products with the launch of &lt;a href="http://www.biotage.com/DynPage.aspx?id=100500" target="_blank"&gt;EVOLUTE WAX&lt;/a&gt;.&lt;/p&gt;</content></entry><entry><id>ea1b71bf-7dba-4ec0-a5d5-bb1184c317dc</id><title type="text">Protagen Counts on Scienion Technology </title><updated>2011-04-19T16:19:56+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/631-Protagen-Counts-on-Scienion-Technology-.aspx" /><content type="html">&lt;p&gt;&lt;strong&gt;&lt;/strong&gt;&lt;a href="http://www.protagen.de" target="_blank"&gt;Protagen AG&lt;/a&gt; today announced that &lt;a href="http://www.scienion.com" target="_blank"&gt;Scienion AG&lt;/a&gt; will produce protein microarray batches for the clinical validation of the proprietary biomarker panels of Protagen. The batch sizes will comprise more than 1000 arrays.&lt;/p&gt;</content></entry><entry><id>70b4b2f5-37c7-4bb6-b9dc-f5fcfd542664</id><title type="text">Crystallics – a New Company with a Long History in Pharmaceutical Development</title><updated>2011-04-19T10:05:46+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/630-Crystallics---a-New-Company-with-a-Long-History-in-Pharmaceutical-Development.aspx" /><content type="html">&lt;p&gt;Pharma BV, a leader in solid state research and pre-formulation for the pharmaceutical industry over the last 11 years, has been spun out from Avantium Holding BV in a management buy-out to create &lt;a href="http://www.crystallics.com/" target="_blank"&gt;Crystallics&lt;/a&gt;.&lt;/p&gt;</content></entry><entry><id>7785363a-f780-4910-b657-b844c1d65226</id><title type="text">Olympic gold medalist Nicole Cooke supports charity bike ride</title><updated>2011-04-18T15:01:54+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/641-Olympic-gold-medalist-Nicole-Cooke-supports-charity-bike-ride.aspx" /><content type="html">&lt;p&gt;&lt;strong&gt;April 18 2011 - Olympic gold medal-winning cyclist Nicole Cooke  MBE, winner of the 2008 Women's Road Race, is supporting this years  Christian Aid London to Paris bike ride (20-24 July) and encouraging  last minute entries before the closing date of 12 May 2011.&lt;/strong&gt;&lt;/p&gt;</content></entry><entry><id>98d81231-5026-4a66-af27-54bfd0d7d0cd</id><title type="text">Successful Pilot Study for Non-Invasive Prenatal Diagnostic Test to Determine Trisomy 21</title><updated>2011-04-15T17:08:47+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/627-Successful-Pilot-Study-for-Non-Invasive-Prenatal-Diagnostic-Test-to-Determine-Trisomy-21.aspx" /><content type="html">&lt;p&gt;At the moment, the only reliable way of diagnosing chromosomal irregularities during pregnancy is to use invasive prenatal methods. This causes miscarriage in about one per cent of these risky surgical procedures.&lt;/p&gt;</content></entry><entry><id>fa371258-145f-487e-89a8-8508f5752a24</id><title type="text">Cellmid Signs Antibody Humanisation Collaboration</title><updated>2011-04-15T16:59:31+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/626-Cellmid-Signs-Antibody-Humanisation-Collaboration.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.cellmid.com.au/" target="_blank"&gt;Cellmid Limited&lt;/a&gt; (ASX: CDY) has signed a collaboration agreement with &lt;a href="http://www.antitope.co.uk/"&gt;Antitope Ltd&lt;/a&gt; (Cambridge, UK) for the humanisation of its lead therapeutic monoclonal antibody candidate. The collaboration is expected to deliver a drug candidate, a first in class humanised anti-midkine antibody, using Cellmid&amp;rsquo;s patented sequence and Antitope&amp;rsquo;s proprietary EpiScreen&amp;trade; and Composite Human Antibody&amp;trade; technologies.&lt;/p&gt;</content></entry><entry><id>f095c1d4-e02a-47d8-b354-7c21d212870a</id><title type="text">Neurotune Strengthens Management </title><updated>2011-04-15T16:52:25+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/625-Neurotune-Strengthens-Management-.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.neurotune.com/" target="_blank"&gt;Neurotune AG&lt;/a&gt;, a Swiss biopharmaceutical company, today announced personnel changes in its board of directors as well as management. Dr. Raimund Eckel will form the Board of Directors together Mr. Gerhard Musshafen and Dr. Bruno Oesch (Chairman). Furthermore, Dr. Armin W. M&amp;auml;der, former CFO of Neurotune assumes the CEO position of Neurotune from Dr. Bruno Oesch who will focus more on strategic as well as business development. These changes will enhance and streamline the management capabilities to achieve Neurotune&amp;rsquo;s ambitious targets in neuropathic pain and sarcopenia.&lt;/p&gt;</content></entry><entry><id>5467b16d-a0a3-485d-9da0-02e97052e9b9</id><title type="text">KINAXO Announces European Patent Granted for its Chemical Proteomics Applications</title><updated>2011-04-15T16:13:10+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/624-KINAXO-Announces-European-Patent-Granted-for-its-Chemical-Proteomics-Applications.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.kinaxo.com/" target="_blank"&gt;KINAXO Biotechnologies GmbH&lt;/a&gt; announced today that the European Patent Office has granted a patent entitled &amp;ldquo;Proteome-wide quantification of small molecule binding to cellular target proteins&amp;rdquo; (EP2045332B1). The patent covers technologies exclusively marketed by KINAXO under the trademarks &lt;a href="http://www.kinaxo.com/tec_ctp.html" target="_blank"&gt;Cellular Target Profiling&lt;sup&gt;&amp;reg;&lt;/sup&gt;&lt;/a&gt;, &lt;a href="http://www.kinaxo.com/tec_kinaff.html" target="_blank"&gt;KinAffinity&lt;sup&gt;&amp;reg;&lt;/sup&gt; &lt;/a&gt;and Epigenetics Target Profiling&amp;trade;. Patent applications in the United States and Japan are pending.&lt;/p&gt;</content></entry><entry><id>84605fd1-ae1f-4623-ae4b-d2bb533f1d2a</id><title type="text">Charity’s push to get Salford girl wheely going again</title><updated>2011-04-15T12:31:06+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/623-Charity-s-push-to-get-Salford-girl-wheely-going-again.aspx" /><content type="html">&lt;p&gt;A children&amp;rsquo;s charity desperately wants support to help get a disabled girl specialist equipment which her mum says brings the youngster &amp;lsquo;immense enjoyment&amp;rsquo; and helps with her condition.&lt;/p&gt;
&lt;p&gt;&amp;nbsp;Ten-year-old Estheruth Bowes from Worsley has Cerebral Palsy, a condition that affects her mobility and means she requires a wheelchair for her day to day needs. Since being a toddler, Estheruth has been able to enjoy the benefits of a specially adapted tricycle which has helped strengthen her muscles, build self esteem and ride a bike like her brothers and friends. But the youngster has now outgrown the cherished item.&lt;/p&gt;</content></entry><entry><id>9485ba66-8ca8-4d34-8c6f-3689e83f0a34</id><title type="text">COASTAL CHIC FROM CHRISTY</title><updated>2011-04-14T16:07:18+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/christy/522-COASTAL-CHIC-FROM-CHRISTY.aspx" /><content type="html">&lt;p&gt;Create the feel of a relaxing seaside retreat with the choice of three towel collections from Christy.&lt;/p&gt;
&lt;p&gt;&lt;br /&gt;With a selection of blue tones from soft Chalk Blues to bold Deep Sea colours the Supreme collections offers a selection of costal hues.&lt;/p&gt;</content></entry><entry><id>8d66be97-0aa8-473d-a25d-ca1cd63813c9</id><title type="text">Gorvins partner appointed Court of Protection Deputy</title><updated>2011-04-14T10:13:46+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/gorvins/514-Gorvins-partner-appointed-Court-of-Protection-Deputy.aspx" /><content type="html">&lt;p&gt;Gorvins partner, Moira Percival, has been accepted on to the newly formed select panel of Court of Protection appointed Deputies.&lt;/p&gt;
&lt;p&gt;There are only 60 such Deputies across the whole of England and Wales.&lt;/p&gt;</content></entry><entry><id>64ac40bb-668e-4161-8c0f-1228396e377d</id><title type="text">HOLD YOUR OWN ROYAL WEDDING PARTY WITH WILLIAM AND KATE </title><updated>2011-04-13T11:25:10+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/622-HOLD-YOUR-OWN-ROYAL-WEDDING-PARTY-WITH-WILLIAM-AND-KATE-.aspx" /><content type="html">&lt;p&gt;Thinking of organising something special with your friends and family on the day of the Royal Wedding? Sue Ryder has just what you are looking for to get the &amp;lsquo;wow&amp;rsquo; factor.&lt;/p&gt;</content></entry><entry><id>4661db2c-740e-4707-b2a2-d94f8f325cd0</id><title type="text">Glencore and first quantum are subjects of complaint to OECD</title><updated>2011-04-12T15:01:59+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/640-Glencore-and-first-quantum-are-subjects-of-complaint-to-OECD.aspx" /><content type="html">&lt;p&gt;&lt;strong&gt; Campaigning organisations have filed a complaint with the OECD  against commodities giant Glencore and First Quantum Minerals, based on  allegations that a mine they own may be evading tax in Zambia in a way  which would be inconsistent with OECD guidelines for multinational  companies. &lt;/strong&gt;&lt;/p&gt;</content></entry><entry><id>afd91051-7f53-419c-aa17-d68b51150a10</id><title type="text">Agricultural Research Council in South Africa Selects CLC bio's Enterprise Platform</title><updated>2011-04-07T12:12:35+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/621-Agricultural-Research-Council-in-South-Africa-Selects-CLC-bio-s-Enterprise-Platform.aspx" /><content type="html">&lt;p&gt;Today inqaba biotec, reseller of CLC bio's solutions in South Africa, announced that they have finalized a contract with the Agricultural Research Council (ARC) in South Africa, to install CLC bio's enterprise platform throughout the ARC, across several geographical locations.&lt;/p&gt;</content></entry><entry><id>0091879d-92fb-47df-b87b-3fd620be51c7</id><title type="text">Myconostica’s MycAssay™ Aspergillus Kit Shows its Sensitivity in Serum</title><updated>2011-04-07T10:36:50+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/620-Myconostica-s-MycAssay--Aspergillus-Kit-Shows-its-Sensitivity-in-Serum.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.myconostica.co.uk/" target="_blank"&gt;Myconostica&lt;/a&gt; announces the&lt;a href="http://jcm.asm.org/cgi/reprint/JCM.02390-10v1?view=long&amp;amp;pmid=21367988" target="_blank"&gt; publication&lt;/a&gt; (White et al, J. Clin. Microbiol. 2011) of an evaluation of the analytical and preliminary clinical performance of its &lt;a href="http://www.myconostica.co.uk/aspergillus" target="_blank"&gt;MycAssay&amp;trade; Aspergillus&lt;/a&gt; kit for the diagnosis of &lt;strong&gt;Invasive Aspergillosis&lt;/strong&gt; (IA) using serum samples. The trial tested 31 high risk haematology subjects. 10 patients were classified as having proven/probable IA and 21 as at risk of IA with a total of 170 samples. The sensitivity of the assay was &amp;gt;70% and the specificity &amp;gt;90%. This was a retrospective study with stored samples and the authors note that some degradation of the DNA was likely to have occurred so it is proposed that a prospective study would improve the assay sensitivity.&lt;/p&gt;</content></entry><entry><id>84d2d4b6-cfa8-4252-b1f9-ba2102587fe8</id><title type="text">IMPROVING END OF LIFE CARE  FOR THE LOCAL COMMUNITY</title><updated>2011-04-06T16:26:04+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/619-IMPROVING-END-OF-LIFE-CARE--FOR-THE-LOCAL-COMMUNITY.aspx" /><content type="html">&lt;p&gt;In 2010 the Department of Health released a &amp;pound;40million grant to improve end of life care for people living with life-limiting conditions. Sue Ryder Manorlands Hospice near Keighley was one of the 123 hospices to benefit from these funds.&lt;/p&gt;</content></entry><entry><id>778e7a87-7cdc-4ee7-897a-69416f81725e</id><title type="text">COLOURFUL SUMMER DAYS WITH CHRISTY’S BEACH TOWEL COLLECTION</title><updated>2011-04-06T16:07:12+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/christy/519-COLOURFUL-SUMMER-DAYS-WITH-CHRISTY-S-BEACH-TOWEL-COLLECTION.aspx" /><content type="html">&lt;p&gt;Colour blocking and graphic trends are a must-have for this year&amp;rsquo;s summer wardrobe, so complete the look with summer brights on striking beach towels from Christy&amp;rsquo;s Spring/Summer collection.&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;</content></entry><entry><id>120ba999-0cdc-4e50-8cbb-344dd6f3f8c0</id><title type="text">British Red Cross launches appeal in response to humanitarian crisis in Ivory Coast and bordering countries</title><updated>2011-04-06T11:51:27+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/redcross/618-British-Red-Cross-launches-appeal-in-response-to-humanitarian-crisis-in-Ivory-Coast-and-bordering-countries.aspx" /><content type="html">&lt;ul&gt;
&lt;/ul&gt;
&lt;p&gt;The British Red Cross has launched an appeal in response to the growing  humanitarian crisis in Ivory Coast, which has spilled across into  Liberia and other bordering countries.&lt;/p&gt;</content></entry><entry><id>8bc0e074-87a0-4e2b-9325-3a5cdd48a9fb</id><title type="text">Glycotope Biotechnology Expands GMP Production Facility to 11 kg Antibody per Year</title><updated>2011-04-05T11:06:17+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/617-Glycotope-Biotechnology-Expands-GMP-Production-Facility-to-11-kg-Antibody-per-Year.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.glycotope-bt.com/en/index.php" target="_blank"&gt;Glycotope Biotechnology GmbH&lt;/a&gt; in Heidelberg, Germany, a full subsidiary of Berlin based &lt;a href="http://www.glycotope.com/" target="_blank"&gt;Glycotope GmbH&lt;/a&gt;, has initiated the setup of further clean room facilities as a first step in the expansion of its GMP-production capacities. By mid 2011, the company will thus be able to produce 4kg of recombinant antibodies per year and up to 11 kg upon completion of works towards the end of 2011. In sum, additional 1400 m&amp;sup2; of facility and office space will be created.&lt;/p&gt;</content></entry><entry><id>b0051e75-8a0f-43e0-b17c-bc71a5b7df12</id><title type="text">Selvita Signs a Computational Chemistry Services Agreement with The Institutes for Pharmaceutical Discovery</title><updated>2011-04-04T15:58:24+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/616-Selvita-Signs-a-Computational-Chemistry-Services-Agreement-with-The-Institutes-for-Pharmaceutical-Discovery.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.selvita.com/" target="_blank"&gt;Selvita&lt;/a&gt;,&amp;nbsp;Poland based integrated discovery partner for the pharmaceutical and biotechnology industry, announced today an agreement with the &lt;a href="http://ipd-discovery.com/"&gt;Institutes for Pharmaceutical Discovery&lt;/a&gt; (IPD) in Branford, CT, USA to provide computational chemistry services to IPD.&lt;/p&gt;</content></entry><entry><id>27a1ebcd-bf7e-4b9f-aaa0-093df915933b</id><title type="text">Specialist Palliative Care Services in Berkshire West transfer to Sue Ryder </title><updated>2011-04-04T14:49:18+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/615-Specialist-Palliative-Care-Services-in-Berkshire-West-transfer-to-Sue-Ryder-.aspx" /><content type="html">&lt;p&gt;On Friday 1 April, Berkshire West Primary Care Trust (PCT) transferred all specialist palliative care services to the health and social care charity, Sue Ryder as part of the Department of Health&amp;rsquo;s Transforming Community Services (TCS) agenda.&lt;/p&gt;</content></entry><entry><id>1ace8d0e-be03-4a74-b6f4-271f8a7ea431</id><title type="text">Chrysler and Jeep set to rejuvenate in 2011</title><updated>2011-04-04T14:35:58+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/506-Chrysler-and-Jeep-set-to-rejuvenate-in-2011.aspx" /><content type="html">&lt;p&gt;Chrysler have announced that they will bring two new models to the UK in 2011 &amp;ndash; the Delta hatchback and Ypsilon supermini.&lt;/p&gt;</content></entry><entry><id>641745a5-6c4e-4bba-8e6e-61f84d6957ac</id><title type="text">Vauxhall MasterFit’s Summer Safety check brings an early ray of sunshine to value-driven motorists.</title><updated>2011-04-04T13:42:13+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/505-Vauxhall-MasterFit-s-Summer-Safety-check-brings-an-early-ray-of-sunshine-to-value-driven-motorists-.aspx" /><content type="html">&lt;p&gt;For an inflation-busting &amp;pound;35, the same price as in 2010 despite the rise in VAT, Vauxhall owners who visit Pentagon will benefit from knowing their car is topped up with all essential fluids* and that it will be visually inspected for any potential safety issues by Vauxhall MasterFit trained technicians.&amp;nbsp;&lt;/p&gt;</content></entry><entry><id>40ce95ac-d4bc-4f5c-81db-6cd1ae97a6b5</id><title type="text">Myconostica Announces Publication of Trial Results with MycAssay TM Pneumocystis Kit </title><updated>2011-04-04T09:44:42+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/614-Myconostica-Announces-Publication-of-Trial-Results-with-MycAssay-TM-Pneumocystis-Kit-.aspx" /><content type="html">&lt;p&gt;&lt;strong&gt;- &lt;/strong&gt;&lt;a href="http://www.myconostica.co.uk/"&gt;Myconostica&lt;/a&gt;, specialising in rapid molecular diagnostic tests for life-threatening fungal infections, announces the publication (&lt;a href="http://jcm.asm.org/cgi/reprint/JCM.02390-10v1?view=long&amp;amp;pmid=21367988" target="_blank"&gt; Hauser et al, J. Clin. Microbiol.)&lt;/a&gt; of a multicentre prospective trial of its CE marked kit, &lt;a href="http://www.myconostica.co.uk/pneumocystis" target="_blank"&gt;MycAssay&amp;trade; Pneumocystis&lt;/a&gt; for the detection of Pneumocystis jirovecii. The trial results compare well with clinical diagnosis using non-molecular methods and demonstrate the high sensitivity and specificity of the PCR diagnostic assay.&lt;/p&gt;</content></entry><entry><id>169eab19-3a68-47be-b8ea-4db92c91c8ea</id><title type="text">New Desktop Liquid Handling Instrument from Biohit</title><updated>2011-03-31T09:51:14+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/612-New-Desktop-Liquid-Handling-Instrument-from-Biohit.aspx" /><content type="html">&lt;p&gt;More efficient R&amp;amp;D and production processes are leading to increased liquid handling automation in many laboratories. Industrial laboratories in particular are seeking to move away from handheld pipettes towards computer-controlled analysis systems and liquid handling equipment that makes use of robotics.&lt;/p&gt;</content></entry><entry><id>5cb4fd78-428d-45d0-995a-a4847957b25e</id><title type="text">Government emasculated Bribery Act, warns Christian Aid</title><updated>2011-03-30T17:05:21+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/611-Government-emasculated-Bribery-Act--warns-Christian-Aid.aspx" /><content type="html">&lt;p&gt;Guidance published today by the Ministry of Justice effectively emasculates the 2010 UK Bribery Act, Christian Aid is warning. &lt;br /&gt;&lt;br /&gt;The Ministry of Justice highlighted paragraph 40 of the Guidance, which states:&lt;/p&gt;
&lt;p&gt;A bribe paid on behalf of a joint venture entity by one of its employees or agents will therefore not trigger liability for members of the joint venture simply by virtue of them benefiting indirectly from the bribe through their investment in or ownership of the joint venture.&lt;/p&gt;</content></entry><entry><id>1d535d91-fd38-4c6c-9167-5133703e62f4</id><title type="text">The Pentagon  Masterfit Promise Keeps Vauxhall Drivers In First Place</title><updated>2011-03-30T15:08:34+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/504-The-Pentagon--Masterfit-Promise-Keeps-Vauxhall-Drivers-In-First-Place.aspx" /><content type="html">&lt;p&gt;The Vauxhall MasterFit Promise is keeping the servicing and repair programme at the head of the pack during these financially challenging times by continuing to offer customers quality and good value.&lt;/p&gt;</content></entry><entry><id>31e3e02f-97c7-4114-8872-64ab242955b9</id><title type="text">Pentagon Grows With Nissan and Fiat</title><updated>2011-03-29T13:06:06+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/503-Pentagon-Grows-With-Nissan-and-Fiat.aspx" /><content type="html">&lt;p&gt;Pentagon has announced the appointment of two new dealerships in Yorkshire this month with the addition of Fiat to their existing site on Barugh Green in Barnsley and the opening of a new Nissan site in Huddersfield.&lt;/p&gt;</content></entry><entry><id>8258410d-4c93-4437-b429-b449e2fe02a1</id><title type="text"> Refreshed 9-3 With New Exterior and Interior Styling</title><updated>2011-03-29T11:58:03+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/502--Refreshed-9-3-With-New-Exterior-and-Interior-Styling.aspx" /><content type="html">&lt;p&gt;The new Saab 9-3 MY12 range, announced today, features refreshed exterior and interior styling, backed by a more powerful, fuel-efficient engine range.&lt;/p&gt;</content></entry><entry><id>c226eb78-050f-455d-80c5-706d93c72da9</id><title type="text">Protagen to Apply UNIarray® Platform for Biogen Idec</title><updated>2011-03-29T09:32:15+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/610-Protagen-to-Apply-UNIarray--Platform-for-Biogen-Idec.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.protagen.de/" target="_blank"&gt;Protagen AG&lt;/a&gt;, a specialist in &lt;em&gt;in-vitro &lt;/em&gt;diagnostics and GMP-compliant protein analysis&lt;em&gt; &lt;/em&gt;announced today that they will be using the &lt;a href="http://www.protagen.de/diagnostic-products/uniarray.html" target="_blank"&gt;UNIarray&lt;strong&gt;&lt;sup&gt;&amp;reg;&lt;/sup&gt;&lt;/strong&gt;&lt;/a&gt; Platform to help discover biomarkers in relapsing remitting multiple sclerosis for Biogen Idec, Inc. Under the terms of the agreement, Protagen will apply its UNIarray&lt;sup&gt;&amp;reg;&lt;/sup&gt; technology platform and expertise in autoantibody research to support retrospective analysis of samples from a Biogen Idec clinical trial for the purpose of finding predictive and response biomarkers associated with multiple sclerosis (MS) therapy.&lt;/p&gt;</content></entry><entry><id>56452a59-6787-4b58-b091-b88881f1e18a</id><title type="text">SAAB 9-3 Convertible Independance Edition Announced</title><updated>2011-03-29T09:26:41+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/501-SAAB-9-3-Convertible-Independance-Edition-Announced.aspx" /><content type="html">&lt;p&gt;Saab is celebrating the first anniversary of its independence by launching an exclusive Independence Edition of its 9-3 Convertible.&lt;/p&gt;</content></entry><entry><id>94a1768a-6eab-4ea4-9d98-8f1162cc00e2</id><title type="text">PHOENIX Phase III Trial of PHP for Distributive Shock to Continue after Positive Midpoint Recommendation from DMB </title><updated>2011-03-28T16:40:35+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/609-PHOENIX-Phase-III-Trial-of-PHP-for-Distributive-Shock-to-Continue-after-Positive-Midpoint-Recommendation-from-DMB-.aspx" /><content type="html">&lt;p&gt;The PHOENIX trial is a European, placebo-controlled, Phase III study treating&lt;strong&gt; &lt;/strong&gt;catecholamine-resistant patients in distributive shock with the Nitric Oxide (NO) scavenger Pyridoxalated Haemoglobin Polyoxyethylene Conjugate (PHP). The study was launched by &lt;a href="http://www.curacyte.com/" target="_blank"&gt;Curacyte AG&lt;/a&gt; in Austria, Belgium, Germany, Spain, The Netherlands and in the United   Kingdom in 2009. Today the successful completion of the second interim analysis on safety and mortality data of 50% of the study population in the trial is reported. Statistical results were reviewed in an unblinded fashion by an independent Data Monitoring Board (DMB). The DMB, consisting of intensive care physicians, bioethical experts and statisticians from the US and Europe came to the conclusion, that the study should be continued without change.&lt;/p&gt;</content></entry><entry><id>c105545e-4945-47d8-ac47-71b4d6c3514f</id><title type="text">Plans to build disaster resilience is welcomed by Christian Aid</title><updated>2011-03-28T16:25:45+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/608-Plans-to-build-disaster-resilience-is-welcomed-by-Christian-Aid.aspx" /><content type="html">&lt;p&gt;Christian Aid welcomes the Humanitarian Emergency Response Review&amp;rsquo;s focus on building disaster resilience and calls on the UK Government to step up its support for such programmes.&lt;/p&gt;
&lt;p&gt;It warns that success will depend on working with local partner organisations and communities in strengthening their ability to cope.&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;</content></entry><entry><id>705488bd-6370-43fe-b6ab-58646bdefc0f</id><title type="text">Only a quarter of the public think Britain’s approach in Afghanistan is working, shows poll</title><updated>2011-03-28T16:20:32+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/603-Only-a-quarter-of-the-public-think-Britain-s-approach-in-Afghanistan-is-working--shows-poll.aspx" /><content type="html">&lt;p&gt;Joint campaign launches to call for &amp;lsquo;new approach&amp;rsquo; to Afghanistan: A majority of people in Britain (58%) say they are not clear what Britain is trying to achieve in Afghanistan and only one in four (26%) think the current approach is working well, according to an opinion poll&amp;nbsp; commissioned by a new campaign coalition, Together Afghanistan, released today as the UN votes on renewing the mandate for its mission in Afghanistan.&amp;nbsp;&amp;nbsp;&lt;/p&gt;</content></entry><entry><id>a64a1273-2c50-47ae-93ca-0fd47c025576</id><title type="text">Cell Dormancy in Petaka brings infinite flexibility to the cell culture laboratory</title><updated>2011-03-28T11:42:20+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/607-Cell-Dormancy-in-Petaka-brings-infinite-flexibility-to-the-cell-culture-laboratory.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.celartia.com/" target="_blank"&gt;Celartia&lt;/a&gt;, the pioneering Life Sciences group and manufacturers of &lt;a href="http://www.petaka.com/" target="_blank"&gt;Petaka&lt;/a&gt;&lt;sup&gt;TM&lt;/sup&gt; reveal&amp;nbsp; how some of the most innovative aspects of the product offers some truly unique applications in the research labs, cell line supply &amp;amp; cord blood collection.&lt;/p&gt;</content></entry><entry><id>c0d68004-57e8-4e4a-9faf-13fa83387c73</id><title type="text">Giving to charity now saves you money</title><updated>2011-03-24T10:13:40Z</updated><link rel="alternate" href="http://pressroom.ackura.com/gorvins/515-Giving-to-charity-now-saves-you-money.aspx" /><content type="html">&lt;p&gt;Hidden amongst the hundreds of pages of detail released after the 2011 Budget speech, tucked away between obscure changes to rules on Alcohol Duty and Gift Aid, came a rare piece of good news about Inheritance Tax.&lt;/p&gt;
&lt;p&gt;For deaths occuring on or after 6th April 2012, there is a way to reduce the rate of Inheritance Tax that an Estate pays. There is a catch; at least 10% of the Estate must be given to charity.&lt;/p&gt;</content></entry><entry><id>b47b805a-fed2-4ab2-b3da-b3cc79cf72cd</id><title type="text">Biotage Introduces Unique, Entry-Level System for Microwave-Assisted Peptide Synthesis</title><updated>2011-03-24T09:56:40Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/606-Biotage-Introduces-Unique--Entry-Level-System-for-Microwave-Assisted-Peptide-Synthesis.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.biotage.com/" target="_blank"&gt;Biotage&lt;sup&gt;&amp;reg;&lt;/sup&gt;&lt;/a&gt; (STO: BIOT), a leading supplier of tools and technology for medicinal, analytical and peptide chemistry, introduced the Biotage &lt;a href="http://www.biotage.com/DynPage.aspx?id=100440"&gt;Initiator Peptide Workstation&lt;/a&gt; for manual microwave-assisted peptide synthesis. The Workstation utilizes a unique microwave peptide vial available in two sizes; 2-5 mL for 75-150 &amp;mu;mol scale or 10-20 mL for 250-500 &amp;mu;mol scale synthesis.&lt;/p&gt;</content></entry><entry><id>4d76faea-b67c-4205-ba79-be6ce9c62e2c</id><title type="text">Vauxhalls VXR8 Is Back...</title><updated>2011-03-23T15:02:02Z</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/499-Vauxhalls-VXR8-Is-Back---.aspx" /><content type="html">&lt;p&gt;Vauxhall&amp;rsquo;s storming VXR8 model is back with a vengeance, packing heavily revised front- and rear-end styling, a new cabin and a raft of new technology to enhance its appeal to drivers in search of one of the last, great rear-drive V8 super-saloons.&lt;/p&gt;</content></entry><entry><id>a97f9db3-4442-4a77-94a8-481be145b8bc</id><title type="text">Best of British Asian Music set for showcase tour </title><updated>2011-03-23T14:52:43Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/605-Best-of-British-Asian-Music-set-for-showcase-tour-.aspx" /><content type="html">&lt;p&gt;Some of the UK&amp;rsquo;s hottest acts from the thriving British Asian music scene are set to feature in a live showcase tour, hitting three cities later this year as part of the Live &amp;amp; Louder Tour.&lt;/p&gt;
&lt;p&gt;Electro-pop and bhangra fusion group, Swami, will perform tracks from their eagerly awaited album live on stage alongside renowned British Asian artists including, H Dhami, Romy, Abbas Hasan, Mona Singh, DJ Ri, Sham D and girl group, Serese.&lt;/p&gt;</content></entry><entry><id>b3ce8fe4-8985-4d05-b204-5990ab262ed9</id><title type="text">N-Ice boost for disabled teen </title><updated>2011-03-23T12:57:41Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/604-N-Ice-boost-for-disabled-teen-.aspx" /><content type="html">&lt;p&gt;A talented teenager from Lincolnshire, who is showing huge potential on the ice, has received a sporting boost worth over &amp;pound;650 to help him reach his Paralympic dream.&lt;/p&gt;
&lt;p&gt;Daniel Grummitt (14) is one of the UK&amp;rsquo;s best junior ice sledge hockey players. The sport, which is the Paralympic equivalent of ice hockey, is played on a bladed sled designed for able bodied and disabled bodied alike.&lt;/p&gt;</content></entry><entry><id>7fbfa3f6-3e62-488e-b8cd-02991e7e6bcc</id><title type="text">Public is challenged to live below the line by Christian Aid</title><updated>2011-03-23T11:06:12Z</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/602-Public-is-challenged-to-live-below-the-line-by-Christian-Aid.aspx" /><content type="html">&lt;p&gt;This May (2-6) Christian Aid will be challenging the public to live on just &amp;pound;1 a day for 5 days to raise &amp;pound;500,000 to help some of the world&amp;rsquo;s poorest people.&lt;/p&gt;</content></entry><entry><id>91a24176-8be0-4535-bd2b-94dd863347db</id><title type="text">Medicyte Starts its Involvement in the Prestigious Hepatic Microfluidic Bioreactor Project </title><updated>2011-03-22T13:50:58Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/601-Medicyte-Starts-its-Involvement-in-the-Prestigious-Hepatic-Microfluidic-Bioreactor-Project-.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.medicyte.com/" target="_blank"&gt;Medicyte&lt;/a&gt; has now started operational activities to provide and qualify different types of &lt;a href="http://www.medicyte.com/products/upcyte.html"&gt;upcyte&amp;reg;&lt;/a&gt; liver cells for use in the multi-international Hepatic Microfluidic Bioreactor (HeMiBio) project. HeMiBio is an artificial liver that may be more predictive for human liver toxicity and liver metabolism of drugs than current in vitro and animal models.&lt;/p&gt;</content></entry><entry><id>a2aa48da-88c4-4386-b237-8043e3440af3</id><title type="text">First Patient Included in Multicenter Study to Evaluate SIRS-Lab’s Diagnostic Test for Blood-Stream Infection </title><updated>2011-03-22T09:32:42Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/600-First-Patient-Included-in-Multicenter-Study-to-Evaluate-SIRS-Lab-s-Diagnostic-Test-for-Blood-Stream-Infection-.aspx" /><content type="html">&lt;p&gt;&lt;strong&gt;&lt;/strong&gt;&lt;a href="http://www.sirslab.com/" target="_blank"&gt;SIRS-Lab&lt;/a&gt;, a molecular diagnostics company based in Jena, Germany, announced the inclusion of the first patient in a 1000-patient clinical study evaluating their &lt;a href="http://www.sirslab.com/english/products-services/vyoo.html" target="_blank"&gt;molecular pathogen test VYOO&lt;/a&gt;. The multicenter trial, performed in 11 key centers across Germany and initiated in February 2011, will deliver data about the utility of the PCR test compared to conventional methods to identify microbes in ICU patients with suspected sepsis.&lt;/p&gt;</content></entry><entry><id>e96d8ad4-bcbf-4efe-bec5-fbf84850fe7a</id><title type="text">KMP Digitata builds Milligan an inspiring new website </title><updated>2011-03-21T15:33:00Z</updated><link rel="alternate" href="http://pressroom.ackura.com/kmp/598-KMP-Digitata-builds-Milligan-an-inspiring-new-website-.aspx" /><content type="html">&lt;p&gt;&lt;a title="KMP Digitata - Milligan" href="http://kmp.co.uk/home/milligan" target="_blank"&gt;KMP Digitata&lt;/a&gt; is proud to announce a new partnership with &lt;a title="Milligan Retail Homepage" href="http://www.milliganretail.com/" target="_blank"&gt;Milligan Retail&lt;/a&gt;, the award winning retail developer. Milligan approached KMP Digitata with a mission to refresh the design and update the architecture of their existing website.&lt;/p&gt;</content></entry><entry><id>c48d527d-2344-41e1-966d-dbafd25246f1</id><title type="text">Mucosis Starts Clinical Study with its Lead Product, FluGEM™</title><updated>2011-03-21T10:45:28Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/599-Mucosis-Starts-Clinical-Study-with-its-Lead-Product--FluGEM-.aspx" /><content type="html">&lt;p&gt;Dutch biotechnology company &lt;a href="http://www.mucosis.com/" target="_blank"&gt;Mucosis B.V.&lt;/a&gt; today announced the start of a Phase 1 clinical study with its lead product FluGEM&amp;trade;, a novel improved influenza vaccine for the elderly. It is the first-ever study in man with a vaccine candidate based on &lt;a href="http://www.mucosis.com/mimopath.php" target="_blank"&gt;Mimopath&amp;trade;&lt;/a&gt;, a proprietary platform technology for developing more potent vaccines.&lt;/p&gt;</content></entry><entry><id>ee1c5914-eb6e-42b3-b0a4-c187d761c55c</id><title type="text">Saab IQon Open Innovation in Car Infotainment </title><updated>2011-03-21T10:35:40Z</updated><link rel="alternate" href="http://pressroom.ackura.com/pentagon/497-Saab-IQon-Open-Innovation-in-Car-Infotainment-.aspx" /><content type="html">&lt;p&gt;Saab Automobile is changing the auto industry infotainment landscape  by engaging external partners in &amp;lsquo;open innovation&amp;rsquo; for the development  of its new IQon infotainment concept, using Google&amp;rsquo;s Android operating  system.&lt;/p&gt;
&lt;p&gt;Saab IQon delivers a completely new car infotainment user experience,  combining all that&amp;rsquo;s best from the mobile industry with Saab&amp;rsquo;s  automotive knowledge and innovative spirit to create an infotainment  system for the next generation of Saab cars.&lt;/p&gt;</content></entry><entry><id>973363f9-7bdc-4e49-9be8-9771c0943b6d</id><title type="text">Milligan launch inspiring new website built with SiteManager</title><updated>2011-03-18T12:39:31Z</updated><link rel="alternate" href="http://pressroom.ackura.com/ackura/596-Milligan-launch-inspiring-new-website-built-with-SiteManager.aspx" /><content type="html">&lt;p&gt;&lt;a title="Milligan Retail Homepage" href="http://www.milliganretail.com/" target="_blank"&gt;Milligan Retail&lt;/a&gt; have launched their brand new website, built by &lt;a title="KMP Digitata - Milligan" href="http://kmp.co.uk/home/milligan/" target="_blank"&gt;KMP Digitata&lt;/a&gt;, and used the &lt;a title="Ackura SiteManager" href="http://ackura.com/sitemanager.aspx" target="_blank"&gt;Ackura SiteManager&lt;/a&gt; as the CMS system.&lt;/p&gt;</content></entry><entry><id>627f8ee1-8011-43ef-ad2c-c0187357f8a2</id><title type="text">FOLLOW IN CELEBRITY FOOTSTEPS AND TAKE ON LIFE-CHANGING DESERT TREK</title><updated>2011-03-18T10:22:03Z</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/597-FOLLOW-IN-CELEBRITY-FOOTSTEPS-AND-TAKE-ON-LIFE-CHANGING-DESERT-TREK.aspx" /><content type="html">&lt;p&gt;The celebrity lives of Lorraine Kelly, Olly Murs and Dermot O&amp;rsquo; Leary may appear poles apart from a local self-employed double-glazer in Bedford.&amp;nbsp; Yet when it comes to life changing experiences, as Malcolm Patrickson (44) has shown, they are not just the preserve of the celebrity.&lt;/p&gt;
&lt;p&gt;Inspired to take on an October desert trek for Sue Ryder in memory of his friend who died recently, Malcolm watched the celebrity Red Nose desert trek (broadcast on BBC1 on 17 March) with interest.&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/p&gt;</content></entry><entry><id>d29bf170-a5d8-4f70-aec9-689701ee32c5</id><title type="text">AMSilk Closes 5 Million Euro Financing Round </title><updated>2011-03-17T09:55:23Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/595-AMSilk-Closes-5-Million-Euro-Financing-Round-.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.amsilk.com/en" target="_blank"&gt;AMSilk&lt;/a&gt;, a privately-held company specializing in the development and production of high performance materials based on spider silk, is announcing the successful completion of a 5 million Euro Series B financing round. Investors include MIG Fonds 6, MIG Fonds 7 and MIG Fonds 11, as well as AT Newtec. The newly raised funds will secure AMSilk&amp;rsquo;s advancement and commercialization efforts for its first spider silk-based products.&lt;/p&gt;</content></entry><entry><id>9dc837a6-d9b9-4ab1-be41-0c7ac2f203ca</id><title type="text">KINAXO Extends Collaboration with Takeda </title><updated>2011-03-16T10:44:19Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/594-KINAXO-Extends-Collaboration-with-Takeda-.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.kinaxo.com/" target="_blank"&gt;KINAXO Biotechnologies GmbH&lt;/a&gt; announced today that it has entered a second collaboration with Takeda Pharmaceutical Company Limited Osaka, Japan. Under the agreement KINAXO will apply its quantitative phosphoproteomics technology &lt;a href="http://www.kinaxo.com/tec_phospho.html" target="_blank"&gt;PhosphoScout&lt;sup&gt; &amp;reg;&lt;/sup&gt;&lt;/a&gt; to assist in research of drugs under development at Takeda. This will allow Takeda to take early educated decisions on drug efficacy and safety. Financial details of the agreement were not disclosed.&lt;/p&gt;</content></entry><entry><id>9b57c185-f397-489d-9355-83a5d8f1371d</id><title type="text">Tipping Point Film Fund Hosts Screening of Oscar-winning Documentary ‘Inside Job’</title><updated>2011-03-15T11:27:04Z</updated><link rel="alternate" href="http://pressroom.ackura.com/tippingpoint/593-Tipping-Point-Film-Fund-Hosts-Screening-of-Oscar-winning-Documentary--Inside-Job-.aspx" /><content type="html">&lt;p&gt;Charles Ferguson&amp;rsquo;s film about the origins of the financial crash is a damning condemnation of the banking&amp;nbsp;industry and its role in the financial meltdown of 2008. Premiered at the Cannes film festival in 2010,&amp;nbsp;selected for many festivals worldwide and narrated by Matt Damon, the film traces the connections&amp;nbsp;between government and financial institutions, as well as theoretically independent academics, showing&amp;nbsp;how they combined to trigger excessive profit-taking and endanger the wider economy.&lt;/p&gt;
&lt;p&gt;As public anger continues to be felt over ongoing banking bonuses being paid while the rest of us deal&amp;nbsp;with the fall-out, Tipping Point Film Fund hosts a screening of this highly informative film at the Lexi Cinema on Monday 28th March at 7.45pm.&lt;/p&gt;</content></entry><entry><id>4e00bed5-a7a1-403f-b045-4d557f36b2bd</id><title type="text">AFFiRiS AG: ALZHEIMER'S VACCINATION SHOWS PROMISING RESULTS</title><updated>2011-03-11T11:43:06Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/592-AFFiRiS-AG--ALZHEIMER-S-VACCINATION-SHOWS-PROMISING-RESULTS.aspx" /><content type="html">&lt;p&gt;AFFiRiS' Alzheimer's vaccine candidate AD02 showed indicative evidence for potential efficacy in a phase I clinical trial. This was demonstrated by the analysis of the data from secondary clinical study endpoints.&lt;/p&gt;</content></entry><entry><id>056fc6cc-f40d-4045-8150-7680db94cbba</id><title type="text">ProteoNic and Oxford Expression Technologies Join Forces Combining UNic with flashBAC Protein Expression Platform</title><updated>2011-03-08T17:27:59Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/591-ProteoNic-and-Oxford-Expression-Technologies-Join-Forces-Combining-UNic-with-flashBAC-Protein-Expression-Platform.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.proteonic.nl/" target="_blank"&gt;ProteoNic BV&lt;/a&gt;, the protein production experts, and &lt;a href="http://www.oetltd.com/" target="_blank"&gt;Oxford Expression Technologies Ltd&lt;/a&gt; (OET), a leading provider of baculovirus-based protein expression products and services, have joined forces in the field of recombinant protein production technology with the aim of jointly offering a superior platform and services. Several projects combining ProteoNic&amp;rsquo;s &lt;a href="http://www.proteonic.nl/technology/" target="_blank"&gt;UNic&amp;trade;&lt;/a&gt; translation enhancement elements with OET&amp;rsquo;s &lt;a href="http://oetltd.com/more-information-products/" target="_blank"&gt;&lt;em&gt;flash&lt;/em&gt; BAC&amp;trade;&lt;/a&gt; system have been initiated.&lt;/p&gt;</content></entry><entry><id>aaac9957-1db4-43e9-9a92-89e26f5bc318</id><title type="text">Critical Pharmaceuticals’ CriticalSorb™ Nasal Drug Delivery Technology Shows Excellent Local Tolerability in Long Term Preclinical Studies</title><updated>2011-03-08T12:18:59Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/590-Critical-Pharmaceuticals--CriticalSorb--Nasal-Drug-Delivery-Technology-Shows-Excellent-Local-Tolerability-in-Long-Term-Preclinical-Studies.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.criticalpharmaceuticals.com/" target="_blank"&gt;Critical Pharmaceuticals&lt;/a&gt; today announces the results of a long-term preclinical study that confirms the excellent local tolerability of its unique and proprietary &lt;a href="http://www.criticalpharmaceuticals.com/technology.php" target="_blank"&gt;CriticalSorb&amp;trade;&lt;/a&gt; nasal drug delivery technology. The emerging biotechnology company is now preparing to take the technology forward into a phase I clinical trial.&lt;/p&gt;</content></entry><entry><id>85689ee4-2d02-4332-983b-6f3edf144702</id><title type="text">Dana-Farber Cancer Institute selects CLC bio's enterprise platform</title><updated>2011-03-08T11:57:00Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/589-Dana-Farber-Cancer-Institute-selects-CLC-bio-s-enterprise-platform.aspx" /><content type="html">&lt;p&gt;After a thorough head-to-head evaluation against various competing solutions, the Center for Cancer Computational Biology (CCCB) at the Dana-Farber Cancer Institute has selected CLC bio's enterprise platform for next generation sequence analysis.&lt;/p&gt;</content></entry><entry><id>a152f848-fc35-4dab-8452-16937bb9fb20</id><title type="text">British Red Cross to test emergency response at Exercise Watermark. </title><updated>2011-03-07T15:04:37Z</updated><link rel="alternate" href="http://pressroom.ackura.com/redcross/588-British-Red-Cross-to-test-emergency-response-at-Exercise-Watermark--.aspx" /><content type="html">&lt;p&gt;Voluntary organisations including the British Red Cross will support the emergency services in Exercise Watermark activities, taking place across Lincolnshire this week (7 &amp;ndash; 11 March).&lt;/p&gt;
&lt;p&gt;Exercise Watermark is one of the biggest emergency response exercises to take place nationally, and will test the arrangements across England and Wales to respond to severe, wide-spread flooding. It will use scenarios based on severe weather conditions including flooding from the sea, rivers, surface water and reservoirs.&lt;/p&gt;</content></entry><entry><id>73889353-2ee1-4fbf-bf6d-733dadda2a05</id><title type="text">Take That duo confirmed as charity entertainment</title><updated>2011-03-07T11:01:25Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/587-Take-That-duo-confirmed-as-charity-entertainment.aspx" /><content type="html">&lt;p&gt;Fundraisers at national charity, Caudwell Children, have today confirmed rumours that Robbie Williams and Gary Barlow will be performing alongside Robin Gibb at an exclusive black-tie event in London later this year.&lt;/p&gt;
&lt;p&gt;The three stars have donated their time to perform at the &amp;lsquo;Butterfly Benefit&amp;rsquo; fundraising event will take place on Thursday May 12&lt;sup&gt;th&lt;/sup&gt; 2011 at the Banqueting House in Whitehall, London.&lt;/p&gt;</content></entry><entry><id>8d142998-8ddf-4037-92e6-6b07304846f8</id><title type="text">Swapping fireman’s pole for paddle</title><updated>2011-03-07T10:07:18Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/585-Swapping-fireman-s-pole-for-paddle.aspx" /><content type="html">&lt;p&gt;An intrepid member of the Fire Service is getting ready for a challenge, which will see him kayak a marathon distance every day for a month.&lt;/p&gt;
&lt;p&gt;With little experience on the water, Sean Dolan from Hull, will attempt to kayak 700 miles from Christchurch in Devon, to Carlisle; taking around twenty-five days in a challenge that has never been done before.&lt;/p&gt;</content></entry><entry><id>b9eac39b-2faf-4834-af6c-35712ac9f7cc</id><title type="text">Domainex to Invest in its Drug Discovery Services and Internal Oncology Pipeline in 2011 </title><updated>2011-03-07T09:52:02Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/586-Domainex-to-Invest-in-its-Drug-Discovery-Services-and-Internal-Oncology-Pipeline-in-2011-.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.domainex.co.uk/" target="_blank"&gt;Domainex Ltd&lt;/a&gt;, a biotechnology company providing world-class &lt;a href="http://www.domainex.co.uk/index.asp" target="_blank"&gt;drug discovery services&lt;/a&gt; to support both its own and customer research programmes, has announced plans to significantly expand its &lt;a href="http://www.domainex.co.uk/cbs_mc.asp" target="_blank"&gt;medicinal chemistry&lt;/a&gt; and biology capabilities in 2011. The expansion will involve relocation to larger laboratories in Cambridge and investment in new technologies that will enhance its current service offering. This will allow Domainex to provide even better support to its growing client base and enable it to expand work on the Company&amp;rsquo;s own discovery-phase &lt;a href="http://www.domainex.co.uk/ddp.asp" target="_blank"&gt;oncology drug pipeline&lt;/a&gt; .&lt;/p&gt;</content></entry><entry><id>174dd5a9-362d-4d8f-b271-bd2331274679</id><title type="text">Our Junior Interactive Designer wins the Cbeebies Student Commission</title><updated>2011-03-04T11:08:46Z</updated><link rel="alternate" href="http://pressroom.ackura.com/kmp/584-Our-Junior-Interactive-Designer-wins-the-Cbeebies-Student-Commission.aspx" /><content type="html">&lt;p&gt;In 2010 the BBC approached Universities in the North West with the hope of uncovering new and exciting talent in our part of the country. The Ceebies Student Commission invited students to pitch ideas for short films, the winning of which would feature on the Cbeebies website.&lt;/p&gt;</content></entry><entry><id>5324398a-9bcb-416f-a974-66a8a09dbb82</id><title type="text">Striking Development releases accelerated Paracel BLAST plug-in for CLC bio’s platform</title><updated>2011-03-03T11:18:13Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/583-Striking-Development-releases-accelerated-Paracel-BLAST-plug-in-for-CLC-bio-s-platform.aspx" /><content type="html">&lt;p&gt;Today, CLC bio and Striking Development announced the release of the highly accelerated Paracel BLAST plug-in for integration into CLC bio&amp;rsquo;s enterprise platform: CLC Genomics Server.&lt;/p&gt;</content></entry><entry><id>57286c97-5930-46eb-88a8-553c147c521e</id><title type="text">Riemser Arzneimittel AG Sells Veterinary Business to Ecuphar N.V.</title><updated>2011-03-03T10:10:22Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/582-Riemser-Arzneimittel-AG-Sells-Veterinary-Business-to-Ecuphar-N-V-.aspx" /><content type="html">&lt;p&gt;&lt;a title="Riemser Arzneimittel AG" href="http://www.riemser.com/index.php?id=149&amp;amp;L=1"&gt;Riemser Arzneimittel AG&lt;/a&gt; and Belgian company &lt;a title="Ecuphar" href="http://www.ecuphar.com/"&gt;Ecuphar N.V.&lt;/a&gt; have announced that they have agreed on the sale of a large part of the veterinary business of Riemser to Ecuphar. The sale should take place during the first quarter of 2011.&lt;/p&gt;</content></entry><entry><id>4d04e582-ec5d-4738-8fdc-92a005c5e04d</id><title type="text">SUE RYDER RESPONDS TO DISPATCHES' SECRET NHS DIARIES:</title><updated>2011-03-02T14:06:10Z</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/580-SUE-RYDER-RESPONDS-TO-DISPATCHES--SECRET-NHS-DIARIES-.aspx" /><content type="html">&lt;p&gt;Sue Ryder coments on the recent Dispatches programme about Palliative Care in the NHS.&lt;/p&gt;</content></entry><entry><id>ee8207dc-b225-453c-a1c0-5b7a4f886d5e</id><title type="text">AID BUDGET IS ‘MAJOR STAND AGAINST THE GLOBAL SCANDAL OF POVERTY.’ </title><updated>2011-03-01T18:02:15Z</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/579-AID-BUDGET-IS--MAJOR-STAND-AGAINST-THE-GLOBAL-SCANDAL-OF-POVERTY---.aspx" /><content type="html">&lt;ul&gt;
&lt;li&gt;Aid to India welcome&lt;/li&gt;
&lt;li&gt;Government misses chance to press World Bank on climate change&lt;/li&gt;
&lt;li&gt;Why is FAO funding under threat? &lt;/li&gt;
&lt;li&gt;Move to consider &amp;lsquo;effective&amp;rsquo; funding for UN Women welcome &lt;/li&gt;
&lt;/ul&gt;</content></entry><entry><id>b63a436c-621d-4e47-b6d7-7f9c0f633373</id><title type="text">Climate change 'chain gang' demands World Bank ‘free us from fossil fuels’ </title><updated>2011-03-01T16:51:55Z</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/578-Climate-change--chain-gang--demands-World-Bank--free-us-from-fossil-fuels--.aspx" /><content type="html">&lt;p&gt;Today climate change campaigners formed a &amp;lsquo;chain gang&amp;rsquo; outside the London headquarters of the World Bank Group. They&amp;nbsp;demand that the Bank frees developing countries from fossil fuel investments. Actions are also taking place in cities across Europe and in South Africa.&lt;/p&gt;</content></entry><entry><id>2d240dc5-d7bc-493e-9e27-f3c484e45720</id><title type="text">Exclusive news flash: Superheroes on bikes!</title><updated>2011-03-01T11:04:42Z</updated><link rel="alternate" href="http://pressroom.ackura.com/norwood/577-Exclusive-news-flash--Superheroes-on-bikes-.aspx" /><content type="html">&lt;p&gt;Superheroes along with the 3 amigos &amp;amp; morph&amp;nbsp;have been spotted cycling somewhere between London and Hove...&lt;/p&gt;</content></entry><entry><id>05f7c880-0db0-4a91-b03c-d94a14cd6ca4</id><title type="text">Biotage Introduces New SNAP XL Flash Purification</title><updated>2011-03-01T09:24:55Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/576-Biotage-Introduces-New-SNAP-XL-Flash-Purification.aspx" /><content type="html">&lt;p&gt;&lt;strong&gt;&amp;ndash;&lt;/strong&gt; &lt;a href="http://www.biotage.com/" target="_blank"&gt;Biotage&lt;sup&gt;&amp;reg;&lt;/sup&gt;&lt;/a&gt; (STO: BIOT), a leading supplier of tools and technology for analytical and medicinal chemistry, announced 2 new additions to its &lt;a href="http://www.biotage.com/DynPage.aspx?id=82644"&gt;SNAP XL&lt;/a&gt; family of cartridges for large scale and development purification. Released in both 750g and 1500g sizes, the new cartridges offer powerful solutions for reverse phase chromatography (KP-C18-HS) and also optimized silica for the separation of amines (KP-NH).&lt;/p&gt;</content></entry><entry><id>7b0dc8c7-f51e-4e61-b77b-bca572683f11</id><title type="text">Recent Study Reveals Animal-Free Expansion Media Components Eliminate Need for Blood Products in Mononuclear and Hematopoietic Stem Cells</title><updated>2011-03-01T09:20:50Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/575-Recent-Study-Reveals-Animal-Free-Expansion-Media-Components-Eliminate-Need-for-Blood-Products-in-Mononuclear-and-Hematopoietic-Stem-Cells.aspx" /><content type="html">&lt;p&gt;A recent study demonstrated that &lt;a href="http://www.invitria.com/products-and-services/details/17/6/albumin/cellastim.html?Itemid=116" target="_blank"&gt;Cellastim&amp;reg;&lt;/a&gt; (recombinant human albumin)&amp;nbsp;and&amp;nbsp;&lt;a href="http://www.invitria.com/products-and-services/details/28/9/transferrin/optiferrin.html?Itemid=158" target="_blank"&gt; Optiferrin&amp;reg;&lt;/a&gt;&amp;nbsp;(recombinant human transferrin)&amp;nbsp;deliver superior xeno-free and animal-free solutions for primary cell and stem cell expansion media. The study revealed that the combination of Cellastim and Optiferrin delivered a 250-300% increase in performance over the best animal-derived combination. These research findings were presented at the Stem Cells &amp;amp; Regenerative Medicine World Congress, January 2011 poster session.&lt;/p&gt;</content></entry><entry><id>0cfbf92d-c737-4509-92df-afccfde72f45</id><title type="text">NovAliX Signs Multiyear Services Agreement for Chemistry </title><updated>2011-02-28T10:36:19Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/572-NovAliX-Signs-Multiyear-Services-Agreement-for-Chemistry-.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.novalix-pharma.com/" target="_blank"&gt;NovAlix&lt;/a&gt; today announces that it has entered into a multi-year research services agreement for chemistry with Janssen-Cilag, France, to support its drug discovery efforts.&lt;/p&gt;</content></entry><entry><id>a08e166e-67c8-4d63-a092-601bf1c98b26</id><title type="text">AFFIRIS ANNOUNCES AN EXTENSION OF ITS EXISTING ALZHEIMER´S DISEASE VACCINE DEVELOPMENT COLLABORATION WITH GLAXOSMITHKLINE </title><updated>2011-02-28T10:32:07Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/571-AFFIRIS-ANNOUNCES-AN-EXTENSION-OF-ITS-EXISTING-ALZHEIMER-S-DISEASE-VACCINE-DEVELOPMENT-COLLABORATION-WITH-GLAXOSMITHKLINE-.aspx" /><content type="html">&lt;p&gt;AFFiRiS AG announced today significant progress in their collaboration with GlaxoSmithKline Biologicals (GSK) for the development of an active vaccination programme against Alzheimer&amp;acute;s disease. While the lead vaccine candidate AD02 is currently in phase II clinical testing, two additional preclinical programmes have been completed successfully. The second programme was related to alternative vaccine candidates generated by AFFiRiS&amp;acute; AFFITOME&amp;reg; technology, including candidate AD03. Based on the promising preliminary results of this programme, GSK exercised its option for the alternative vaccine candidates which triggered a EUR 2.5 million payment to AFFiRiS. An additional EUR 1 million payment became due simultaneously for the successful completion of tests of alternative vaccine formulations.&lt;/p&gt;</content></entry><entry><id>36e777af-0396-4566-bd4c-8bb8a7c440a5</id><title type="text">Glamour is on the menu for Lincoln’s first Purple Ball</title><updated>2011-02-25T10:08:35Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/570-Glamour-is-on-the-menu-for-Lincoln-s-first-Purple-Ball.aspx" /><content type="html">&lt;p&gt;A Lincolnshire couple are inviting people to a night of glitz and glamour as they prepare to host the first ever Purple Ball in aid of national charity, Caudwell Children.&lt;/p&gt;
&lt;p&gt;Dan and Collette Nicholls are raising money for the Charity&amp;rsquo;s &amp;lsquo;Destination Dreams&amp;rsquo; project, a week-long trip to DisneyWorld in Florida for children fighting life-limiting illnesses.&lt;/p&gt;</content></entry><entry><id>daa45bad-ab54-471c-b176-2f550cf7fd8f</id><title type="text">Adventurous evening planned for charity fundraiser</title><updated>2011-02-24T17:59:46Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/569-Adventurous-evening-planned-for-charity-fundraiser.aspx" /><content type="html">&lt;p&gt;A renowned British mountaineer and the inspiration for the Bafta-winning film, Touching The Void, is set to talk at a fundraising event for local charity, Caudwell Children.&lt;/p&gt;
&lt;p&gt;Simon Yates, whose terrifying experiences in The Andes with fellow climber and friend, Joe Simpson, have become one of the World&amp;rsquo;s greatest tales of human endurance and mental fortitude, will be talking at Beech Hall School in Macclesfield on Thursday 24&lt;sup&gt;th&lt;/sup&gt; March at 7:30pm.&lt;/p&gt;
&lt;p&gt;The special event is open to members of the local community and will feature a presentation by Yates and an intriguing insight into the mind of an adventurer who has climbed some of the most remote and inaccessible mountain ranges in the World.&lt;/p&gt;
&lt;p&gt;?&lt;/p&gt;</content></entry><entry><id>c7991e6e-4f91-47f8-ba67-0824fa1fb978</id><title type="text">Oncolytics Announces Completion of Enrollment in Translational Clinical Trial Investigating REOLYSIN in Patients with Metastatic Colorectal Cancer </title><updated>2011-02-24T11:35:35Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/568-Oncolytics-Announces-Completion-of-Enrollment-in-Translational-Clinical-Trial-Investigating-REOLYSIN-in-Patients-with-Metastatic-Colorectal-Cancer-.aspx" /><content type="html">&lt;p&gt;Oncolytics Biotech Inc. announced yestertoday that enrollment has been completed in a U.K. translational clinical trial investigating intravenous administration of REOLYSIN in patients with metastatic colorectal cancer prior to surgical resection of liver metastases (REO 013). The principal investigator is Professor Alan Melcher of St. James's University Hospital and the trial is sponsored by the University of Leeds, UK.&lt;/p&gt;</content></entry><entry><id>419bf3ed-20bc-422e-aeaf-d892766420c7</id><title type="text">Critical Outcome Technologies Inc. Selected for Trade Mission to Biopartnering North America</title><updated>2011-02-24T10:20:45Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/565-Critical-Outcome-Technologies-Inc--Selected-for-Trade-Mission-to-Biopartnering-North-America.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.criticaloutcome.com/" target="_blank"&gt;Critical Outcome Technologies Inc.&lt;/a&gt; (COTI) have announced that the Company was selected by the International Trade Branch and the Ontario Ministry of Economic Development and Trade in partnership with the Ontario BioScience Industry Organization to participate in a Trade Mission to BioPartnering North America in Vancouver, Canada taking place February 27 - March 1, 2011. BioPartnering North America is one of the premier annual international pharmaceutical partnering events.&lt;/p&gt;</content></entry><entry><id>0f8d962b-388f-4a81-8312-7ea8285813b6</id><title type="text">Presenter honoured for his work</title><updated>2011-02-23T11:27:25Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/564-Presenter-honoured-for-his-work.aspx" /><content type="html">&lt;p&gt;Kids TV star, Alex Winters, is the latest name to join a prestigious roster of ambassadors for national charity, Caudwell Children.&lt;/p&gt;
&lt;p&gt;Alex has been made &amp;lsquo;Families Ambassador&amp;rsquo; for the charity, which helps sick and disabled children throughout the UK by providing providing specialist equipment, treatment and therapy as well as its annual &amp;lsquo;Destination Dreams&amp;rsquo; holiday.&lt;/p&gt;</content></entry><entry><id>cf132d6f-fe08-46a2-88e2-dd7ca772e6f6</id><title type="text">Businessmen get in the frame to give £1,000 boost for local charity</title><updated>2011-02-23T11:03:06Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/563-Businessmen-get-in-the-frame-to-give--1-000-boost-for-local-charity.aspx" /><content type="html">&lt;p&gt;Five brave businessmen are sitting pretty after their cheeky idea has generated over &amp;pound;1,000 for a local charity.&lt;/p&gt;
&lt;p&gt;The funds have been raised by the group after they posed for a risqu&amp;eacute; calendar, which went on sale earlier this year in aid of Stoke-based charity Caudwell Children.&lt;/p&gt;</content></entry><entry><id>6735ec1e-e1c9-456e-ba0e-7236a6d8f1de</id><title type="text">UK’S FINANCIAL TRANSPARENCY MOVE IS CRUCIAL FIRST STEP AGAINST CORRUPTION</title><updated>2011-02-22T11:40:55Z</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/561-UK-S-FINANCIAL-TRANSPARENCY-MOVE-IS-CRUCIAL-FIRST-STEP-AGAINST-CORRUPTION.aspx" /><content type="html">&lt;p&gt;The UK government&amp;rsquo;s decision to back a &amp;lsquo;publish-what-you-pay&amp;rsquo; standard for mining and other &amp;lsquo;extractive&amp;rsquo; companies across the world is an exciting and welcome move which will challenge corruption in the oil, mining and gas sectors but does not go far enough to tackle the massive damage done by tax dodging and financial secrecy, Christian Aid says today.&lt;/p&gt;</content></entry><entry><id>29fe8802-abe6-4051-b3cc-433c687db64c</id><title type="text">Zambia must launch copper mining tax probe, says Christian Aid partner</title><updated>2011-02-22T11:38:35Z</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/557-Zambia-must-launch-copper-mining-tax-probe--says-Christian-Aid-partner.aspx" /><content type="html">&lt;p&gt;A subsidiary of one of the world&amp;rsquo;s largest commodity trading companies stands accused of a series of tax irregularities in Zambia &amp;ndash; a desperately poor developing country where life expectancy is 47 and tax revenues are urgently needed.&lt;/p&gt;</content></entry><entry><id>41a70f7b-bf03-4b0c-b7c1-8c8527504b6f</id><title type="text">IOTA Pharmaceuticals, KinaseDetect &amp; SARomics Biostructures Announce the Formation of the KINOMED Partnership</title><updated>2011-02-22T10:33:29Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/560-IOTA-Pharmaceuticals--KinaseDetect---SARomics-Biostructures-Announce-the-Formation-of-the-KINOMED-Partnership.aspx" /><content type="html">&lt;p&gt;The &lt;a href="http://www.kinomed.com/" target="_blank"&gt;KINOMED&lt;/a&gt; Partnership, funded by the Eurostars program of the European Union, has been established to provide an integrated package of services for protein kinase inhibitor discovery and development. Kinase production, kinase assay development, kinase crystal structure determination, kinase fragment library construction, hit finding and optimisation, in silico screening, kinase biochemical and biophysical screening, structure- and ligand-based drug design and medicinal chemistry services are all included within a single, state-of-the-art offering.&lt;/p&gt;</content></entry><entry><id>bbb7b4eb-502c-4a4e-8b41-94d9633be60f</id><title type="text">Nitto Denko to Start-up Prototyping Centre in Singapore Research Institute </title><updated>2011-02-22T10:05:37Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/558-Nitto-Denko-to-Start-up-Prototyping-Centre-in-Singapore-Research-Institute-.aspx" /><content type="html">&lt;p&gt;Nitto Denko Asia Technical Centre (NAT) will be expanding its Singapore base to include a prototyping centre in Singapore. The centre will be pioneered at A*STAR's Institute of Materials Research and Engineering (IMRE) under a unique Lab-in-RI programme. NAT can leverage on existing infrastructure, research expertise, and save cost on facilities and equipment while working to establish the new prototyping centre.&lt;/p&gt;</content></entry><entry><id>b52cedc1-b665-4af2-87f5-37f1ab9a8bfb</id><title type="text">KMP use Facebook to send Trekkers on the Ultimate Road Trip with TrekAmerica</title><updated>2011-02-21T10:14:09Z</updated><link rel="alternate" href="http://pressroom.ackura.com/kmp/556-KMP-use-Facebook-to-send-Trekkers-on-the-Ultimate-Road-Trip-with-TrekAmerica.aspx" /><content type="html">&lt;p&gt;&lt;strong&gt;KMP Digitata and &lt;a title="Tui Travel plc" href="http://www.tuitravelplc.com/tui/pages/home" target="_blank"&gt;TUI Travel plc&lt;/a&gt; has been embracing social media with the &lt;a title="TrekAmerica homepage" href="http://www.trekamerica.co.uk/" target="_blank"&gt;TrekAmerica&lt;/a&gt; brand and the new community website we built for them, &lt;a title="TrekAmerica Live" href="http://www.trekamericalive.com/" target="_blank"&gt;TrekAmerica Live&lt;/a&gt;. Last year KMP Digitata were assigned the task of developing a social media campaign that would embody the TrekAmerica brand ethos and increase the number of entries to the annual &lt;em&gt;"&lt;a title="TrekAmerica Ultimate Road Trip" href="http://eightmates.trekamerica.co.uk/" target="_blank"&gt;Win the ultimate Road Trip&lt;/a&gt;"&lt;/em&gt; competition.&lt;/strong&gt;&lt;/p&gt;</content></entry><entry><id>d69b6a9f-adbc-4d0b-97cc-bad4cf7bbad0</id><title type="text">In silico cloning and BLAST made easier with new release from CLC bio </title><updated>2011-02-17T10:12:56Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/555-In-silico-cloning-and-BLAST-made-easier-with-new-release-from-CLC-bio-.aspx" /><content type="html">&lt;p&gt;Today, CLC bio announced the release of several desktop software packages for analyzing biological sequence data including the popular products such as the CLC Main Workbench 6.0 and CLC DNA Workbench 6.0. This update offers large improvements to two of the most important bioinformatics tools used by biomedical researchers everywhere, namely &lt;em&gt;in silico&lt;/em&gt; cloning and BLAST.&lt;/p&gt;</content></entry><entry><id>2d8f3a4b-119a-4d98-8116-e3ebad4895d8</id><title type="text">You can help make a dream come true</title><updated>2011-02-16T18:00:46Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/554-You-can-help-make-a-dream-come-true.aspx" /><content type="html">&lt;p&gt;A national children&amp;rsquo;s charity is calling for people across the country to help make the dreams come true for a group of children with life-limiting illnesses, by volunteering to support families on a trip to DisneyWorld in the USA.&lt;/p&gt;
&lt;p&gt;Caudwell Children will be taking up to 25 children and their families to the Florida theme parks for seven days in December as part of their annual Destination Dreams campaign, and are once again looking for volunteers to support families during the trip.&lt;/p&gt;</content></entry><entry><id>836c14cb-d175-4caf-ad1a-1e0b9699facc</id><title type="text">CONTINUED AID TO INDIA WELCOMED BY CHRISTIAN AID </title><updated>2011-02-16T16:51:54Z</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/553-CONTINUED-AID-TO-INDIA-WELCOMED-BY-CHRISTIAN-AID-.aspx" /><content type="html">&lt;p&gt;Christian Aid has welcomed the UK Government&amp;rsquo;s continued commitment to fight poverty in India, describing recent criticism of the pledged aid as &amp;lsquo;misguided.&amp;rsquo;&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;</content></entry><entry><id>38d24901-40d6-4b46-8b6c-418cda41678f</id><title type="text">Oncolytics Biotech® Inc. Announces Start of Enrollment in Randomized Phase II Pancreatic Cancer Study </title><updated>2011-02-16T14:18:57Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/552-Oncolytics-Biotech--Inc--Announces-Start-of-Enrollment-in-Randomized-Phase-II-Pancreatic-Cancer-Study-.aspx" /><content type="html">&lt;p&gt;Oncolytics Biotech Inc. announced today that enrollment has begun in a 2-Arm randomized Phase II study of carboplatin, paclitaxel plus REOLYSIN&lt;sup&gt;&amp;reg;&lt;/sup&gt; versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer. The Principal Investigator is Dr. Tanios Bekaii-Saab, Medical Director of Gastrointestinal Oncology at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. The Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, U.S. National Cancer Institute (NCI), which is part of the National Institutes of Health, is sponsoring the trial under its Clinical Trials Agreement with Oncolytics, while Oncolytics will provide clinical supplies of REOLYSIN.&lt;/p&gt;</content></entry><entry><id>be9fc99f-95fb-4475-89da-3ebdd70e1ee4</id><title type="text">Biotechgate welcomes two new partners in France and Italy</title><updated>2011-02-16T10:53:29Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/551-Biotechgate-welcomes-two-new-partners-in-France-and-Italy.aspx" /><content type="html">&lt;p&gt;Biotechgate is expanding its international network further with two new partners: Assobiotec, the Italian Biotech Association and APIM &amp;ndash; the Lille Metropole Development Agency.&lt;/p&gt;</content></entry><entry><id>732cd12b-1f13-438c-9469-ef0e716d61fb</id><title type="text">VIE at Home Facebook application adds event creation feature</title><updated>2011-02-16T09:46:28Z</updated><link rel="alternate" href="http://pressroom.ackura.com/kmp/528-VIE-at-Home-Facebook-application-adds-event-creation-feature.aspx" /><content type="html">&lt;p&gt;The &lt;a title="VIE at Home Facebook page" href="http://www.facebook.com/VIEathomeofficial"&gt;VIE at Home Facebook&lt;/a&gt; app, built by KMP Digitata, is the first of its kind in the Direct Selling industry and has been extremely well received by the VIE at Home Consultant network.&lt;/p&gt;</content></entry><entry><id>d654add6-6db4-4942-905a-5204cbb98f72</id><title type="text">National competition wins pupils celebrity surprise</title><updated>2011-02-15T16:05:33Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/547-National-competition-wins-pupils-celebrity-surprise.aspx" /><content type="html">&lt;p&gt;Pupils at a Shepperton school are set for a star surprise this week, as a famous face arrives to meet them.&lt;/p&gt;
&lt;p&gt;&amp;nbsp;CBeebies presenter Alex Winters will visit Littleton C of E Infant School on Wednesday, February 16&lt;sup&gt;th&lt;/sup&gt;, after they won a national charity competition to have the celebrity visit their school.&lt;/p&gt;</content></entry><entry><id>174de55e-e131-4eeb-902d-9608432083de</id><title type="text">PEQLAB Expands Liquid Handling and Centrifuge Product Lines.</title><updated>2011-02-15T13:54:16Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/546-PEQLAB-Expands-Liquid-Handling-and-Centrifuge-Product-Lines-.aspx" /><content type="html">&lt;p&gt;PEQLAB, the supplier of products for molecular biology has announced the launch of five new products in their liquid handling and centrifugation product range. These new products build upon the popularity of their existing range to offer more quality and value to the researcher.&lt;/p&gt;</content></entry><entry><id>a537be3b-d502-4eeb-a59b-4b9a2ae51ab6</id><title type="text">Raptor Pharmaceutical to Enroll Five Additional Patients in Pivotal Phase 3 Clinical Trial of DR Cysteamine</title><updated>2011-02-15T11:30:14Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/545-Raptor-Pharmaceutical-to-Enroll-Five-Additional-Patients-in-Pivotal-Phase-3-Clinical-Trial-of-DR-Cysteamine.aspx" /><content type="html">&lt;p&gt;Raptor Pharmaceutical Corp. today announced it has reopened enrollment in its Phase 3 clinical trial of its proprietary delayed-release oral formulation of cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis"). The pivotal Phase 3 clinical trial is designed as a study of the safety, tolerability, pharmacokinetics ("PK") and pharmacodynamics ("PD") of DR Cysteamine compared with immediate-release cysteamine bitartrate.&lt;/p&gt;</content></entry><entry><id>66bf305a-3e28-4158-a7f1-c7989704ef53</id><title type="text">German Federal Minister of Economic Cooperation and Development Tours Vetter</title><updated>2011-02-15T10:50:25Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/529-German-Federal-Minister-of-Economic-Cooperation-and-Development-Tours-Vetter.aspx" /><content type="html">&lt;p&gt;Dirk Niebel, Germany&amp;rsquo;s Federal Minister for Economic Cooperation and Development, stopped today at Vetter&amp;rsquo;s Ravensburg Vetter South facility during a regional tour. Vetter is an independent international specialist in the aseptic filling of drug-delivery systems.&lt;/p&gt;</content></entry><entry><id>f8c6933f-4981-403a-8c89-ae8c8f5f7620</id><title type="text">New Standard Template for PressRoom</title><updated>2011-02-14T14:00:31Z</updated><link rel="alternate" href="http://pressroom.ackura.com/ackura/458-New-Standard-Template-for-PressRoom.aspx" /><content type="html">&lt;p&gt;With PressRoom you can design your own attractive online press rooms or have one of our skilled designers create a bespoke template for you. If you chose not to have a bespoke press room then fear not because the standard template has received a brand new design available to everyone.&lt;/p&gt;</content></entry><entry><id>d0ea2ad3-d610-4031-8c04-4f80fd9caf17</id><title type="text">Oncolytics Biotech® Inc. Meets Primary Endpoint for First Part of U.S. Phase 2 Pancreatic Cancer Clinical Trial </title><updated>2011-02-14T13:54:11Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/527-Oncolytics-Biotech--Inc--Meets-Primary-Endpoint-for-First-Part-of-U-S--Phase-2-Pancreatic-Cancer-Clinical-Trial-.aspx" /><content type="html">&lt;p&gt;Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today announced preliminary results from a U.S. Phase 2 clinical trial&amp;nbsp; (REO 017) using intravenous administration of REOLYSIN&lt;sup&gt;&amp;reg;&lt;/sup&gt; in combination with gemcitabine (Gemzar&lt;sup&gt;&amp;reg;&lt;/sup&gt;) in patients with advanced pancreatic cancer. The trial is being conducted at the Cancer Therapy &amp;amp; Research Center at The University of Texas Health Science Center at San Antonio (CTRC). The Principal Investigator is Dr. Monica Mita of the CTRC.&lt;/p&gt;</content></entry><entry><id>b3b672e5-dc4e-4dbe-8cec-00c7563ba635</id><title type="text">Celartia Establish Strategic Alliances to Facilitate Global Availability of PetakaG3</title><updated>2011-02-14T12:15:56Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/524-Celartia-Establish-Strategic-Alliances-to-Facilitate-Global-Availability-of-PetakaG3.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.celartia.com/" target="_blank"&gt;Celartia&lt;/a&gt;, the pioneering Life Sciences group, has announced they have entered into a number strategic alliances with major life science organisations aimed at growing availability of the &lt;a href="http://www.petaka.com/" target="_blank"&gt;Petaka&lt;/a&gt;&lt;sup&gt;TM&lt;/sup&gt; product for its global markets. Agreements are in place in several key markets covering Europe, the Far East, South America and Australia and they plan to add other territories to their worldwide network to complement offices already based in Columbus, Ohio and Valencia, Spain. The move is a result of an increasing demand for new innovative and efficient cell culture devices, with many technicians still using antiquated methods that date back to the 1950's.&lt;/p&gt;</content></entry><entry><id>6c8554b9-a089-4072-a421-fa46b81414ed</id><title type="text">Disabled five-year-old in danger of losing only chance to walk</title><updated>2011-02-10T16:19:52Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/523-Disabled-five-year-old-in-danger-of-losing-only-chance-to-walk.aspx" /><content type="html">&lt;p&gt;A single mother from Shepperton is making a final desperate plea for help to send her brave disabled son to America for a life-changing operation.&lt;/p&gt;
&lt;p&gt;For the past three months the generous friends and family of&amp;nbsp; Astrid Mallan have come together to support five-year-old Ajay&amp;rsquo;s campaign to receive ground-breaking Cerebral Palsy treatment in the USA and have so far raised &amp;pound;13,000.&lt;/p&gt;</content></entry><entry><id>d487e76b-bd2b-4d2b-beaa-f24583a7406a</id><title type="text">Sue Ryder appointed to run popular Warwickshire Reuse and Recycling Centre</title><updated>2011-02-09T14:38:35Z</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/520-Sue-Ryder-appointed-to-run-popular-Warwickshire-Reuse-and-Recycling-Centre.aspx" /><content type="html">&lt;p&gt;After a competitive tender process, Warwickshire County Council has appointed charity Sue Ryder to manage the Reuse Shop at the Princes Drive Household Waste Recycling Centre in Leamington Spa.&lt;/p&gt;</content></entry><entry><id>3314f27f-1cd5-4432-b5a6-7caba163f852</id><title type="text">InVitria Achieves cGMP Qualification Milestone </title><updated>2011-02-09T09:21:03Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/519-InVitria-Achieves-cGMP-Qualification-Milestone-.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.invitria.com/" target="_blank"&gt;InVitria&lt;/a&gt; announces that its Lysobac cell lysing reagent is manufactured at the Company&amp;rsquo;s Junction City, Kansas facility under cGMP (Current Good Manufacturing Practice) standards. Lysobac is a completely animal component free reagent that is substantially more effective and consistent than hen egg white lysozyme and complies with global regulatory standards for manufacturing biotherapeutics.&lt;/p&gt;</content></entry><entry><id>fe782f75-35e7-4f86-a802-a66d8b420337</id><title type="text">CAMPAIGNERS CALL ON SARKOZY TO ENSURE G20 END TAX HAVEN SECRECY</title><updated>2011-02-08T16:01:03Z</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/518-CAMPAIGNERS-CALL-ON-SARKOZY-TO-ENSURE-G20-END-TAX-HAVEN-SECRECY.aspx" /><content type="html">&lt;p&gt;French President Nicolas Sarkozy faces a global campaign demanding that the G20 commits to ending tax haven secrecy when it meets in Cannes, France later this year.&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;</content></entry><entry><id>06fcd843-0501-448e-8ed3-efcd7b1878c8</id><title type="text">To Mark Fairtrade Fortnight, Tipping Point Film Fund Screens Philippe Diaz’s film The End of Poverty?</title><updated>2011-02-08T12:37:31Z</updated><link rel="alternate" href="http://pressroom.ackura.com/tippingpoint/517-To-Mark-Fairtrade-Fortnight--Tipping-Point-Film-Fund-Screens-Philippe-Diaz-s-film-The-End-of-Poverty-.aspx" /><content type="html">&lt;p&gt;As Fairtrade sales go from strength to strength, Tipping Point Film Fund screens this thought-provoking film at the Lexi Cinema on Monday 28th February at 8pm.&lt;/p&gt;
&lt;p&gt;The &lt;em&gt;End of Poverty?&lt;/em&gt;&amp;nbsp;released in 2009 and selected for 25 international film festivals around the world, including Critics Weeks at Cannes, this film by award-winning director, Philippe Diaz, narrated by Martin Sheen, is a daring, thought-provoking and timely film from the Cinema Libre Studio in the USA.&lt;/p&gt;</content></entry><entry><id>02f8e6ae-818d-442f-9043-d8183f912978</id><title type="text">Omixon release SOLiD variant detection plug-in for CLC bio’s platform</title><updated>2011-02-08T11:02:44Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/516-Omixon-release-SOLiD-variant-detection-plug-in-for-CLC-bio-s-platform.aspx" /><content type="html">&lt;p&gt;Today, CLC bio and Omixon announced the release of the Omixon Gapped SOLiD Alignment plug-in for full integration into CLC Genomics Workbench. CLC bio is a leader in algorithm performance and provides an integrated solution for high-throughput sequencing data analysis, and Omixon is a leader in variant detection accuracy with their application for Life Technologies&amp;rsquo; SOLiD sequencing platform. The release agreement allows CLC bio to offer Omixon&amp;rsquo;s plug-in directly to customers.&lt;/p&gt;</content></entry><entry><id>b128428f-64e3-4300-b277-5ec234eeab07</id><title type="text">Toumaz CEO Professor Chris Toumazou to present “Electronics for healthy living” at International Solid State Circuits Conference (ISSCC) 2011</title><updated>2011-02-08T09:21:05Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/515-Toumaz-CEO-Professor-Chris-Toumazou-to-present--Electronics-for-healthy-living--at-International-Solid-State-Circuits-Conference--ISSCC--2011.aspx" /><content type="html">&lt;p&gt;&lt;strong&gt;Toumaz&lt;/strong&gt;, the leading provider of ultra-low power wireless telemetry technologies for medical monitoring and internet-connected consumer devices, today announces that Toumaz CEO Professor Chris Toumazou FRS will be an invited speaker at the 58th International Solid State Circuits Conference (ISSCC), the premier forum for presenting advances in solid-state circuits and systems-on-a-chip (February 20th&amp;ndash;24th 2011, San Francisco, California). The theme of this year&amp;rsquo;s conference is &amp;ldquo;Electronics for healthy living&amp;rdquo;, with a focus on integrated circuits for biomedical systems.&lt;/p&gt;</content></entry><entry><id>e1a50fe9-ea34-4be2-b1e8-0fce2616b8e1</id><title type="text">Fancy going somewhere hot? Join our Sahara Desert Trek 2011</title><updated>2011-02-03T17:03:00Z</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/514-Fancy-going-somewhere-hot--Join-our-Sahara-Desert-Trek-2011.aspx" /><content type="html">&lt;p&gt;This ten day trek is Sue Ryders first bespoke&amp;nbsp;international challenge event. Join a team of trekkers all raising money for Sue Ryder and have the experience of a lifetime.&lt;/p&gt;
&lt;p&gt;It takes place&amp;nbsp;between 7th - 16th October 2011&lt;/p&gt;</content></entry><entry><id>c3ce4b9d-e236-4906-944b-42a0a3815fa1</id><title type="text">CHRISTIAN AID AND D.LIGHT TO BRING SOLAR LIGHTING TO POOR FAMILIES IN INDIA</title><updated>2011-02-03T14:16:36Z</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/512-CHRISTIAN-AID-AND-D-LIGHT-TO-BRING-SOLAR-LIGHTING-TO-POOR-FAMILIES-IN-INDIA.aspx" /><content type="html">&lt;p&gt;&lt;span style="font-size: 11pt; line-height: 150%; font-family: Arial;"&gt;Christian Aid has teamed up with solar lighting specialist d.light design to launch an innovative micro finance project that will bring solar lighting to more than 4,400 socially excluded poor rural households in three Indian states during its first year.&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;</content></entry><entry><id>76d47c2c-f794-4cf9-a089-6c1a0ef6cc9d</id><title type="text">Now supporting paired-end data for RNA-seq with new version of premier desktop software package from CLC bio </title><updated>2011-02-03T14:14:25Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/513-Now-supporting-paired-end-data-for-RNA-seq-with-new-version-of-premier-desktop-software-package-from-CLC-bio-.aspx" /><content type="html">&lt;p&gt;CLC bio announced the release of CLC bio's premier desktop software package for working with genomics, transcriptomics, and epigenomics: Version 4.5 of CLC Genomics Workbench - an update which gives molecular biologists access to analyze high-througput sequencing datasets with powerful bioinformatics algorithms through a user-friendly graphical user-interface.&lt;/p&gt;</content></entry><entry><id>2301c5ca-8dd8-427a-89a2-163869483e20</id><title type="text">CTS Europe 2011: Cell Therapy Leaders Meet to Shape the Future</title><updated>2011-02-03T14:05:32Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/511-CTS-Europe-2011--Cell-Therapy-Leaders-Meet-to-Shape-the-Future.aspx" /><content type="html">&lt;p&gt;During the exclusive &lt;a href="http://www.ctsconference.com/" target="_blank"&gt;Cell Therapy Summit Europe 2011&lt;/a&gt; (CTS Europe 2011) cell therapy leaders will meet to discuss the needs of the cell therapy sector and shape innovation paths for the future. Dr. Paula Salmikangas, vice-chair of the Committee for Advanced Therapies (CAT) of the European Medicines Agency (EMA) has joined the conference to discuss future regulatory needs including the usefulness of additional guidance for drug development. In addition, industry CEOs, investors and leading scientists will discuss key issues in product development, financing, production and commercialization. Registration is open.&lt;/p&gt;</content></entry><entry><id>e40748dc-90b0-492f-b410-801be4329e07</id><title type="text">Antisense Pharma Receives Approval for Clinical Studies in South Korea and Taiwan in Malignant Brain Tumors </title><updated>2011-02-02T09:57:04Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/510-Antisense-Pharma-Receives-Approval-for-Clinical-Studies-in-South-Korea-and-Taiwan-in-Malignant-Brain-Tumors-.aspx" /><content type="html">&lt;p&gt;The biopharmaceutical company &lt;a href="http://www.antisense-pharma.com/" target="_blank"&gt;Antisense Pharma&lt;/a&gt; today announced that the South Korean health agency KFDA as well as the Taiwanese health&lt;strong&gt; &lt;/strong&gt;agency TFDA&lt;strong&gt; &lt;/strong&gt;have granted their approvals for the implementation of clinical studies using the anti-cancer drug trabedersen for patients with high-grade brain tumors. &lt;a href="http://www.antisense-pharma.de/pdf/3_Trabedersen_clinical_backgrounder_100413.pdf" target="_blank"&gt;Trabedersen&lt;/a&gt; is a gene-silencing substance inhibiting the tumor factor Transforming Growth Factor beta 2 (TGF-&amp;beta;2) at its translational level. The efficacy and tolerability of trabedersen for high-grade glioma has already been demonstrated during &lt;a href="http://neuro-oncology.oxfordjournals.org/content/early/2010/10/26/neuonc.noq142.long" target="_blank"&gt;a randomized and actively controlled Phase IIb study&lt;/a&gt;.&lt;sup&gt;1&lt;/sup&gt; The substance is currently also in clinical development for indications such as advanced pancreas carcinoma, malignant melanoma and colorectal carcinoma. The involvement of Southeast Asian countries for clinical testing of trabedersen is part of Antisense Pharma&amp;rsquo;s strategic development program for the global marketing of this compound. Including South Korea and Taiwan, a total of 13 countries are now participating in the international pivotal study&lt;/p&gt;</content></entry><entry><id>35d3ebc1-1b10-48fa-a5f8-c604b8d8ff7f</id><title type="text">Sistemic Sales Gain Pace in 2011 </title><updated>2011-02-02T09:36:48Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/509-Sistemic-Sales-Gain-Pace-in-2011-.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.sistemic.co.uk/" target="_blank"&gt;Sistemic&lt;/a&gt;, focussed on providing microRNA-based problem solving services and kit based products to the life sciences research and development markets, is certainly living up to its high growth expectations and award winning tag as &lt;a href="http://www.nexxusscotland.com/awards"&gt;Nexxus, Most Promising Company of the Year&lt;/a&gt; and has now started 2011 with a bang. This month the company has signed Master Service Agreements with RedX Pharma based in Liverpool, a subsidiary of a large pharmaceutical company in Cambridge, Massachusetts and not forgetting about their home ground, Glasgow University. The gain in the market has been driven by their solid science aligned with their focused commercial strategy which in turn has driven an 82 % increase in sales from the same month a year ago. This places Sistemic on a very firm footing from which it will further expand its efforts globally over the coming year as well as marks a significant milestone in its growth.&lt;/p&gt;</content></entry><entry><id>733195a9-8287-4f9d-9718-429a07151c6f</id><title type="text">Bribery Act delay undermines government commitment to fight corruption</title><updated>2011-02-01T18:08:37Z</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/508-Bribery-Act-delay-undermines-government-commitment-to-fight-corruption.aspx" /><content type="html">&lt;p&gt;The coalition government&amp;rsquo;s decision to delay the implementation of the landmark Bribery Act for the second time casts serious doubt on its commitment to combating corruption, said Global Witness, Tearfund, CAFOD and Christian Aid today. Passed with an all-party consensus in April 2010, the Act was supposed to be implemented last October, but was first shifted to April and is now delayed indefinitely.&lt;/p&gt;</content></entry><entry><id>81899300-7282-44f6-bda5-b0f1ad94b23e</id><title type="text">SPRING HAS SPRUNG BOTH INSIDE AND OUT</title><updated>2011-02-01T16:07:10Z</updated><link rel="alternate" href="http://pressroom.ackura.com/christy/520-SPRING-HAS-SPRUNG-BOTH-INSIDE-AND-OUT.aspx" /><content type="html">&lt;p&gt;CREATE A FRESH FLORAL SETTING AT HOME THIS SEASON WITH THE ARRIVAL OF CHRISTY&amp;rsquo;S NEW SPRING/SUMMER 11 COLLECTION&lt;br /&gt;&lt;br /&gt;&lt;/p&gt;</content></entry><entry><id>a4f7740c-1931-4691-9f27-4db56ebed1d1</id><title type="text">Apeiron &amp; Merck KGaA in License Deal</title><updated>2011-02-01T10:15:47Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/507-Apeiron---Merck-KGaA-in-License-Deal.aspx" /><content type="html">&lt;p&gt;Vienna-based biotech company Apeiron Biologics AG strengthens its cancer immunotherapy portfolio by acquiring rights to further develop and commercialize the immunocytokine hu14.18-IL2 from Merck KGaA, Germany. This investigational antibody-based biologic has met drug development checkpoints to proceed to Phase III in certain pediatric neuroblastoma subjects in a Phase II clinical study and Apeiron plans to continue clinical development of hu14.18-IL2 in 2011. Following a first in-licensing deal closed in October 2010 (project rhSOD from Polymun), this agreement complements the company's successful program to broaden its clinical development pipeline. This project expansion was initiated as a consequence of Apeiron's out-licensing of the Phase I project APN01 to GSK in January 2010.&lt;/p&gt;</content></entry><entry><id>9529de11-0a69-43fb-8019-e47c781616cc</id><title type="text">Be creative for Sue Ryder's Febru-hairy month</title><updated>2011-01-31T15:29:34Z</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/506-Be-creative-for-Sue-Ryder-s-Febru-hairy-month.aspx" /><content type="html">&lt;p&gt;Sue Ryder&amp;nbsp;is putting the fun into fundraising with the launch of its Febru-hairy month. People are being encouraged to sport creative styles and funny hair to raise vital funds for the health and social care charity.&lt;/p&gt;</content></entry><entry><id>0b84c0b9-f199-41a4-a715-d13d32b25357</id><title type="text">Norwood has chosen PressRoom</title><updated>2011-01-31T11:26:16Z</updated><link rel="alternate" href="http://pressroom.ackura.com/ackura/280-Norwood-has-chosen-PressRoom.aspx" /><content type="html">&lt;p&gt;Norwood "Change a Life" has chosen to use PressRoom to publish their news online and help spread the word of all the great things they achieve.&lt;/p&gt;</content></entry><entry><id>049db48d-259f-40f5-9d50-f1b0d1bcece3</id><title type="text">Norwood launches online gift shop</title><updated>2011-01-27T12:25:07Z</updated><link rel="alternate" href="http://pressroom.ackura.com/norwood/504-Norwood-launches-online-gift-shop.aspx" /><content type="html">&lt;p&gt;Eat your heart out Tiffany&amp;rsquo;s! With Valentine&amp;rsquo;s Day just around the corner, romantic gift hunters need look no further than Norwood.&lt;/p&gt;
&lt;p&gt;The charity has launched a new online shop which sells jewellery and other items made by adults with learning disabilities.&lt;/p&gt;</content></entry><entry><id>d6e0e2d2-85d3-4923-a867-4959f326b51b</id><title type="text">Biotage Releases Comprehensive New Catalog of Sample Preparation Products and Applications</title><updated>2011-01-26T15:07:36Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/503-Biotage-Releases-Comprehensive-New-Catalog-of-Sample-Preparation-Products-and-Applications.aspx" /><content type="html">&lt;p&gt;&lt;strong&gt;&lt;/strong&gt;&lt;a href="http://www.biotage.com/" target="_blank"&gt;Biotage&lt;/a&gt; , a leading supplier of tools and technology for medicinal and analytical chemistry, announced the release of its new Analytical Sample Preparation Catalog. The expanded, 200-page catalog includes a range of products for Bioanalytical, Forensic, Clinical, Environmental, Agrochemical and Food Applications. To order or download the catalog, visit &lt;a href="http://www.biotage.com/" target="_blank"&gt;www.biotage.com&lt;/a&gt; or contact a representative. A searchable version of the catalog is also available on the Biotage website.&lt;/p&gt;</content></entry><entry><id>c0163cc9-33bc-4531-b561-76fb438e4e72</id><title type="text">Cangene announces CEO is stepping down</title><updated>2011-01-26T10:10:45Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/502-Cangene-announces-CEO-is-stepping-down.aspx" /><content type="html">&lt;p&gt;Cangene today announces that Dr. John Langstaff, President and CEO of Cangene Corporation, has advised the Board of Directors ("Board") of the Company of his intention to step down from his current role after serving in this position for more than 20 years.&amp;nbsp; Effective immediately, Dr. Langstaff resigns from his position as President and CEO, and from the Board of Directors, but will continue as a special advisor to the Company.&amp;nbsp; Dr. Langstaff, after successfully leading the Company through years of tremendous challenges and significant growth, has decided to leave the Company to pursue personal interests.&amp;nbsp; The Board wishes to thank Dr. Langstaff for his many years of valued contribution.&amp;nbsp;&lt;/p&gt;</content></entry><entry><id>63521c43-b3b9-4745-8902-247c289efc61</id><title type="text">Managing time for communities - a guide for us all</title><updated>2011-01-25T10:03:44Z</updated><link rel="alternate" href="http://pressroom.ackura.com/BcToolkit/550-Managing-time-for-communities---a-guide-for-us-all.aspx" /><content type="html">&lt;p&gt;With several years&amp;rsquo; experience, conceiving and delivering social media campaigns one of the most common problems we see is just how little understanding there is of how much time you actually need to invest to meet the needs of your community - wherever it is. And, given that Monday was &lt;a title="Community Manager appreciation day presentation" href="http://darmano.typepad.com/logic_emotion/2011/01/cm_day.html"&gt;Community Manager Appreciation Day&lt;/a&gt;, this seems a more-than-appropriate post!&lt;br /&gt;&lt;br /&gt;&lt;a title="Community Manager appreciation day presentation" href="http://darmano.typepad.com/logic_emotion/2011/01/cm_day.html"&gt;Celebrating Community Manager Appreciation Day presentation&lt;/a&gt;&lt;/p&gt;</content></entry><entry><id>18aa7bcc-2aa8-4d3d-a0d3-5cc06f340590</id><title type="text">Teijin-developed Novel Drug for Chronic Management of Hyperuricemia 'TMX-67 (febuxostat)' Approved in Japan </title><updated>2011-01-21T10:38:08Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/501-Teijin-developed-Novel-Drug-for-Chronic-Management-of-Hyperuricemia--TMX-67--febuxostat---Approved-in-Japan-.aspx" /><content type="html">&lt;p&gt;Teijin Pharma Limited, the core company of the Teijin Group's medical and pharmaceutical business, announced today that Japan's Ministry of Health, Labour and Welfare approved TMX-67 (febuxostat), Teijin Pharma's novel drug for treating hyperuricemia, on January 21. Teijin Pharma will market the product as tablets in 10mg, 20mg, and 40mg strengths in Japan under the brand name Feburic(R) beginning this spring.&lt;/p&gt;</content></entry><entry><id>4d47fd5e-6c1a-43cf-923a-dd78fc3b6c45</id><title type="text">InVitria Taps Industry Expert to Launch Cell Culture Supplements Product Line</title><updated>2011-01-21T09:36:11Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/500-InVitria-Taps-Industry-Expert-to-Launch-Cell-Culture-Supplements-Product-Line.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.invitria.com/"&gt;InVitria&lt;/a&gt; announced the expansion of its sales and marketing team with the addition of Shawn Smith as Vice President, Sales &amp;amp; Marketing. InVitria has introduced a line of animal component free and defined cell culture media supplements that deliver improved performance for customers in regenerative medicine, bioproduction, life science research and diagnostics.&lt;/p&gt;</content></entry><entry><id>147cc04d-b363-415a-904b-d4ae1d4cddb6</id><title type="text">Calvert Labs Announces New iPhone App And Secured Website</title><updated>2011-01-20T14:21:46Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/499-Calvert-Labs-Announces-New-iPhone-App-And-Secured-Website.aspx" /><content type="html">&lt;p&gt;Underscoring its commitment to responsive customer service, Calvert Labs announced today that its newest communication tool, an iPhone application, has been released through Apple&amp;rsquo;s iTunes Store. In addition, the company has launched a secure, near real-time, info-on-demand section of its website.&lt;/p&gt;</content></entry><entry><id>bfa37a12-02de-472b-ae8a-257edc4263e8</id><title type="text">Sue Ryder Strives To Create a Caring Community By Offering Employment Opportunities</title><updated>2011-01-20T11:14:39Z</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/498-Sue-Ryder-Strives-To-Create-a-Caring-Community-By-Offering-Employment-Opportunities.aspx" /><content type="html">&lt;p&gt;Sue Ryder &amp;ndash; Stagenhoe is inspiring&amp;nbsp;job seekers in Hertfordshire to think about caring career opportunities this New Year.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;&amp;nbsp;&lt;/strong&gt;On 26&lt;sup&gt;th&lt;/sup&gt; January at the Goldsmiths Centre, North Hertfordshire College, between 10.00 &amp;ndash; 15.00 Sue Ryder will be taking part in&amp;nbsp;a local recruitment fair&amp;nbsp;with Jobcentre Plus.&amp;nbsp;The national charity hopes to encourage job seekers to take up a career in health and social care.&lt;/p&gt;</content></entry><entry><id>a03f1428-41f9-4554-9c54-bf159849b6c6</id><title type="text">Sue Ryder comment on Health and Social Care Bill</title><updated>2011-01-19T16:27:04Z</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/497-Sue-Ryder-comment-on-Health-and-Social-Care-Bill.aspx" /><content type="html">&lt;p&gt;Sue Ryder welcomes&amp;nbsp;the publication of the Health and Social Care Bill (19 Jan 2011). Since the publication of the NHS White paper last year the charity&amp;nbsp;has been eager to see the detail of the government's plans for reform.&lt;/p&gt;
&lt;p&gt;Steve&amp;nbsp;Jenkin, director of health and social care at Sue Ryder comments on the government's Health and Social Care Bill (published 19 January 2011).&amp;nbsp;&amp;nbsp;&lt;/p&gt;</content></entry><entry><id>3936a956-eab4-43c3-b36e-1a563c59ff87</id><title type="text">Dr. Marie-Paule Richard to Join AiCuris as CMO </title><updated>2011-01-19T12:03:59Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/496-Dr--Marie-Paule-Richard-to-Join-AiCuris-as-CMO-.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.aicuris.com/" target="_blank"&gt;AiCuris&lt;/a&gt; today announced that Dr. Marie-Paule Richard has assumed the responsibility of Chief Medical Officer at AiCuris, Germany. Dr. Richard has over 24 years of experience in the pharmaceutical industry in leading global clinical development projects, supervising clinical-regulatory strategies, clinical operations, pharmacovigilance, medical affairs, and managing multicultural and cross-functional teams and departments. She has been responsible for the global development of a large number of anti-infectives and vaccines that she led successfully to international registrations.&lt;/p&gt;</content></entry><entry><id>3e8c0e3d-d1c3-45f9-9602-7b71370dae4b</id><title type="text">Spark Impact opens office in Liverpool Science Park</title><updated>2011-01-18T15:26:01Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/495-Spark-Impact-opens-office-in-Liverpool-Science-Park.aspx" /><content type="html">&lt;p&gt;Spark Impact, facilitator of the new &amp;pound;25M Northwest Fund for Biomedical, has opened an office within Liverpool Science Park.&lt;/p&gt;</content></entry><entry><id>03b753f4-14cf-4cdc-9b52-1b25112a4e49</id><title type="text">Oncolytics Biotech® Inc. Announces 2-Arm, Randomized Phase II Pancreatic Cancer Study</title><updated>2011-01-18T14:11:15Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/494-Oncolytics-Biotech--Inc--Announces-2-Arm--Randomized-Phase-II-Pancreatic-Cancer-Study.aspx" /><content type="html">&lt;p&gt;Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that the Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, U.S. National Cancer Institute (NCI), which is part of the National Institutes of Health, has agreed to sponsor a 2-Arm randomized Phase II study of carboplatin, paclitaxel plus REOLYSIN&lt;sup&gt;&amp;reg;&lt;/sup&gt; versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer.&amp;nbsp; The NCI is sponsoring the trial under its Clinical Trials Agreement with Oncolytics, while Oncolytics will provide clinical supplies of REOLYSIN. The Principal Investigator is Dr. Tanios Bekaii-Saab of The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.&lt;/p&gt;</content></entry><entry><id>33a9a771-75d5-4e41-af9b-692626e3eda1</id><title type="text">KMP Digitata and Manchester Airport Launch pig-a-pult</title><updated>2011-01-18T11:59:28Z</updated><link rel="alternate" href="http://pressroom.ackura.com/kmp/449-KMP-Digitata-and-Manchester-Airport-Launch-pig-a-pult.aspx" /><content type="html">&lt;p&gt;We love nothing more than creating fun, interactive solutions that fulfil the client&amp;rsquo;s request then go beyond what they expect. &lt;a title="pig-a-pult" href="http://apps.facebook.com/pig-a-pult/default.aspx"&gt;pig-a-pult&lt;/a&gt; is KMP Digitata&amp;rsquo;s and Manchester Airport&amp;rsquo;s latest adventure into the exciting world of social media.&lt;/p&gt;</content></entry><entry><id>ba1cb5a1-1c2d-4498-8d65-1ee3af9096fb</id><title type="text">UK MUST URGE WORLD BANK TO ABANDON ‘DIRTY’ FOSSIL FUELS </title><updated>2011-01-17T16:28:19Z</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/493-UK-MUST-URGE-WORLD-BANK-TO-ABANDON--DIRTY--FOSSIL-FUELS-.aspx" /><content type="html">&lt;p&gt;&lt;span style="font-size: 11pt; line-height: 150%; font-family: Arial;"&gt;Christian Aid is urging international development secretary Andrew Mitchell to use his position on the board of the World Bank to press for an end to investment in carbon-intensive energy projects.&lt;/span&gt;&lt;/p&gt;</content></entry><entry><id>d6e393a8-386a-4af3-b0d0-34db71d056e2</id><title type="text">Rentschler to Manufacture Faron Product Traumakine®</title><updated>2011-01-17T11:21:15Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/492-Rentschler-to-Manufacture-Faron-Product-Traumakine-.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.faronpharmaceuticals.com/" target="_blank"&gt;Faron Pharmaceuticals Ltd.&lt;/a&gt; and &lt;a href="http://www.rentschler.de/?L=1" target="_blank"&gt;Rentschler Biotechnologie GmbH&lt;/a&gt; announced today that they have signed a manufacturing and supply agreement for the Faron product FP-1201 that is also known as &lt;strong&gt;Traumakine&amp;reg;&lt;/strong&gt;. The active pharmaceutical ingredient of the FP-1201 is recombinant human interferon beta-1a (IFN-beta 1a) that was first produced by Rentschler already in the late 1980&amp;rsquo;s. According to the agreement Rentschler will become the sole global manufacturer of IFN-beta 1a for Faron and also manufacture Faron&amp;rsquo;s proprietary bulk drug product. Traumakine&amp;reg; is formulated so that it is stable at room temperature and readily available for critical care doctors at intensive treatment units. Traumakine&amp;reg; is meant to prevent vascular leakage in patients with acute lung injuries (ALI) and its more severe form ARDS. This prevention is critical to sustain respiratory function in ALI/ARDS patients. Financial details of the agreement were not disclosed.&lt;/p&gt;</content></entry><entry><id>59e88dd1-61b8-472f-b125-b92dbe826992</id><title type="text">Sue Ryder encourages you to leave a lasting legacy and secure the future of loved ones</title><updated>2011-01-13T14:24:56Z</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/490-Sue-Ryder-encourages-you-to-leave-a-lasting-legacy-and-secure-the-future-of-loved-ones.aspx" /><content type="html">&lt;p&gt;National health and social care charity Sue Ryder is launching its Legacy Campaign through its nationwide network of 350 charity shops to raise awareness of the importance of writing a Will. Now in its third year, the campaign also asks people to consider leaving a gift in their Will in aid of the charity.&lt;/p&gt;
&lt;p&gt;Sue Ryder&amp;rsquo;s customers and donors will also have the chance to enter a free raffle for a chance to win a cruise for two to The Dutch Bulb Fields given by Phoenix Holidays Ltd.&lt;/p&gt;</content></entry><entry><id>fd1bd305-51a4-45e9-bdbe-5fbfb3a68ccd</id><title type="text">New form of public involvement in release experiment with genetically modified grapevines</title><updated>2011-01-13T14:18:36Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/491-New-form-of-public-involvement-in-release-experiment-with-genetically-modified-grapevines.aspx" /><content type="html">&lt;p&gt;The Institut National de Recherche Agronomique in Alsace has been trialling a new form of public involvement over recent years. A release experiment with genetically modified grapevines was monitored for six years by a Local Monitoring Committee, which helped develop the biosafety research questions. The project ended in 2010 when the trial field was destroyed. The final report appeared in the online journal PLosBiology at the end of 2010.&lt;/p&gt;</content></entry><entry><id>bf56bb74-4bc4-4c5d-a7c9-c801519bc2a8</id><title type="text">CLC bio Leads Pan-European €1.6M Comparative Genomics Project </title><updated>2011-01-13T10:24:56Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/489-CLC-bio-Leads-Pan-European--1-6M-Comparative-Genomics-Project-.aspx" /><content type="html">&lt;p&gt;CLC bio announced to be heading a pan-European comparative genomics project, COGANGS (Comparative Genomics and Next Generation Sequencing), to develop a software suite, where up to one thousand genomes, can be used as knowledge input in gene regulation analysis.&lt;/p&gt;</content></entry><entry><id>930c1114-c0ca-4be2-912e-ee142ebd3b5e</id><title type="text">Cenix BioScience Grows, Establishing New R&amp;D Subsidiary in Flanders, Belgium</title><updated>2011-01-12T14:10:57Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/488-Cenix-BioScience-Grows--Establishing-New-R-D-Subsidiary-in-Flanders--Belgium.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.cenix-bioscience.com/" target="_blank"&gt;Cenix BioScience GmbH&lt;/a&gt;, a leading contract research organization specializing in RNA interference- (RNAi) and microRNA- (miRNA) based drug discovery, today announced that it is growing its R&amp;amp;D operations by establishing a new subsidiary in Flanders, Belgium.&lt;/p&gt;</content></entry><entry><id>3cbb129f-29fb-42c9-bc01-55a03ec2c126</id><title type="text">VAXIMM Closes a CHF 7.8 Million Financing Round</title><updated>2011-01-12T09:49:02Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/487-VAXIMM-Closes-a-CHF-7-8-Million-Financing-Round.aspx" /><content type="html">&lt;p&gt;Swiss biotech firm and Merck KGaA spin-off &lt;a href="http://www.vaximm.com/" target="_blank"&gt;VAXIMM AG&lt;/a&gt; announced today the closing of a private financing round totaling CHF 7.8 million from new and existing investors. BB Biotech Ventures and Merck KGaA were joined by new investors Sunstone Capital, Merck Serono Ventures and BioMedPartners. The company plans to use the proceeds of the financing to progress its lead program &lt;a href="http://www.vaximm.com/english/About_VXM01.php" target="_blank"&gt;VXM01&lt;/a&gt; into and through clinical phase I testing.&lt;/p&gt;</content></entry><entry><id>24ad808d-948a-4ace-9d0b-579ff2546667</id><title type="text">LAND RIGHTS CONFUSION IS MAIN OBSTACLE HAMPERING HAITI REBUILDING EFFORTS, WARN AGENCIES</title><updated>2011-01-11T16:57:35Z</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/482-LAND-RIGHTS-CONFUSION-IS-MAIN-OBSTACLE-HAMPERING-HAITI-REBUILDING-EFFORTS--WARN-AGENCIES.aspx" /><content type="html">&lt;p&gt;It has been nearly a year since a 7.0 magnitude earthquake struck Haiti, killing more than 230,000 people and devastating the nation&amp;rsquo;s capital.&lt;/p&gt;
&lt;p&gt;As Haiti commemorates the dead, international attention is focused on the slow pace of reconstruction, with an estimated 1.3 million still forced to live in tents nearly a year after the disaster.&lt;/p&gt;</content></entry><entry><id>c02b1607-8a30-4a26-b24d-0beca0b1d0ba</id><title type="text">Sue Ryder's CEO talks to Word on Health about Personalisation</title><updated>2011-01-11T16:11:38Z</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/486-Sue-Ryder-s-CEO-talks-to-Word-on-Health-about-Personalisation.aspx" /><content type="html">&lt;p&gt;As the government picks up the pace on personalisation and embedding personal budgets, care providers like Sue Ryder need to look at how to embed personalised working practices and appeal to personal budget holders in a time of spending cuts and financial constraints.&lt;/p&gt;
&lt;p&gt;Paul Woodward, CEO of health and social care charity, Sue Ryder talks to Word on Health, about personalisation.&amp;nbsp;&amp;nbsp;&lt;/p&gt;</content></entry><entry><id>48ba78be-58ab-40f1-ae6c-c1c2dcdae12f</id><title type="text">Critical Outcome Technologies Inc. Meeting with Prospective COTI-2 Partners at Biotech Showcase</title><updated>2011-01-11T09:55:41Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/485-Critical-Outcome-Technologies-Inc--Meeting-with-Prospective-COTI-2-Partners-at-Biotech-Showcase.aspx" /><content type="html">&lt;p&gt;&lt;a href="http://www.criticaloutcome.com/" target="_blank"&gt;Critical Outcome Technologies Inc.&lt;/a&gt; (COTI) (TSX Venture: COT) announced today that representatives of the Company will meet with several prospective partners who have expressed interest in its lead oncology drug candidate &lt;a href="http://www.criticaloutcome.com/COTI-2.html"&gt;COTI-2&lt;/a&gt; at Biotech Showcase. Biotech Showcase is a pharmaceutical partnering conference held concurrent to J.P. Morgan's 29&lt;sup&gt;th&lt;/sup&gt; annual Healthcare Conference taking place in San Francisco, California on January 10-12, 2011.&lt;/p&gt;</content></entry><entry><id>57fd27e2-7840-44a5-87ba-b899775deb41</id><title type="text">Oncolytics Biotech® Inc. Announces Opening of Enrollment in U.S. Phase I Colorectal Cancer Study </title><updated>2011-01-10T14:57:06Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/484-Oncolytics-Biotech--Inc--Announces-Opening-of-Enrollment-in-U-S--Phase-I-Colorectal-Cancer-Study-.aspx" /><content type="html">&lt;p&gt;Oncolytics Biotech Inc. announced today that a U.S. Phase I study of REOLYSIN&lt;sup&gt;&amp;reg;&lt;/sup&gt; in combination with FOLFIRI (Folinic Acid (leucovorin) + Fluorouracil (5-FU) + Irinotecan) in patients with oxaliplatin refractory/intolerant &lt;em&gt;Kras&lt;/em&gt; mutant colorectal cancer (REO 022) is now open to enrollment. The principal investigator is Dr. Sanjay Goel of the Montefiore Medical Center at The Albert Einstein College of Medicine in New York.&lt;/p&gt;</content></entry><entry><id>70e2699f-080f-427f-a05c-34d5436cbf47</id><title type="text">Biotage Announces New Methods for the Extraction of Key Compounds for Clinical, Environmental and Forensic Applications</title><updated>2011-01-10T14:10:42Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/481-Biotage-Announces-New-Methods-for-the-Extraction-of-Key-Compounds-for-Clinical--Environmental-and-Forensic-Applications.aspx" /><content type="html">&lt;p&gt;Biotage, a leading supplier of tools and technology for analytical and medicinal chemistry, introduced a new series of application notes utilizing the industry-standard &lt;a href="http://www.biotage.com/DynPage.aspx?id=91936" target="_blank"&gt;RapidTrace&lt;sup&gt;&amp;reg;&lt;/sup&gt; SPE Workstation&lt;/a&gt;. These methods are now available at &lt;a href="http://www.biotage.com/" target="_blank"&gt;www.biotage.com&lt;/a&gt;. New applications include extractions from plasma, urine and whole blood, typically assayed in clinical and forensic protocols. Additionally, a new soil analysis method for dioxins and furans joins the presently available EPH protocols from Biotage.&lt;/p&gt;</content></entry><entry><id>3b2f8479-8817-4898-9d05-43dbc28bd61c</id><title type="text">Experience Venture Capitalist/Pharma Manager joins Apeiron's Business Development Team</title><updated>2011-01-10T11:49:26Z</updated><link rel="alternate" href="http://pressroom.ackura.com/Biofind/480-Experience-Venture-Capitalist-Pharma-Manager-joins-Apeiron-s-Business-Development-Team.aspx" /><content type="html">&lt;p&gt;Vienna (Austria), 10 January 2011 - APEIRON Biologics AG (Apeiron) today announced that Patrick Burgermeister, a seasoned venture capital and pharma manager will play a leading role in the company's business development activities. He will be engaged in identification and evaluation of new projects, in-licensing/out-licensing activities, portfolio assessment and sourcing new financing opportunities. Patrick Burgermeister has a dual background in business administration and molecular biology and brings in extensive industry experience from the areas of biotech, pharma, medtech, banking and venture capital.&lt;/p&gt;</content></entry><entry><id>bac9bf8b-f768-4e7c-bbf3-925d4d2ef61e</id><title type="text">A happy New Year? VAT increase stands to lose charities £140million</title><updated>2011-01-05T10:26:12Z</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/477-A-happy-New-Year--VAT-increase-stands-to-lose-charities--140million.aspx" /><content type="html">&lt;p&gt;Sue Ryder launch campaign to urge government to cut red tape on VAT for charities and the care it provides.&lt;/p&gt;</content></entry><entry><id>25e31d07-c1b7-4b4e-8d79-c01790225036</id><title type="text">KMP Digitata are raising money for Arthritis Research UK</title><updated>2010-12-20T10:42:08Z</updated><link rel="alternate" href="http://pressroom.ackura.com/kmp/475-KMP-Digitata-are-raising-money-for-Arthritis-Research-UK.aspx" /><content type="html">&lt;p&gt;Over the years KMP enjoyed creating festive themed campaigns, such as a  Snowball Fight Facebook app in 2007, a Christmas shopping website in  2008 and last year we built the free iPhone game &lt;a title="Glacier  Racer" href="http://www.glacierracer.co.uk/" target="_blank"&gt;Glacier Racer&lt;/a&gt;.  This year KMP want to give more back to those who need it the most and  so their winter campaign this year is to try and raise money for &lt;a title="Arthritis Research UK Homepage" href="http://www.arthritisresearchuk.org/" target="_blank"&gt;Arthritis  Research UK&lt;/a&gt; with the help of their clients and friends. Arthritis  Research UK is a charity funding high class research and raising  awareness of arthritis in the UK. It is a charity that was supported by  KMP Digitata's co-founder, Bill Daring, who suffered from rheumatoid  arthritis for many years.&lt;/p&gt;</content></entry><entry><id>3bfa971d-474c-46a5-b2ae-2351657fd337</id><title type="text">A message of comfort at Christmas by Pam Rhodes</title><updated>2010-12-16T15:38:10Z</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/476-A-message-of-comfort-at-Christmas-by-Pam-Rhodes.aspx" /><content type="html">&lt;p&gt;Pam Rhodes, best known for presenting BBC1 &amp;lsquo;Songs of Praise' and a keen supporter of the charity, has dedicated a poignant message to all the people that like her this Christmas will have an empty chair around the dinner table:&lt;/p&gt;</content></entry><entry><id>555503ce-f17a-4f46-a8a6-96925ad87512</id><title type="text">Norwood is one of Britain’s best charities, says Chancellor</title><updated>2010-12-13T09:37:54Z</updated><link rel="alternate" href="http://pressroom.ackura.com/norwood/473-Norwood-is-one-of-Britain-s-best-charities--says-Chancellor.aspx" /><content type="html">&lt;p&gt;The Rt Hon George Osborne MP, Chancellor of the Exchequer, hailed Norwood as one of the best charities in Britain as he helped the organisation raise an incredible &amp;pound;26,000 at the YN Current Affairs Reception.&lt;/p&gt;</content></entry><entry><id>e55bbcf9-1c9b-47e2-b119-3f80acb9c6e8</id><title type="text">PressRoom version 3.0 is here</title><updated>2010-11-25T11:22:52Z</updated><link rel="alternate" href="http://pressroom.ackura.com/ackura/457-PressRoom-version-3-0-is-here.aspx" /><content type="html">&lt;p&gt;The third version of Ackura PressRoom is now live with new and improved features that will help make social media ready press releases more effective than ever before.&lt;/p&gt;</content></entry><entry><id>d88b75ed-6a32-412f-961a-182eaefac836</id><title type="text">Sue Ryder responds to the Government's Vision for Adult Social Care</title><updated>2010-11-16T17:32:20Z</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/470-Sue-Ryder-responds-to-the-Government-s-Vision-for-Adult-Social-Care.aspx" /><content type="html">Following the announcement of the government’s vision for social care (16 November 2010), Paul Woodward, Chief Executive of Sue Ryder welcomed the government’s publication of its Vision for Adult Social Care, recognising the urgent need for reform of a system which is at breaking point.  
</content></entry><entry><id>21be44ce-ee6d-4923-a1d7-f8bfb2e40dc8</id><title type="text">NATO countries should agree to push UN-backed Afghan peace talks or risk civil war after troops leave, warns report</title><updated>2010-11-15T15:43:00Z</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/469-NATO-countries-should-agree-to-push-UN-backed-Afghan-peace-talks-or-risk-civil-war-after-troops-leave--warns-report.aspx" /><content type="html">Britain and other NATO countries must now agree to formal peace talks with all parties in the Afghanistan conflict, including the Taliban and Afghanistan’s neighbours, say a group of leading development, human rights and conflict prevention organisations. 
</content></entry><entry><id>9c45a3c0-82d0-45af-a59a-3043d6b55854</id><title type="text">Sporting stars add to ball glamour</title><updated>2010-11-12T14:26:10Z</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/468-Sporting-stars-add-to-ball-glamour.aspx" /><content type="html">&lt;p&gt;Two of the country&amp;rsquo;s leading sports personalities will be guests of honour at a Christmas ball in aid of national charity, Caudwell Children. &lt;br /&gt;&lt;br /&gt;Paralympians, Lee Pearson CBE and Matthew Dimbylow, will be joining the host of local businesses and charity supporters at the glamorous Winter Wonderland Ball to be held at Wychwood Park in Cheshire next month.?&lt;/p&gt;</content></entry><entry><id>5c8309ee-7a2b-4858-96ff-1687979e8675</id><title type="text">Where does your time go?</title><updated>2010-11-12T10:04:01Z</updated><link rel="alternate" href="http://pressroom.ackura.com/BcToolkit/549-Where-does-your-time-go-.aspx" /><content type="html">&lt;p&gt;Here at &lt;a title="bcToolkit website" href="http://www.bctoolkit.com/"&gt;bcToolkit&lt;/a&gt; we are always pleased when our customers have a &amp;ldquo;Light-Bulb&amp;rdquo; moment.  Using bcToolkit as a Basecamp Reporting Tool, often one of the  first&amp;nbsp;reports that a customer runs is analysing where time is spent  throughout their business. The report is sometimes a big shock and has a  profound effect on their business model from then on. That&amp;rsquo;s their  Light Bulb moment because this report stimulates a different way of  thinking and leads to further analysis of time in the business.&lt;/p&gt;</content></entry><entry><id>087ff415-c193-4ab7-96ad-2a5830595b16</id><title type="text">Olly Murs leads Big Christmas Sing at Old Spitalfields Market</title><updated>2010-11-01T17:05:55Z</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/456-Olly-Murs-leads-Big-Christmas-Sing-at-Old-Spitalfields-Market.aspx" /><content type="html">Last year’s X Factor runner up, and No1 artist, Olly Murs will launch Christian Aid’s Big Christmas Sing at Old Spitalfields Market, London on Wednesday 10th November. Performing alongside this year’s X Factor contestant John Adeleye and Britain’s Got Talent finalist Faryl Smith, the free concert will begin at 5.30pm and aims to get shoppers in the Christmas spirit and promote the charity’s annual singing event. 
</content></entry><entry><id>e375930b-48f3-4c96-aaaf-59a15c17f1a5</id><title type="text">Embargoed until Midnight 31st October 2010 </title><updated>2010-11-01T10:15:22Z</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/455-Embargoed-until-Midnight-31st-October-2010-.aspx" /><content type="html">
		&lt;p&gt;Society’s wall of silence around dying and death prompts call for national debate &lt;/p&gt;
&lt;p&gt;&lt;/p&gt;
</content></entry><entry><id>a9b1e30b-a6f9-41f0-b3df-c088368c9eba</id><title type="text">Productivity calculations using bcToolkit</title><updated>2010-11-01T10:03:23Z</updated><link rel="alternate" href="http://pressroom.ackura.com/BcToolkit/548-Productivity-calculations-using-bcToolkit.aspx" /><content type="html">&lt;div class="entry-content"&gt;
&lt;p&gt;At bcToolkit we have had some interesting feedback on calculating  productivity for a service-based business. Using bcToolkit as a  Basecamp reporting tool allows you to be completely flexible on how you  calculate your productivity.&lt;/p&gt;
&lt;p&gt;The feedback we received was around the % recoverable time or  &amp;ldquo;productivity&amp;rdquo; we talked about in our blog post entiled &lt;a href="http://blog.bctoolkit.com/2010/10/bctoolkit-provides-framework-for-business-utopia/"&gt;&amp;ldquo;bcToolkit  provides framework for business utopia&amp;rdquo;&lt;/a&gt;. We&amp;nbsp;stated that if a  service-based business was billing 50% of time available then they were  doing well.&amp;nbsp;This caused a bit of a discussion in particular around the %  level. We would like to point out the % depends very much on who you  are including in your time available calculation.&amp;nbsp;With this initial  figure of 50% we&amp;nbsp;envisaged that all staff would be included. This we  appreciate is&amp;nbsp;quite a loose calculation but nevertheless gives a  benchmark average across the business. If you exclude all staff who have  no impact on the delivery of projects then we would of course expect a  much higher level of productivity. In fact somewhere around 80% would be  more appropriate to expect.&lt;/p&gt;
&lt;p&gt;The good thing is that as a&amp;nbsp;Project Manager,&amp;nbsp;bcToolkit allows you to  make the productivity calculation any way you like to suit your  business. This is because when you use bcToolkit as&amp;nbsp;your reporting tool  for Basecamp from 37signals you&amp;nbsp;can include or exclude resources as you  wish and therefore be as granular or general as you require.&amp;nbsp; Basecamp  from &lt;a title="37signals website" href="http://37signals.com/"&gt;37signals&lt;/a&gt; is a good place to start for an online project management or online  collaboration tool. And if you want a &lt;a title="Basecamp homepage" href="http://basecamphq.com/"&gt;Basecamp &lt;/a&gt;Reporting Tool then look no  further than bcToolkit to unlock business-changing information from your  Basecamp data.&lt;/p&gt;
&lt;/div&gt;</content></entry><entry><id>b80cebb8-88f8-4ec0-a90e-26a35c1ebca8</id><title type="text">Call for Tanzanian election winner to abolish unfair tax anomalies</title><updated>2010-10-29T16:26:14+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/450-Call-for-Tanzanian-election-winner-to-abolish-unfair-tax-anomalies.aspx" /><content type="html">Christian Aid is calling on the winner of this Sunday’s general election in Tanzania to commit to ending tax anomalies that have deprived a country rich in mineral resources of badly needed revenue that could have been spent on schools, hospitals and other infrastructure improvements. 
</content></entry><entry><id>89558b20-2549-400b-8635-3ce6b0da5987</id><title type="text">Major new move could force multinational tax transparency </title><updated>2010-10-29T16:19:06+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/448-Major-new-move-could-force-multinational-tax-transparency-.aspx" /><content type="html">Multinational companies could be forced to reveal far more about their finances in developing countries following a European Commission move which Christian Aid experts welcomed as ‘hugely exciting’. 
</content></entry><entry><id>05696607-73fd-4b22-8384-e9aeae4450dd</id><title type="text">Sue Ryder responds to comprehensive spending review </title><updated>2010-10-21T16:23:31+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/444-Sue-Ryder-responds-to-comprehensive-spending-review-.aspx" /><content type="html">Specialist health care charity Sue Ryder responds to the recent spending review, with comments from Chief Executive Paul Woodwood. 
</content></entry><entry><id>2e21e930-b1d4-4095-8c27-f61d2a24ce57</id><title type="text">Sue Ryder Care calls on nation to raise vital funds to support it to provide end of life care</title><updated>2010-10-18T14:15:56+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/408-Sue-Ryder-Care-calls-on-nation-to-raise-vital-funds-to-support-it-to-provide-end-of-life-care.aspx" /><content type="html">In line with World Hospice and Palliative Care day (9 Oct), Sue Ryder highlights the importance of an individualised approach to end of life care, and calls on people nationwide to support the charity to raise vital funds. The charity is using the event to encourage local people and communities to take on a fundraising challenge or support its 350 shops to help raise the £13million it needs to continue to provide 4 million hours of care each year.
</content></entry><entry><id>073a8429-6626-4526-b6b9-1c0c96ccc1ad</id><title type="text">bcToolkit provides framework for business utopia</title><updated>2010-10-15T14:56:22+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/BcToolkit/431-bcToolkit-provides-framework-for-business-utopia.aspx" /><content type="html">For a service-based company such as a design agency, marketing consultancy or a law firm the ideal or "utopia" is a balanced and controlled state for the business where all the time available to all the resources within the business is being used efficiently and as planned. 
</content></entry><entry><id>b3eb5b98-f4c3-4713-aa43-d4db5e8b603a</id><title type="text">Rev Jesse Jackson calls on MPs to give ‘Power to the Poor’</title><updated>2010-10-14T17:02:21+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/430-Rev-Jesse-Jackson-calls-on-MPs-to-give--Power-to-the-Poor-.aspx" /><content type="html">American civil rights activist, the Reverend Jesse Jackson, will be in London on Wednesday 20 October to back Christian Aid’s lobby of Parliament, aimed at moving climate change and global tax transparency up the political agenda. 
</content></entry><entry><id>d90ec74a-16b2-47c1-b26b-11d3034f8ea2</id><title type="text">bcToolkit reveals amazing information about your business</title><updated>2010-10-14T15:40:43+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/BcToolkit/429-bcToolkit-reveals-amazing-information-about-your-business.aspx" /><content type="html">
		&lt;p&gt;As a Basecamp reporting tool bcToolkit has core functionality that is detailed on bctoolkit.com. However, what also really interests us is the by-product functionality and information that our customers have discovered by using bcToolkit as a Basecamp reporting tool in their business. An obvious and simple example of the kind of functionality/information we are talking about is that with bcToolkit you can very easily get detailed information on your billable time, but along with that by definition, you can also get detailed information on non-billable time. Non-billable time in itself could be a very interesting area to investigate. You may for example discover time that you could bill within your non-billable time! &lt;/p&gt;
&lt;p&gt;&lt;/p&gt;
&lt;p&gt;Other interesting information bcToolkit  has given our customers includes:&lt;/p&gt;
</content></entry><entry><id>45f7239d-074a-4450-95b7-9c5ead925917</id><title type="text">‘Inside the Revolution’ at the Inn on the Green</title><updated>2010-10-06T11:59:21+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/tippingpoint/403--Inside-the-Revolution--at-the-Inn-on-the-Green.aspx" /><content type="html">		&lt;!--StartFragment--&gt;&lt;span size="2" face="verdana" style="font-family: verdana; font-size: 10pt;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;
&lt;p class="MsoNormal"&gt;&lt;span face="verdana" style="font-family: verdana;"&gt;&lt;span size="2" style="font-size: 10pt;"&gt;Tipping Point Film Fund and Alborada.net will jointly host an evening of Latin American music and a screening of Pablo Navarrete’s 2009 documentary ‘Inside the Revolution: A Journey into the Heart of Venezuela’, on Tuesday 26 October at the Inn on the Green in Ladbroke Grove.&lt;br /&gt;
&lt;br /&gt;
The film will be followed by a Tipping Point Film Fund hosted Q&amp;amp;A and panel discussion with the director, Pablo Navarrete, and editor-in-chief of Pambazuka News, Firoze Manji. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span face="verdana" style="font-family: verdana;"&gt;&lt;span size="2" style="font-size: 10pt;"&gt;From 9pm, there will be Latin and African music from acclaimed Afro-Venezuelan percussionist, William Cumberbache, and Movimientos’ DJ Arias. &lt;/span&gt;&lt;br /&gt;
&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal"&gt;&lt;span face="verdana" style="font-family: verdana;"&gt;
&lt;!--StartFragment--&gt;
&lt;/span&gt;&lt;/p&gt;
&lt;span size="2" face="verdana" style="font-family: verdana; font-size: 10pt;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;
&lt;!--EndFragment--&gt;
&lt;!--EndFragment--&gt;
</content></entry><entry><id>3a0e57d9-42d6-4f21-9b30-22584e260410</id><title type="text">Meningitis Trust launches charity iPhone app</title><updated>2010-10-06T11:45:09+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/meningitis/410-Meningitis-Trust-launches-charity-iPhone-app.aspx" /><content type="html">&lt;p&gt;With the introduction of this iPhone application The Meningitis Trust will be helping to save lives through giving millions of iPhone users easy access to the disease&amp;rsquo;s signs and symptoms.&lt;/p&gt;</content></entry><entry><id>45ef80a3-80a3-4582-8296-d70178b053c6</id><title type="text">City business group on target to net £1million success.</title><updated>2010-10-05T18:11:50+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/409-City-business-group-on-target-to-net--1million-success-.aspx" /><content type="html">
		&lt;p style="line-height: 150%"&gt;
				&lt;span style="font-family: 'arial','sans-serif'"&gt;A local business network group is closing in on its target of passing £1 million of city business after a successful morning that has launched them in touching distance of their target.&lt;/span&gt; &lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;span style="font-family: 'arial','sans-serif'"&gt; &lt;/span&gt;&lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;span style="font-family: 'arial','sans-serif'"&gt;Over £44,000 worth of business was passed at the lastmeeting (Thursday, September 30&lt;sup&gt;th&lt;/sup&gt;)  amongst members at the Britannia group of Business Networking International (BNI) who meet in Hanley, making it a total of £927,000 passed in the last 14 months. &lt;/span&gt;&lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;span style="font-family: 'arial','sans-serif'"&gt; &lt;/span&gt;&lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;span style="font-family: 'arial','sans-serif'"&gt;It comes after the Britannia group appealed for more like-minded business people to join the group and share their success, which is making them the most successful BNI group in Staffordshire and Shropshire as well as launching them into being one of the best in the UK. &lt;/span&gt;&lt;/p&gt;
</content></entry><entry><id>537c04d4-43dc-4293-a2f6-6c2f23a9a457</id><title type="text">Films for Black History Month with Dr. Robert Beckford</title><updated>2010-10-05T17:38:57+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/tippingpoint/402-Films-for-Black-History-Month-with-Dr--Robert-Beckford.aspx" /><content type="html">		&lt;!--StartFragment--&gt;
&lt;p class="MsoNormal" style="line-height: 12.25pt; vertical-align: baseline;"&gt;&lt;span size="2" style="font-size: 10pt;"&gt;To celebrate Black History Month, Tipping Point Film Fund will be hosting a double bill screening of Robert Beckford’s Channel 4 documentaries, The Empire Pays Back and Great African Scandal, at The Bernie Grant Arts Centre on Thursday 28 October at 7.30pm. &lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="line-height: 12.25pt; vertical-align: baseline;"&gt;
&lt;/p&gt;
&lt;p class="MsoNormal" style="line-height: 12.25pt; vertical-align: baseline;"&gt;
&lt;/p&gt;
&lt;p class="MsoNormal" style="line-height: 12.25pt; vertical-align: baseline;"&gt;&lt;span size="2" style="font-size: 10pt;"&gt;The films will be followed by a Q&amp;amp;A with Dr. Robert Beckford – an opportunity to explore the range of issues raised in both films, from reparation for Jamaica to the impact of IMF and World Bank policies on Ghana. &lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="line-height: 12.25pt; vertical-align: baseline;"&gt;
&lt;/p&gt;
&lt;p class="MsoNormal" style="line-height: 12.25pt; vertical-align: baseline;"&gt;&lt;span size="2" style="font-size: 10pt;"&gt;Tipping
Point Film Fund promotes the power of film as a campaigning tool to bring about
political and social change. Robert’s films help to do just that, by exposing
and challenging the inequity in the relationship between rich and poor
countries and raising timely questions about the extent to which former
colonies have truly shaken off colonial shackles and secured real economic
independence.&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="line-height: 12.25pt; vertical-align: baseline;"&gt;&lt;span size="2" style="font-size: 10pt;"&gt;&lt;strong&gt;Dr. Robert Beckford&lt;/strong&gt;&lt;/span&gt;&lt;span size="2" style="font-size: 10pt;"&gt; is an academic and award winning broadcaster based
in Birmingham. He has authored half-a-dozen books in the field of theology and
culture and made over 20 documentaries for the BBC and Channel 4, averaging two
films per year with Channel 4, becoming a regular fixture on the prime time
television slots of Christmas Day and Easter Sunday.&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="line-height: 12.25pt; vertical-align: baseline;"&gt;&lt;span&gt;
&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="line-height: 12.25pt; vertical-align: baseline;"&gt;&lt;span size="2" style="font-size: 10pt;"&gt;&lt;span size="2" style="font-size: 10pt;"&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="line-height: 12.25pt; vertical-align: baseline;"&gt;&lt;span size="2" style="font-size: 10pt;"&gt;&lt;span size="2" style="font-size: 10pt;"&gt;&lt;strong&gt;The Empire Pays Back&lt;/strong&gt;&lt;/span&gt; &lt;br /&gt;
"I believe African slaves were ripped off by the British Empire. I want
to know who bankrolled it, who insured it and who made a mint from it".
Beckford
believes that Britain should pay reparations to the descendants of
slaves, and
hires a team of experts to put a monetary figure on the amount owing. In
the
process, he details how institutions such as the Bank of England, Guys’
Hospital, HSBC, Barclays and the National Gallery all have slavery in
their
histories. The final figure put on the amount owing will shock!&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="line-height: 12.25pt; vertical-align: baseline;"&gt;
&lt;/p&gt;
&lt;p class="MsoNormal" style="line-height: 12.25pt; vertical-align: baseline;"&gt;&lt;span size="2" style="font-size: 10pt;"&gt;&lt;strong&gt;Great African Scandal&lt;br /&gt;
&lt;/strong&gt;&lt;/span&gt;&lt;span size="2" style="font-size: 10pt;"&gt;In this thought-provoking documentary, made with the help of Christian
Aid, Robert Beckford undertakes a challenging, emotional journey to Ghana in
West Africa. This is where, two centuries ago, Robert Beckford’s ancestors were
seized and taken as slaves to Jamaica. Now he is making a journey to the land
of his roots to discover the hidden costs of rice, chocolate and gold.&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="line-height: 12.25pt; vertical-align: baseline;"&gt;&lt;span size="2" style="font-size: 10pt;"&gt;Working
alongside local people, Robert struggles to survive on the average wage of 60p
a day. He asks why, 50 years after independence, this country, which is rich in
minerals and is a stable democracy, is still one of the poorest in the world.&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="line-height: 12.25pt; vertical-align: baseline;"&gt;&lt;span size="2" style="font-size: 10pt;"&gt;He examines the activities of multinational corporations, as well as the World Bank and the International Monetary Fund, to find out whether they have actually made countries like Ghana worse off. And, most importantly, he asks how we, as consumers and citizens, can make a difference.&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="line-height: 12.25pt; vertical-align: baseline;"&gt;&lt;span size="2" style="font-size: 10pt;"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;span size="2" style="font-size: 10pt;"&gt;&lt;br /&gt;
&lt;/span&gt;
&lt;p class="MsoNormal" style="line-height: 12.25pt; vertical-align: baseline;"&gt;&lt;span size="2" style="font-size: 10pt;"&gt; &lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="line-height: 12.25pt; vertical-align: baseline;"&gt;&lt;span size="2" style="font-size: 10pt;"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="line-height: 12.25pt; vertical-align: baseline;"&gt;&lt;span size="2" style="font-size: 10pt;"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="line-height: 12.25pt; vertical-align: baseline;"&gt; &lt;/p&gt;
&lt;p class="MsoNormal" style="line-height: 12.25pt; vertical-align: baseline;"&gt;&lt;span size="2" style="font-size: 10pt;"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;span size="2" style="font-size: 10pt;"&gt;&lt;/span&gt;
&lt;span size="2" style="font-size: 10pt;"&gt; &lt;/span&gt;
&lt;p class="MsoNormal" style="line-height: 12.25pt; vertical-align: baseline;"&gt;&lt;span size="2" style="font-size: 10pt;"&gt; &lt;br /&gt;
&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="line-height: 12.25pt; vertical-align: baseline;"&gt;&lt;span size="2" face="verdana" style="font-family: verdana; font-size: 10pt;"&gt; &lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="line-height: 12.25pt; vertical-align: baseline;"&gt;&lt;span size="2" face="verdana" style="font-family: verdana; font-size: 10pt;"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="line-height: 12.25pt; vertical-align: baseline;"&gt;&lt;span size="2" face="verdana" style="font-family: verdana; font-size: 10pt;"&gt;&lt;br /&gt;
&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="line-height: 12.25pt; vertical-align: baseline;"&gt;&lt;span size="2" face="verdana" style="font-family: verdana; font-size: 10pt;"&gt; &lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="line-height: 12.25pt; vertical-align: baseline;"&gt;&lt;span size="2" face="verdana" style="font-family: verdana; font-size: 10pt;"&gt;&lt;br /&gt;
&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;
&lt;!--EndFragment--&gt;
</content></entry><entry><id>8f96de04-d7ed-445f-81f0-57b277a3972a</id><title type="text">Sue Ryder champion peoples' right for choice of care at party conferences</title><updated>2010-09-29T13:49:13+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/399-Sue-Ryder-champion-peoples--right-for-choice-of-care-at-party-conferences.aspx" /><content type="html">At this years party political conferences, Sue Ryder is urging members of the three main parties, Liberal Democrat, Labour and Conservative, to support its vision of a continuum of care that enables people to make personal choices about the services they receive. 
</content></entry><entry><id>4c42d6a4-b9e0-4e04-a5d3-b5d2d670bbb5</id><title type="text">Media Trust wins IVCA Clarion Award</title><updated>2010-09-28T14:31:46+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/mediatrust/398-Media-Trust-wins-IVCA-Clarion-Award.aspx" /><content type="html">Media Trust took home a prestigious award at the IVCA Clarion Awards held in London on Friday. The awards recognise best practice in CSR, diversity, community development, ethical, health and welfare issues, charity and social enterprise.
&lt;p&gt; &lt;/p&gt;
</content></entry><entry><id>717d2885-95b8-4eaa-b805-ee4548305aee</id><title type="text">Basecamp Reporting#1 Time is money</title><updated>2010-09-28T08:58:06+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/BcToolkit/397-Basecamp-Reporting-1-Time-is-money.aspx" /><content type="html">bcToolkit adds to Basecamp from 37signals and gives further business changing information. Often we hear from our customers in project management in the service industry that project teams just focus on getting the job done no matter what. After all a happy client or project sponsor is the most important thing right! Well we at bcToolkit would say “only half right” because if your client is happy but as a result you are losing money by spending too much time on projects then you will be seriously under billing and putting your business at risk 
</content></entry><entry><id>cb7afd00-8326-4b99-82d7-bb0be28c5269</id><title type="text">Still time to go casual and help little Leo</title><updated>2010-09-21T08:54:27+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/393-Still-time-to-go-casual-and-help-little-Leo.aspx" /><content type="html">		&lt;br _moz_editor_bogus_node="TRUE" /&gt;
&lt;!--[if gte mso 9]&gt;&lt;xml&gt; Normal 0 false false false EN-US X-NONE X-NONE &lt;-[endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 10]&gt;
&lt;div id='RadEditorStyleKeeper1' style='display:none;'&gt;&amp;nbsp;&lt;/div&gt;
&lt;div id='RadEditorStyleKeeper1' style='display:none;'&gt;&amp;nbsp;&lt;/div&gt;
&lt;style reoriginalpositionmarker='RadEditorStyleKeeper1' reoriginalpositionmarker='RadEditorStyleKeeper1'&gt;
    /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi;}
&lt;/style&gt;
&lt;![endif]--&gt;
&lt;p style="line-height: 150%;"&gt;&lt;span size="2" face="&amp;quot;arial&amp;quot;,&amp;quot;sans-serif&amp;quot;" style="line-height: 150%; font-family: &amp;quot;arial&amp;quot;,&amp;quot;sans-serif&amp;quot;; font-size: 10pt;"&gt;There is still time to sign up for Peterborough’s first City-wide dress down day and help four-year-old Leo Waites get life-changing Cerebral Palsy treatment in America.&lt;/span&gt;&lt;/p&gt;
&lt;p style="line-height: 150%;"&gt;&lt;span size="2" face="&amp;quot;arial&amp;quot;,&amp;quot;sans-serif&amp;quot;" style="line-height: 150%; font-family: &amp;quot;arial&amp;quot;,&amp;quot;sans-serif&amp;quot;; font-size: 10pt;"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="line-height: 150%;"&gt;&lt;span size="2" face="&amp;quot;arial&amp;quot;,&amp;quot;sans-serif&amp;quot;" style="line-height: 150%; font-family: &amp;quot;arial&amp;quot;,&amp;quot;sans-serif&amp;quot;; font-size: 10pt;"&gt;Single mum, Joanne Holland (23), is fighting to fundraise enough money for her son’s life changing Cerebral Palsy treatment and is calling for all local businesses to join her in a city-wide ‘Dress Down Friday’ on October 1st.&lt;/span&gt;&lt;/p&gt;
</content></entry><entry><id>189fdad3-ff36-41dc-9310-4ea00a7df8de</id><title type="text">MILLENNIUM AMBITION ‘LOST IN TRANSLATION’, WARNS NEW REPORT ON MDGs</title><updated>2010-09-16T17:37:59+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/388-MILLENNIUM-AMBITION--LOST-IN-TRANSLATION---WARNS-NEW-REPORT-ON-MDGs.aspx" /><content type="html">Much of the radical ambition of the Millennium Declaration got ‘lost in translation’ when the Millennium Development Goals were drawn up, says Christian Aid in a new report on progress towards the MDGs. 
</content></entry><entry><id>6c38f69f-4ab9-41ac-92ac-63911f40b776</id><title type="text">Keep UK development work focused on ending poverty, urges Christian Aid</title><updated>2010-09-16T17:25:09+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/387-Keep-UK-development-work-focused-on-ending-poverty--urges-Christian-Aid.aspx" /><content type="html">In response to today’s speech at the Royal College of Defence Studies by Andrew Mitchell MP, Secretary of State for International Development, Jude Mackenzie, Associate Director of Christian Aid, said: 
</content></entry><entry><id>17107154-34af-470e-b47d-51b078bf02d1</id><title type="text">WORLD BANK COAL FUNDING HITS RECORD HIGH AS IT SEEKS CLIMATE FINANCE CONTROL</title><updated>2010-09-14T16:45:21+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/384-WORLD-BANK-COAL-FUNDING-HITS-RECORD-HIGH-AS-IT-SEEKS-CLIMATE-FINANCE-CONTROL.aspx" /><content type="html">World Bank funding for coal power stations has soared 40-fold over the last five years to hit a record high of $4.4 billion in 2010, new figures reveal. 
</content></entry><entry><id>06febada-deb3-4b01-b520-23c8fa16227a</id><title type="text">Trike is key to Daniels happiness</title><updated>2010-09-14T11:05:44+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/383-Trike-is-key-to-Daniels-happiness.aspx" /><content type="html">
		&lt;p style="line-height: 150%"&gt;
				&lt;b&gt;
						&lt;span style="font-size: 16pt; line-height: 150%; font-family: 'arial','sans-serif'"&gt;Trike is key to Daniels happiness&lt;/span&gt; &lt;/b&gt;
		&lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;b&gt;&lt;span style="font-size: 16pt; line-height: 150%; font-family: 'arial','sans-serif'"&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;&lt;span style="font-family: 'gill sans mt','sans-serif'"&gt;Date: &lt;/span&gt;&lt;/b&gt;&lt;span style="font-family: 'gill sans mt','sans-serif'"&gt;14 September 2010&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;&lt;span style="font-family: 'gill sans mt','sans-serif'"&gt;Media Enquiries: &lt;/span&gt;&lt;/b&gt;&lt;span style="font-family: 'gill sans mt','sans-serif'"&gt;Sian Alcock, Caudwell Children, 01782 600418 or &lt;/span&gt;&lt;a href="mailto:media@caudwellchildren.com"&gt;&lt;span style="font-family: 'gill sans mt','sans-serif'"&gt;media@caudwellchildren.com&lt;/span&gt;&lt;/a&gt; &lt;/p&gt;
&lt;p&gt;&lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;span style="font-family: 'arial','sans-serif'"&gt;A Cheshire boy is wheely proud and showing off his new bike which has been specially adapted to help with his disability.&lt;/span&gt;&lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;span style="font-family: 'arial','sans-serif'"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;span style="font-family: 'arial','sans-serif'"&gt;Ten-year-old Daniel Walker from Crewe, has received a state-of-the-art Panther Tricycle worth £1,200 to help the youngster who has Downs Syndrome, Atrioventricular Septal Defect and associated conditions.&lt;/span&gt;&lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;span style="font-family: 'arial','sans-serif'"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;span style="font-size: 11pt; line-height: 115%; font-family: 'arial','sans-serif'"&gt;As well as providing medical benefits for Daniel, the donation made by Caudwell Children, is helping him be included in activities with other children&lt;/span&gt; 
</content></entry><entry><id>e32af89c-86ad-43ac-8784-c3afad700200</id><title type="text">Tipping Point Film Club launches with 'Life and Debt'</title><updated>2010-09-09T14:17:52+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/tippingpoint/378-Tipping-Point-Film-Club-launches-with--Life-and-Debt-.aspx" /><content type="html">		&lt;!--StartFragment--&gt;
&lt;p class="MsoNormal" style="line-height: 12.25pt; vertical-align: baseline;"&gt;&lt;span size="2" face="verdana" style="font-family: verdana; font-size: 10pt;"&gt;Tipping
Point Film Fund is launching the TPFF Film Club at &lt;span&gt;The
Lexi Cinema&lt;/span&gt; in Kensal Rise on Monday 20 September with a screening
of Stephanie Black’s award-winning ‘&lt;span&gt;Life
and Debt&lt;/span&gt;‘, re-released by Axiom Films on DVD this summer. The film,
which starts at 7.15pm, will be followed by a panel discussion entitled ‘When
will rich countries own up to their responsibility in keeping developing nations
poor in order to grow their own wealth?’&lt;o:p&gt;&lt;/o:p&gt;&lt;/span&gt;&lt;/p&gt;
&lt;!--EndFragment--&gt;
</content></entry><entry><id>b0008dea-de47-4a9f-8009-342e75dcebbf</id><title type="text">KMP Digitata and VIE At Home launch Facebook App</title><updated>2010-09-09T13:06:04+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/kmp/350-KMP-Digitata-and-VIE-At-Home-launch-Facebook-App.aspx" /><content type="html">
		&lt;link rel="File-List" href="file:///C:\Users\GEZDAR~1\AppData\Local\Temp\msohtmlclip1\01\clip_filelist.xml" reoriginalpositionmarker="RadEditorStyleKeeper1" /&gt;
&lt;link rel="themeData" href="file:///C:\Users\GEZDAR~1\AppData\Local\Temp\msohtmlclip1\01\clip_themedata.thmx" reoriginalpositionmarker="RadEditorStyleKeeper2" /&gt;
&lt;link rel="colorSchemeMapping" href="file:///C:\Users\GEZDAR~1\AppData\Local\Temp\msohtmlclip1\01\clip_colorschememapping.xml" reoriginalpositionmarker="RadEditorStyleKeeper3" /&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
&lt;w:WordDocument&gt;
&lt;w:View&gt;Normal&lt;/w:View&gt;
&lt;w:Zoom&gt;0&lt;/w:Zoom&gt;
&lt;w:TrackMoves/&gt;
&lt;w:TrackFormatting/&gt;
&lt;w:PunctuationKerning/&gt;
&lt;w:ValidateAgainstSchemas/&gt;
&lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;
&lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt;
&lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;
&lt;w:DoNotPromoteQF/&gt;
&lt;w:LidThemeOther&gt;EN-GB&lt;/w:LidThemeOther&gt;
&lt;w:LidThemeAsian&gt;X-NONE&lt;/w:LidThemeAsian&gt;
&lt;w:LidThemeComplexScript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;
&lt;w:Compatibility&gt;
&lt;w:BreakWrappedTables/&gt;
&lt;w:SnapToGridInCell/&gt;
&lt;w:WrapTextWithPunct/&gt;
&lt;w:UseAsianBreakRules/&gt;
&lt;w:DontGrowAutofit/&gt;
&lt;w:SplitPgBreakAndParaMark/&gt;
&lt;w:DontVertAlignCellWithSp/&gt;
&lt;w:DontBreakConstrainedForcedTables/&gt;
&lt;w:DontVertAlignInTxbx/&gt;
&lt;w:Word11KerningPairs/&gt;
&lt;w:CachedColBalance/&gt;
&lt;/w:Compatibility&gt;
&lt;m:mathPr&gt;
&lt;m:mathFont m:val="Cambria Math"/&gt;
&lt;m:brkBin m:val="before"/&gt;
&lt;m:brkBinSub m:val="&amp;#45;-"/&gt;
&lt;m:smallFrac m:val="off"/&gt;
&lt;m:dispDef/&gt;
&lt;m:lMargin m:val="0"/&gt;
&lt;m:rMargin m:val="0"/&gt;
&lt;m:defJc m:val="centerGroup"/&gt;
&lt;m:wrapIndent m:val="1440"/&gt;
&lt;m:intLim m:val="subSup"/&gt;
&lt;m:naryLim m:val="undOvr"/&gt;
&lt;/m:mathPr&gt;&lt;/w:WordDocument&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
&lt;w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
DefSemiHidden="true" DefQFormat="false" DefPriority="99"
LatentStyleCount="267"&gt;
&lt;w:LsdException Locked="false" Priority="0" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Normal"/&gt;
&lt;w:LsdException Locked="false" Priority="9" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="heading 1"/&gt;
&lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/&gt;
&lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/&gt;
&lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/&gt;
&lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/&gt;
&lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/&gt;
&lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/&gt;
&lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/&gt;
&lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 1"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 2"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 3"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 4"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 5"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 6"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 7"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 8"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 9"/&gt;
&lt;w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/&gt;
&lt;w:LsdException Locked="false" Priority="10" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Title"/&gt;
&lt;w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/&gt;
&lt;w:LsdException Locked="false" Priority="11" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/&gt;
&lt;w:LsdException Locked="false" Priority="22" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Strong"/&gt;
&lt;w:LsdException Locked="false" Priority="20" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/&gt;
&lt;w:LsdException Locked="false" Priority="59" SemiHidden="false"
UnhideWhenUsed="false" Name="Table Grid"/&gt;
&lt;w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/&gt;
&lt;w:LsdException Locked="false" Priority="1" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/&gt;
&lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading"/&gt;
&lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List"/&gt;
&lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid"/&gt;
&lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1"/&gt;
&lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2"/&gt;
&lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1"/&gt;
&lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2"/&gt;
&lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1"/&gt;
&lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2"/&gt;
&lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3"/&gt;
&lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List"/&gt;
&lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading"/&gt;
&lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List"/&gt;
&lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid"/&gt;
&lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/&gt;
&lt;w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/&gt;
&lt;w:LsdException Locked="false" Priority="34" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/&gt;
&lt;w:LsdException Locked="false" Priority="29" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Quote"/&gt;
&lt;w:LsdException Locked="false" Priority="30" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/&gt;
&lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="19" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/&gt;
&lt;w:LsdException Locked="false" Priority="21" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/&gt;
&lt;w:LsdException Locked="false" Priority="31" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/&gt;
&lt;w:LsdException Locked="false" Priority="32" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/&gt;
&lt;w:LsdException Locked="false" Priority="33" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Book Title"/&gt;
&lt;w:LsdException Locked="false" Priority="37" Name="Bibliography"/&gt;
&lt;w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/&gt;
&lt;/w:LatentStyles&gt;
&lt;/xml&gt;&lt;![endif]--&gt;
&lt;style reoriginalpositionmarker="RadEditorStyleKeeper4"&gt;
    &lt;!--
    /* Font Definitions */
    @font-face
    {font-family:"Cambria Math";
    panose-1:2 4 5 3 5 4 6 3 2 4;
    mso-font-charset:1;
    mso-generic-font-family:roman;
    mso-font-format:other;
    mso-font-pitch:variable;
    mso-font-signature:0 0 0 0 0 0;}
    @font-face
    {font-family:Calibri;
    panose-1:2 15 5 2 2 2 4 3 2 4;
    mso-font-charset:0;
    mso-generic-font-family:swiss;
    mso-font-pitch:variable;
    mso-font-signature:-1610611985 1073750139 0 0 159 0;}
    /* Style Definitions */
    p.MsoNormal, li.MsoNormal, div.MsoNormal
    {mso-style-unhide:no;
    mso-style-qformat:yes;
    mso-style-parent:"";
    margin-top:0cm;
    margin-right:0cm;
    margin-bottom:10.0pt;
    margin-left:0cm;
    line-height:115%;
    mso-pagination:widow-orphan;
    font-size:11.0pt;
    font-family:"Calibri","sans-serif";
    mso-ascii-font-family:Calibri;
    mso-ascii-theme-font:minor-latin;
    mso-fareast-font-family:Calibri;
    mso-fareast-theme-font:minor-latin;
    mso-hansi-font-family:Calibri;
    mso-hansi-theme-font:minor-latin;
    mso-bidi-font-family:"Times New Roman";
    mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US;}
    .MsoChpDefault
    {mso-style-type:export-only;
    mso-default-props:yes;
    mso-ascii-font-family:Calibri;
    mso-ascii-theme-font:minor-latin;
    mso-fareast-font-family:Calibri;
    mso-fareast-theme-font:minor-latin;
    mso-hansi-font-family:Calibri;
    mso-hansi-theme-font:minor-latin;
    mso-bidi-font-family:"Times New Roman";
    mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US;}
    .MsoPapDefault
    {mso-style-type:export-only;
    margin-bottom:10.0pt;
    line-height:115%;}
    @page WordSection1
    {size:612.0pt 792.0pt;
    margin:72.0pt 72.0pt 72.0pt 72.0pt;
    mso-header-margin:36.0pt;
    mso-footer-margin:36.0pt;
    mso-paper-source:0;}
    div.WordSection1
    {page:WordSection1;}
    --&gt;
&lt;/style&gt;
&lt;!--[if gte mso 10]&gt;
&lt;div id='RadEditorStyleKeeper5' style='display:none;'&gt;&amp;nbsp;&lt;/div&gt;
&lt;div id='RadEditorStyleKeeper5' style='display:none;'&gt;&amp;nbsp;&lt;/div&gt;
&lt;div id='RadEditorStyleKeeper5' style='display:none;'&gt;&amp;nbsp;&lt;/div&gt;
&lt;style reoriginalpositionmarker='RadEditorStyleKeeper5' reoriginalpositionmarker='RadEditorStyleKeeper5' reoriginalpositionmarker='RadEditorStyleKeeper5'&gt;
    /* Style Definitions */
    table.MsoNormalTable
    {mso-style-name:"Table Normal";
    mso-tstyle-rowband-size:0;
    mso-tstyle-colband-size:0;
    mso-style-noshow:yes;
    mso-style-priority:99;
    mso-style-qformat:yes;
    mso-style-parent:"";
    mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
    mso-para-margin-top:0cm;
    mso-para-margin-right:0cm;
    mso-para-margin-bottom:10.0pt;
    mso-para-margin-left:0cm;
    line-height:115%;
    mso-pagination:widow-orphan;
    font-size:11.0pt;
    font-family:"Calibri","sans-serif";
    mso-ascii-font-family:Calibri;
    mso-ascii-theme-font:minor-latin;
    mso-fareast-font-family:"Times New Roman";
    mso-fareast-theme-font:minor-fareast;
    mso-hansi-font-family:Calibri;
    mso-hansi-theme-font:minor-latin;}
&lt;/style&gt;
&lt;![endif]--&gt;
&lt;p class="MsoNormal"&gt;VIE at home (previously known as Virgin Vie At Home), has
chosen KMP Digitata as the developer of their Facebook application designed to
help VIE at home Consultants advertise their products and parties.&lt;/p&gt;
</content></entry><entry><id>06aca178-24f0-4e2a-8588-76e5ea7acbcd</id><title type="text">FLOODING HITS TEN MILLION PEOPLE IN INDIA’S MOST POPULOUS AND POOREST STATE </title><updated>2010-09-03T17:03:28+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/367-FLOODING-HITS-TEN-MILLION-PEOPLE-IN-INDIA-S-MOST-POPULOUS-AND-POOREST-STATE-.aspx" /><content type="html">Christian Aid is launching an immediate appeal for the people hit by the devastating India floods.  More than 800,000 people have had their villages submerged by severe flooding in Uttar Pradesh, Northern India.  
</content></entry><entry><id>37d114d2-7549-4b18-99f9-8ac69949b6bc</id><title type="text">Local companies to share business boost success</title><updated>2010-09-03T09:20:26+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/366-Local-companies-to-share-business-boost-success.aspx" /><content type="html">
		&lt;p style="line-height: 150%"&gt;
		&lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;b&gt;&lt;span style="font-size: 16pt; line-height: 150%; font-family: 'arial','sans-serif'"&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p&gt;&lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;span&gt;&lt;strong&gt;Date: &lt;/strong&gt;03 September 2010&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;b&gt;&lt;span style="font-size: 11pt; line-height: 150%; font-family: 'arial','sans-serif'"&gt;Media Enquiries: &lt;/span&gt;&lt;/b&gt;&lt;span style="font-size: 11pt; line-height: 150%; font-family: 'arial','sans-serif'"&gt;Sian Alcock, Caudwell Children, 01782 600418 or media@caudwellchildren.com&lt;/span&gt; &lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;b&gt;&lt;span style="font-family: 'arial','sans-serif'"&gt; &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;span style="font-family: 'arial','sans-serif'"&gt;A Staffordshire-based organisation is inviting local businesses to join in their success as they aim to reach £1million of business referrals in the final quarter.&lt;/span&gt;&lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;span style="font-family: 'arial','sans-serif'"&gt; &lt;/span&gt;&lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;span style="font-family: 'arial','sans-serif'"&gt;With over £800,000 worth of business passed amongst members in the last thirteen months, the Britannia Chapter of Business Network International (BNI), which is already the most successful in Staffordshire and Shropshire, is now on its way to becoming one of the best in the country.&lt;/span&gt;&lt;/p&gt;
&lt;p style="line-height: 150%"&gt; &lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;span style="font-family: 'arial','sans-serif'"&gt;Following a recent recruitment drive, the Chapter’s membership was boosted to 38 in just four weeks, making it the largest group in the region, and only ten members short of the UK’s largest BNI Group.&lt;/span&gt;&lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;span style="font-family: 'arial','sans-serif'"&gt; &lt;/span&gt;&lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;b&gt;&lt;span style="font-family: 'arial','sans-serif'"&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
</content></entry><entry><id>c019a0b2-bbe3-4ca7-81c7-5c79d14bb4ee</id><title type="text">Tyneside cousins dive in to help terminally ill kids.</title><updated>2010-09-03T09:03:14+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/365-Tyneside-cousins-dive-in-to-help-terminally-ill-kids-.aspx" /><content type="html">
		&lt;p style="line-height: 150%"&gt;
				&lt;span style="font-family: 'arial','sans-serif'"&gt;Two Tyneside cousins are set to tackle the UK’s biggest swim event in a bid to send terminally ill youngsters on the trip of a lifetime.&lt;/span&gt; &lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;span style="font-family: 'arial','sans-serif'"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;span style="font-family: 'arial','sans-serif'"&gt;Daniel Hetherington and James Younger from Throckley will attempt the British Gas Great North Swim this weekend across Lake Windermere in Cumbria, where a record 9,000 swimmers are expected to take part.&lt;/span&gt;&lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;span style="font-family: 'arial','sans-serif'"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;span style="font-family: 'arial','sans-serif'"&gt;The duo have already raised over £250 to go towards Caudwell Children’s “Destination Dreams” programme, &lt;/span&gt;&lt;span style="font-family: 'arial','sans-serif'"&gt;a magical trip to Orlando specifically designed for children battling life-threatening illnesses.&lt;/span&gt;&lt;/p&gt;
</content></entry><entry><id>521d0e0d-cfdc-4416-a0b1-43b1864f93b1</id><title type="text">Christian Aid urges household name firms to back accounting reform</title><updated>2010-09-01T16:18:46+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/362-Christian-Aid-urges-household-name-firms-to-back-accounting-reform.aspx" /><content type="html">Christian Aid is launching a new phase of its Trace the Tax campaign for greater financial transparency by multinational companies. 
</content></entry><entry><id>28bb3d44-f931-4bba-a891-e5fb577a3bed</id><title type="text">Volunteers needed for social groups in Nottingham</title><updated>2010-09-01T15:58:02+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/autism/363-Volunteers-needed-for-social-groups-in-Nottingham.aspx" /><content type="html">&lt;p&gt;The National Autistic Society (NAS) is seeking volunteers to help out with their social group that supports adults with Asperger syndrome, a form of autism in Nottingham.&lt;/p&gt;</content></entry><entry><id>b37ab399-1f05-4cd1-8354-348cb1426e92</id><title type="text">OMID DJALILI IS ‘THE QUIZAID MASTER’ </title><updated>2010-08-17T17:15:48+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/318-OMID-DJALILI-IS--THE-QUIZAID-MASTER--.aspx" /><content type="html">Award-winning comedian and actor, Omid Djalili, has accepted a new role as QuizAid Master for Christian Aid’s first ever Twitter Quiz. Omid will host a live online quiz held on his Twitter page (omid9) on 6 September at 12.30pm to launch this year’s QuizAid. 
</content></entry><entry><id>e22c5793-7e16-4be7-b109-11c80ec6abcb</id><title type="text">Minister launches £1 million business to create jobs for people with autism</title><updated>2010-08-16T12:48:55+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/autism/311-Minister-launches--1-million-business-to-create-jobs-for-people-with-autism.aspx" /><content type="html">John Swinney MSP, Cabinet Secretary for Finance and Sustainable Growth in the Scottish Government, today unveiled a £700k investment in a unique new social enterprise which is expected to create up to 50 jobs for people with autism by providing highly-skilled software testing services to leading blue chip companies.$0
$0
Specialisterne Scotland, which was opened in Glasgow, is the first of its kind outside of Denmark.
$0$0
$0
$0The business has been developed over the past four years by Community Enterprise in Scotland (CEiS), the leading social enterprise support agency, in partnership with The National Autistic Society Scotland (NAS Scotland) and the Autism Resource Centre (ARC).$0
$0
</content></entry><entry><id>3c31fcf5-07e7-4358-afc6-95961b204ab0</id><title type="text">British Red Cross launches “robots in war” online educational videos</title><updated>2010-08-16T10:46:10+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/redcross/307-British-Red-Cross-launches--robots-in-war--online-educational-videos.aspx" /><content type="html">&lt;p&gt;&amp;ldquo;You are in a conflict area. Your home is about to be searched by an armed soldier or an armed robot. Which would you prefer?&amp;rdquo; Human soldiers have emotions. Robots don't. Could using robots make armed conflict more humane? &lt;br /&gt; &lt;br /&gt; This is one of the many thought-provoking questions posed in the new online resource withi the charity&amp;rsquo;s freshly redesigned website.&lt;/p&gt;</content></entry><entry><id>b33ed68a-b74f-4df7-9d09-2b80584bf269</id><title type="text">British Red Cross re-launches website</title><updated>2010-08-16T09:51:06+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/redcross/306-British-Red-Cross-re-launches-website.aspx" /><content type="html">The new look British Red Cross website, aims to provide simplified functionality, better access to information and integration with social media channels. &lt;br /&gt;
&lt;br /&gt;
Right from the homepage visitors to www.redcross.org.uk will be offered a simplified user-journey which enables them to find information about British Red Cross services at the click of a mouse. The site also carries regular updates of beneficiaries’, staff and volunteers stories, blogs and pictures. &lt;br /&gt;
</content></entry><entry><id>86cde107-4f78-4375-9018-47c080df56eb</id><title type="text">Sue Ryder Care shops raise extra £6.3million from gift aid</title><updated>2010-08-12T18:03:30+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/302-Sue-Ryder-Care-shops-raise-extra--6-3million-from-gift-aid.aspx" /><content type="html">Thanks to the support of shoppers nationwide, Sue Ryder Care is delighted to announce it has raised an extra £6.3million from Gift Aid on donated items to its 350 shops. The healthcare charity is using this milestone to encourage more people across the country to become gift aid members and help raise vital funds.     
</content></entry><entry><id>22bb9688-9a11-41bd-b28e-ee0afe3ce152</id><title type="text">Running in big American style in aid of Sue Ryder Care</title><updated>2010-08-12T17:11:12+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/301-Running-in-big-American-style-in-aid-of-Sue-Ryder-Care.aspx" /><content type="html">
		&lt;p&gt;A new running group is planning a massed assault on the Great North Run to raise vital funds for Sue Ryder Care. The Airedale Dodgers is a new friendly running group based at Airedale General Hospital. &lt;/p&gt;
&lt;p&gt;&lt;/p&gt;
&lt;p&gt;The group includes more than 40 runners amongst consultants, nurses, dieticians, pharmacists, physiotherapists, general practitioners, healthcare support workers and managers and will tackle the race on 19 September with the goal to raise at least £5,000 for the health and social care charity. &lt;/p&gt;
</content></entry><entry><id>7631063f-b93f-4cb3-9641-c616ce303fc5</id><title type="text">Eccentric superhero full of beans for Welsh walk</title><updated>2010-08-12T12:51:35+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/300-Eccentric-superhero-full-of-beans-for-Welsh-walk.aspx" /><content type="html">                    An eccentric fundraiser from South Wales is preparing for one of his most ambitious challenges to date, in a bid to help a local disabled boy.&lt;br /&gt;
&lt;br /&gt;
Charity Superhero, Captain Beany, has already made it into the record books for his baked bean fundraising achievements and now he plans to be the first person to walk around Wales holding a plate of beans on toast!
</content></entry><entry><id>01127e40-df44-4c87-9745-499f1fc28b44</id><title type="text">Charity commends autism research </title><updated>2010-08-12T10:21:47+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/298-Charity-commends-autism-research-.aspx" /><content type="html">		&lt;br _moz_editor_bogus_node="TRUE" /&gt;
National charity, Caudwell Children, has spoken out in support of research announced this week regarding the diagnosis of autism.&lt;br /&gt;
&lt;br /&gt;
New research conducted by King's College and the Institute of Psychiatry was released that has found MRI scans could potentially be used as a diagnostic tool for autism.&lt;br /&gt;
</content></entry><entry><id>caddb143-3f28-4950-b222-ed6881584ef0</id><title type="text">bcToolkit future updates</title><updated>2010-08-11T10:51:23+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/BcToolkit/296-bcToolkit-future-updates.aspx" /><content type="html">Hi all bcToolkit users. Just a quick news release to keep you in the loop with
some of our scheduled ongoing development following your great feedback
on bcToolkit.
</content></entry><entry><id>1e38d466-e8d5-4fab-a76e-6f623bccdd70</id><title type="text">KMP Digitata launch Trek America into Social Media</title><updated>2010-08-10T14:08:35+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/kmp/284-KMP-Digitata-launch-Trek-America-into-Social-Media.aspx" /><content type="html">KMP Digitata are extremely proud to announce the launch of Trek America Live, a social media portal where Trekkers can update and share their travel experiences.
</content></entry><entry><id>ed526996-3f86-4aee-9a19-009ce7e8dbb7</id><title type="text">Rev Jesse Jackson to ask MPs to help the world's poor</title><updated>2010-08-10T13:39:22+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/292-Rev-Jesse-Jackson-to-ask-MPs-to-help-the-world-s-poor.aspx" /><content type="html">
		&lt;p&gt;American civil rights activist, the Reverend Jesse Jackson, is coming to London on 20 October to give his backing to Christian Aid’s lobby of Parliament that day, aimed at moving climate change and global tax transparency up the political agenda. &lt;/p&gt;
&lt;p&gt;&lt;/p&gt;
&lt;p&gt;&lt;/p&gt;
&lt;p&gt;Jackson, who was part of the civil rights movement in the US and a strident opponent of apartheid in South Africa, will address supporters at Methodist Central Hall in Westminster at 11am, alongside new Director Loretta Minghella and Christian Aid partners from India and Zambia. &lt;/p&gt;
</content></entry><entry><id>fd5341ca-f57f-4b39-85dd-54b17d0e79c2</id><title type="text">Wickham Festival to screen social issue documentaries, 6-7 August</title><updated>2010-08-06T08:32:14+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/tippingpoint/287-Wickham-Festival-to-screen-social-issue-documentaries--6-7-August.aspx" /><content type="html">This year at Wickham Festival, The Co-operative supported Tipping Point Film Fund and Good With Film will screen powerful and provocative cinematic documentaries including Black Gold, Jeremy Hardy versus the Israeli Army, Burma VJ and The Yes Men Fix the World. The screenings will take place at the Groovy Movie Picture House on 6-7 August.
</content></entry><entry><id>8c10df72-756c-413d-9910-c3cd17fc22e6</id><title type="text">Drifter desire for venues big launch</title><updated>2010-08-05T11:22:11+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/286-Drifter-desire-for-venues-big-launch.aspx" /><content type="html">
		&lt;p style="line-height: 150%"&gt;
				&lt;span style="font-family: 'arial','sans-serif'"&gt;An R&amp;amp;B icon will be drifting into Stourbridge to perform for the opening of a newly-refurbished town centre hot spot.&lt;/span&gt; &lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;span style="font-family: 'arial','sans-serif'"&gt;Singing sensation, Ray Lewis, who&lt;/span&gt;&lt;span style="font-family: 'arial','sans-serif'"&gt; performed with the world famous rhythm and blues band, The Drifters, will take to the stage at the new Desire night club later this month.&lt;/span&gt;&lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;span style="font-family: 'arial','sans-serif'"&gt;It comes as part of celebrations at the Hagely Road venue for the much anticipated grand re-opening on Friday, August 27&lt;sup&gt;th&lt;/sup&gt;. Desire will launch under new management and after a major revamp of the iconic old Picture House night spot. &lt;/span&gt;&lt;/p&gt;
</content></entry><entry><id>27f51204-8645-4105-83f1-b6be0a431a68</id><title type="text">Norwood to extend Family Support service into Hertfordshire</title><updated>2010-08-02T15:26:49+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/norwood/281-Norwood-to-extend-Family-Support-service-into-Hertfordshire.aspx" /><content type="html">In response to the needs of a growing Jewish community in Hertfordshire, Norwood’s Family Support service is branching out to help children and families in need living in the area. Social Workers, Counsellors and Family Support Workers based at the Kennedy Leigh Family Centre in Hendon already provide support to many families in Hertfordshire.  &lt;br /&gt;
&lt;br /&gt;
However, the demand for services is growing and, from 13 October, families wishing to use the service will have the opportunity to meet with a member of the Family Support team at Allum Lane Community Centre, in Elstree, every Wednesday between 9am and 12pm. A registered Norwood professional will be on-hand to provide a range of practical and emotional support, although initial meetings are by appointment only. &lt;br /&gt;
</content></entry><entry><id>e109a78a-6e26-4d98-9747-f95371f4892d</id><title type="text">Speedy Cody’s world set alight with £8,500 life changing donation</title><updated>2010-07-30T14:48:48+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/283-Speedy-Cody-s-world-set-alight-with--8-500-life-changing-donation.aspx" /><content type="html">
		&lt;p style="line-height: 150%"&gt;
				&lt;span style="font-family: 'arial','sans-serif'"&gt;A disabled toddler from Chester has been given a state-of-the-art powered wheelchair worth over £8,500 to help him keep up to speed.&lt;/span&gt; &lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;span style="font-family: 'arial','sans-serif'"&gt;Inspired by his love of anything to do with fire engines, four year old Cody Mannion has received a racing red Permobil Koala Miniflex Powered Wheelchair which allows him to keep up with his best friend and brother, Ronnan (5).&lt;/span&gt;&lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;span style="font-family: 'arial','sans-serif'"&gt;The high-tech chair allows Cody, who has Spinal Muscular Atrophy (SMA), to adjust his height, meaning he can independently reach house utilities, wash his hands and reach things which are usually above his normal chair level.&lt;/span&gt;&lt;/p&gt;
</content></entry><entry><id>939ed478-e9e1-4690-9e00-4d097418b14d</id><title type="text">Refine your budgets with bcToolkit</title><updated>2010-07-30T11:35:29+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/BcToolkit/275-Refine-your-budgets-with-bcToolkit.aspx" /><content type="html">		BcToolkit uses the Basecamp API to further improve your time reporting across all your projects.&lt;br /&gt;
</content></entry><entry><id>d7685604-d792-408d-9e48-8273b7cb7f83</id><title type="text">Media Trust are enriching their press releases with PressRoom</title><updated>2010-07-29T15:16:35+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/ackura/267-Media-Trust-are-enriching-their-press-releases-with-PressRoom.aspx" /><content type="html">&lt;p&gt;PressRoom has been chosen by Media Trust to publish their news online and help share it on social media channels&lt;/p&gt;</content></entry><entry><id>44e90cf9-2a95-481e-aa2e-97d954f238ed</id><title type="text">PressRoom is now helping the Caudwell Children's Charity</title><updated>2010-07-28T13:42:20+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/ackura/268-PressRoom-is-now-helping-the-Caudwell-Children-s-Charity.aspx" /><content type="html">&lt;p&gt;PressRoom has been chosen by Caudwell to help them publish their news online in a format that is easy for the readers to access and share amoung their peers.&lt;/p&gt;</content></entry><entry><id>4eb2594c-8185-495c-b680-e437db694969</id><title type="text">Detailed productivity metrics uncovered by bcToolkit</title><updated>2010-07-28T10:11:12+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/BcToolkit/274-Detailed-productivity-metrics-uncovered-by-bcToolkit.aspx" /><content type="html">Our customers are reporting back to us that they are staggered at the
amount of productivity information that bcToolkit can unlock from
everyday &lt;a href="http://http//basecamphq.com/"&gt;Basecamp&lt;/a&gt; data. For
example the simple categorization of all projects into billable and non
billable activities has really opened some eyes out there in the digital
agency world.
</content></entry><entry><id>90ea9128-733e-4de3-9689-45e4710ff1db</id><title type="text">Mum and daughter thrilled thanks to donation of “new legs” </title><updated>2010-07-28T09:37:09+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/277-Mum-and-daughter-thrilled-thanks-to-donation-of--new-legs--.aspx" /><content type="html">
		&lt;p style="line-height: 150%"&gt;
				&lt;span style="font-family: 'arial','sans-serif'"&gt;A disabled youngster, who was missing out on activities after being refused vital equipment from the NHS, is again strolling happy thanks to a local children’s charity.&lt;/span&gt; &lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;span style="font-family: 'arial','sans-serif'"&gt;Eight-year-old Ashleigh Bird from Hanford has received a walking frame to help the youngster who has Epilepsy and Cerebral Palsy to get out and about again.&lt;/span&gt;&lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;span style="font-family: 'arial','sans-serif'"&gt;Ashleigh has spent the last six months being pushed around in a manual wheelchair after she outgrew her previous walking frame and was refused a new one from the NHS.&lt;/span&gt;&lt;/p&gt;
</content></entry><entry><id>eaa64119-0c99-49be-86d7-7ed376792a9d</id><title type="text">Local footie legends return to help players net a success</title><updated>2010-07-27T16:56:46+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/276-Local-footie-legends-return-to-help-players-net-a-success.aspx" /><content type="html">
		&lt;p&gt; &lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;span style="font-family: 'arial','sans-serif'"&gt;Football heroes are to return to the pitch and come face to face with players from two local teams in a bid to help change the lives of local sick and disabled kids.&lt;/span&gt;&lt;/p&gt;
&lt;p style="line-height: 150%"&gt;&lt;span style="font-family: 'arial','sans-serif'"&gt;Managed by former Stoke City and Chelsea footballer, Alan Hudson; &lt;span style="color: #000000"&gt;former Stoke City, Port Vale and Manchester United players including &lt;/span&gt;&lt;span style="font-family: 'arial','sans-serif'"&gt;Jimmy Greenhoff&lt;/span&gt;&lt;span style="color: #000000; font-family: 'arial','sans-serif'"&gt;, Alan Dodd and Jackie Marsh, &lt;/span&gt;&lt;span style="font-family: 'arial','sans-serif'"&gt;will be taking on current players from Kidsgrove Athletic FC and The Blue Mugge, (Leek). &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
</content></entry><entry><id>5a755558-de65-4761-9983-ce863bdcface</id><title type="text">Tipping Point Film Fund publish their news with PressRoom</title><updated>2010-07-27T13:42:06+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/ackura/264-Tipping-Point-Film-Fund-publish-their-news-with-PressRoom.aspx" /><content type="html">		PressRoom has been chosen by The Tipping Film Fund to publish their news so that their online audience can easily receive and share it. &lt;br /&gt;
</content></entry><entry><id>273790d9-18b1-45c2-a014-b058772d1023</id><title type="text">RUNNING SHOES WITH EXTRA POWER</title><updated>2010-07-27T13:27:27+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/270-RUNNING-SHOES-WITH-EXTRA-POWER.aspx" /><content type="html">
		&lt;p&gt;Sue Ryder Care is calling runners across the country to join its running team. The health and social care charity offers a personalised service to all runners who have secured their own place at one of the most popular half-marathon races – the Great North Run - and would like extra help to make sure the day will be an unforgettable one. &lt;/p&gt;
&lt;p&gt;Sue Ryder Care has a dedicated running support team and look after its runners from the sign-up to the finishing line. &lt;/p&gt;
</content></entry><entry><id>51220b80-d886-4fa6-9140-5e1a11ba35f9</id><title type="text">Date set for two-way channel swim</title><updated>2010-07-26T15:27:37+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/272-Date-set-for-two-way-channel-swim.aspx" /><content type="html">		&lt;br _moz_editor_bogus_node="TRUE" /&gt;
&lt;link rel="File-List" reoriginalpositionmarker="RadEditorStyleKeeper1" /&gt;
&lt;link rel="themeData" reoriginalpositionmarker="RadEditorStyleKeeper2" /&gt;
&lt;link rel="colorSchemeMapping" reoriginalpositionmarker="RadEditorStyleKeeper3" /&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt; Normal 0 false false false EN-US X-NONE X-NONE MicrosoftInternetExplorer4 &lt;-[endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt; &lt;/xml&gt;&lt;![endif]--&gt;
&lt;style reoriginalpositionmarker="RadEditorStyleKeeper4"&gt;
    &lt;!-- /* Font Definitions */ @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-1610611985 1107304683 0 0 159 0;} @font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-1610611985 1073750139 0 0 159 0;} /* Style Definitions */ p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin-top:0cm; margin-right:0cm; margin-bottom:10.0pt; margin-left:0cm; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB;} .MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi;} .MsoPapDefault {mso-style-type:export-only; margin-bottom:10.0pt; line-height:115%;} @page Section1 {size:612.0pt 792.0pt; margin:72.0pt 72.0pt 72.0pt 72.0pt; mso-header-margin:36.0pt; mso-footer-margin:36.0pt; mso-paper-source:0;} div.Section1 {page:Section1;} --&gt;
&lt;/style&gt;
&lt;!--[if gte mso 10]&gt;
&lt;div id='RadEditorStyleKeeper5' style='display:none;'&gt;&amp;nbsp;&lt;/div&gt;
&lt;style reoriginalpositionmarker='RadEditorStyleKeeper5'&gt;
    /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:10.0pt; mso-para-margin-left:0cm; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin;}
&lt;/style&gt;
&lt;![endif]--&gt;
&lt;p&gt;
&lt;/p&gt;
&lt;link rel="File-List" reoriginalpositionmarker="RadEditorStyleKeeper6" /&gt;
&lt;link rel="themeData" reoriginalpositionmarker="RadEditorStyleKeeper7" /&gt;
&lt;link rel="colorSchemeMapping" reoriginalpositionmarker="RadEditorStyleKeeper8" /&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt; Normal 0 false false false EN-US X-NONE X-NONE MicrosoftInternetExplorer4 &lt;-[endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt; &lt;/xml&gt;&lt;![endif]--&gt;
&lt;style reoriginalpositionmarker="RadEditorStyleKeeper9"&gt;
    &lt;!-- /* Font Definitions */ @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-1610611985 1107304683 0 0 159 0;} @font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-1610611985 1073750139 0 0 159 0;} /* Style Definitions */ p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin-top:0cm; margin-right:0cm; margin-bottom:10.0pt; margin-left:0cm; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB;} .MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi;} .MsoPapDefault {mso-style-type:export-only; margin-bottom:10.0pt; line-height:115%;} @page Section1 {size:612.0pt 792.0pt; margin:72.0pt 72.0pt 72.0pt 72.0pt; mso-header-margin:36.0pt; mso-footer-margin:36.0pt; mso-paper-source:0;} div.Section1 {page:Section1;} --&gt;
&lt;/style&gt;
&lt;!--[if gte mso 10]&gt;
&lt;div id='RadEditorStyleKeeper10' style='display:none;'&gt;&amp;nbsp;&lt;/div&gt;
&lt;style reoriginalpositionmarker='RadEditorStyleKeeper10'&gt;
    /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:10.0pt; mso-para-margin-left:0cm; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin;}
&lt;/style&gt;
&lt;![endif]--&gt;
&lt;p&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;A fanatical fundraiser from Swansea is once again preparing to dive into the icy waters of the Bristol Channel as he attempts a double crossing, swimming from Penarth to Weston-super-Mare and back to raise money for a local disabled boy.&lt;/span&gt;&lt;/p&gt;
</content></entry><entry><id>d4798404-9484-4b93-9ed4-aa4ec8b44600</id><title type="text">Productivity reporting is central to Project Management</title><updated>2010-07-26T14:37:12+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/BcToolkit/271-Productivity-reporting-is-central-to-Project-Management.aspx" /><content type="html">If you use &lt;a href="http://37signals.com/"&gt;Basecamp&lt;/a&gt; from &lt;a href="http://37signals.com/"&gt;37Signals&lt;/a&gt;, whilst it is great for the
project management bit and we know we have been using it for 3 years
now, it doesn’t provide you with the opportunity to measure your
productivity. That’s where bcToolkit comes in.
</content></entry><entry><id>d3863ef3-d187-47ee-97f1-bb067dc74f45</id><title type="text">CAMRA are now using PressRoom</title><updated>2010-07-26T13:45:34+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/ackura/263-CAMRA-are-now-using-PressRoom.aspx" /><content type="html">		CAMRA campaigns for real ale have chosen PressRoom to help them publish their news online and help get it out into the social media channels&lt;br _moz_editor_bogus_node="TRUE" /&gt;
</content></entry><entry><id>723645d4-689e-441d-8aa9-95ae0b054356</id><title type="text">PressRoom is now available for free to Charities</title><updated>2010-07-22T12:12:59+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/ackura/262-PressRoom-is-now-available-for-free-to-Charities.aspx" /><content type="html">		Ackura PressRoom is now available to charities free of charge to help them spread their heart warming news.&lt;br _moz_editor_bogus_node="TRUE" /&gt;
</content></entry><entry><id>9c351cb3-4530-4118-b10d-a5a47eee93fa</id><title type="text">Christian Aid joins Bono and Soros in welcoming landmark law on business transparency</title><updated>2010-07-21T16:28:59+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/261-Christian-Aid-joins-Bono-and-Soros-in-welcoming-landmark-law-on-business-transparency.aspx" /><content type="html">Christian Aid today welcomes a new US law which will challenge corruption in poor countries and boost the pressure for global reforms to combat tax dodging and bribery. 
</content></entry><entry><id>fed62c99-837e-4412-bafb-ddb35c44e68f</id><title type="text">Michelle Collins joins KMP Digitata</title><updated>2010-07-21T10:21:05+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/kmp/260-Michelle-Collins-joins-KMP-Digitata.aspx" /><content type="html">
		&lt;link reoriginalpositionmarker="RadEditorStyleKeeper1" href="file:///C:\Users\GEZDAR~1\AppData\Local\Temp\msohtmlclip1\01\clip_filelist.xml" rel="File-List" /&gt;
&lt;link reoriginalpositionmarker="RadEditorStyleKeeper2" href="file:///C:\Users\GEZDAR~1\AppData\Local\Temp\msohtmlclip1\01\clip_themedata.thmx" rel="themeData" /&gt;
&lt;link reoriginalpositionmarker="RadEditorStyleKeeper3" href="file:///C:\Users\GEZDAR~1\AppData\Local\Temp\msohtmlclip1\01\clip_colorschememapping.xml" rel="colorSchemeMapping" /&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
&lt;w:WordDocument&gt;
&lt;w:View&gt;Normal&lt;/w:View&gt;
&lt;w:Zoom&gt;0&lt;/w:Zoom&gt;
&lt;w:TrackMoves/&gt;
&lt;w:TrackFormatting/&gt;
&lt;w:PunctuationKerning/&gt;
&lt;w:ValidateAgainstSchemas/&gt;
&lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;
&lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt;
&lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;
&lt;w:DoNotPromoteQF/&gt;
&lt;w:LidThemeOther&gt;EN-GB&lt;/w:LidThemeOther&gt;
&lt;w:LidThemeAsian&gt;X-NONE&lt;/w:LidThemeAsian&gt;
&lt;w:LidThemeComplexScript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;
&lt;w:Compatibility&gt;
&lt;w:BreakWrappedTables/&gt;
&lt;w:SnapToGridInCell/&gt;
&lt;w:WrapTextWithPunct/&gt;
&lt;w:UseAsianBreakRules/&gt;
&lt;w:DontGrowAutofit/&gt;
&lt;w:SplitPgBreakAndParaMark/&gt;
&lt;w:DontVertAlignCellWithSp/&gt;
&lt;w:DontBreakConstrainedForcedTables/&gt;
&lt;w:DontVertAlignInTxbx/&gt;
&lt;w:Word11KerningPairs/&gt;
&lt;w:CachedColBalance/&gt;
&lt;/w:Compatibility&gt;
&lt;w:BrowserLevel&gt;MicrosoftInternetExplorer4&lt;/w:BrowserLevel&gt;
&lt;m:mathPr&gt;
&lt;m:mathFont m:val="Cambria Math"/&gt;
&lt;m:brkBin m:val="before"/&gt;
&lt;m:brkBinSub m:val="&amp;#45;-"/&gt;
&lt;m:smallFrac m:val="off"/&gt;
&lt;m:dispDef/&gt;
&lt;m:lMargin m:val="0"/&gt;
&lt;m:rMargin m:val="0"/&gt;
&lt;m:defJc m:val="centerGroup"/&gt;
&lt;m:wrapIndent m:val="1440"/&gt;
&lt;m:intLim m:val="subSup"/&gt;
&lt;m:naryLim m:val="undOvr"/&gt;
&lt;/m:mathPr&gt;&lt;/w:WordDocument&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
&lt;w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
DefSemiHidden="true" DefQFormat="false" DefPriority="99"
LatentStyleCount="267"&gt;
&lt;w:LsdException Locked="false" Priority="0" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Normal"/&gt;
&lt;w:LsdException Locked="false" Priority="9" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="heading 1"/&gt;
&lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/&gt;
&lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/&gt;
&lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/&gt;
&lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/&gt;
&lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/&gt;
&lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/&gt;
&lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/&gt;
&lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 1"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 2"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 3"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 4"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 5"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 6"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 7"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 8"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 9"/&gt;
&lt;w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/&gt;
&lt;w:LsdException Locked="false" Priority="10" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Title"/&gt;
&lt;w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/&gt;
&lt;w:LsdException Locked="false" Priority="11" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/&gt;
&lt;w:LsdException Locked="false" Priority="22" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Strong"/&gt;
&lt;w:LsdException Locked="false" Priority="20" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/&gt;
&lt;w:LsdException Locked="false" Priority="59" SemiHidden="false"
UnhideWhenUsed="false" Name="Table Grid"/&gt;
&lt;w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/&gt;
&lt;w:LsdException Locked="false" Priority="1" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/&gt;
&lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading"/&gt;
&lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List"/&gt;
&lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid"/&gt;
&lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1"/&gt;
&lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2"/&gt;
&lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1"/&gt;
&lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2"/&gt;
&lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1"/&gt;
&lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2"/&gt;
&lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3"/&gt;
&lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List"/&gt;
&lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading"/&gt;
&lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List"/&gt;
&lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid"/&gt;
&lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/&gt;
&lt;w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/&gt;
&lt;w:LsdException Locked="false" Priority="34" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/&gt;
&lt;w:LsdException Locked="false" Priority="29" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Quote"/&gt;
&lt;w:LsdException Locked="false" Priority="30" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/&gt;
&lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="19" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/&gt;
&lt;w:LsdException Locked="false" Priority="21" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/&gt;
&lt;w:LsdException Locked="false" Priority="31" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/&gt;
&lt;w:LsdException Locked="false" Priority="32" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/&gt;
&lt;w:LsdException Locked="false" Priority="33" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Book Title"/&gt;
&lt;w:LsdException Locked="false" Priority="37" Name="Bibliography"/&gt;
&lt;w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/&gt;
&lt;/w:LatentStyles&gt;
&lt;/xml&gt;&lt;![endif]--&gt;
&lt;style reoriginalpositionmarker="RadEditorStyleKeeper4"&gt;
    &lt;!--
    /* Font Definitions */
    @font-face
    {font-family:"Cambria Math";
    panose-1:2 4 5 3 5 4 6 3 2 4;
    mso-font-charset:1;
    mso-generic-font-family:roman;
    mso-font-format:other;
    mso-font-pitch:variable;
    mso-font-signature:0 0 0 0 0 0;}
    @font-face
    {font-family:Calibri;
    panose-1:2 15 5 2 2 2 4 3 2 4;
    mso-font-charset:0;
    mso-generic-font-family:swiss;
    mso-font-pitch:variable;
    mso-font-signature:-1610611985 1073750139 0 0 159 0;}
    /* Style Definitions */
    p.MsoNormal, li.MsoNormal, div.MsoNormal
    {mso-style-unhide:no;
    mso-style-qformat:yes;
    mso-style-parent:"";
    margin-top:0cm;
    margin-right:0cm;
    margin-bottom:10.0pt;
    margin-left:0cm;
    line-height:115%;
    mso-pagination:widow-orphan;
    font-size:11.0pt;
    font-family:"Calibri","sans-serif";
    mso-ascii-font-family:Calibri;
    mso-ascii-theme-font:minor-latin;
    mso-fareast-font-family:Calibri;
    mso-fareast-theme-font:minor-latin;
    mso-hansi-font-family:Calibri;
    mso-hansi-theme-font:minor-latin;
    mso-bidi-font-family:"Times New Roman";
    mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US;}
    .MsoChpDefault
    {mso-style-type:export-only;
    mso-default-props:yes;
    mso-ascii-font-family:Calibri;
    mso-ascii-theme-font:minor-latin;
    mso-fareast-font-family:Calibri;
    mso-fareast-theme-font:minor-latin;
    mso-hansi-font-family:Calibri;
    mso-hansi-theme-font:minor-latin;
    mso-bidi-font-family:"Times New Roman";
    mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US;}
    .MsoPapDefault
    {mso-style-type:export-only;
    margin-bottom:10.0pt;
    line-height:115%;}
    @page WordSection1
    {size:612.0pt 792.0pt;
    margin:72.0pt 72.0pt 72.0pt 72.0pt;
    mso-header-margin:36.0pt;
    mso-footer-margin:36.0pt;
    mso-paper-source:0;}
    div.WordSection1
    {page:WordSection1;}
    --&gt;
&lt;/style&gt;
&lt;!--[if gte mso 10]&gt;
&lt;div id='RadEditorStyleKeeper5' style='display:none;'&gt;&amp;nbsp;&lt;/div&gt;
&lt;div id='RadEditorStyleKeeper5' style='display:none;'&gt;&amp;nbsp;&lt;/div&gt;
&lt;div id='RadEditorStyleKeeper5' style='display:none;'&gt;&amp;nbsp;&lt;/div&gt;
&lt;div id='RadEditorStyleKeeper5' style='display:none;'&gt;&amp;nbsp;&lt;/div&gt;
&lt;style reoriginalpositionmarker='RadEditorStyleKeeper5' reoriginalpositionmarker='RadEditorStyleKeeper5' reoriginalpositionmarker='RadEditorStyleKeeper5' reoriginalpositionmarker='RadEditorStyleKeeper5'&gt;
    /* Style Definitions */
    table.MsoNormalTable
    {mso-style-name:"Table Normal";
    mso-tstyle-rowband-size:0;
    mso-tstyle-colband-size:0;
    mso-style-noshow:yes;
    mso-style-priority:99;
    mso-style-qformat:yes;
    mso-style-parent:"";
    mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
    mso-para-margin-top:0cm;
    mso-para-margin-right:0cm;
    mso-para-margin-bottom:10.0pt;
    mso-para-margin-left:0cm;
    line-height:115%;
    mso-pagination:widow-orphan;
    font-size:11.0pt;
    font-family:"Calibri","sans-serif";
    mso-ascii-font-family:Calibri;
    mso-ascii-theme-font:minor-latin;
    mso-hansi-font-family:Calibri;
    mso-hansi-theme-font:minor-latin;
    mso-fareast-language:EN-US;}
&lt;/style&gt;
&lt;![endif]--&gt;
&lt;p class="MsoNormal"&gt;Michelle Collins, formerly of Flame Digital, has joined KMP
Digitata as Client Services Manager, taking over the role from Gerard Daring,
who is now the Business Development Director for the company.&lt;/p&gt;
</content></entry><entry><id>ed6a32bc-0d06-47ca-adbc-a23311287e18</id><title type="text">Sue Ryder Care comment on Terms of Reference for the Commission on the Funding of Care and Support (issued 20 July 2010)</title><updated>2010-07-20T17:09:38+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/259-Sue-Ryder-Care-comment-on-Terms-of-Reference-for-the-Commission-on-the-Funding-of-Care-and-Support--issued-20-July-2010-.aspx" /><content type="html">Sue Ryder Care welcomes today’s announcement on the establishment of a commission to determine an affordable and sustainable funding system for care and support, for all adults in England, both in the home and other settings (Terms of Reference for the Commission on the Funding of Care and Support, 20 July 2010).  
</content></entry><entry><id>7f4bd7e0-69ff-4d10-a788-cf0c2d0a254c</id><title type="text">Four-year-old Connor just wants his brother to walk</title><updated>2010-07-20T15:01:13+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/258-Four-year-old-Connor-just-wants-his-brother-to-walk.aspx" /><content type="html">		&lt;br _moz_editor_bogus_node="TRUE" /&gt;
A four-year-old from South Wales is trying to raise £60,000 to help his disabled twin brother walk independently by paying for a ground-breaking operation in America.
</content></entry><entry><id>fed2a2af-9623-4a40-82c4-e7c64d33dafe</id><title type="text">Victoria to face volcanic challenge for charity</title><updated>2010-07-20T11:49:20+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/257-Victoria-to-face-volcanic-challenge-for-charity.aspx" /><content type="html">		&lt;br _moz_editor_bogus_node="TRUE" /&gt;
Active volcanoes, boiling mud pools and spouting geysers are just a few of the perils fundraiser, Victoria Senter (28), is set to face on an Icelandic charity trek later this week.&lt;br /&gt;
&lt;br /&gt;
On Wednesday 21st July Victoria, from Fenton in Staffordshire, will jet off to the Icelandic capital, Reykjavik before heading to the barren lava fields of the Southern Highlands where she will embark on a 5 day trek along the Landmannalaugar route.&lt;br /&gt;
</content></entry><entry><id>4b5d852a-3a8e-439c-ac5a-cc8cb082a5d0</id><title type="text">Play online charity game and win a quad bike experience for two</title><updated>2010-07-19T17:45:36+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/256-Play-online-charity-game-and-win-a-quad-bike-experience-for-two.aspx" /><content type="html">Sue Ryder Care is offering people the chance to win an exciting quad biking experience for two.  Visit www.suerydercare.org/game to play the healthcare charity’s fun new online arcade game, and when you submit your score you’ll be entered into a prize draw.  Closing date for entries is 30 September 2010. 
</content></entry><entry><id>b381932c-1269-4295-8cfa-1f11c1c60c45</id><title type="text">Steve Jenkin comments on End of Life (EoLC) Strategy</title><updated>2010-07-19T17:28:12+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/sueryder/255-Steve-Jenkin-comments-on-End-of-Life--EoLC--Strategy.aspx" /><content type="html">
		&lt;p&gt;The National Audit Office (Nov, 2008) and Public Accounts Committee reports (May, 2009) on end of life care both highlighted that existing palliative care services are increasingly underfunded by comissioners, and worryingly, a relience on voluntary fundraising is growing. &lt;/p&gt;
&lt;p&gt;&lt;/p&gt;
&lt;p&gt;Sue Ryder Care is calling on the government to implement its plan for a tariff for palliative and end of life care services at the earliest opportunity. While the exact benefits of funding received remain hazy in some areas the Strategy has supported end of life care to rise up the political agenda and public consciousness of the subject. &lt;/p&gt;
&lt;p&gt;&lt;/p&gt;
</content></entry><entry><id>43fbcbe9-75dc-4e29-a765-f2204a839e7f</id><title type="text">Speedy prize on offer at special networking event</title><updated>2010-07-19T09:27:19+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/254-Speedy-prize-on-offer-at-special-networking-event.aspx" /><content type="html">                    An Audi TT for the weekend is on offer at a business networking event to be held in Stoke later this week.&lt;br /&gt;
&lt;br /&gt;
The Sir Stanley Matthews chapter of Business Network International (BNI) are offering the chance to win the luxury prize to visitors at their free business event on July 21st at 4pm.&lt;br /&gt;
</content></entry><entry><id>9e220da6-0062-4410-906d-e38bb3a65800</id><title type="text">Shirt sponsor gift will boost charity awareness</title><updated>2010-07-15T17:22:32+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/253-Shirt-sponsor-gift-will-boost-charity-awareness.aspx" /><content type="html">		&lt;br _moz_editor_bogus_node="TRUE" /&gt;
A football team are following in the footsteps of Aston Villa and Barcelona by ditching their sponsor logo and replacing it with a charity badge.&lt;br /&gt;
&lt;br /&gt;
Kidsgrove Athletic FC, who are sponsored by J &amp;amp; S Seddon Group, will have Caudwell Children’s logo emblazoned on their first team shirts in support of the national charity, who are committed to changing the lives of sick and disabled children.
</content></entry><entry><id>1724ed71-4021-4a62-98c5-fc14429fa313</id><title type="text">Disabled people sought for mentoring opportunities</title><updated>2010-07-14T16:29:50+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/252-Disabled-people-sought-for-mentoring-opportunities.aspx" /><content type="html">Disabled people living in and around Stoke-on-Trent are being sought for a new scheme designed to help disabled children access leisure activities. The ‘On a Level’ project has been launched by national charity, Caudwell Children, and seeks to encourage young disabled people to access leisure activities by providing volunteer mentors or ‘buddies’. 
</content></entry><entry><id>82e980ee-74f6-4170-a63c-cb2311b1e542</id><title type="text">Volunteers wanted - help make a dream come true</title><updated>2010-07-14T15:51:09+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/caudwell/250-Volunteers-wanted---help-make-a-dream-come-true.aspx" /><content type="html">Caudwell Children charity is calling for people to help make the dreams come true for a group of children with life-limiting illnesses, by volunteering to support families on a trip to DisneyWorld in the USA. &lt;br /&gt;
&lt;br /&gt;
The charity will be taking up to 25 children and their families to the Florida theme parks for seven days in November as part of their annual Destination Dreams campaign, and are looking for volunteers to support families during the trip. &lt;br /&gt;
</content></entry><entry><id>43a20143-3618-41ec-a393-340c36218d0a</id><title type="text">Oliver Stone's 'South of the Border' at The Lexi Cinema, followed by ‘radical Latin American leaders' debate</title><updated>2010-07-14T13:40:31+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/tippingpoint/249-Oliver-Stone-s--South-of-the-Border--at-The-Lexi-Cinema--followed-by--radical-Latin-American-leaders--debate.aspx" /><content type="html">		Tipping Point Film Fund will host a screening of the new Oliver Stone film ‘South of the Border’ on the film’s opening weekend, Friday 30 July.  The film, which starts at 6.15pm, is showing at The Lexi Cinema in Kensal Rise and will be followed by a panel discussion entitled Radical Latin American leaders – what’s to be afraid of?&lt;br _moz_editor_bogus_node="TRUE" /&gt;
</content></entry><entry><id>f5456916-231a-44a7-8424-ff9d1b01e1e8</id><title type="text">Haiti - Six months on after earthquake, conditions remain ‘extremely harsh’</title><updated>2010-07-12T17:22:57+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/248-Haiti---Six-months-on-after-earthquake--conditions-remain--extremely-harsh-.aspx" /><content type="html">Six months on from the earthquake which devastated Haiti’s capital, Port-au-Prince, and surrounding  towns and villages, conditions for many of the country’s inhabitants remain extremely harsh. 
</content></entry><entry><id>5f197415-50dc-4f09-a019-d172f2dc78e8</id><title type="text">Lounge on the Farm to screen social issue documentaries using solar power</title><updated>2010-07-08T16:54:58+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/tippingpoint/243-Lounge-on-the-Farm-to-screen-social-issue-documentaries-using-solar-power.aspx" /><content type="html">
		&lt;p&gt;
&lt;span face="arial,sans-serif" style="border-collapse: collapse; font-size: 15px; font-family: arial,sans-serif;"&gt;
&lt;span size="2" style="line-height: 18px; font-size: 10pt;"&gt;This year at the Lounge on the Farm festival in Kent, The Co-operative supported &lt;em&gt;Tipping Point Film Fund&lt;/em&gt; and &lt;em&gt;Good With Film&lt;/em&gt; will screen&lt;/span&gt; &lt;span size="2" style="line-height: 18px; font-size: 10pt;"&gt;powerful and provocative cinematic documentaries including, Jeremy Hardy versus the Israeli Army, Dirty Oil and The&lt;/span&gt; &lt;span size="2" style="line-height: 18px; font-size: 10pt;"&gt;Yes Men Fix the World. The screenings, which are powered by solar, will take place at the Groovy Movie Picture House between 10 and 11 July.&lt;/span&gt;&lt;/span&gt; &lt;/p&gt;
&lt;p&gt;&lt;/p&gt;
</content></entry><entry><id>0f4cb091-a9db-4b6c-bcb1-0fba01325ae1</id><title type="text">MBE FOR HELPING BURMESE REFUGEES IN THAILAND</title><updated>2010-07-08T16:44:01+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/christianaid/247-MBE-FOR-HELPING-BURMESE-REFUGEES-IN-THAILAND.aspx" /><content type="html">Sally Thompson, Deputy Director of the Thailand Burma Border Consortium (TBBC), a Christian Aid partner organisation, has been awarded an MBE in the Queen's Birthday Honours list for her work with displaced people from Burma.
</content></entry><entry><id>927faca6-6b56-4968-9d5e-96e1bef42518</id><title type="text">Thornbridge to launch new brewery bar at Great British Beer Festival </title><updated>2010-07-07T11:46:08+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/camra/246-Thornbridge-to-launch-new-brewery-bar-at-Great-British-Beer-Festival-.aspx" /><content type="html">&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;!--[if gte mso 9]&gt;&lt;xml&gt; &lt;w:WordDocument&gt; &lt;w:View&gt;Normal&lt;/w:View&gt; &lt;w:Zoom&gt;0&lt;/w:Zoom&gt; &lt;w:TrackMoves /&gt; &lt;w:TrackFormatting /&gt; &lt;w:PunctuationKerning /&gt; &lt;w:ValidateAgainstSchemas /&gt; &lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt; &lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt; &lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt; &lt;w:DoNotPromoteQF /&gt; &lt;w:LidThemeOther&gt;EN-GB&lt;/w:LidThemeOther&gt; &lt;w:LidThemeAsian&gt;X-NONE&lt;/w:LidThemeAsian&gt; &lt;w:LidThemeComplexScript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt; &lt;w:Compatibility&gt; &lt;w:BreakWrappedTables /&gt; &lt;w:SnapToGridInCell /&gt; &lt;w:WrapTextWithPunct /&gt; &lt;w:UseAsianBreakRules /&gt; &lt;w:DontGrowAutofit /&gt; &lt;w:SplitPgBreakAndParaMark /&gt; &lt;w:DontVertAlignCellWithSp /&gt; &lt;w:DontBreakConstrainedForcedTables /&gt; &lt;w:DontVertAlignInTxbx /&gt; &lt;w:Word11KerningPairs /&gt; &lt;w:CachedColBalance /&gt; &lt;/w:Compatibility&gt; &lt;w:BrowserLevel&gt;MicrosoftInternetExplorer4&lt;/w:BrowserLevel&gt; &lt;m:mathPr&gt; &lt;m:mathFont m:val="Cambria Math" /&gt; &lt;m:brkBin m:val="before" /&gt; &lt;m:brkBinSub m:val="&amp;#45;-" /&gt; &lt;m:smallFrac m:val="off" /&gt; &lt;m:dispDef /&gt; &lt;m:lMargin m:val="0" /&gt; &lt;m:rMargin m:val="0" /&gt; &lt;m:defJc m:val="centerGroup" /&gt; &lt;m:wrapIndent m:val="1440" /&gt; &lt;m:intLim m:val="subSup" /&gt; &lt;m:naryLim m:val="undOvr" /&gt; &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt; &lt;w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true" DefSemiHidden="true" DefQFormat="false" DefPriority="99" LatentStyleCount="267"&gt; &lt;w:LsdException Locked="false" Priority="0" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Normal" /&gt; &lt;w:LsdException Locked="false" Priority="9" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="heading 1" /&gt; &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2" /&gt; &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3" /&gt; &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4" /&gt; &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5" /&gt; &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6" /&gt; &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7" /&gt; &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8" /&gt; &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9" /&gt; &lt;w:LsdException Locked="false" Priority="39" Name="toc 1" /&gt; &lt;w:LsdException Locked="false" Priority="39" Name="toc 2" /&gt; &lt;w:LsdException Locked="false" Priority="39" Name="toc 3" /&gt; &lt;w:LsdException Locked="false" Priority="39" Name="toc 4" /&gt; &lt;w:LsdException Locked="false" Priority="39" Name="toc 5" /&gt; &lt;w:LsdException Locked="false" Priority="39" Name="toc 6" /&gt; &lt;w:LsdException Locked="false" Priority="39" Name="toc 7" /&gt; &lt;w:LsdException Locked="false" Priority="39" Name="toc 8" /&gt; &lt;w:LsdException Locked="false" Priority="39" Name="toc 9" /&gt; &lt;w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption" /&gt; &lt;w:LsdException Locked="false" Priority="10" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Title" /&gt; &lt;w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font" /&gt; &lt;w:LsdException Locked="false" Priority="11" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Subtitle" /&gt; &lt;w:LsdException Locked="false" Priority="22" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Strong" /&gt; &lt;w:LsdException Locked="false" Priority="20" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Emphasis" /&gt; &lt;w:LsdException Locked="false" Priority="59" SemiHidden="false" UnhideWhenUsed="false" Name="Table Grid" /&gt; &lt;w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text" /&gt; &lt;w:LsdException Locked="false" Priority="1" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="No Spacing" /&gt; &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading" /&gt; &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List" /&gt; &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid" /&gt; &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1" /&gt; &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2" /&gt; &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1" /&gt; &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2" /&gt; &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1" /&gt; &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2" /&gt; &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3" /&gt; &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List" /&gt; &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading" /&gt; &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List" /&gt; &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid" /&gt; &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 1" /&gt; &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 1" /&gt; &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 1" /&gt; &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1" /&gt; &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1" /&gt; &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 1" /&gt; &lt;w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision" /&gt; &lt;w:LsdException Locked="false" Priority="34" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="List Paragraph" /&gt; &lt;w:LsdException Locked="false" Priority="29" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Quote" /&gt; &lt;w:LsdException Locked="false" Priority="30" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Intense Quote" /&gt; &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 1" /&gt; &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1" /&gt; &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1" /&gt; &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1" /&gt; &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 1" /&gt; &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 1" /&gt; &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 1" /&gt; &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 1" /&gt; &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 2" /&gt; &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 2" /&gt; &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 2" /&gt; &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2" /&gt; &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2" /&gt; &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 2" /&gt; &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 2" /&gt; &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2" /&gt; &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2" /&gt; &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2" /&gt; &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 2" /&gt; &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 2" /&gt; &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 2" /&gt; &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 2" /&gt; &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 3" /&gt; &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 3" /&gt; &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 3" /&gt; &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3" /&gt; &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3" /&gt; &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 3" /&gt; &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 3" /&gt; &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3" /&gt; &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3" /&gt; &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3" /&gt; &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 3" /&gt; &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 3" /&gt; &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 3" /&gt; &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 3" /&gt; &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 4" /&gt; &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 4" /&gt; &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 4" /&gt; &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4" /&gt; &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4" /&gt; &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 4" /&gt; &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 4" /&gt; &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4" /&gt; &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4" /&gt; &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4" /&gt; &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 4" /&gt; &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 4" /&gt; &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 4" /&gt; &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 4" /&gt; &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 5" /&gt; &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 5" /&gt; &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 5" /&gt; &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5" /&gt; &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5" /&gt; &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 5" /&gt; &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 5" /&gt; &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5" /&gt; &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5" /&gt; &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5" /&gt; &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 5" /&gt; &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 5" /&gt; &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 5" /&gt; &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 5" /&gt; &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 6" /&gt; &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 6" /&gt; &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 6" /&gt; &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6" /&gt; &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6" /&gt; &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 6" /&gt; &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 6" /&gt; &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6" /&gt; &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6" /&gt; &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6" /&gt; &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 6" /&gt; &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 6" /&gt; &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 6" /&gt; &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 6" /&gt; &lt;w:LsdException Locked="false" Priority="19" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis" /&gt; &lt;w:LsdException Locked="false" Priority="21" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis" /&gt; &lt;w:LsdException Locked="false" Priority="31" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference" /&gt; &lt;w:LsdException Locked="false" Priority="32" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Intense Reference" /&gt; &lt;w:LsdException Locked="false" Priority="33" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Book Title" /&gt; &lt;w:LsdException Locked="false" Priority="37" Name="Bibliography" /&gt; &lt;w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading" /&gt; &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt; &lt;!--     /* Font Definitions */     @font-face     {font-family:"Cambria Math";     panose-1:2 4 5 3 5 4 6 3 2 4;     mso-font-charset:1;     mso-generic-font-family:roman;     mso-font-format:other;     mso-font-pitch:variable;     mso-font-signature:0 0 0 0 0 0;}     @font-face     {font-family:Calibri;     panose-1:2 15 5 2 2 2 4 3 2 4;     mso-font-charset:0;     mso-generic-font-family:swiss;     mso-font-pitch:variable;     mso-font-signature:-520092929 1073786111 9 0 415 0;}     /* Style Definitions */     p.MsoNormal, li.MsoNormal, div.MsoNormal     {mso-style-unhide:no;     mso-style-qformat:yes;     mso-style-parent:"";     margin:0cm;     margin-bottom:.0001pt;     mso-pagination:widow-orphan;     font-size:11.0pt;     font-family:"Calibri","sans-serif";     mso-fareast-font-family:Calibri;     mso-fareast-theme-font:minor-latin;}     .MsoChpDefault     {mso-style-type:export-only;     mso-default-props:yes;     mso-ascii-font-family:Calibri;     mso-ascii-theme-font:minor-latin;     mso-fareast-font-family:Calibri;     mso-fareast-theme-font:minor-latin;     mso-hansi-font-family:Calibri;     mso-hansi-theme-font:minor-latin;     mso-bidi-font-family:"Times New Roman";     mso-bidi-theme-font:minor-bidi;     mso-fareast-language:EN-US;}     .MsoPapDefault     {mso-style-type:export-only;     margin-bottom:10.0pt;     line-height:115%;}     @page WordSection1     {size:612.0pt 792.0pt;     margin:72.0pt 72.0pt 72.0pt 72.0pt;     mso-header-margin:36.0pt;     mso-footer-margin:36.0pt;     mso-paper-source:0;}     div.WordSection1     {page:WordSection1;} --&gt; &lt;!--[if gte mso 10]&gt;
&lt;div id='RadEditorStyleKeeper5' style="display:none;" _mce_style="display: none;"&gt;&amp;nbsp;&lt;/div&gt;
&lt;div id='RadEditorStyleKeeper5' style="display:none;" _mce_style="display: none;"&gt;&amp;nbsp;&lt;/div&gt;
&lt;div id='RadEditorStyleKeeper5' style="display:none;" _mce_style="display: none;"&gt;&amp;nbsp;&lt;/div&gt;
&lt;div id='RadEditorStyleKeeper5' style="display:none;" _mce_style="display: none;"&gt;&amp;nbsp;&lt;/div&gt;
&lt;div id='RadEditorStyleKeeper5' style="display:none;" _mce_style="display: none;"&gt;&amp;nbsp;&lt;/div&gt;
&lt;div id='RadEditorStyleKeeper5' style="display:none;" _mce_style="display: none;"&gt;&amp;nbsp;&lt;/div&gt;
&lt;div id='RadEditorStyleKeeper5' style="display:none;" _mce_style="display: none;"&gt;&amp;nbsp;&lt;/div&gt;
&lt;mce:style reoriginalpositionmarker='RadEditorStyleKeeper5' reoriginalpositionmarker='RadEditorStyleKeeper5' reoriginalpositionmarker='RadEditorStyleKeeper5' reoriginalpositionmarker='RadEditorStyleKeeper5' reoriginalpositionmarker='RadEditorStyleKeeper5' reoriginalpositionmarker='RadEditorStyleKeeper5' reoriginalpositionmarker='RadEditorStyleKeeper5'&gt;&lt;!      /* Style Definitions */     table.MsoNormalTable     {mso-style-name:"Table Normal";     mso-tstyle-rowband-size:0;     mso-tstyle-colband-size:0;     mso-style-noshow:yes;     mso-style-priority:99;     mso-style-qformat:yes;     mso-style-parent:"";     mso-padding-alt:0cm 5.4pt 0cm 5.4pt;     mso-para-margin-top:0cm;     mso-para-margin-right:0cm;     mso-para-margin-bottom:10.0pt;     mso-para-margin-left:0cm;     line-height:115%;     mso-pagination:widow-orphan;     font-size:11.0pt;     font-family:"Calibri","sans-serif";     mso-ascii-font-family:Calibri;     mso-ascii-theme-font:minor-latin;     mso-fareast-font-family:"Times New Roman";     mso-fareast-theme-font:minor-fareast;     mso-hansi-font-family:Calibri;     mso-hansi-theme-font:minor-latin;     mso-bidi-font-family:"Times New Roman";     mso-bidi-theme-font:minor-bidi;} --&gt; &lt;!--[endif]--&gt;
&lt;p class="MsoNormal"&gt;Thornbridge to launch new brewery bar at Great British Beer Festival&lt;/p&gt;
&lt;!--[if gte mso 9]&gt;&lt;xml&gt; &lt;w:WordDocument&gt; &lt;w:View&gt;Normal&lt;/w:View&gt; &lt;w:Zoom&gt;0&lt;/w:Zoom&gt; &lt;w:TrackMoves /&gt; &lt;w:TrackFormatting /&gt; &lt;w:PunctuationKerning /&gt; &lt;w:ValidateAgainstSchemas /&gt; &lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt; &lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt; &lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt; &lt;w:DoNotPromoteQF /&gt; &lt;w:LidThemeOther&gt;EN-GB&lt;/w:LidThemeOther&gt; &lt;w:LidThemeAsian&gt;X-NONE&lt;/w:LidThemeAsian&gt; &lt;w:LidThemeComplexScript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt; &lt;w:Compatibility&gt; &lt;w:BreakWrappedTables /&gt; &lt;w:SnapToGridInCell /&gt; &lt;w:WrapTextWithPunct /&gt; &lt;w:UseAsianBreakRules /&gt; &lt;w:DontGrowAutofit /&gt; &lt;w:SplitPgBreakAndParaMark /&gt; &lt;w:DontVertAlignCellWithSp /&gt; &lt;w:DontBreakConstrainedForcedTables /&gt; &lt;w:DontVertAlignInTxbx /&gt; &lt;w:Word11KerningPairs /&gt; &lt;w:CachedColBalance /&gt; &lt;/w:Compatibility&gt; &lt;w:BrowserLevel&gt;MicrosoftInternetExplorer4&lt;/w:BrowserLevel&gt; &lt;m:mathPr&gt; &lt;m:mathFont m:val="Cambria Math" /&gt; &lt;m:brkBin m:val="before" /&gt; &lt;m:brkBinSub m:val="&amp;#45;-" /&gt; &lt;m:smallFrac m:val="off" /&gt; &lt;m:dispDef /&gt; &lt;m:lMargin m:val="0" /&gt; &lt;m:rMargin m:val="0" /&gt; &lt;m:defJc m:val="centerGroup" /&gt; &lt;m:wrapIndent m:val="1440" /&gt; &lt;m:intLim m:val="subSup" /&gt; &lt;m:naryLim m:val="undOvr" /&gt; &lt;/m:mathPr&gt;&lt;/w:WordDocument&gt; &lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt; &lt;w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true" DefSemiHidden="true" DefQFormat="false" DefPriority="99" LatentStyleCount="267"&gt; &lt;w:LsdException Locked="false" Priority="0" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Normal" /&gt; &lt;w:LsdException Locked="false" Priority="9" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="heading 1" /&gt; &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2" /&gt; &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3" /&gt; &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4" /&gt; &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5" /&gt; &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6" /&gt; &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7" /&gt; &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8" /&gt; &lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9" /&gt; &lt;w:LsdException Locked="false" Priority="39" Name="toc 1" /&gt; &lt;w:LsdException Locked="false" Priority="39" Name="toc 2" /&gt; &lt;w:LsdException Locked="false" Priority="39" Name="toc 3" /&gt; &lt;w:LsdException Locked="false" Priority="39" Name="toc 4" /&gt; &lt;w:LsdException Locked="false" Priority="39" Name="toc 5" /&gt; &lt;w:LsdException Locked="false" Priority="39" Name="toc 6" /&gt; &lt;w:LsdException Locked="false" Priority="39" Name="toc 7" /&gt; &lt;w:LsdException Locked="false" Priority="39" Name="toc 8" /&gt; &lt;w:LsdException Locked="false" Priority="39" Name="toc 9" /&gt; &lt;w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption" /&gt; &lt;w:LsdException Locked="false" Priority="10" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Title" /&gt; &lt;w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font" /&gt; &lt;w:LsdException Locked="false" Priority="11" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Subtitle" /&gt; &lt;w:LsdException Locked="false" Priority="22" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Strong" /&gt; &lt;w:LsdException Locked="false" Priority="20" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Emphasis" /&gt; &lt;w:LsdException Locked="false" Priority="59" SemiHidden="false" UnhideWhenUsed="false" Name="Table Grid" /&gt; &lt;w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text" /&gt; &lt;w:LsdException Locked="false" Priority="1" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="No Spacing" /&gt; &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading" /&gt; &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List" /&gt; &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid" /&gt; &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1" /&gt; &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2" /&gt; &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1" /&gt; &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2" /&gt; &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1" /&gt; &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2" /&gt; &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3" /&gt; &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List" /&gt; &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading" /&gt; &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List" /&gt; &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid" /&gt; &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 1" /&gt; &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 1" /&gt; &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 1" /&gt; &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1" /&gt; &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1" /&gt; &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 1" /&gt; &lt;w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision" /&gt; &lt;w:LsdException Locked="false" Priority="34" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="List Paragraph" /&gt; &lt;w:LsdException Locked="false" Priority="29" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Quote" /&gt; &lt;w:LsdException Locked="false" Priority="30" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Intense Quote" /&gt; &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 1" /&gt; &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1" /&gt; &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1" /&gt; &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1" /&gt; &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 1" /&gt; &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 1" /&gt; &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 1" /&gt; &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 1" /&gt; &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 2" /&gt; &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 2" /&gt; &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 2" /&gt; &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2" /&gt; &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2" /&gt; &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 2" /&gt; &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 2" /&gt; &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2" /&gt; &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2" /&gt; &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2" /&gt; &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 2" /&gt; &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 2" /&gt; &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 2" /&gt; &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 2" /&gt; &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 3" /&gt; &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 3" /&gt; &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 3" /&gt; &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3" /&gt; &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3" /&gt; &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 3" /&gt; &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 3" /&gt; &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3" /&gt; &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3" /&gt; &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3" /&gt; &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 3" /&gt; &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 3" /&gt; &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 3" /&gt; &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 3" /&gt; &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 4" /&gt; &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 4" /&gt; &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 4" /&gt; &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4" /&gt; &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4" /&gt; &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 4" /&gt; &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 4" /&gt; &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4" /&gt; &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4" /&gt; &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4" /&gt; &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 4" /&gt; &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 4" /&gt; &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 4" /&gt; &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 4" /&gt; &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 5" /&gt; &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 5" /&gt; &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 5" /&gt; &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5" /&gt; &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5" /&gt; &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 5" /&gt; &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 5" /&gt; &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5" /&gt; &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5" /&gt; &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5" /&gt; &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 5" /&gt; &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 5" /&gt; &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 5" /&gt; &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 5" /&gt; &lt;w:LsdException Locked="false" Priority="60" SemiHidden="false" UnhideWhenUsed="false" Name="Light Shading Accent 6" /&gt; &lt;w:LsdException Locked="false" Priority="61" SemiHidden="false" UnhideWhenUsed="false" Name="Light List Accent 6" /&gt; &lt;w:LsdException Locked="false" Priority="62" SemiHidden="false" UnhideWhenUsed="false" Name="Light Grid Accent 6" /&gt; &lt;w:LsdException Locked="false" Priority="63" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6" /&gt; &lt;w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6" /&gt; &lt;w:LsdException Locked="false" Priority="65" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 1 Accent 6" /&gt; &lt;w:LsdException Locked="false" Priority="66" SemiHidden="false" UnhideWhenUsed="false" Name="Medium List 2 Accent 6" /&gt; &lt;w:LsdException Locked="false" Priority="67" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6" /&gt; &lt;w:LsdException Locked="false" Priority="68" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6" /&gt; &lt;w:LsdException Locked="false" Priority="69" SemiHidden="false" UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6" /&gt; &lt;w:LsdException Locked="false" Priority="70" SemiHidden="false" UnhideWhenUsed="false" Name="Dark List Accent 6" /&gt; &lt;w:LsdException Locked="false" Priority="71" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Shading Accent 6" /&gt; &lt;w:LsdException Locked="false" Priority="72" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful List Accent 6" /&gt; &lt;w:LsdException Locked="false" Priority="73" SemiHidden="false" UnhideWhenUsed="false" Name="Colorful Grid Accent 6" /&gt; &lt;w:LsdException Locked="false" Priority="19" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis" /&gt; &lt;w:LsdException Locked="false" Priority="21" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis" /&gt; &lt;w:LsdException Locked="false" Priority="31" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference" /&gt; &lt;w:LsdException Locked="false" Priority="32" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Intense Reference" /&gt; &lt;w:LsdException Locked="false" Priority="33" SemiHidden="false" UnhideWhenUsed="false" QFormat="true" Name="Book Title" /&gt; &lt;w:LsdException Locked="false" Priority="37" Name="Bibliography" /&gt; &lt;w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading" /&gt; &lt;/w:LatentStyles&gt; &lt;/xml&gt;&lt;![endif]--&gt; &lt;!--     /* Font Definitions */     @font-face     {font-family:"Cambria Math";     panose-1:2 4 5 3 5 4 6 3 2 4;     mso-font-charset:1;     mso-generic-font-family:roman;     mso-font-format:other;     mso-font-pitch:variable;     mso-font-signature:0 0 0 0 0 0;}     @font-face     {font-family:Calibri;     panose-1:2 15 5 2 2 2 4 3 2 4;     mso-font-charset:0;     mso-generic-font-family:swiss;     mso-font-pitch:variable;     mso-font-signature:-520092929 1073786111 9 0 415 0;}     /* Style Definitions */     p.MsoNormal, li.MsoNormal, div.MsoNormal     {mso-style-unhide:no;     mso-style-qformat:yes;     mso-style-parent:"";     margin:0cm;     margin-bottom:.0001pt;     mso-pagination:widow-orphan;     font-size:11.0pt;     font-family:"Calibri","sans-serif";     mso-fareast-font-family:Calibri;     mso-fareast-theme-font:minor-latin;}     .MsoChpDefault     {mso-style-type:export-only;     mso-default-props:yes;     mso-ascii-font-family:Calibri;     mso-ascii-theme-font:minor-latin;     mso-fareast-font-family:Calibri;     mso-fareast-theme-font:minor-latin;     mso-hansi-font-family:Calibri;     mso-hansi-theme-font:minor-latin;     mso-bidi-font-family:"Times New Roman";     mso-bidi-theme-font:minor-bidi;     mso-fareast-language:EN-US;}     .MsoPapDefault     {mso-style-type:export-only;     margin-bottom:10.0pt;     line-height:115%;}     @page WordSection1     {size:612.0pt 792.0pt;     margin:72.0pt 72.0pt 72.0pt 72.0pt;     mso-header-margin:36.0pt;     mso-footer-margin:36.0pt;     mso-paper-source:0;}     div.WordSection1     {page:WordSection1;} --&gt;</content></entry><entry><id>47ffdd65-c845-4cd3-af45-86445188745f</id><title type="text">KMP Digitata Launch the Manchester Airport iPhone App</title><updated>2010-05-20T15:23:29+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/kmp/232-KMP-Digitata-Launch-the-Manchester-Airport-iPhone-App.aspx" /><content type="html">		KMP Digitata is proud to announce the launch of the Manchester Airport iPhone application. The app has been developed to give all travellers passing through Manchester Airport real time information at their fingertips.
</content></entry><entry><id>13f5b354-39b8-4ce1-84d1-7633f780414e</id><title type="text">A new addition to the KMP Digitata team</title><updated>2010-05-14T10:00:22+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/kmp/234-A-new-addition-to-the-KMP-Digitata-team.aspx" /><content type="html">
		&lt;link reoriginalpositionmarker="RadEditorStyleKeeper1" href="file:///C:\Users\GEZDAR~1\AppData\Local\Temp\msohtmlclip1\01\clip_filelist.xml" rel="File-List" /&gt;
&lt;link reoriginalpositionmarker="RadEditorStyleKeeper2" href="file:///C:\Users\GEZDAR~1\AppData\Local\Temp\msohtmlclip1\01\clip_themedata.thmx" rel="themeData" /&gt;
&lt;link reoriginalpositionmarker="RadEditorStyleKeeper3" href="file:///C:\Users\GEZDAR~1\AppData\Local\Temp\msohtmlclip1\01\clip_colorschememapping.xml" rel="colorSchemeMapping" /&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
&lt;w:WordDocument&gt;
&lt;w:View&gt;Normal&lt;/w:View&gt;
&lt;w:Zoom&gt;0&lt;/w:Zoom&gt;
&lt;w:TrackMoves/&gt;
&lt;w:TrackFormatting/&gt;
&lt;w:PunctuationKerning/&gt;
&lt;w:ValidateAgainstSchemas/&gt;
&lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;
&lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt;
&lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;
&lt;w:DoNotPromoteQF/&gt;
&lt;w:LidThemeOther&gt;EN-GB&lt;/w:LidThemeOther&gt;
&lt;w:LidThemeAsian&gt;X-NONE&lt;/w:LidThemeAsian&gt;
&lt;w:LidThemeComplexScript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;
&lt;w:Compatibility&gt;
&lt;w:BreakWrappedTables/&gt;
&lt;w:SnapToGridInCell/&gt;
&lt;w:WrapTextWithPunct/&gt;
&lt;w:UseAsianBreakRules/&gt;
&lt;w:DontGrowAutofit/&gt;
&lt;w:SplitPgBreakAndParaMark/&gt;
&lt;w:DontVertAlignCellWithSp/&gt;
&lt;w:DontBreakConstrainedForcedTables/&gt;
&lt;w:DontVertAlignInTxbx/&gt;
&lt;w:Word11KerningPairs/&gt;
&lt;w:CachedColBalance/&gt;
&lt;/w:Compatibility&gt;
&lt;m:mathPr&gt;
&lt;m:mathFont m:val="Cambria Math"/&gt;
&lt;m:brkBin m:val="before"/&gt;
&lt;m:brkBinSub m:val="&amp;#45;-"/&gt;
&lt;m:smallFrac m:val="off"/&gt;
&lt;m:dispDef/&gt;
&lt;m:lMargin m:val="0"/&gt;
&lt;m:rMargin m:val="0"/&gt;
&lt;m:defJc m:val="centerGroup"/&gt;
&lt;m:wrapIndent m:val="1440"/&gt;
&lt;m:intLim m:val="subSup"/&gt;
&lt;m:naryLim m:val="undOvr"/&gt;
&lt;/m:mathPr&gt;&lt;/w:WordDocument&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
&lt;w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
DefSemiHidden="true" DefQFormat="false" DefPriority="99"
LatentStyleCount="267"&gt;
&lt;w:LsdException Locked="false" Priority="0" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Normal"/&gt;
&lt;w:LsdException Locked="false" Priority="9" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="heading 1"/&gt;
&lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/&gt;
&lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/&gt;
&lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/&gt;
&lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/&gt;
&lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/&gt;
&lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/&gt;
&lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/&gt;
&lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 1"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 2"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 3"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 4"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 5"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 6"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 7"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 8"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 9"/&gt;
&lt;w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/&gt;
&lt;w:LsdException Locked="false" Priority="10" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Title"/&gt;
&lt;w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/&gt;
&lt;w:LsdException Locked="false" Priority="11" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/&gt;
&lt;w:LsdException Locked="false" Priority="22" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Strong"/&gt;
&lt;w:LsdException Locked="false" Priority="20" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/&gt;
&lt;w:LsdException Locked="false" Priority="59" SemiHidden="false"
UnhideWhenUsed="false" Name="Table Grid"/&gt;
&lt;w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/&gt;
&lt;w:LsdException Locked="false" Priority="1" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/&gt;
&lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading"/&gt;
&lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List"/&gt;
&lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid"/&gt;
&lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1"/&gt;
&lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2"/&gt;
&lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1"/&gt;
&lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2"/&gt;
&lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1"/&gt;
&lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2"/&gt;
&lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3"/&gt;
&lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List"/&gt;
&lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading"/&gt;
&lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List"/&gt;
&lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid"/&gt;
&lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/&gt;
&lt;w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/&gt;
&lt;w:LsdException Locked="false" Priority="34" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/&gt;
&lt;w:LsdException Locked="false" Priority="29" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Quote"/&gt;
&lt;w:LsdException Locked="false" Priority="30" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/&gt;
&lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/&gt;
&lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/&gt;
&lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/&gt;
&lt;w:LsdException Locked="false" Priority="19" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/&gt;
&lt;w:LsdException Locked="false" Priority="21" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/&gt;
&lt;w:LsdException Locked="false" Priority="31" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/&gt;
&lt;w:LsdException Locked="false" Priority="32" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/&gt;
&lt;w:LsdException Locked="false" Priority="33" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Book Title"/&gt;
&lt;w:LsdException Locked="false" Priority="37" Name="Bibliography"/&gt;
&lt;w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/&gt;
&lt;/w:LatentStyles&gt;
&lt;/xml&gt;&lt;![endif]--&gt;
&lt;style reoriginalpositionmarker="RadEditorStyleKeeper4"&gt;
    &lt;!--
    /* Font Definitions */
    @font-face
    {font-family:"Cambria Math";
    panose-1:2 4 5 3 5 4 6 3 2 4;
    mso-font-charset:1;
    mso-generic-font-family:roman;
    mso-font-format:other;
    mso-font-pitch:variable;
    mso-font-signature:0 0 0 0 0 0;}
    @font-face
    {font-family:Calibri;
    panose-1:2 15 5 2 2 2 4 3 2 4;
    mso-font-charset:0;
    mso-generic-font-family:swiss;
    mso-font-pitch:variable;
    mso-font-signature:-1610611985 1073750139 0 0 159 0;}
    /* Style Definitions */
    p.MsoNormal, li.MsoNormal, div.MsoNormal
    {mso-style-unhide:no;
    mso-style-qformat:yes;
    mso-style-parent:"";
    margin:0cm;
    margin-bottom:.0001pt;
    mso-pagination:widow-orphan;
    font-size:12.0pt;
    font-family:"Times New Roman","serif";
    mso-fareast-font-family:Calibri;
    mso-fareast-theme-font:minor-latin;}
    .MsoChpDefault
    {mso-style-type:export-only;
    mso-default-props:yes;
    mso-ascii-font-family:Calibri;
    mso-ascii-theme-font:minor-latin;
    mso-fareast-font-family:Calibri;
    mso-fareast-theme-font:minor-latin;
    mso-hansi-font-family:Calibri;
    mso-hansi-theme-font:minor-latin;
    mso-bidi-font-family:"Times New Roman";
    mso-bidi-theme-font:minor-bidi;
    mso-fareast-language:EN-US;}
    .MsoPapDefault
    {mso-style-type:export-only;
    margin-bottom:10.0pt;
    line-height:115%;}
    @page Section1
    {size:612.0pt 792.0pt;
    margin:72.0pt 72.0pt 72.0pt 72.0pt;
    mso-header-margin:36.0pt;
    mso-footer-margin:36.0pt;
    mso-paper-source:0;}
    div.Section1
    {page:Section1;}
    --&gt;
&lt;/style&gt;
&lt;!--[if gte mso 10]&gt;
&lt;div id='RadEditorStyleKeeper5' style='display:none;'&gt;&amp;nbsp;&lt;/div&gt;
&lt;div id='RadEditorStyleKeeper5' style='display:none;'&gt;&amp;nbsp;&lt;/div&gt;
&lt;div id='RadEditorStyleKeeper5' style='display:none;'&gt;&amp;nbsp;&lt;/div&gt;
&lt;div id='RadEditorStyleKeeper5' style='display:none;'&gt;&amp;nbsp;&lt;/div&gt;
&lt;div id='RadEditorStyleKeeper5' style='display:none;'&gt;&amp;nbsp;&lt;/div&gt;
&lt;div id='RadEditorStyleKeeper5' style='display:none;'&gt;&amp;nbsp;&lt;/div&gt;
&lt;div id='RadEditorStyleKeeper5' style='display:none;'&gt;&amp;nbsp;&lt;/div&gt;
&lt;div id='RadEditorStyleKeeper5' style='display:none;'&gt;&amp;nbsp;&lt;/div&gt;
&lt;div id='RadEditorStyleKeeper5' style='display:none;'&gt;&amp;nbsp;&lt;/div&gt;
&lt;div id='RadEditorStyleKeeper5' style='display:none;'&gt;&amp;nbsp;&lt;/div&gt;
&lt;style reoriginalpositionmarker='RadEditorStyleKeeper5' reoriginalpositionmarker='RadEditorStyleKeeper5' reoriginalpositionmarker='RadEditorStyleKeeper5' reoriginalpositionmarker='RadEditorStyleKeeper5' reoriginalpositionmarker='RadEditorStyleKeeper5' reoriginalpositionmarker='RadEditorStyleKeeper5' reoriginalpositionmarker='RadEditorStyleKeeper5' reoriginalpositionmarker='RadEditorStyleKeeper5' reoriginalpositionmarker='RadEditorStyleKeeper5' reoriginalpositionmarker='RadEditorStyleKeeper5'&gt;
    /* Style Definitions */
    table.MsoNormalTable
    {mso-style-name:"Table Normal";
    mso-tstyle-rowband-size:0;
    mso-tstyle-colband-size:0;
    mso-style-noshow:yes;
    mso-style-priority:99;
    mso-style-qformat:yes;
    mso-style-parent:"";
    mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
    mso-para-margin-top:0cm;
    mso-para-margin-right:0cm;
    mso-para-margin-bottom:10.0pt;
    mso-para-margin-left:0cm;
    line-height:115%;
    mso-pagination:widow-orphan;
    font-size:11.0pt;
    font-family:"Calibri","sans-serif";
    mso-ascii-font-family:Calibri;
    mso-ascii-theme-font:minor-latin;
    mso-fareast-font-family:"Times New Roman";
    mso-fareast-theme-font:minor-fareast;
    mso-hansi-font-family:Calibri;
    mso-hansi-theme-font:minor-latin;}
&lt;/style&gt;
&lt;![endif]--&gt;
&lt;p class="MsoNormal"&gt;KMP Digitata is very pleased to announce a new addition to
their sales team. Steve Kitt, who joins from NewVision Group, will be
responsible for sales of KMP Digitata's range of Ackura online marketing tools.
Steve brings with him 9 years experience and knowledge in the digital marketing
industry, further increasing KMP Digitata's expertise in user centric digital
solutions that deliver outstanding return on investment.&lt;/p&gt;
</content></entry><entry><id>e0e80f55-1ce9-4221-82f5-f2256adc5962</id><title type="text">InBlackandWhite returns with great new website and 2010 seminar schedule</title><updated>2010-03-05T14:01:46Z</updated><link rel="alternate" href="http://pressroom.ackura.com/kmp/227-InBlackandWhite-returns-with-great-new-website-and-2010-seminar-schedule.aspx" /><content type="html">After the success of 2009, InBlackandWhite Seminars returns with a brand new website and an exciting 2010 seminar schedule
</content></entry><entry><id>36b0d1f2-8e6e-455f-973d-1616127a2e88</id><title type="text">KMP Digitata embark on a new adventure with Trek America</title><updated>2010-02-01T14:29:00Z</updated><link rel="alternate" href="http://pressroom.ackura.com/kmp/221-KMP-Digitata-embark-on-a-new-adventure-with-Trek-America.aspx" /><content type="html">KMP Digitata are proud to announce their involvement in an exciting new adventure with Trek America. The project aims to push the Trek America brand into the social media space their product is primed to accommodate. This move into a new social media sphere will greatly enhance the service and experience they already deliver to their customers.
&lt;p&gt;&lt;br type="_moz" /&gt;
&lt;/p&gt;
</content></entry><entry><id>560129da-0139-4438-99a8-e3381302fb73</id><title type="text">Two Promotions at KMP Digitata</title><updated>2010-01-14T12:17:25Z</updated><link rel="alternate" href="http://pressroom.ackura.com/kmp/225-Two-Promotions-at-KMP-Digitata.aspx" /><content type="html">KMP Digitata adds two job roles to their senior management.
</content></entry><entry><id>99913533-0998-49f2-8372-4972108bbff3</id><title type="text">Bill Daring Chairman of KMP Digitata dies peacefully at home</title><updated>2009-12-31T17:02:27Z</updated><link rel="alternate" href="http://pressroom.ackura.com/kmp/222-Bill-Daring-Chairman-of-KMP-Digitata-dies-peacefully-at-home.aspx" /><content type="html">KMP is sad to report that on Sunday morning 27 Dec, in peace and surrounded by his family, a pillar of the NW digital sector and one of KMP Digitata’s founders Bill Daring passed away after a short period of illness. 
</content></entry><entry><id>3b20139c-0919-4a0d-98b9-4ea53abfc2f7</id><title type="text">KMP Delivers Asda Groceries Virtual Assistant</title><updated>2009-10-30T12:28:29Z</updated><link rel="alternate" href="http://pressroom.ackura.com/kmp/218-KMP-Delivers-Asda-Groceries-Virtual-Assistant.aspx" /><content type="html">		KMP Digitata is proud to announce the launch of Amy, the Asda Grocery
Platform’s Virtual Assistant. Designed to guide customers through the
new online shopping site, Amy provides a 24/7 customer service
solution, dealing with enquiries directly online to boost user
experience.
</content></entry><entry><id>30cd524c-e709-4e9a-baab-6917705da8db</id><title type="text">Cricketers Dream Run in Art Gallery</title><updated>2009-06-01T12:06:47+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/demo/204-Cricketers-Dream-Run-in-Art-Gallery.aspx" /><content type="html">Australian cricketers had a dream run this week in the test. Followed by a trip to the Biennale. 
</content></entry><entry><id>9abcdbaf-bb84-4105-828f-4615a345d7dd</id><title type="text">PressRoom Demo available</title><updated>2009-05-27T09:52:33+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/demo/203-PressRoom-Demo-available.aspx" /><content type="html">Ackura PressRoom now features a demo mode to allow interested users to try out the software.</content></entry><entry><id>96e4b6c4-ac02-4a95-8508-281a63248f04</id><title type="text">PressRoom add YouTube integration</title><updated>2009-05-27T09:52:33+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/demo/202-PressRoom-add-YouTube-integration.aspx" /><content type="html">Pressroom now includes the ability to embed videos from YouTube in news releases.</content></entry><entry><id>6a451272-e85c-4330-aa8e-706523656fa8</id><title type="text">PressRoom Twitter integration</title><updated>2009-05-27T09:52:33+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/demo/201-PressRoom-Twitter-integration.aspx" /><content type="html">PressRoom integrates Twitter to utilise Twitter networks as a way of publicising Social Media Releases.</content></entry><entry><id>c642a366-5d57-453f-a0e0-6ca6522877e7</id><title type="text">KMP Digitata Launches new Manchester Airport parking site – JetParks.co.uk</title><updated>2009-05-26T11:13:46+01:00</updated><link rel="alternate" href="http://pressroom.ackura.com/kmp/200-KMP-Digitata-Launches-new-Manchester-Airport-parking-site---JetParks-co-uk.aspx" /><content type="html">
		&lt;link reoriginalpositionmarker="RadEditorStyleKeeper1" href="file:///C:\DOCUME~1\ZOE~1.COL\LOCALS~1\Temp\msohtmlclip1\01\clip_filelist.xml" rel="File-List" /&gt;
&lt;link reoriginalpositionmarker="RadEditorStyleKeeper2" href="file:///C:\DOCUME~1\ZOE~1.COL\LOCALS~1\Temp\msohtmlclip1\01\clip_themedata.thmx" rel="themeData" /&gt;
&lt;link reoriginalpositionmarker="RadEditorStyleKeeper3" href="file:///C:\DOCUME~1\ZOE~1.COL\LOCALS~1\Temp\msohtmlclip1\01\clip_colorschememapping.xml" rel="colorSchemeMapping" /&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
&lt;w:WordDocument&gt;
&lt;w:View&gt;Normal&lt;/w:View&gt;
&lt;w:Zoom&gt;0&lt;/w:Zoom&gt;
&lt;w:TrackMoves/&gt;
&lt;w:TrackFormatting/&gt;
&lt;w:PunctuationKerning/&gt;
&lt;w:ValidateAgainstSchemas/&gt;
&lt;w:SaveIfXMLInvalid&gt;false&lt;/w:SaveIfXMLInvalid&gt;
&lt;w:IgnoreMixedContent&gt;false&lt;/w:IgnoreMixedContent&gt;
&lt;w:AlwaysShowPlaceholderText&gt;false&lt;/w:AlwaysShowPlaceholderText&gt;
&lt;w:DoNotPromoteQF/&gt;
&lt;w:LidThemeOther&gt;EN-US&lt;/w:LidThemeOther&gt;
&lt;w:LidThemeAsian&gt;X-NONE&lt;/w:LidThemeAsian&gt;
&lt;w:LidThemeComplexScript&gt;X-NONE&lt;/w:LidThemeComplexScript&gt;
&lt;w:Compatibility&gt;
&lt;w:BreakWrappedTables/&gt;
&lt;w:SnapToGridInCell/&gt;
&lt;w:WrapTextWithPunct/&gt;
&lt;w:UseAsianBreakRules/&gt;
&lt;w:DontGrowAutofit/&gt;
&lt;w:SplitPgBreakAndParaMark/&gt;
&lt;w:DontVertAlignCellWithSp/&gt;
&lt;w:DontBreakConstrainedForcedTables/&gt;
&lt;w:DontVertAlignInTxbx/&gt;
&lt;w:Word11KerningPairs/&gt;
&lt;w:CachedColBalance/&gt;
&lt;/w:Compatibility&gt;
&lt;w:BrowserLevel&gt;MicrosoftInternetExplorer4&lt;/w:BrowserLevel&gt;
&lt;m:mathPr&gt;
&lt;m:mathFont m:val="Cambria Math"/&gt;
&lt;m:brkBin m:val="before"/&gt;
&lt;m:brkBinSub m:val="&amp;#45;-"/&gt;
&lt;m:smallFrac m:val="off"/&gt;
&lt;m:dispDef/&gt;
&lt;m:lMargin m:val="0"/&gt;
&lt;m:rMargin m:val="0"/&gt;
&lt;m:defJc m:val="centerGroup"/&gt;
&lt;m:wrapIndent m:val="1440"/&gt;
&lt;m:intLim m:val="subSup"/&gt;
&lt;m:naryLim m:val="undOvr"/&gt;
&lt;/m:mathPr&gt;&lt;/w:WordDocument&gt;
&lt;/xml&gt;&lt;![endif]--&gt;&lt;!--[if gte mso 9]&gt;&lt;xml&gt;
&lt;w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
DefSemiHidden="true" DefQFormat="false" DefPriority="99"
LatentStyleCount="267"&gt;
&lt;w:LsdException Locked="false" Priority="0" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Normal"/&gt;
&lt;w:LsdException Locked="false" Priority="9" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="heading 1"/&gt;
&lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/&gt;
&lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/&gt;
&lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/&gt;
&lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/&gt;
&lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/&gt;
&lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/&gt;
&lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/&gt;
&lt;w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 1"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 2"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 3"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 4"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 5"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 6"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 7"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 8"/&gt;
&lt;w:LsdException Locked="false" Priority="39" Name="toc 9"/&gt;
&lt;w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/&gt;
&lt;w:LsdException Locked="false" Priority="10" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Title"/&gt;
&lt;w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/&gt;
&lt;w:LsdException Locked="false" Priority="11" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/&gt;
&lt;w:LsdException Locked="false" Priority="22" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Strong"/&gt;
&lt;w:LsdException Locked="false" Priority="20" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/&gt;
&lt;w:LsdException Locked="false" Priority="59" SemiHidden="false"
UnhideWhenUsed="false" Name="Table Grid"/&gt;
&lt;w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/&gt;
&lt;w:LsdException Locked="false" Priority="1" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/&gt;
&lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading"/&gt;
&lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List"/&gt;
&lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid"/&gt;
&lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1"/&gt;
&lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2"/&gt;
&lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1"/&gt;
&lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2"/&gt;
&lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1"/&gt;
&lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2"/&gt;
&lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3"/&gt;
&lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List"/&gt;
&lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading"/&gt;
&lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List"/&gt;
&lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid"/&gt;
&lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/&gt;
&lt;w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/&gt;
&lt;w:LsdException Locked="false" Priority="34" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/&gt;
&lt;w:LsdException Locked="false" Priority="29" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Quote"/&gt;
&lt;w:LsdException Locked="false" Priority="30" SemiHidden="false"
UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/&gt;
&lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/&gt;
&lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="72" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful List Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="73" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/&gt;
&lt;w:LsdException Locked="false" Priority="60" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Shading Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="61" SemiHidden="false"
UnhideWhenUsed="false" Name="Light List Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="62" SemiHidden="false"
UnhideWhenUsed="false" Name="Light Grid Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="63" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="64" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="65" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="66" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="67" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="68" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="69" SemiHidden="false"
UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="70" SemiHidden="false"
UnhideWhenUsed="false" Name="Dark List Accent 3"/&gt;
&lt;w:LsdException Locked="false" Priority="71" SemiHidden="false"
UnhideWhenUsed="false" Name="Colorful Shading Accen
